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Bacterial FAD synthetases (FADS) are bifunctional and bimodular proteins that 
carry out the synthesis of the essential cofactors FMN and FAD from Riboflavin 
(RF,vitamin B2). These proteins are organized in two almost independent modules, 
each of which performs one of the activities that lead to FMN and FAD synthesis. The 
C-terminus module transforms RF into FMN through its riboflavin kinase activity 
(RFK), while the N-terminus module catalyzes the FMN adenylyltransferase activity 
(FMNAT) that transforms FMN into FAD. Having into account the essential character 
of the FMN and FAD flavinic cofactors, and the differences between prokaryotic 
FADSs and the corresponding human enzymes (especially between the FMNAT 
module of the bacterial proteins and mammalian enzymes that transform FMN into 
FAD), these enzymes appear as potential drug target. Thus, these bifunctional proteins 
are worthy of being studied in detail, with the objective of shedding light on their 
catalytic cycles, and on their regulatory strategies, focusing on the dissimilarities 
between different members of the family. 
In that way, in the present thesis we have tackled three main projects: 
 The study of the structural determinants that modulate the oligomerization tendency 
of the FADS from the organism Corynebacterium ammoniagenes (CaFADS). During 
its catalytic cycles, CaFADS stabilizes different oligomeric assemblies, being of 
especial relevance the formation of a hexamer formed by a dimer of trimers. The 
head to tail disposition that the protomers adopt within such structure, suggests an 
active role of the dimer of trimers in channeling the FMN product from the RFK 
active site to the FMNAT one, to be subsequently transformed into FAD. To 
demostrate this hypothesis we produced and characterized point mutants in positions 
located in the interface between protomers. The studied residues apparently 
stabilized the dimer of trimers establishing salt bridges, Van der Waals contacts, or 
hydrophobic interactions with residues located at the other module of a neighboring 
protomer. Our results revealed that all the mutated variants were active and able to 
stabilize quaternary organizations, although many of them presented altered RFK 
and FMNAT activities, as well as ligand binding parameters and oligomerization 
tendency. Special attention requires the fact that mutations located at the RFK 
module altered the FMNAT activity and vice versa. These results only can be 
explained in the context of the dimer of trimers, where residues of different modules, 
which are very distant in the monomer, are in close contact within the trimer. These 
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results validate our hypothesis about the formation of oligomeric structures during 
the catalytic cycles of CaFADS, where the protomers might adopt a head to tail 
disposition. Additionally, our study allows inferring the role that specific residues 
have in the RFK and FMNAT catalytic cycles of this enzyme.  
 Comparative characterization of the RFK and FMNAT catalytic cycles of the FADSs 
from the organisms C. ammoniagenes and Streptococcus pneumoniae (CaFADS and 
SpnFADS, respectively). Despite the overall similarities between bacterial FADSs, 
enzymes from different organisms display important behavioral differences. The 
study of such differences might provide us with the suitable tools to design species-
selective compounds, able to neutralize a specific organism through the selective 
inhibition of its FADS without affecting the flora of the host. That is the case of 
CaFADS and SpnFADS, which show great structural homology but important 
dissimilarities in their activities. Thus, we have addressed a first functional 
characterization of SpnFADS, identifying the three main differences of this protein 
regarding CaFADS. Thus, contrary to CaFADS, SpnFADS i) does not stabilize the 
dimer of trimers, ii) its FMNAT activity requires strong reducing conditions and iii) 
its RFK activity is not inhibited by excess of the RF substrate. Furthermore, a more 
detailed study of the RFK activity of both enzymes allowed us to identify the 
thermodynamic and kinetic determinants responsible of such differences. The 
integration of our data, and its interpretation in the context of the available 
crystallographic structures, bring to light the differential regulatory strategies 
adopted by these two enzymes. 
  Development of new antibacterial drugs targeting bifunctional FADSs. Due to the 
emergence during the last decades of bacterial resistant strains, the need to find new 
antibacterial targets and drugs against them is a fact. In that way, because of their 
essential nature, and other good characteristics, we propose prokaryotic FADSs as 
exploitable targets for the development of new antibacterial drugs. In this work, we 
have optimized a protocol do identify potential inhibitors of these enzymes, using as 
model CaFADS, and we have utilized this methodology to identify broad-spectrum 
or species-selective compounds. Our methodology starts with the identification of 
potential inhibitors using an activity-based high-throughput screening protocol, and 
the subsequent identification of the affected activity. The best inhibitors of the 
FMNAT activity (they are more probable to have no effect on the mammal proteins) 
were further characterized, and their inhibition mechanisms identified. Concurrently, 
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the effect of the hits of the screening was tested in different bacterial strains. In this 
project, we have identified promising compounds that could act either as selective 







Las FAD sintetasas bacterianas (FADS) son enzimas bifuncionales y bimodulares 
cuya función es producir los cofactores esenciales FMN y FAD a partir de Riboflavina 
(RF o vitamina B2). Estas proteínas se organizan en dos módulos casi independientes, 
cada uno de los cuales lleva a cabo una de las actividades mediante las cuales se 
sintetizan FMN y FAD. El módulo C-terminal transforma RF en FMN mediante una 
actividad riboflavin quinasa, mientras que el módulo N-terminal cataliza la actividad 
FMN:adenililtransferasa que transforma el FMN en FAD. Debido al carácter esencial de 
los cofactores FMN y FAD y a las diferencias entre FADSs bacterianas y las 
correspondientes enzimas de mamíferos (sobre todo entre el módulo FMNAT de las 
enzimas bacterianas y las enzimas que transforman FMN en FAD en mamíferos), estas 
enzimas son potenciales dianas terapéuticas. Por este motivo, merece la pena 
profundizar en el estudio de las FADs bacterianas, en la comprensión de sus ciclos 
catalíticos y de sus estrategias regulatorias, centrándonos en las diferencias entre 
diferentes miembros de esta familia.  
Por lo tanto, durante el desarrollo de la presente tesis doctoral hemos abordado los 
siguientes proyectos: 
 Estudio de los determinantes estructurales que modulan el equilibrio de 
oligomerización de la FADS del organismo Corynebacterium ammoniagenes 
(CaFADS). CaFADS estabiliza durante sus ciclos catalíticos distintos ensamblados 
oligoméricos, siendo especialmente relevante la formación de un hexámero 
compuesto por un dímero de trímeros. En esta estructura los protómeros adoptan una 
disposición cabeza-cola, lo que sugiere que el dímero de trímeros podría tener un 
papel activo en la canalización del FMN desde el sitio RFK hasta el sitio FMNAT, 
donde será transformado en FAD. Para validar esta hipótesis, producimos y 
caracterizamos mutantes puntuales localizados en la interfase entre protómeros. 
Aparentemente, los residuos mutados estabilizaban el dímero de trímeros mediante la 
formación de puentes salinos, interacciones de Van der Waals o interacciones 
hidrófobas con residuos localizados en el módulo opuesto del protómero adyacente 
en cada trímero. Nuestros resultados revelaron que todas las variantes eran activas y 
capaces de estabilizar estructuras cuaternarias, aunque la mayoría de ellas muestran 
alteradas sus actividades RFK y FMNAT, así como los parámetros de interacción 
con los ligandos y la tendencia a la oligomerización. Mención especial requiere el 
hecho de que mutaciones localizadas en el módulo RFK modulaban la actividad 
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FMNAT y viceversa. Estos resultados sólo pueden explicarse en el marco del dímero 
de trímeros, en el que residuos de diferentes módulos están en estrecho contacto. 
Estos resultados validan la hipótesis de la formación de estructuras oligoméricas, en 
las que los protómeros adoptan una disposición cabeza-cola, durante los ciclos 
catalíticos de CaFADS. Además, nuestros estudios permiten determinar el papel de 
residuos concretos en las actividades RFK y FMNAT de esta enzima.  
 Estudio comparativo de los ciclos catalíticos RFK y FMNAT de las FADSs de los 
organismos C. ammoniagenes y Streptococcus pneumoniae (CaFADS y SpnFADS, 
respectivamente). A pesar de las similitudes generales entre FADSs bacterianas, 
enzimas de diferentes organismos muestran importantes diferencias funcionales. El 
estudio de estas disparidades puede proporcionar las herramientas adecuadas para el 
diseño de compuestos selectivos de especie, que sean capaces de neutralizar un 
organismo específico mediante la inhibición selectiva de su FADS, sin afectar la 
flora del huésped. Este es el caso de CaFADS y SpnFADS, que muestran gran 
homología estructural pero importantes diferencias en sus actividades. En este 
proyecto hemos llevado a cabo una primera caracterización funcional de SpnFADS, 
identificando tres importantes diferencias respecto a CaFADS. De este modo y 
contrariamente a CaFADS, SpnFADS i) no estabiliza el dímero de trímeros, ii) su 
actividad FMNAT requiere condiciones reductoras fuertes, y iii) la actividad RFK de 
SpnFADS no muestra inhibición por el sustrato RF. Asimismo, un estudio más 
detallado de la actividad RFK de ambas enzimas nos permitió identificar los 
determinantes cinéticos y termodinámicos responsables de las citadas diferencias. La 
integración de nuestros datos experimentales y su interpretación en el marco de las 
estructuras cristalográficas disponibles, ha arrojado luz sobre las diferentes 
estrategias reguladoras adoptadas por estas dos enzimas.   
 Desarrollo de nuevos fármacos antibacterianos contra FADSs bifuncionales. Debido 
a la irrupción durante las últimas décadas de cepas bacterianas resistentes a 
antibióticos, la necesidad de nuevas dianas terapéuticas antibacterianas, así como de 
fármacos dirigidos contra ellas ha quedado manifiesta. De este modo, y debido a su 
carácter esencial, junto a otras características deseables, proponemos a las FADS 
procariotas como dianas terapéuticas explotables durante el proceso de búsqueda de 
nuevos antibióticos. En este proyecto hemos optimizado un protocolo para la 
identificación de potenciales inhibidores de estas enzimas, utilizando como modelo 
CaFADS. Posteriormente hemos utilizado esta metodología para identificar 
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compuestos que podrían ser utilizados como drogas de amplio espectro o selectivas 
de especie. Nuestro protocolo comienza con la identificación de potenciales 
inhibidores mediante un cribado de alto rendimiento, basado en las actividades 
enzimáticas de la proteína y la consiguiente identificación de la actividad inhibida. 
Los mejores inhibidores de la actividad FMNAT (ya que es más probable que estos 
compuestos no afecten a las enzimas de mamíferos) fueron estudiados más 
detalladamente y sus mecanismos de inhibición determinados. Paralelamente, se 
comprobó el efecto bacteriostático de los compuestos identificados mediante el 
cribado en diferentes cepas bacterianas. En este proyecto hemos identificado 
compuestos prometedores que podrían usarse como inhibidores selectivos de la 
FADS de un organismo en concreto, y otros que podrían desarrollarse como 










1. The need of new antibacterial targets 
1.1. From the beginnings to the golden era in the development of antibiotics  
Antibiotics are chemical substances produced by various microorganisms and fungi 
(or its synthetic derivatives) that are able to kill or to inhibit the growth of bacteria 
and other microorganisms.  
It is thought that antibiotics were used for the first time in China, more than 2500 
years ago, where it was known that the application of moldy curd from soybean 
improved some kind of infections. Nevertheless, principles of antibiosis were not 
established until the 19th century, in 1877, when Louis Pasteur and Robert Koch 
reported the competitive inhibition of Bacillus anthracis growth by another bacillus 
[1, 2]. Twenty years later, in 1897 Ernest Duchesne discovered the penicillin while 
he was working with fungi from the Penicillum genus, although his discovery was 
unnoticed by the scientific community [3]. The next step in the antibiotics 
development took place in 1909, when Paul Ehrlich synthetically produced the 
compound arsphenamine and described its use in the treatment of syphilis [4]. One of 
the most important facts in the antibiotics development, came in 1929 from the hand 
of Alexander Fleming, who published in the “British Journal of Experimental 
Pathology” his findings about a substance produced by fungi of the genus 
Penicillum, that was able to inhibit the growth of the bacteria Staphylococcus aureus 
[5]. Unfortunately, Fleming failed in his attempts to isolate the so-called penicillin, 
and it was not until ten years later that Ernst Chain and Howard Walter Florey 
achieved to purify a form of this compound [6]. Their studies led them to win, 
together with Fleming, the Nobel Price in 1945. This β-lactam antibiotic was among 
the first medications effective against different bacterial infections caused by 
Staphylococcus and Streptococcus. The importance of this drug was capital during 
the Second World War, where the War Production Board did a great effort drawing a 
plan for the distribution of penicillin to Allied troops in Europe [7]. In 1939 René 
Dubos isolated gramidicin [8], one of the first commercial antibiotics that was also 
used during the Second World War. Since 1943 the use of antibiotics has become 
widespread for the treatment of different bacterial infections, being most of them 
developed during the so-called “antibiotic golden age”.  
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Figure 1.1. Action mechanisms of different types of antibiotics grouped according to 
their target. Figure from [9]. 
Nowadays, in rough outline, antibiotics can be classified attending to their targets 
[9]. In that way, we can distinguish among; i) antibiotics, such as penicillin and all 
generations of cephalosporins that affect the synthesis of the bacterial wall, 
specifically inhibiting the peptidoglycan synthesis [10], ii) those that alter the 
stability of the cellular membrane acting as detergents, being gramidicin an example 
of these drugs, iii) substances as actinomycin or sulphamides that prevent the 
synthesis of nucleic acids or proteins through the inhibition of the DNA polymerase 
or the nitrogenous bases synthesis, and iv) antibiotics that distinctivaly bind to the 
30S or the 50S subunits of the bacterial ribosome, inhibiting the synthesis of 
proteins. To this last group belong the tetracyclines and the aminoglycosides (Fig. 
1.1).   
1.2. The resistance era put in check our effectiveness against pathogens 
Bacteria always develop the molecular tools to acquire resistance. Thus, after the 
antibiotic golden era it came the resistance epoch, as a result of the indiscriminate 
use of antibiotics to treat human and animal infections, as well as in the agriculture 
(Fig. 1.2). These conditions have produced the mobilization of resistance elements in 
bacterial populations, and their capture by pathogens previously sensitive to 
antibiotics. Bacteria have acquired resistance to drugs through three main 
mechanisms [11]; i) the sequential capture of resistance genes through the 
mobilization and the horizontal transfer from environmental sources, ii) the over-
I. Introduction 
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activation of intrinsic resistance mechanisms as efflux pumps [12], or the 
overexpression of the enzymes inactivated by antibiotics [13], and iii) the freezing of 
polymorphisms in antibiotic target genes that neutralize the effects on fitness of the 
drug-resistance mutations [14]. Due to the irruption of multidrug resistant pathogens, 
which are resistant to most or even all the known antibiotics, we are losing our 
ability to control infections using these drugs, and consequently, we have reached the 
post-antibiotic era (Fig. 1.2) [11].  
Figure 1.2. Timeline of the past and future of antibiotics development. The guidelines 
leading the research during each period of time are indicated, as also the efficacy of the 
developed drugs.  
1.3. What makes a drug target good? 
Since we have lost the potential to fight multidrug resistant pathogens using the 
available antibiotics, we need to elaborate new antibacterial strategies. The first step 
in the discovery of new drugs is the identification of good antibacterial targets. 
Therefore, first of all, the characteristics of good antimicrobial drug targets have to 
be established.  
1) The target has to be involved in metabolic pathways that provide essential 
molecules for the survival of the pathogen. The inhibition of the target must interrupt 
the pathway, which finally leads to the death of the pathogen.  
2) No alternative pathway must supply the metabolic route blocked by the 
inhibition of the target. 
3) The drug target should have a low mutation rate. This feature hinders the 
appearance of resistances.  
4) To favor the specificity of the drug and to avoid side effects in the host, the 
pathogen target protein must differ as much as possible from those in other microbes 
and in the host.  
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5) A 3D-structure of the target protein, or of a close homologous protein, should 
be available for druggability (capacity of a drug to bind the target with high affinity) 
assessment.  
6) The target should have a favorable ‘assayability’ (capacity to be easily assayed) 
enabling high throughput screening. 
7) Additionally, favorable predictions of potential side effects must be considered.  
1.4.  Proteins involved in flavins synthesis are promising drug targets  
FMN and FAD are biomolecules that act as cofactors of a huge quantity of 
flavoproteins and flavoenzymes, which execute essential functions in all kind of 
organisms. Some of the processes that involve flavoproteins are, among others, 
protein folding [15], electron transport in the respiratory and photosynthetic chains, 
β-oxidation of fatty acids [16], nucleotide synthesis [17] and signal transduction 
during apoptosis [18] (Fig. 1.3). The lack of FMN and FAD leads to the 
accumulation of unfolded apoproteins, which are unable to perform their functions, 
and finally to the death of the organism. Regarding the points previously indicated, 
the synthesis of FMN and FAD perfectly fits the requirements of good antibacterial 
targets since; 
1) The lack of FMN and FAD prevents from the very beginning all the pathways 
that involve flavoproteins. Since most of these processes are essential for survival, 
the final consequence of the inhibition of the flavins syntheses is cell death.  
2) In bacteria there is a unique pathway for FMN and FAD synthesis that, in 
general, involves a single bifunctional protein, the prokaryotic FAD synthetase 
(FADS).  
3) Enzymes hold a strict relationship between their structure and their function. 
Therefore, big insertions or deletions alter the protein function, while punctual 
mutations usually have two effects depending on their location. On the one hand, if 
the mutated residue is at the active site or indirectly affects its conformation, it is 
highly probable that the protein will lose the capacity to perform its function. On the 
other hand if the mutations are located in peripheral regions, the enzymatic efficiency 
will not be affected unless the mutation produces big structural rearrangements. 
Having into account that most of drugs that target enzymes affect their active sites, 
enzymes in general, and FADSs in particular, are less prone to generate resistances, 
since mutations causing resistance also might compromise the protein function.  
I. Introduction 
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4) The synthesis of FMN and FAD differs between mammals and prokaryotes. 
Mammals own two independent enzymes (a FMN adenylyl transferase and a 
riboflavin kinase), while bacteria have the single bifunctional (and bimodular) 
FADS. Although eukaryotic riboflavin kinases are structurally similar to the module 
that performs the same activity in bacterial FADSs, the prokaryotic module involved 
in FAD production is completely different from the corresponding eukaryotic 
enzyme. Therefore, drugs that target bacterial FADSs, and specifically their FMN 
adenylyltransferase domain, might not affect the mammalian homologous proteins, 
which would reduce the side effects caused by these drugs.  
5) The crystallographic structures of some FADSs (those from the organisms 
Thermotoga maritima (TmFADS), Streptococcus pneumoniae (SpnFADS) and 
Corynebacterium ammoniagenes (CaFADS), PDBs 1T6Y, 3OP1 and 2X0K, 
respectively) are available, which facilitates the evaluation of their druggability.  
6) FADSs show great assayability, since their activities can be easily followed 
registering the flavin fluorescence of substrates and products (see section 2.4 of this 
chapter). Hence, activity based high-throughput screenings can be used to identify 
potential drugs.  
Consequently, once the potentiality as drug target of the FMN and FAD 
biosynthesis pathway has been set, this system must be understood in detail.  
 
Figure 1.3. Overall structure of flavins and some biologically relevant processes they are 
involved in. Figure from [19]. 
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2. Flavins and flavoproteins: past, present and properties 
2.1. A brief history of flavins and flavoproteins 
Nowadays, we know that flavins constitute a family of yellow compounds 
structurally derived from the 7,8-dimethyl-10-alkylisoalloxazine (Fig.1.3). However, 
these important compounds were unnoticed until 1897, when the English chemist 
Wynter Blyth observed a bright yellow pigment that could be isolated from cow milk 
[20]. Some years later, in the late 1920s and early 1930s, other yellow pigments were 
isolated from different sources and they were named lactoflavin, ovoflavin or 
hepatoflavin according to their founts. Those pigments were identified as a molecule 
that belongs to the vitamin B complex, the B2 vitamin. In 1934 and 1935, 
respectively, Richard Kuhn and Paul Karrer published the structure of that vitamin 
and they chemically synthesized it [21, 22]. All previous names given to the 
molecule were then substituted by riboflavin (RF), regarding the ribityl side chain 
and the yellow color of the conjugated ring system (flavus in latin means yellow). 
At the same time, in 1933, Otto Warburg during his research about the respiratory 
chain, isolated the “old yellow protein” which catalyzed the NADPH oxidation by 
oxygen [23], discovering in that way the first flavoprotein. Two years later Hugo 
Theorell observed that through precipitation, this yellow protein yielded two 
different fractions; a white precipitate and a yellow supernatant. Separately, neither 
the precipitate nor the supernatant were able to catalyze the NADPH oxidation [24]. 
The yellow fraction showed the same spectroscopic properties as RF, but RF did not 
restore the activity of the flavoprotein. Finally, Theorell solved the mystery when he 
realized that the flavin differed from RF in a phosphate group, attached to the 
terminal hydroxyl of the ribityl chain [24]. Today, this flavin is known as flavin 
mononucleotide or FMN. The main achievement of the Theorell´s work was that it 
demonstrated by the first time, and from a biochemical approach, the role of RF as a 
vitamin, since it acted as a cofactor during the enzymatic catalysis. Few years later 
Hans Krebs, during his studies about the amino-acids deamination, discovered 
another important flavoprotein; the D-amino acid oxidase [25]. As Theorell did in 
1935, Warburg and Christian separated the apoprotein and the flavin cofactor, 
identifying this latter one as the flavin adenine dinucleotide or FAD, obtained as a 
product of the condensation of FMN and AMP [26]. FAD was synthesized years 
later, in 1954, in Cambridge by Christie and Todd [27].  
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Since its discovery in 1933 [23] until the date, lots of flavoproteins have been 
identified and characterized [28-34]. That fact together with the huge quantity of 
different processes they are involved in, evince the biological importance of these 
proteins.  
2.2.  Flavins are heterocyclic molecules 
Flavins are heterocyclic compounds that contain an isoalloxazine ring, and more 
specifically, the flavins that we can find in living organisms derive from the 7,8-
dimethil-isoalloxazine (Fig. 1.4).  
 
 
Figure 1.4. Chemical structure and atomic numbering of the 7,8-dimethil-isoalloxazine 
ring. R determines the nature of the flavin: R=CH3, lumiflavin; R=ribityl, riboflavin 
(RF); R=ribityl-5′-phosphate, flavin mononucleotide (FMN); R=ribityl-(9-adenosyl)-
pyrophosphate, flavin adenine dinucleotide (FAD).  
The oxidized flavin isoalloxazine ring is expected to be planar and shows two 
faces, named the Re and the Si. The Re face is that at the front when the benzene ring 
is at the left and N10 at the bottom of the molecule, being the Si face the back one in 
this position (Figure 1.5) [35].  
 
Figure 1.5. Re and Si faces of the isoalloxazine ring in FMN.  
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Among all the flavins that we can find in biological systems, there are three with 
especial relevance; RF or vitamin B2 (7,8-dimethil-10-(1´-D-ribityl) isoalloxazine) 
and their derivatives, FMN or flavin mononucleotide (riboflavin 5´phosphate) and 
FAD or flavin adenine dinucleotide (Fig. 1.6). 
Even though there is a broad distribution of flavins in the tissues, just a little 
amount stay as free flavins, being found much more frequently acting as cofactors 
and prosthetic groups of flavoproteins, which are involved in most cases in redox 
reactions (since FMN and FAD are able to accept or transfer one or two electrons at 
a time) [36-38]. Normally, FMN and FAD are not covalently bound to the protein, 
and the flavin-protein binding takes place mainly through the N(10)-ribityl side chain 
of the flavin [39]. For the vast majority of FAD-containing flavoproteins, the 
pyrophosphate moiety binds to the most strongly conserved sequence motif, 
indicating that pyrophosphate binding is an important determinant of molecular 
recognition [40]. In addition to their roles as cofactors, flavins can act as coenzymes 
of a family of oxidoreductases, named NAD(P)H:flavin-reductases, that catalyzed 
the FMN and FAD reduction, and exceptionally, also the reduction of RF by the 
nucleotide NAD(P)H [41, 42].  
 
Figure 1.6. Chemical structure of the oxidized isoalloxazine ring (red) and of its three 
most biologically relevant derivatives; RF (with a ribityl chain attached to the N10), FMN 
(formed through addition of a phosphate group to the 5´ carbon of the RF ribityl chain) 
and FAD (formed by condensation of FMN with a molecule of AMP).  
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2.3.  Flavins exhibit versatile redox properties 
One of the most important properties of RF, FMN and FAD, is their capacity to 
participate in redox reactions [43]. These flavins can interchange two electrons at a 
time, and additionally, under particular environments (as when are forming part of 
flavoproteins), also a single electron. In that way, they can act as intermediates, 
hitching reactions where one of the substrates can only accept or transfer one 
electron, and the other one needs to interchange two electrons at a time [36]. This 
valuable property is possible because flavins (within flavoproteins) can stabilize 
three different redox states; the oxidized form, the semi-reduced state or semiquinone 
(one electron reduction), and the fully two electrons reduced state or hydroquinone 
[44]. Consequently, flavoproteins can transfer just a single electron, a hydrogen atom 
or a hydride ion, being for this reason very versatile in terms of substrates 
modifications, and types of reactions in which they are involved. Additionally, 
flavins also show a pH-dependent equilibrium (Fig. 1.7) [45]. Nevertheless, all of the 
structures shown in figure 1.7 could not be found in physiological conditions, or 
within flavoproteins.  
 
 
Figure 1.7. Redox states and acid-base equilibrium of the isoalloxazine ring. Figure 
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At pH 7.0 the oxidized state is stable against the oxygen, being the predominant 
form the neutral one. At neutral pH, the semiquinone state of the free flavin, which 
adds an electron with respect to the oxidized one [46, 47], is thermodynamically 
unstable, since only about 5% is stabilized as radical in a 50-50 mixture of the 
reduced and the oxidized forms [39]. The destabilization of the semiquinone state 
makes the reduction midpoint potential Eox/sq more negative than the Esq/rd. For this 
reason, free flavins are only able to interchange two electrons at a time. Nevertheless, 
when flavins are part of flavoproteins, their midpoint redox potentials, which are 
both ~-200 mV for the free flavins [48], can be modified from -400 to +60 mV as a 
consequence of their isoalloxazine ring interaction with the protein [49]. For this 
reason, and depending on relative modulation of Eox/sq and Esq/rd values, some 
flavoproteins reach the stabilization of near to 100% of the semiquinone state. This is 
an interesting fact, because in these situations flavoproteins are able to mediate as 
intermediates in reactions where either one or two electrons are being transferred. 
Under physiological conditions and depending on the pH, the semiquinone state in 
flavoproteins can be found either in the anionic form, that presents red color or in the 
neutral blue one. Also under these conditions, the hydroquinone or reduced state of 
flavoproteins can only be found in the anionic and neutral forms [50]. Besides all 
these forms, electronic states where partial charge is transferred from or to one of the 
states previously described to a neighboring molecule can be found. They are known 
as charge-transfer states.  
2.4.  Flavins show useful spectroscopic properties 
2.4.1. Absorption in the UV depends on the redox state 
 The absorption spectra of flavins are highly dependent on their redox state, 
since each form shows a particular electronic distribution. All oxidized flavins show 
high absorption in the UV and visible regions, with three maxima at wavelengths 
close to 265, 370 nm (band II) and 450 nm (band I) (Table 1.1, Fig. 1.8) [39]. The 
spectral shape is practically the same for RF and FMN, but shows little wavelength 
displacement and lower intensity for FAD, due to the formation of an internal 
complex between the isoalloxazine ring and the adenine of the molecule [51, 52]. 
The neutral semiquinone form exhibits a broad 500-650 nm band with a maximum 
around 589-600 nm, while the anionic semiquinone shows two maxima at 370 and 
490 nm, and barely absorbs at wavelengths higher than 550 nm (Fig. 1.8) [53]. The 
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absorption of the bands I and II is bleached for the reduced flavins, that also present a 
shoulder around 290 nm (Fig. 1.8) [51]. 
Table 1.1. Position of the maxima and molar extinction coefficient for free oxidized 










RF 266 32.5 373 10.6 445 12.5 
FMN 266 31.8 373 10.4 445 12.5 
FAD 263 38.0 375 9.3 450 11.3 
 
 
Figure 1.8. Characteristic absorption spectra of flavoproteins in different redox states. 
The completely reduced and oxidized forms are shown in solid lines, the neutral 
semiquinone in dotted line and the anionic semiquinone in dashed line. Figure modified 
from [39]. 
The absorption spectrum of flavins when forming part of flavoproteins, and that 
exhibited by the free flavins, are highly similar. Nevertheless, the protein 
environment usually induces small displacements in the position of the maxima and 
in their intensities, as well as the apparition of spectral shoulders. This makes the 
spectra of each flavoprotein unique.  
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2.4.2. Flavins are fluorescent compounds  
Together with aromatic amino-acids, flavins are the most important fluorescent 
groups that can be found in proteins. The oxidized state of flavins exhibits a high 
quantum yield of fluorescence, being the maxima of absorption and emission around 
440-450 and 525-530 nm respectively [55]. The quantum yield of fluorescence for 
RF and FMN at pH 7.0, is ten times higher than that of FAD. Once again, this effect 
is the result of the internal interaction between the isoalloxazine ring and the adenine 
group of the nucleotide (which quenches the fluorescence of the isoalloxazine ring). 
In aqueous solution this conformation is in equilibrium with the open fluorescent one 
[51, 52]. 
When FMN and FAD become part of flavoproteins their fluorescence can be 
moderately altered, completely disappear [56] or stay unaltered [57], depending on 
the manner in which the isoalloxazine ring gets allocated within the protein [51].  
2.5.  Biosynthesis of FMN and FAD in different organisms  
Bacteria, fungi and plants have the ability to synthesize RF de novo, using five 
molecules of ribulose and one of GTP (Fig.1.9). Nevertheless, for some organisms, 
as animals, RF is a vitamin (vitamin B2) and they need to acquire it from the diet. 
Both the synthesis and the intake of RF are processes greatly regulated [58-60].  
Independently on the endogenous or exogenous origin of RF, all the organisms 
show the ability to transform RF into FMN and FAD through two sequential 
reactions. Firstly, RF is phosphorylated to FMN by a riboflavin kinase activity (RFK, 
ATP:riboflavin 5´phosphotransferse, EC 2.7.1.26), which transfers a phosphate 
group from ATP to the C5´ ribityl chain (Eqn. 1.1). After the phosphorylation step, 
an ATP:FMN adenylyltransferase (FMNAT, EC 2.7.7.2) activity converts FMN into 
FAD (Eqn. 1.2).   
RF + ATP → FMN + ADP Eqn. 1.1 
FMN + ATP → FAD + PPi Eqn. 1.2  
Although all organisms synthesize FMN and FAD from RF, they utilize different 





Figure 1.9. Pathway for FAD biosynthesis in prokaryotes. The enzymes involved in the 
metabolic route are: GTP cyclohydrolase II (I), 2,5-diamino-6-ribosylamino-4(3H)-
pyrimidinone-5´-phosphate deaminase (II), 5-amino-6-ribosylamino-2,4(1H,3H)-
pyrimidinone-5´-phosphate reductase (III), 5-Amino-6-ribitylamino-2,4(1H,3H)-
pyrimidinedione phosphatase (VI), 3,4-dihydroxi-2-butanone-4-phosphate synthase (VII), 
6,7-dimethil-8-ribityl-lumazine synthase (VIII), RF synthase (IX), RF kinase (X), FMN 
adenylyltransferase (XI). Eubacteria and plants produce RF through (II) and (III) while 
yeasts utilize path through (IV) and (V). The numbers indicate the following compounds: 
GTP (1), 2,5-diamino-6-ribosylamino-4(3H)- pyrimidinone-5´-phosphate (2), 5-amino-6-
ribosylamino-2,4(1H,3H)-pyrimidinone-5´-phosphate (3), 5-Amino-6-ribitylamino-
2,4(1H,3H)-pyrimidinedione-5´-phosphatase (5), 5-Amino-6-ribitylamino-2,4(1H,3H)-
pyrimidinedione (6), ribulose-5-phosphate (7), 3,4-dihydrosi-2-butanone-4-phosphate (8), 
6,7-dimethil-8-ribityl-lumazine (9), RF (10), FMN (11) and FAD (12). Figure modified 
from [61].  
3. FMN and FAD biosynthesis in different types of organisms 
Until some decades ago, the knowledge about the enzymes involved in FMN and 
FAD synthesis was relatively limited. Nowadays a great number of sequences of 
proteins that synthesize FMN and FAD is available, as well as the tridimensional 
structure of some of them. Comparative studies of these sequences, have allowed 
shedding light on some key aspects of the metabolism of flavins. In that way, it is 
now known that different organisms use dissimilar enzymes to perform the FMN and 
RF FMN FAD 
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FAD synthesis. Additionally, highly conserved consensus sequences, which might 
play essential roles during the catalysis, have been also identified. 
 
Different organisms use distinct enzymes for FMN and FAD biosynthesis 
Contrary to prokaryotes, yeasts, animals and, in general, non-photosynthetic 
eukaryotes, are unable to synthesize RF and they need to ingest it with diet [62, 63]. 
To transform RF into FMN and FAD, animals own two independent monofunctional 
enzymes; one catalyzes a RFK activity and the other a FMNAT one (Fig. 1.10). The 
first known eukaryotic gen codifying for a RFK activity (FMN1), was identified in 
Saccharomyces cerevisiae. This gen codifies for a membrane protein that shows 
sequences for its location in microsomes and in the inner mitochondrial membrane 
[64]. The first gen that putatively codified for a eukaryotic FMNAT was also 
identified in S. cerevisiae, in 1995. This protein was named as FAD1, and 
corresponds to a 35 kDa cytosolic protein [65]. After that, more eukaryotic RFKs and 
FADs have been identified. Sequence analyses revealed that monofunctional RKFs 
are ATP-dependent, and show greatly conserved the PTAN motif (Fig. 1.11) and a 
glutamic that acts as catalytic base. On their side, eukaryotic FMNATs belong to the 
Adenosine nucleotide α-hydroxilase-like superfamily. Both proteins present different 
isoforms with mitochondrial and cytosolic locations [64, 66-68] (Fig. 1.10). 
In plants the situation is more intricate, since additionally to the monofunctional 
RFK and FMNAT, two different bifunctional FAD synthetases have been found. One 
of them presents RFK activity in its C-terminus module, and hydrolase activity in its 
N-terminus one [69]. The other bifunctional enzyme shows a N-terminus module 
similar to prokaryotic FMNATs, and a shorter C-terminal module without the PTAN 
motif, that must perform a different activity but which is still unknown [70] (Fig. 
1.10). These last proteins have been named as Plant-type FADSs. The 
monofunctional FMNATs and RFKs localize in the mitochondrion [71]. However, 
the location of the bifunctional enzymes with FMN hydrolase activity is still 
unknown, but they might be located in mitochondrion and chloroplast, since they 
have location sequences for those organelles.  
Archaeas possess two monofunctional proteins. The RFK enzyme differs from the 
bacterial one in the nucleotide utilized as substrate, since contrary to other RFKs they 
are CTP-dependent. The archaeal FMNAT also belongs to the nucleotidyl-
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transferase superfamily, although they do not present some of its characteristic 
motifs [72], and either ATP or CTP can be used as substrates.  
 
Figure 1.10. Distribution of the activities related to FMN and FAD synthesis in the 
subcellular locations of different organisms. Activities and enzymes shown in dot lines 
and italic, respectively, indicate that there are bioinformatics analyses that support the 
existence of the enzyme even though it has not been found experimentally. Activities in 
solid lines have been purified and characterized. Enzymes shown in black belong to the 
type I-FADS and those in green to the plant-type FADS. In addition to the type I-FADS, 
some bacteria are predicted to own a second type II-FADS (shown in blue). RFK 
(riboflavin kinase), FMNAT (FMN adenylyltransferase), FADasa (FAD hydrolase), 
FADpp (FAD pyrophosphorilase), FHy (FMN hydrolase). Figure modified from [73]. 
Most of bacteria possess bifunctional type-I FADSs, with a RFK module 
homologous to monofunctional eukaryotic proteins (that present the consensus 
PTAN motif and the catalytic glutamic residue) [74-76], and a FMNAT module 
different from mammalian eukaryotic FMNATs that belongs to the nucleotidyl-
transferases superfamily [76, 77]. Additionally to the type-I FADS, a small group of 
bacteria also owns monofunctional enzymes with RFK and FMNAT activities, which 
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show sequence identity with the C-terminus and the N-terminus module, 
respectively, of bifunctional FADS [70, 78]. Finally, some bacteria, among them 
Listeria monocytogenes, Lactobacillus plantarum or Oceanobacillus iheyensis, 
besides the type-I FADS present another bifunctional protein that shows high 
sequence similitude with the previous one, but with a shorter RFK module that lacks 
the consensus PTAN motif [70]. These proteins have been named type-II FADS and 
even though their N-terminal domain is able to transform FMN into FAD, the 
function of the RFK module remains unknown [78, 79]. 
3.1.  Prokaryotes own bifunctional FAD Synthetases 
 
Figure 1.11. Primary structure of bifunctional Type I FADSs. Sequence logos for the 
bifunctional Type I FADS family consensus regions. The numeration of CaFADS is used. 
The sequence logo was produced using the WebLogo server, http://weblogo.berkeley.edu 
[80].  
Prokaryotic bifunctional proteins with RFK and FMNAT activities have been 
cloned and purified from bacteria. These type-I FADSs are organized in two different 
modules, each of them mainly related to one of the activities. The C-terminus module 
performs the RF phosphorylation, while the N-terminus one transforms FMN into 
FAD [74, 79, 81, 82]. The N-terminal FMNAT module of these FADSs presents 
several consensus sequences, GxFDGxHxGH and SS(T/S)x(I/V)R, which are also 
conserved in nucleotidyl-transferases, as well as own motifs FxP(H/Q)P and 
G(D/N)(F/Y/H)x(F/Y)G [76]. The C-terminus module of FADSs exhibits the several 
conserved consensus sequences, GxVxxGxxG, G(F/Y)PT(A/L/I/V)N, 
PxxG(V/I)(Y/F), PT(F/V/I), and (L/V/I)Ex(H/F/Y/N)x(F/L)(D/N)(F/W/Y)xx(D/N/E) 
(L/I/A/V)Y(G/D/N], as well as an invariant conserved acidic residue (Glu268 in 
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CaFADS), which is proposed to act as catalytic base during the phosphorylation 
reaction. All these sequences are also conserved in eukaryotic RFKs [76]. 
The first tridimensional structure reported for a FADS was that from Thermotoga 
maritima (TmFADS, PDB entry 1T6Y). In this 30 kDa protein, a single loop 
connects the two modules (Fig 1.12). The N-terminal module (residues 1-158) 
presents a characteristic nucleotide binding Rossman fold [83], while the C-terminus 
module (residues 158-293) folds into a β-barrel of six antiparallel β-strands, 
surrounded by 3 α-helixes perpendicularly oriented to the β-barrel [75]. The 3D 
structure does not show the disposition of some loops, probably because they are 
regions with great flexibility. Additionally, the crystallographic structure of the 
enzyme in complex with different ligands is available. This structure reveals that 
TmFADS owns two adenine nucleotide binding sites (one in each module), and a 
single binding site for flavins located in the C-terminal module [74]. Nowadays, the 
structures of two additional bacterial FADSs are available; the FADSs from 
Streptococcus pneumoniae and Corynebacterium ammoniagenes (SpnFADS and 
CaFADS, PDB entries, 3OP1 and 2X0K respectively), being CaFADS the member 
of the family best characterized [70, 84-90].  
 
Figure 1.12. Overview of the crystallographic structure of the FADS from T. maritima 
(TmFADS, PDB 1T6Y) in complex with FMN (yellow) and ADP (green) attached to the 
C-terminus module, and AMP (red) to the N-terminus domain.  
María Sebastián Valverde 
 32 
3.2.  The FAD Synthetase from Corynebacterium ammoniagenes is the best 
characterized member of the family 
The FADS from C. ammoniagenes was described for the first time in 1976 as an 
enzyme that catalyzed the transformation of 5-deazariboflavin (5-dRF) into 5-
deazaFAD (5-dFAD) [91]. However, it was not characterized until 1986, when 
Manstein and Pai achieved to purified it to homogeneity [82]. A single polypeptide 
chain of 338 residues constitutes the protein, which shows an apparent molecular 
weight of 38 kDa and an isoelectric point of 4.6. The CaFADS catalyzes the RF 
phosphorylation in 5´ and the subsequent adenylylation of FMN, exhibiting wide 
specificity for flavin substrates. It seems that the important elements of flavins for 
binding to this enzyme are: the position 3 of the isoalloxazine ring, the existence of a 
hydroxyl group at 5´ and a substitution at position 7 [92, 93]. However, the protein is 
absolutely specific for ATP [82]. The phosphorylation reaction is irreversible while 
the adenylylation can be reverted to transform FAD into FMN in the presence of PPi 
(FADpp activity) [81] (Fig. 1.13). 
Figure 1.13. Reactions catalyzed by the CaFADS.  
The FMNAT reaction is MgCl2 dependent, and it does not occur in the absence of 
the ion, while it was reported that the RFK activity can take place even in the 
absence of Mg2+ [82]. Nevertheless, the optimum Mg2+ concentration for each 
reaction differs, being 0.4 mM for the RFK activity [82] (0.75 mM according to [94]) 
and 10 mM for the FMNAT one. Consequently, through modification of the ion 
concentration either one reaction or the other one can be favored, since the RFK 
activity decreases at MgCl2 concentrations higher than 0.8 mM [82]. The optimum 
pH and temperature were 7.8-8 and 35-37 ºC for the RFK reaction and 7.0-7.4, 37-40 
ºC for the FMNAT one [94].  
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3.2.1. Kinetics of CaFADS and interaction with substrates and products 
Kinetic parameters for the RFK and the FMNAT activities of CaFADS 
Kinetic constants for the both RFK and FMNAT activities of CaFADS have been 
determined [88]. For the RFK reaction, the enzyme shows different behaviors 
depending on the saturating substrate. At saturating ATP, the reaction rate is 
inhibited when the RF substrate concentration is higher than 7.5 µM (Fig. 1.14B), 
being the values reported (at 37ºC, in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2) for the 
Michaelis constant (Km
RF), the inhibition constant (Ki) and the catalytic constant (kcat) 
<13 µM, 4 µM and <302 min-1, respectively. For this reason it is not possible to work 
under saturating RF conditions, therefore a RF concentration at which the protein 
shows the 80 % of it maximal velocity was selected for future characterizations (for 
those experiments that require a constant RF concentration). Under these conditions 
(5 µM RF) the protein shows a Michaelis-like kinetic profile when varying ATP, 
being the Km
ATP and the kcat values 13.7 µM and 68 min
-1 respectively (Fig. 1.14A) 
[88].   
 
Figure 1.14. Steady state kinetic behaviors for the RFK reaction of CaFADS 
(RF+ATPFMN+ADP). (A) Reaction rates measured at 5 µM RF (concentration at 
which the protein shows the 80 % of its maximal rate) as a function of the ATP substrate. 
(B) Reaction rates at saturating ATP concentration as a function of the RF substrate. 
Measurements performed at 37ºC, in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2. 
It has been suggested that the inhibitory effect produced by the RF excess might be 
related to the formation of non-productive enzyme-substrate (or enzyme-products) 
complexes, that might not be able to evolve [95]. Nonetheless, until the moment the 
nature of these complexes remains unclear. Some possible explications would be that 
the products of the reaction, ADP and FMN establish a highly stable 
CaFADS:FMN:ADP complex, where ADP would hinder the initiation of a new 
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catlytic cycle; or maybe the excess of RF might provoke the binding of two 
molecules of this flavin, preventing the incorporation of the other substrate of the 
reaction. Therefore, more detailed kinetic studies are required to elucidate the nature 
of the inhibition suffered by the CaFADS RFK reaction. 
 
Figure. 1.15. Steady state kinetics behaviors for the FMNAT activity of CaFADS (FMN 
+ ATP FAD + PPi) at (A) as a function of ATP at saturating FMN and (B) as a 
function of FMN at saturating ATP. Measurements performed at 37ºC, in 20 mM PIPES, 
pH 7.0, 10 mM MgCl2. 
Regarding the FMNAT reaction of CaFADS, no inhibition has been observed 
neither at high concentrations of FMN nor of ATP. In this case the enzyme shows 
kinetic profiles that perfectly fit the Michaelis-Menten model (Fig. 1.15), being the 
values reported, at 37ºC, in 20 mM PIPES, pH 7.0, 10 mM MgCl2, for the kinetic 
constants Km
ATP, Km




Thermodynamic parameters for the CaFADS interaction with substrates 
and products 
Early studies postulated a single site for flavin binding, shared by the RFK and the 
FMNAT activities, and two independent binding sites for the adenine nucleotide 
ligands, each of them involved in one of the activities [81]. Nevertheless, subsequent 
studies about substrates binding through ITC provided new information that led to 
postulate a new interaction model [84]. 
CaFADS has two independent ATP binding sites in the presence of Mg2+, while 
in the absence of the ion only a single binding site is observable [84]. A single 
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binding site is detected both for FMN and FAD, while CaFADS presents two 
binding sites for RF. Calorimetric titrations performed in the presence of ADP, 
revealed that this adenine nucleotide induces the formation of an additional 
independent binding site for FMN, demonstrating that CaFADS holds two binding 
sites for adenine nucleotides and two for flavin nucleotides. This ITC study also 
allowed determining the values of the dissociation constant (Kd), for the interaction 
of CaFADS with all of its ligands (Table 1.2). These experiments also suggested that 
the FMN and ADP products show positive cooperation, since the presence of one 
favors the binding of the other [84]. 
Table 1.2. Dissociation constants for the interaction between CaFADS and its substrates 
and products. Data from [90]. The titrations were performed in 20 mM PIPES, pH 7.0, 10 












CaFADS 24.1b 7.8 0.7 5.5 30.2 
 (2) (1) (1) (1) (2) 
CaFADS:ADP Site 1 0.06    
 Site 2 0.9    
N indicates the number of binding sites observed for each ligand 
a Experiments performed in the absence of Mg2+. 
b Kd averaged value for two independent binding sites.  
3.2.2. The CaFADS is organized in two independent modules 
The overall structure of CaFADS 
The analysis of the CaFADS primary structure reveals that this protein shows all 
the consensus sequences of RFKs and prokaryotic FMNATs (Figs. 1.11 and 1.16) 
[76]. The crystallographic structure of the CaFADS has been obtained at 1.95 Å 
resolution (PDB 2X0K) [85]. The asymmetric unit contains two chains of 338 
residues similarly folded. CaFADS is a ∼70-Å prokaryotic type-I FADS that presents 
two structural domains. The N-terminus FMNAT module (residues 1-186) shows an 
α/β dinucleotide binding domain with a Rossmann fold topology [83]. This module 
owns a parallel β-sheet compound by six strands (β1n–β6n) and five α-helixes (α1n-
α5n) arranged at both sides of the β-sheet. At the end of the module a small 
subdomain built by a β-hairpin (β7n and β8n) and two short α-helixes (α6n and α7n) 
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can be found (Fig. 1.17). The C-terminal module (residues 187-338) folds in a ∼25-Å 
diameter globular domain, formed by a β-barrel with six antiparallel β-strands (β1c-
β6c), a long α-helix (α1c) and seven loops connecting them (Fig. 1.17). Three salt 
bridges (His186-Asp321, Asp273-Arg315 and Arg292-Arg310) and hydrophobic 
interactions stabilize the relative position between the β-barrel and the α1c helix. The 
main differences between the CaFADS RFK module and eukaryotic RFKs, such as 
those from Homo sapiens (HsRFK) and Schizosaccharomyces pombe (SpRFK) [96, 
97], are found in the loops that connect secondary structure elements. CaFADS owns 
a 12 residues insertion in L3c (Leu232-Val246) that is only observed in 
corynebacteria and mycobacteria [85]. Additionally, loops L1c or Flap I (Val193-
Thr208) and L4c or Flap II (Pro258-Glu263), CaFADS numbering, show different 
conformations in CaFADS and eukaryotic kinases [85, 96-98]. These loops are 
involved in the stabilization of nucleotides and flavins [85]. Another important 
difference is the position of Pro207 and Thr208 located at the 207-PTAN-210 
consensus sequence of RFK and FADS families [76]. CaFADS also holds a 15 
residues loop, named L7c (Ala324-Ser338), that shows two different conformations 
(Fig. 1.18) and that it is not found neither in the monofunctional SpRFK (PDB entry 
1N05) nor in HsRFK (PDB entry 1Q9S) 
 
Figure 1.16. Primary structure of CaFADS. The residues that belong to the N-terminus 
and C-terminus modules are shown in orange and blue, respectively. Consensus 





Figure 1.17. (A) Overall structure of the CaFADS showing the different secondary 
structure elements. Sulfate and PPi are displayed as sticks. (B) Scheme of the CaFADS 
topology, with the names assigned to every element of secondary structure. The C-
terminal or RFK domain is displayed in orange, while the N-terminal or FMNAT one is 
shown in green. Figure from [85]. 
The RFK and FMNAT modules interact with each other through H-bonds and the 
formation of a hydrophobic core that provides rigidity to the interface between 
modules. Loop L2c, which is implicated in these interactions, is a α-helix in 
eukaryotic RFKs. This difference seems to be a distinctive feature of bifunctional 
FADSs, since this region is affected by the existence of the FMNAT module [85]. 
Special attention deserves the interaction between the His186 of the FMNAT module 
with the Glu286 located at the RFK one, seeing that the Glu residue is greatly 
conserved in the RFK family [74-76] (Fig. 1.11).  
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Figure 1.18. Detailed cartoon representation of the RFK (A) and FMNAT (B) modules of 
CaFADS, with the nomenclature for their structural motifs. RFK and FMNAT modules 
are represented in orange and green, respectively, with their loops in purple. The 
alternative conformation of the loop L7c, in the RFK module, is shown in light blue. 
Figure modified from [85].  
The active site at the FMNAT module of CaFADS  
The FMN synthesized in the RFK module needs first to be released, to then bind 
to the FMNAT N-terminal domain to be transformed into FAD. In that way, the ATP 
adenine moiety is close enough to the FMN, and the adenylyl group can be 
transferred. Furthermore, this FMNAT module also performs the reverse reaction, 
this is the transformation of FAD and PPi into FMN and ADP. The surface of the 
FMNAT module shows an open cavity (Fig. 1.19) between the C-terminus of β3n, 
β2n and β5n, the α1n-helix, the small subdomain and the α2n-helix. This cavity is 
completed by the loop that connects β5n and α5n. The positively charged residues 
His28, His31, His57, Arg161, and Arg168 conform the central part of the cavity, 
contributing to the stabilization of the negative charges of the phosphate groups of 




Figure 1.19. Active site of the FMNAT module of CaFADS with modeled interactions 
with ligands. (A) Cartoon representation of the FMNAT module. AMP, PPi and FMN are 
shown in orange, blue and purple sticks, respectively. (B) Same view of the N-terminal 
module than in (A), but showing its molecular surface. (C) Detail of the binding cavity at 
the FMNAT module. The residues involved in ligands binding are shown in green. Figure 
from [85]. 
Sequence and structural analysis of Type I bacterial FADSs suggest that residues 
His28, His31, Asn125 and Ser164, which belong to the greatly conserved 28-HxGH-
31, 123-Gx(D/N)-125 and 161-xxSSTxxR-168 motifs (Fig. 1.11 and 1.16), might 
play a key role in the FMNAT activity, through the stabilization of the phosphate 
groups of the substrates [76]. These residues might be also implicated in the 
formation of the catalytically ternary complex, and in the FMNAT and FADpp 
activities [76, 77]. A mutagenic study where these positively charged residues were 
replaced by negative ones [90], confirms this hypothesis since CaFADS variants 
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showed altered FMNAT and FADpp activities. In addition, the binding parameters 
that describe the interaction of the variants with the ligands of the FMNAT activity 
also differed from those reported for WT CaFADS. All together, these data 
confirmed the implication of these motifs in the formation of the catalytically 
competent complex as well as in the FMNAT and FADpp catalytic events [90]. 
Special mention deserves Asn125, which is the catalytic base of the FMNAT 
reaction. Thus, mutagenic studies in which N125A and N125D variants were 
characterized revealed the importance of this residue, since both variants did not 
performed the FMNAT activity, and they showed altered interaction parameters with 
the substrates of this reaction.  
The flavin binding site at this domain is a wide open cavity that might allow 
different allocations of the isoalloxazine ring. For the moment, crystal structures 
reported at this site have only been obtained in the presence of the PPi product, but 
some models have been produced to show the putative binding of adenine and flavin 
nucleotides [85]. Hydrophobic contacts with Phe54, Phe62, Phe94, Tyr106 and 
Phe126 might stabilize the isoalloxazine ring within the flavin cavity [85]. 
Mutagenic studies, where these aromatic residues were substituted by others of 
different nature, confirmed their relevance. Phe62 affects the affinity of the binding 
site at the FMNAT module for the substrates and the products, as well as the 
conformation of the catalytic complex. Tyr106 and Phe128 are directly involved in 
the organization of the FMNAT cavity, and might be implicated in the 
conformational changes required for the FMNAT and FADpp reactions [78].  
The active site at the RFK module of CaFADS 
Although at the beginning of this Thesis crystal structure of CaFADS in complex 
with ligands were reduced to that containing the PPi product of the fMNAT reaction, 
a model for the allocation of the substrates and products within the RFK module was 
proposed. For this modeling, the available structures of monofunctional RFKs with 
ligands, such as HsRFK in complex with FMN and ADP (PDB 1Q9S), and the 
model for SpRFK in complex with FMN and ADP (PDB 1N05) were considered [96, 
97]. A posterior study where the structure of the isolated CaFADS RFK domain was 
obtained in complex with some of its ligands corroborated the model [99].  
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Crystal structures of HsRFK and SpRFK in the presence of ligands, suggested 
large conformational changes during this catalytic cycle [96, 98]. These changes 
involved the Flap I and Flap II regions (L1c and L4c, respectively, in CaFADS) that 
open the nucleotide binding site (which is closed and inaccessible to the ATP in the 
apo form) and close the flavin cavity after RF binding. This catalytically active 
conformation approaches the O5´-hydroxyl of RF to the catalytic base Glu268 
(CaFADS numbering), facilitating the Mg2+ coordination with the oxygens from 
ATP phosphates and with the Asn210 (numeration for CaFADS) from the consensus 
PTAN motif [85]. 
 
Figure 1.20. Active site of the CaFADS RFK module. (A) Representation of the ligands 
within the active site of the RFK domain (orange). (B) Same view than (A) but with the 
RFK module represented in surface. (C) Detail of the flavin binding site with the highly 
conserved residues predicted to interact with FMN. (D) Superimposition of the RFK 
domains of CaFADS (orange) and HsRFK (blue). L3c apparently induces the 
displacement of L5c. The blue arrows indicate the expected movements of L5c, L1c and 
L4c according to those observed for HsRFK. Figure from [85]. 
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 According to the structure of other members of the RFK family, the RFK active 
site of CaFADS is placed outside the β-barrel, at the opposite side of the interface 
between modules (Fig. 1.20A). Within the CaFADS RFK module, the highly 
hydrophobic region given by residues Val224, Phe270, Met294, Phe297, Leu303, 
and Met307, provides an accurate environment to stabilize the isoalloxazine ring 
(Fig. 1.20B). Additionally, H-bonds between Arg292 or Glu295 and N3, O4 and N5 
of the flavin ring might also stabilize it. The poor density found for residues 
conforming L4c (259-261) and a solvent-exposed Phe260, suggest that in CaFADS 
this loop is highly flexible, and upon RF binding could suffer conformational 
changes, similar to those observed for monofunctional RFKs [85]. The adenine 
moiety of the adenine nucleotide substrate binds in a pocket, between the N-terminus 
of β2c and the C-terminus of β5c, with L5c (Leu272-His281) surrounding its ring 
(Fig. 1.20C). The phosphates (and the Mg2+ that stabilizes its negative charges) are 
located between L1c and β1c. However, the CaFADS adenine nucleotide binding site 
at the RFK module is small and closed, preventing the direct nucleotide access. It 
needs to be highlighted that contrary to other RFKs, in CaFADS L1c-Flap-I is folded 
towards L5c, with the side chain of Thr208 occupying the adenine binding site of 
ATP. The conformation of L1c, L3c and L5c is stabilized by polar and hydrophobic 
interactions, including six H-bonds. When comparing the CaFADS RFK module 
with monofunctional RFKs, in the apo-form of SpRFK, the adenine nucleotide 
binding site is also blocked, but in this case only the position of Flap-I produces the 
closed conformation [96]. All these data suggested that the conformational changes 
during the RFK catalytic cycle of CaFADS are more intricate than those reported for 
the monofunctional RFKs, since a concerted movement of the loops L1c, L3c and 
L5c of CaFADS is required for the opening of the cavity and for the ATP binding, as 
well as the conformational rearrangement of the PTAN motif (Fig. 1.20C) [85]. 
3.2.3. Notable conformational changes occur during the CaFADS RFK 
catalytic cycle 
Crystallographic structures of the isolated RFK module of CaFADS in complex 
with some of its ligands are now available (binary RFK:ADP complex, PDB entry 
5a88 and ternary RFK:ADP:FMN complex, PDB entry 5a89). In a recent study, 
which completes the structural information with computational analyses and kinetic 
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and binding information, a model for the structural rearrangements occurring during 
the RFK catalytic cycle has been proposed [99].   
The structure of the RFK module in the apo form of the CaFADS significantly 
differs from those found for the binary RFK:ADP-Mg2+, and the ternary 
RFK:FMN:ADP-Mg2+ complexes. Both complexes exhibit important structural 
rearrangements that affect the conformation of the 207-PTAN-210 motif, as well as 
the majority of the protein loops with the only exception of L2c.  
As indicated in the previous section, in the apo-protein the adenine nucleotide 
binding site of the RFK module is closed, due to the conformation of L1c, L3c and 
L5c, which interact with each other (Fig. 1.21B). The formation of the ternary 
complex induces a conformational change in L1c that is displaced to α1c, while part 
of it becomes a short helix. In that way, L1c loses its interaction with L3c and L5c, 
which move to the opposite direction expanding the adenine nucleotide cavity (Figs. 
1.22C and 1.21B). The binary and the ternary complexes show the same disposition 
of these three loops, therefore the structural rearrangements are induced by the 
binding of the adenine nucleotide regardless of flavin binding. Molecular Dynamics 
(MD) simulations of the free RFK module show that in solution loops L3c, L5c and 
particularly L1c establish an open-close equilibrium for the adenine nucleotide 
binding site. These simulations also reveal that the presence of either flavin or 
adenine nucleotides increases the opening probability of the cavity [99]. Regarding 
the flavin binding site of the RFK module, L4c is disarranged in the binary complex 
and as a consequence the flavin binding cavity is open and wide (Fig. 1.21A). In 
contrast, FMN binding induces a change in the size, shape and solvent accessibility 
of the cavity (Fig. 1.21B) [99]. 
We focus now on the relative position in the different structures of the consensus 
207-PTAN-210 motif that stabilizes the ATP phosphates and the Mg2+ ion during the 
reaction. In the free enzyme, the side chain of the Thr208 is occupying the position 
where the adenine ring is located both in the binary and in the ternary complexes 
(Fig. 1.22E). Therefore, the ADP/ATP binding necessarily undergoes a huge 
conformational change that results in the opening of the adenine nucleotide cavity. 
Considering that in the ternary complex Thr208 is the only residue interacting with 
FMN, ADP-Mg2+ and with the Glu268 catalytic base, this residue seems to be crucial 
for the competent binding of ligands within the active site. Site-directed mutagenesis 
studies where T208A and T208D variants were characterized confirmed the 
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relevance of this residue [88]. Another residue that also executes a key role in the 
conformation of the ternary complex active site is Asn210, also from the PTAN 
motif. The Asn210 side chain interacts with FMN, Mg2+ and Glu268, setting the 
geometry of the catalytically competent complex, and contributing to maintain the 
phosphate of the ATP donor and the OH acceptor of the RF in the accurate position 
[99]. MD simulations show that the presence of either the flavin or the adenine 
nucleotides is not sufficient to induce the Thr208 conformational change. Moreover, 
these simulations suggest that the coordination of its side chain with ADP/ATP 
through the Mg2+ ion is the most probable determinant for the achievement of the 
catalytically competent geometry of the PTAN motif. 
 
 
Figure 1.21. Surface view of both the flavin and the adenine nucleotide binding sites at 
the RFK module. (A) Superposition of the free CaFADS RFK structure with the binary 
and ternary complexes. The free protein is shown in blue surface while both complexes 
are displayed in cartoon. In the free RFK, the flavin binding site is open and the adenine 
nucleotide binding site is closed. (B) Superposition of the same structures is shown as 
cartoon and the ternary complex as brown surface. In this case the adenine nucleotide 
cavity is open in both complexes, while the flavin cavity is closed only in the ternary 





Figure 1.22. Superposition of the free CaFADS RFK domain (light blue), the binary 
complex (light pink) and the ternary complex (brown). (A) Overall view of the alignment 
of the three structures. The most significant differences are highlighted with squares. (B) 
Detail of the flavin binding site indicating with a yellow arrow the displacement of loop 
L4c that closes the flavin cavity in the ternary complex. (C) Zoom into the adenine 
nucleotide binding site. Conformational changes of loops L1c, L3c and L5c are indicated 
with yellow arrows. (D) Detail of the position of L7c in the free protein and in both 
complexes that share the same conformation of that loop. (E) Conformation of the PTAN 
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motif in the three structures. The conformational change of Pro207 and Thr208 can be 
appreciated. Figure from [99]. 
All these data suggest that binding of ligands induces the conformational changes 
required during the catalytic cycle of the RFK module. Nevertheless, several aspects 
of this cycle still need to be clarified, such us; do the substrates of the RFK reaction 
bind the module sequentially or an induced-fit is required? or Has the  Mg2+ cation a 
role in this process? Additionally, the inhibition of the RFK reaction by substrates 
and products is a topic worthy of study.  
3.2.4. CaFADS can be organized into a dimer of trimers  
A structural analysis of the crystal structure of the CaFADS suggested the 
existence of an A3B3 hexameric organization in solution (being A and B the two 
chains of the asymmetric unit of the CaFADS crystal) (Fig. 1.23). Such oligomeric 
state would consist on two trimers (A1-A2-A3 and B1-B2-B3, one on top of the other). 
Within each trimer, the three protomers show a head-tail disposition. The trimers are 
stabilized through contacts of different nature between 20 side chains (18 H-bonds, 
18 hydrophobic contacts and 3 salt bridges) (Fig. 1.24A). The interface between 
trimers shows electrostatic complementarity (Fig. 1.23B). Moreover, 14 H-bonds, 4 
salt bridges and 12 hydrophobic contacts strengthen the hexamer [85].  
We focus now on the relative position in the different structures of the consensus 
207-PTAN-210 motif that stabilizes the ATP phosphates and the Mg2+ ion during the 
reaction. In the free enzyme, the side chain of the Thr208 is occupying the position 
where the adenine ring is located both in the binary and in the ternary complexes 
(Fig. 1.22E). Therefore, the ADP/ATP binding necessarily undergoes a huge 
conformational change that results in the opening of the adenine nucleotide cavity. 
Considering that in the ternary complex Thr208 is the only residue interacting with 
FMN, ADP-Mg2+ and with the Glu268 catalytic base, this residue seems to be crucial 
for the competent binding of ligands within the active site. Site-directed mutagenesis 
studies where T208A and T208D variants were characterized confirmed the 
relevance of this residue [88]. Another residue that also executes a key role in the 
conformation of the ternary complex active site is Asn210, also from the PTAN 
motif. The Asn210 side chain interacts with FMN, Mg2+ and Glu268, setting the 
geometry of the catalytically competent complex, and contributing to maintain the 
phosphate of the ATP donor and the OH acceptor of the RF in the accurate position 
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[99]. MD simulations show that the presence of either the flavin or the adenine 
nucleotides is not sufficient to induce the Thr208 conformational change. Moreover, 
these simulations suggest that the coordination of its side chain with ADP/ATP 
through the Mg2+ ion is the most probable determinant for the achievement of the 
catalytically competent geometry of the PTAN motif. 
 
 
Figure 1.23. Oligomeric state of CaFADS. (A) Spatial representation of the dimer of 
trimers. Left, view through the 3 crystallographic axis. Right, lateral view of the hexamer. 
(B) Electrostatic potential of the CaFADS hexamer along the interaction surfaces of the 
two trimers (negative, positive and uncharged residues are shown in red, blue and white 
respectively). The arrows show the positions with electrostatic contacts between trimers 
for the formation of the hexamer. Figure from [85]. 
The CaFADS trimeric state approaches the RFK and FMNAT active sites by 
placing the active centers of different protomers in close contact, which modifies the 
active site environment and its solvent accessibility (Fig. 1.24). That way, in the 
trimer, the RFK cavity appears partially closed by α2n and L4n of the neighboring 
protomer, specifically by the side chains of Phe62, Leu63, Pro64 and Arg66 (Fig. 
1.24A and D). Arg66 from the FMNAT module would establish a salt-bridge with 
the catalytic base Glu268 at the RFK site. Additionally, the FMNAT catalytic site is 
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also modified by residues of the RFK module of a different protomer (Fig. 1.24A and 
C). Concretely, V300 would close the isoalloxazine cavity of the FMNAT module, 
while hydrophilic residues of L6c would block the ribityl binding site. Furthermore, 
the positive dipole of α1c would contribute to stabilize the phosphates of the 
substrates at the FMNAT module. Hence, in the proposed oligomeric state of the 
CaFADS, each active site is composed of residues from its own module and also of 
residues from the other module of a different protomer [85].  
 
Figure 1.24. (A) Detail of the contact between the RFK and the FMNAT modules of 
different protomers within a trimer. (B) Cartoon representation of one of the trimers 
conforming the hexamer. The FMNAT module is shown in green while the RFK one is 
displayed in orange. Surface of each protomer is shown in different colors. The flavin 
products of the reactions are shown as spheres. (C) Detail of the active site at the FMNAT 
module. α1c and L1c of the RFK module of the neighboring protomer close the binding 
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site. (D) Detail of the active site of the RFK module. α2n and L4n of the FMNAT module 
of the neighboring protomer close the binding site. FMN and FAD are represented as 
violet and yellow sticks respectively. Figure from [85]. 
To further infer whether these oligomeric assemblies exit and have any role both 
at in-vitro and in-vivo levels, an analysis of the oligomeric states of CaFADS was 
conducted. The study revealed the existence of such oligomers (in the same 
proportion), in both types of assays, indicating that the oligomerization process was 
relevant both at the molecular and cellular levels [100]. All this information suggests 
that the CaFADS dimer-of-trimers might play a key role during its catalytic cycle. 
3.2.5. Binding of ligands induces oligomerization in CaFADS 
To determine whether the different ligands of CaFADS influence the 
oligomerization tendency of the protein, an atomic force microscopy (AFM) study 
was performed [100]. In this study liquid, jumping mode (JM) AFM allowed 
visualizing single isolated CaFADS molecules, estimating their molecular 
dimensions, as well as distinguishing between the C-terminus and the N-terminus 
modules.  
 
Figure 1.25. AFM topography images of CaFADS after incubation with ATP:Mg2+. The 
different species identified as monomer, dimer, tetramer and a dimer of trimers are 
rounded in black, red, brown and yellow respectively. Figure from [100]. 
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Some substrates of the RFK (RF or ATP:Mg2+), the FMNAT (ATP:Mg2+), and the 
FADpp (FAD) activities of CaFADS induced the oligomerization of the protein, 
yielding different oligomeric assemblies (Fig. 1.25) [100]. Some of these quaternary 
structures, such as dimers and an amorphous hexamer, might act as intermediates 
during the assembly of the organized dimer of trimers, which is specially favored by 
the presence of ATP:Mg2+, and also by the products of the RFK reaction 
(FMN:ADP) (Fig. 1.26). Therefore, during the catalytic cycle, the quaternary 
organizations might be structured by the previous formation of dimers (supported by 
contacts between the RFK and FMNAT modules of different protomers) followed by 
packing of additional protomers to finally raise the dimer of trimers. Furthermore, 
the stabilization of the phosphate groups of ATP/ADP:Mg2+ at the RFK domain 
appeared as a determinant of the oligomerization process.  
 
Figure 1.26. Topography image of CaFADS upon incubation with the products of the 
RFK reaction (FMN and ADP:Mg2+). (A) 3D image of a single organized dimer of 
trimers. (B) Superposition of the crystallographic CaFADS hexamer and its 2D AFM 
image. Figure from [100]. 
Concerning other bifunctional FADSs, possibility of oligomerization has not been 
reported. The structural analysis of the FADSs whose structures are available 
(SpnFADS and TmFADS), does not predict the formation of any quaternary 
organization. The main structural differences of CaFADS regarding other FADSs are 
located in the β1n strand of the FMNAT module (absent in TmFADS), and 
particularly in an insertion of 12 residues in the loop L3c (L232-V246), that is only 
present in Corynebacteria and Mycobacteria species [76]. As previously indicated, 
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the position of this insertion (also lacking in monofunctional RFKs), is stabilized in 
the monomeric CaFADS by H-bonds that connect L3c and L5c. Additionally, L3c 
reinforces the interface between trimers within the hexamer. Therefore, besides all 
these elements that stabilize the dimer of trimers, L3c provides 3 more hydrophobic 
contacts (per protomer), between the three RFK modules of one trimer and residues 
from β1n and α3n at the FMNAT module of the other trimer. Hence, the absence of 
L3c in other FADSs might prevent the dimer of trimers stabilization, and 
consequently, the formation of oligomeric structures.  
Collectively, these data hypothesized the implication of the organized dimer of 
trimers in the catalytic activities of CaFADS. This implication is also supported by a 
site-directed mutagenesis study, that concludes that conformational changes at the 
RFK module produced by ligand binding affect the catalytic efficiency at the 
FMNAT module of CaFADS of the neighboring protomer within the trimer [88]. In 
this study the substitution of the residues T208 and N210, both located in the 
consensus 207-PTAN-210 motif and of E268 (Figs. 1.10 and 1.16), altered the 
kinetic parameters for the RFK reaction, as well as substrates and products binding 
constants. Additionally, mutations of these residues, located at the RFK module of 
CaFADS, also modulated the binding parameters at the FMNAT active site, and the 
catalytic efficiency of the FMN transformation into FAD [88]. 
3.3. Other prokaryotic FADSs 
3.3.1. The FADS from Streptococcus pneumoniae: SpnFADS 
The crystal structure of the FADS from Streptococcus pneumoniae (SpnFADS) 
was released in 2010 (PDB: 3OP1) (Fig. 1.27A). SpnFADS is organized in two 
different modules putatively related to each activity. The C-terminus module 
(residues 187-305), would perform the RFK activity, and it is constituted by a β 
barrel formed by six antiparallel β-strands (β1c- β6c), a long terminal α-helix (α2c) 
and an additional short α-helix (α1c), compound by 4 residues and located in loop I 
that connect β1c and β2c. Six loops connect these secondary structure elements (Fig. 
1.27B). The N-terminal module (residues 1-186) folds into a α/β dinucleotide 
binding domain with the typical Rossman fold, and by homology with CaFADS (Fig. 
1.27B), it is predicted to catalyzed the FMNAT reaction. This domain is organized 
into six β-strands (β1n-β6n) and several α-helixes surrounding the β-strands 
connected by ten loops (L1n-L10n).  




Figure 1.27. Structure of SpnFADS (PDB: 3OP1) (A) Cartoon representation of the 3D 
structure of SpnFADS with the N-terminal domain colored in pink and the C-terminal one 
in yellow. (B) Topology of the N-terminal module (pink) and the C-terminus one 
(orange). α-helix are displayed as solid dark rectangles and β-strands as light arrows. 
Loops connecting secondary structure elements are shown in thick lines. The numbers 
indicate residue positions.  
Sequence analysis shows that SpnFADS contains all the typical features of 
prokaryotic FADSs (Figs. 1.28A and 1.11), and therefore it is expected to be able to 
perform the RFK, FMNAT and FADpp activities. SpnFADS shows 29% sequence 
identity with CaFADS (Fig. 1.28A), and also owns the consensus sequences greatly 
conserved among prokaryotic FADSs. The N-terminus module presents the 30-
HxGH-33, 161-xxSSTxxR-168 and 16-Gx(N/D)-128 motifs (SpnFADS numbering), 
which have been reported to play a key role in the FMNAT activity of CaFADS 
through the stabilization of the ATP phosphates groups (Fig. 1.28A) [90]. 
Additionally, the SpnFADS C-terminal module also contains the 203-PTAN-207 
motif (SpnFADS numbering), whose conformational change leads to the 
establishment of the catalytically competent complex in CaFADS, and the Glu255 
(SpnFADS numbering), that must act as catalytic base during RF phosphorylation 
[88]. Nevertheless, the relative position of these structural motifs, specifically the 
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orientation of the PTAN motif, meaningfully differs between both structures (Fig. 
1.28C). On the other hand, it is noteworthy that the conformation of the PTAN motif 
in SpnFADS significantly resembles the position of this motif in the Δ(1-
182)CaFADS-FMN-ADP ternary complex (PDB: 5a89) (Fig. 1.28D). This important 
variance suggests that SpnFADS might require less structural rearrangements to 
acquire the catalytically competent complex than CaFADS, as well as important 
differences in the RFK catalytic cycle.  
 
Figure 1.28. (A) Structural alignment of CaFADS (PDB: 2X0K) and SpnFADS (PDB: 
3OP1) performed by the SSM server (http://www.ebi.ac.uk/msd-srv/ssm/). Identical 
residues are shown in dark blue and conservative ones in light blue. Consensus motives at 
N-terminal (30-HxGH-33 and 160-xSSTxxR-168) and at C-terminal (103-PTAN-107 and 
E255, SpnFADS numbering) are highlighted with red boxes. (B) Superposition of the 
overall structures of SpnFADS (with its C and N-terminal domains colored in light pink 
and yellow, respectively) and CaFADS (light blue and salmon, respectively). (C) Detail 
of the conformation of the PTAN motif in SpnFADS (CPK code with carbons in orange) 
and in the Δ(1-182)CaFADS ternary complex with FMN and ADP (CPK code with 
carbons in maroon) FMN and ADP products are shown in purple and yellow lines, 
respectively. (D) Zoom into the PTAN motif residues and E255 of SpnFADS (shown in 
orange) and CaFADS (in maroon).  
María Sebastián Valverde 
 54 
3.3.2. The FADSs from Listeria monocytogenes and Mycobacterium 
tuberculosis 
Crystallographic structures for the bifunctional FADSs from the pathogenic 
organisms L. monocytogenes (LmFADS) and M. tuberculosis (MtFADS) are not 
available. However, sequence alignments and structural models have been produced, 
using as models prokaryotic FADSs whose structure are known, mainly CaFADS, 
SpnFADS and TmFADS (PDB codes 2X0K, 3OP1 and 1T6Y, respectively) [78].  
L. monocytogenes owns two different FADSs, named Lm1FADS and Lm2FADS. 
Sequences alignments revealed that Lm1FADS is a type-I FADS, and shows all the 
consensus sequences assigned to RFK and FMNAT activities, in the C-terminal and 
N-terminal modules, respectively (Fig 1.29). Lm2FADS presents in its N-terminal 
module the consensus sequences related to FMNAT activity, while its C-terminus 
module is degenerated, and does not show the consensus sequences displayed by 
RFKs (Fig 1.29). Therefore, the function of the C-terminal module of Lm2FADS has 
not been predicted [78].  
Lm1FADS and Lm2FADS have been purified, and their RFK and FMNAT 
activities have been measured both in the presence and in the absence of reducing 
environment [78, 79]. As it was expected, since Lm2FADS lacks the consensus 
motifs of RFKs, only Lm1FADS was able to transform RF into FMN, both under 
reducing and oxidizing conditions, although the catalytic efficiencies differed [78, 
79]. Both proteins were able to transform FMN into FAD, but interestingly their 
redox requirements were different. Lm1FADS only presented FMNAT activity under 
strong reducing conditions, while Lm2FADS carried out this activity with and 
without the reducing agent, being more efficient under oxidizing environment [78].  
In spite of the great efforts made to overexpress and purified MtFADS, all the 
attempts to produce it have failed [78]. Sequence alignments performed for MtFADS 
indicated that this protein also belongs to the bifunctional type-I FADSs, as it shows 
all the consensus motifs of this family of proteins (Fig 1.29). It is worth to notice the 
high identity percentage between MtFADS and CaFADS, as also the fact that FADSs 
from Corynebacterium and Mycobacterium genus are the only ones that have the 12-






Figure 1.29. Sequence alignment of bifunctional FADSs from different organisms. Residues that are the same for all the five sequences are highlighted in 
red, those found in type-I FADSs but not in type-II FADS are shown in pink, and those present in CaFADS, Lm1FADS, Lm2FADS, and in MtFADS are 
displayed in yellow. The insertion Leu232-Val246 (CaFADS numbering), observable only in Corynebacterium and Mycobacterium genus, is colored in 
gray. The consensus sequence and conserved residues among FADS family is displayed under the alignment. Symbols Φ,Ψ y Ω denote for hydrophobic, 
polar and any residue respectively. Figure modified from [78].  
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3.4.  Bacterial diseases needing new efficient treatments 
As we have discussed in Section 1, the apparition of multidrug resistant pathogens 
evinces the necessity to develop new antibacterial strategies and FADS are 
interesting drug targets in the discovery of antimicrobials.   
3.4.1. Streptococcus pneumoniae and pneumonia 
Streptococcus pneumoniae appears as a main problem for the public health both 
in developing and developed countries. This pathogen is responsible of a great 
variety of clinical profiles, being the causative agent of mild infections as otitis 
media or paranasal sinusitis, as well as of serious infections as septic arthritis, 
pneumonia, and brain abscesses [101]. Additionally, meningitis usually appears 
secondarily to pneumococcal infections. Pneumonia is the world´s leading cause of 
death among children under five, accounting for 15 % of deaths (data from the 
American Thoracic Society). Over the last two decades the incidence rate of 
systemic infections, such as meningitis, caused by Streptococcus pneumoniae have 
increased, and penicillin resistant strains have appeared as well [102].   
Physiology, structure and genetics of S. pneumoniae 
S. pneumoniae cells are Gram-positive, lancet-shaped, typically placed as pairs of 
cocci (diplococci). These bacteria require special culture conditions, needing 
enriched media as blood-agar. When cultured in that media they are alpha-hemolytic 
(under aerobic conditions) or beta-hemolytic (under anaerobic conditions). They 
neither form spores nor are motile. Concerning their metabolism, they are catalase 
negative and ferment glucose to lactic acid. In-vitro cultures require 5% carbon 
dioxide and a source of catalase to neutralize the produced peroxide hydrogen. In 
complex media, at 37ºC, S. pneumoniae has a generation time of 20-30 minutes. The 
pneumococcus is also able to produce autolysin, which is an enzyme that causes the 
culture to undergo autolysis. The autolysin kills the entire culture when it has grown 
to the stationary phase [102].   
S. pneumoniae presents a capsule composed of polysaccharides that completely 
envelops the cells. During invasion, the capsule is a virulence determinant since it 
hinders phagocytosis by preventing the opsonization of the bacteria [103]. The cell 
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wall of S. pneumoniae is composed of peptidoglycan with teichoic acid attached, 
which is a virulence factor. With respect to surface proteins, the pneumococcus is 
estimated to contain more than 500 of them, either associated to the membrane or to 
the cell wall [104]. The latter group includes, among others, five penicillin-binding 
proteins, two neuroaminidases and an IgA protease. Additionally, twelve choline-
binding proteins are non-covalently bound to choline motifs of the cell wall, 
constituting some of them virulence factors [105].  
S. pneumoniae has a natural transformation system as mechanism for genetic 
exchange between related or unrelated bacteria, whose last consequence is the 
apparition of antibiotic resistances. 
Pathogenesis and invasion cycle of the pneumococcus 
S. pneumoniae causes diseases in humans, monkeys, rabbits, horses, mice and 
guinea pigs. 40 % of the population shows nasopharyngeal colonization by the 
pathogen. 
The ecological niche for the pneumococcus is the nasopharynx. When the bacteria 
enter the nasal cavity, the negatively charged capsule protects them from being 
tapped in the mucous, and they can reach the epithelial surface. Many surface 
proteins are involved in the nasopharyngeal colonization, such us hyaluronidase, or 
CbpA [106, 107]. Once bacteria have entered the lower respiratory tract, the 
initiation of pneumonia requires escape from mucous defenses and migration of the 
bacteria into the alveolus (Fig. 1.30). For this purpose, bacterial neuraminidase 
cleaves mucin, and uncovers some glycoconjugates on the host cells, providing sites 
for bacterial attachment.  
The strong adherence of bacteria to the alveolar epithelium, their subsequent 
replication and the initiation of host damage responses, collectively lead to the 
classic evolution of pneumonia. Innate immune defenses, together with products 
secreted by bacteria, and cell surface-anchored bacterial components drive this 
process. The toxin pneumolysin (that produces pore formation) disrupts the alveolar 
epithelium, while edema fluid accumulates in the alveolar space, as a result of the 
alteration of the vascular permeability [108]. During this early host response, S. 
pneumoniae sticks tighter to the alveolar epithelium through the use of several 
adhesins or pili [109].  
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The pneumococci together with other respiratory pathogens have developed a 
common strategy to advance mucosal disease to bacteremia, which is named “innate 
invasion”. For this process the platelet-activating factor receptor located in the host 
cell surface, that binds phosphorylcholine at the bacterial surface, plays a key role. 
This binding initiates the uptake of S. pneumoniae into a vacuole that moves across 
the host cell spreading the bacteria all over the cell, where they can be released to 
seed the bloodstream [110]. When bacteremia (presence of bacteria in blood) 
happens, the risk of meningitis increases, since the pneumococcus can adhere 
specifically to cerebral capillaries, and once in the cerebrospinal fluid initiate the 
inflammatory response in the brain [102]. 
 
Figure 1.30. Progression of the pneumococcal disease. Figure from [111] 
Epidemiology and emergence of antibiotic resistant strains  
Pneumococcal infections cause more deaths than any other vaccine-preventable 
bacterial disease, being especially susceptible to the pathogen, children between 6 
months and 4 years and adults over 60. It is estimated that 25 % of all community-
acquired pneumonia (CAP) is caused by the pneumococcus [112]. Introduction of a 
conjugate vaccine has reduced the incidence of invasive disease [102, 113], although 
epidemics of disease have reappeared in locations such as chronic care hospitals, 
military camps and day care centers, which have not occurred since the pre-antibiotic 
era.  
A matter of concern is the increased emergence of antibiotic resistance among the 
pathogens that cause CAP, and especially the pneumococcus, observed in the past 
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two decades. This phenomenon is occurring worldwide and involves all classes of 
antimicrobial agents to a greater or lesser extent [114, 115]. The Canadian Bacterial 
Surveillance Network shows the progressive rise of resistance among S. pneumoniae 
to penicillin, trimethoprimsulfamethoxazole, macrolides and fluoroquinolones. Data 
from a study of the Tracking Resistance in the United States Today also shows a 
steady rise in pneumococcal resistance against common antibiotics, as well as an 
increase in multidrug-resistant S. pneumoniae [116]. The incidence of penicillin-
resistant pneumococcus increased from 0 in 1988 to 7 % in 2001, while the incidence 
of resistant strains to trimethoprim-sulfamethoxazole increased from 3.7 % to 12 % 
in the same period. Additionally the frequency of macrolide-resistant pneumococci 
has also increased; the number of erythromycin-resistant strains grows from 1.2 % to 
13.1 %, and the number of clindamycin-resistant organisms increased from 1.2% to 
5.8% (Fig. 1.31) [116]. Of greater concern is the rise of the frequency of multidrug-
resistant S. pneumoniae, which means strains resistant to three or more antimicrobial 
classes, most commonly penicillin, trimethoprim-sulfamethoxazole, and macrolides 
[116]. 
  
Figure 1.31. Antibiotic resistance trends for Streptococcus pneumoniae in Canada. TMP-
SMX: rimethoprim-sulfamethoxazole. Figure from [116].  
All these alarming data evince the necessity to develop new efficient antibacterial 
drugs against the pneumococcus. Here we proposed the rational design of new 
medicines targeting the FAD synthetase of S. pneumoniae (SpnFADS), which 
appears to be a strategy worthy to be explored [89]. Therefore, a first 
characterization of SpnFADS seems to be a good starting point to get this purpose. 
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3.4.2. Mycobacterium tuberculosis and tuberculosis 
Tuberculosis (TB) is the world leading cause of death from bacterial infectious 
diseases. The disease affects 1.8 billion people/year, one third of the entire world 
population (data from the World Health Organization, 2015).  
M. tuberculosis is the causative agent of TB. This bacterium was first described in 
1882 by Robert Koch, who subsequently received the Nobel Prize in 1905 for this 
discovery, therefore the bacterium is also known as “Koch´s bacillus”.  
Physiology and structure of M. tuberculosis 
M. tuberculosis is part of the M. tuberculosis complex, together with M. bovis, M. 
bovis BCG, M. africanum and M. microti [117, 118]. All these organisms share 99% 
of sequence identity, although they are very different regarding phenotype and 
pathogenicity [119]. 
M. tuberculosis is a non-motile rod shaped bacterium. This bacterium is an 
obligate aerobe, and a facultative intracellular parasite, normally of macrophages. It 
is a slow-growth bacterium and divides every 15-20 hours, for this reason it takes 4-6 
weeks getting dense cultures. Under adverse conditions, M. tuberculosis can stay in a 
latent state, delaying its growing from some days to several years [118]. Regarding 
its culture conditions, two media can be used to grow this mycobacteria: 
Middlebrook´s medium, which was designed to protect organisms against a variety 
of toxic agents [120]; and Lowenstein-Jensen medium, which is an egg-based 
medium. In both media, colonies appear small and buff colored after 4-6 weeks of 
incubation. M. tuberculosis belongs neither to Gram-positive, nor to Gram-negative 
bacteria, since it does not show the chemical characteristics of either, although the 
cell wall contains peptidoglycan (murein). Gram stain on mycobacterium cells yields 
(and not always) very weakly Gram-positive stain, and therefore, cells are referred as 
“ghosts”. Instead, acid-fast stains such as Ziehl-Neelsen, are used to identify the 
bacillus with a microscope. 
  
The cell wall of M. tuberculosis 
The mycobacterial cell wall requires special attention, since it is unique among 
prokaryotes, and one of the virulence determinants of mycobacteria. The wall has an 
external membrane that shows extremely low permeability [121, 122]. Chemically, 
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the wall is an intrinsically complex structure, made of peptidoglycan, lipids and 
different proteins [123, 124]. Over 60% of the cell wall are lipids, with three major 
components: 
-Mycolic acids; that are alpha-branched lipids. These lipids are molecules highly 
hydrophobic that form a lipid shell around the organism, affecting the permeability 
of the cell wall. Mycolic acids are important virulence determinants, since protect the 
bacteria from the attack of cation proteins [125].  
-Cord factor; is the primary glycolipid found on the surface of mycobacteria cells 
[126]. This molecule induces the disposition of the cells into long and slender 
formation. Cord factor is key for the survival of the pathogen within the hosts [127, 
128], altering immune responses, inducing granulomas formation and inhibiting 
tumor growth [129]. 
-Wax-D; located in the cell envelope, is the major component of Freund´s 
complete adjuvant [130].  
 
Figure 1.32. Structure and chemical composition of the cell wall of M. tuberculosis. 
Figure modified from Doc Kaiser’s microbiology website Community College of 
Baltimore County.  
Regarding the protein fraction, different membrane-associated proteins specific of 
M. tuberculosis have been identified, such as lipoproteins and antigens recognized by 
María Sebastián Valverde 
 62 
B and T lymphocytes. The function of most of these proteins remained unclear, 
although they seem to play a key role in the functionalization of the cell wall [122].  
Apparently, the mycobacterial cell wall is involved in mycobacteria resistance 
against different drugs. Additionally, differences in the composition of the mycolic 
acids might affect the fluidity and permeability of the bilayer. That fact would 
explain the different susceptibility to lipophilic drugs observed among mycobacterial 
species. Hydrophilic inhibitors are expected to cross the cell wall through porin 
channels (Fig. 1.32) [121]. 
 
Virulence factors 
M. tuberculosis owns different and multifaceted virulence factors. This organism 
does not produce any toxins, but it shows a huge repertoire of structural and 
physiological properties, that contribute to its virulence. Among these pathogenicity 
determinants, we can highlight; growth within the macrophage [131], detoxification 
of reactive oxygen species [132], slow generation time and adherence factors [133]. 
Pathogenesis and invasion cycle of M. tuberculosis 
M. tuberculosis is an exclusively human pathogen. The seriousness of the 
infection mainly depends on two parameters; the bacterial virulence, and the host 
resistance against the infection [134]. There are two types of infections, primary and 
post-primary. A complex network of interactions is established between the bacteria 
and the host, that can lead to the bacterial neutralization (no infection), to the log-
term survival of the bacteria (latent infection), or to an active disease (primary 
tuberculosis) [135, 136].  
During the infection the bacteria enter into the alveolar macrophages of the 
host through specific binding to different surface molecules [137, 138]. Through the 
activation of mechanisms that avoid the phagosome-lysosome fusion, the bacteria 
can survive and proliferate within the macrophage [139]. Then, the infection draws 
on through a granuloma formation, as a consequence of the migration of other 
immune cells to the infection spot [139]. The granuloma function is to content the 
pathogen, preventing their growth and spreading to the alveolar tissue and to the 
lungs, and also to focus the immune response [137]. After infection, macrophages 
die either through necrosis or apoptosis, although sometimes they survive. This last 
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fact would determine the result of the infection [140]. If the immune system detects 
and neutralizes the bacillus, the host will not develop the disease, while if the 
mycobacteria evade the immune response and survive, the infectious process will 
continue. In this situation, the host could develop the tuberculosis disease, or the 
bacteria could stay in a latent state, awaiting more favorable future conditions to 
continue the infection [141-143].  
The diagnosis of tuberculosis requires detection of acid-fast bacilli in sputum 
through the Ziehl-Neelsen method. Therefore, bacteria must be cultured, which can 
take 4-6 weeks. The BACTEC system is a faster alternative (it takes 9-16 days) to 
detect the bacilli [144]. The presence of mycobacterial antibodies can also be 
detected through the tuberculin test, which consists on a skin test that uses as antigen 
a purified protein derivative [145]. 
Treatment and emergence of multi drug-resistant tuberculosis strains 
To minimize the apparition of resistances, the tuberculosis treatment involves the 
use of multiple drugs to which the organisms are susceptible. Therefore, tuberculosis 
is normally treated using four different drugs; rifampin, isoniazid, pyrazinamide and 
ethambutol and/or streptomycin [146]. Tuberculosis treatment lasts 6-9 months. 
When this four-drugs treatment is used at the beginning of the therapy, the recovery 
probability of the patient is very high.  
A different strategy against tuberculosis consists on vaccination. The actual anti-
tuberculosis vaccine, Bacillus Calmette-Guérin (BCG), is a live attenuated vaccine 
used around the world. This vaccine protects against severe forms, although shows 
highly variable efficiency against pulmonary forms of tuberculosis, which are 
responsible for the spread of the bacillus. During the last decade, new candidates 
have been proposed as anti-tuberculosis vaccines, being the general objective to 
develop an effective vaccine, that protects against the pulmonary forms of the 
disease [147].  
Resistance to anti-tuberculosis drugs can appear due to the mismanagement of 
these drugs [148]. Attending to the number of drugs to which the bacilli is resistant, 
we can distinguish between multidrug-resistant strains (the bacteria are resistant to at 
least two of the best drugs, normally isoniazid and rifampin, which are considered 
first-line drugs), and extensively drug resistant strains (the bacterial show resistance 
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against isoniazid and rifampin and also against any fluoroquinolone, and against at 
least one of the three second-line drugs) [149, 150]. Patients with extensively drug 
resistant tuberculosis usually have worse treatment outcomes.  
Epidemiology 
Approximately, one-third of the world´s population has been infected with M. 
tuberculosis (data from World Health Organization, 2011). Nevertheless, the 90-95% 
of infections do not progress to an active disease, but it is estimated that 8.6 million 
of chronic cases were active in 2012 (data from the World Health Organization 
http://www.who.int/tb/publications/global_report/en/). Tuberculosis is the second-
most common cause of death from infectious disease, after those due to HIV. 
Tuberculosis has a greater incidence in developing countries, almost 80% of the 
population in Asia and Africa present positive results in the tuberculin test, while in 
USA only 5-10% of the population is tuberculin-positive [151] (Fig. 1.33). The 
control of TB disease is not easy due to different factors, such as the difficulty to 
develop an effective vaccine, the expensive and long diagnostic process and 
treatment and the emergence of drug-resistant strains in the 80s [151]. Tuberculosis 
appears then, as a main problem of public health, and the development of a vaccine, 
or the discovery of new effective anti-tuberculosis agents is a topic worthy of study 
and research.  
 
Figure 1.33. Number of cases of tuberculosis per 100000 people around the world. In 
2007 countries of sub-Saharan Africa, and also of Asia were the ones that registered more 
new cases of tuberculosis. 
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3.5. CaFADS, SpnFADS and MtFADS as drug targets 
The indiscriminate use of antibiotics has produced the apparition of immune 
bacteria. Thus, the apparition of multi-drug resistant microorganisms [11] forces us 
to find new antimicrobial drugs targeting new essential biomolecules. As previously 
said, FADSs seem good potential targets [89], since their selective inhibition 
produces lack of FMN and FAD, with the subsequent accumulation of the apo forms 
of essential flavoproteins that are unable to carry out their functions [32, 33, 152], 
and finally death [153, 154].  
In that way, the selectively inhibition of the FADSs from S. pneumoniae, and M. 
tuberculosis, might be an effective strategy to neutralize these pathogens and to treat 
the diseases they produce. The RFK module of bacterial FADSs shows homology 
with eukaryotic RFKs but the FMNAT module does not [74, 85, 155, 156] (Fig. 
1.34). Therefore, inhibiting this second module is the best option in the drug 
development process [89].  
Unfortunately, until the date attempts to produce stable purified MtFADS have 
failed, and SpnFADS shows some characteristics (low Tm, and need of reduced 
flavins for the FMNAT activity) that hinder performing some high throughput 
assays. Therefore, the use of CaFADS, which is the member of the family best 
characterize [76, 84-86, 90, 95, 99] as model for both proteins, might be good as first 
approximation. SpnFADS presents only 29% sequence identity with CaFADS, but it 
owns the consensus sequences of prokaryotic FADSs and both proteins show very 
similar structures (Fig. 1.28). MtFADS sequence shows 45% identity with CaFADS 
that increases up to 59% when considering conservative substitutions [76]. 
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Figure 1.34. Cartoon representation of the overall structures for the RFK and FMNAT 
modules of CaFADS, and the RFK and FADS enzymes from HsRFK and Candida 
glabrata (CgFMNAT), respectively. The RFK and FMNAT modules of the prokaryotic 
bifunctional CaFADS are displayed in light and deep blue, respectively, while the 
monofunctional eukaryotic HsRFK and CgFMNAT are shown in orange and red, 
respectively. The CaFADS RFK module shares structural elements and catalytic site with 
the correspondent monofunctional enzyme, but that is not the case of the CaFADS 
FMNAT module and the eukaryotic CgFMNAT. PDB codes 2x0k, 1q9s and 3fwk for 




4. Objectives  
The main goal of this thesis is to further delve into the molecular mechanisms of 
prokaryotic bifunctional FADSs, focusing on the regulation of their catalytic properties 
and on the similarities and differences among species. This knowledge will help in 
settling the bases to the use of prokaryotic FADSs as targets in the development of 
antimicrobials. With these general aims, in this study we tackle the following partial 
goals: 
- To determine the roles of residues at the trimer interface of the CaFADS dimer-of-
trimers in the formation of oligomeric species, in the mechanisms of the enzyme 
catalytic cycles, and in the interaction with substrates and products.  
- To propose a kinetic and thermodynamic model that explains the inhibition 
produced by excess of the RF substrate in the RFK activity of CaFADS. 
- To carry out the first functional characterization of the FADS from the human 
pathogen S. pneumoniae, including the description of its RFK and FMNAT catalytic 
cycles, its oligomerization tendency and the interaction with ligands. 
- To set the bases of the different strategies adopted by CaFADS and SpnFADS to 
regulate their RFK activities.  
- To develop an activity-based High Throughput Screening (HTS) assay to discover 
inhibitors of the FMNAT activity of CaFADS. 
- To evaluate the potency of the identified HTS hits on the RFK and FMNAT 
activities of this enzyme, and to characterize the inhibition mechanism and the protein 
binding affinities of the best hits inhibiting the CaFADS FMNAT activity.  
-To evaluate the specificity of the inhibitors for CaFADS FMNAT activity versus 
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1. General techniques in Molecular Biology  
1.1. Production of thermo-competent cells 
Competent cells are those that are able to take up extracellular DNA from their 
environment in a process called transformation. During the production of competent 
cells the cellular membrane is weakened due to the formation of pores, across which 
plasmid DNA gets internalized without provoking cellular collapse.  
To produce competent cells, a chemical treatment with CaCl2 was used [157]. A 
single Escherichia coli colony was grown in 1 ml of sterile Luria Bertani (LB) medium, 
containing no antibiotics. The culture was grown at 37ºC overnight (O.N.) with gently 
agitation. 10 ml of LB were inoculated with 100 μl of the culture and cells were grown 
in the same conditions until reaching the exponential phase, that is until getting an 
O.D.600 nm= 0.3-0.6 AU. At this moment the culture was centrifuged for 10 min at 4ºC 
and the supernatant was discarded. Cells were resuspended in 0.05 M sterile CaCl2 (1ml 
of CaCl2 per 5 ml of culture) and incubated during 20 min in ice bath. 200 l aliquots of 
competent cells were preserved in 20 % glycerol (v/v) and frozen at -80 ºC.  
1.2. Transformation of thermo-competent cells through heat shock 
For the transformation process, competent E. coli cells previously prepared and 
preserved at -80ºC were used. The transformation was performed through heat shock at 
42 ºC. Cells were pre-incubated in ice bath to favor slow defrosting. 100 μl of defrosted 
competent cells were added to sterile eppendorf tubes containing the transforming 
DNA, typically 2-5 μl (40-100 ng) of plasmid DNA. Negative and positive controls 
were included. 10 μl of autoclaved water or 4 μl of plasmid DNA, showing high 
transformation efficiency, were added to the cells as negative or positive controls 
respectively. The mixtures were incubated in ice bath for 15 min and then at 42 ºC for 
50 s, which produces the heat shock that originates the pores across which the DNA is 
taken. Immediately after, the samples were incubated in ice for 2 min. Finally, 900 μl of 
LB medium, without antibiotic and preheated at 37ºC, were added to each eppendorf 
tube under sterile conditions. The samples were then incubated at 37 ºC and 180 r.p.m. 
during 2 hours.  
To check the success of the transformation a culture in solid medium was performed. 
The cells were grown in LB-agar plates containing the selection antibiotic, 30 μg/ml 
kanamycin for pET28a and 100 μg/ml ampicillin for pET15b. 100 μl of each 
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transformation sample were plated. The remaining volume was centrifuged and the 
precipitated was resuspended in 100 μl of LB medium that were plated again. The plates 
were incubated at 37ºC until apparition of colonies (14-18 h). The grown colonies 
assimilated the corresponding antibiotic resistance gene and therefore the transforming 
plasmid DNA.  
1.3. Isolation of plasmid DNA 
A single colony product of the transformation was inoculated in 10 ml of LB 
medium containing the selection antibiotic. The culture was incubated O.N. at 37ºC and 
180 r.p.m. agitation. The extraction of the plasmid DNA was carried out using the 
GenEluteTM Plasmid Miniprep Kit (Sigma-Aldrich®), based on cellular lysis methods in 
alkaline medium and plasmid purification through its union to a fiberglass matrix.  
2. Production of the recombinant CaFADS and its variants 
All the plasmids codifying WT CaFADS and the variants here analyzed were 
produced in advance to the start of this thesis. 
Gen ribF codifying the WT protein had been cloned in the expression plasmid 
pET28a (+) under the promoter of the phage T7, between the Ncol/BamHI restriction 
sites [76]. The different variants of the protein were produced by the company 
Mutagenex (www.mutagenex.com) introducing the appropriate mutations in the 
construct CaFADS-pET28a (+).  
2.1. Over-expression of CaFADS and its variants 
Culture of WT CaFADS and of its variants (including Δ(1-182) CaFADS) were 
initiated either from 100 μl of liquid cultures preserved in glycerol at -80 ºC, or from a 
colony in LB-agar solid medium. In both situations 10 ml of LB medium containing 30 
μg/ml kanamycin were inoculated with the bacteria and incubated at 37ºC for ~8 h 
under 180 r.p.m. agitation. After that, the pre-cultures were transferred to containers 
with 200 ml of LB medium and 30 μg/ml kanamycin, and were incubated O.N. in the 
same conditions. The following morning, 2 l Erlenmeyer flasks containing each one 1 l 
of medium, were inoculated with 10 ml of the overnight cultures and were incubated 
until reaching O.D.600nm= 0.5–1 AU. In that moment the expression of the proteins was 
induced through addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) at a final 
concentration of 1 mM. Then, the cultures were incubated O.N. at 37 ºC under agitation. 
The cells were harvested at 4 ºC by several rounds of 10 min centrifugations at 18000 x 
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g. The precipitate was wash with 0.15 M NaCl and the cells were centrifuged again. The 
supernatant was discarded and the cellular pellet was preserved at -20ºC. Generally, the 
yield was 5-7 g of cells per liter of culture.  
2.2. Purification of CaFADS and its variants 
2.2.1. Preparation of the crude extract  
 E. coli cells overexpressing CaFADS, or its variants, and produced according to 
section 2.1. were resuspended in 5-10 ml of lysis buffer (100 mM Tris/HCl, pH 8.0, 10 
mM EDTA, 12 mM β-mercaptoethanol, 1μM PMSF) per gram of cell. Cells were 
broken through ultrasonic treatment at 4ºC in a sonicator DRH UP200 DR Hielsher, 
using 16 cycles of 45 s with 1 min rest between them. Then, the lysis solution was 
centrifuged at 4 ºC and 48000 x g for 45 min. The yellow color of the supernatant 
(crude extract) is due to a flavin initially bound to the CaFADS, which has been 
identified as FAD [76]. 
 2.2.2. Fractionation with ammonium sulphate 
The resulting crude extract was fractionated through addition of 45 % ammonium 
sulphate in ice bath (25.8 g per 100 ml of crude extract). The salt addition was 
performed under mild stirring of the solution, to avoid the apparition of higher local 
concentrations. The precipitated fraction was removed by centrifuging the extract at 4 
ºC and 48000 x g for 45 min.  
2.2.3. Phenyl-Sepharose affinity chromatography  
The crude extract was loaded upon a Phenyl-Sepharose High Performance column 
(Amersham Biosciences, GE Healthcare) previously equilibrated with 50 mM Tris/HCl, 
pH 8.0, 45 % ammonium sulphate. The column was washed with 50 mM Tris/HCl, pH 
8.0, 13.5 % ammonium sulphate until the yellow flavin, released from CaFADS [76], 
has completely eluted. Then, the protein was eluted through linear 13.50 % 
ammonium sulphate reverse gradient in the same buffer. Absorbance at 280 nm was 
registered while 6-8 ml fractions were collected. Fractions corresponding with peaks 
containing protein were analyzed through 17 % SDS-PAGE, and those containing more 
and purer CaFADS were selected. The selected fractions were dialyzed against 50 mM 
Tris/HCl, pH 8.0.  
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2.2.4. DEAE-Cellulose anionic interchange chromatography 
A second DEAE-Cellulose anionic interchange chromatography was performed. The 
dialyzed protein was loaded upon the column previously equilibrated with 50 mM 
Tris/HCl, pH 8.0. The column was washed with 50 mM Tris/HCl, pH 8.0, 0.1 M NaCl 
and then the protein was eluted using a linear 0.10.5 M NaCl gradient in the same 
buffer. 6 ml fractions were collected while absorbance at 280 nm was recorded. Once 
again, fractions corresponding to peaks that contain protein were analyzed by 17 % 
SDS-PAGE. Fractions containing the pure CaFADS were selected and dialyzed against 
20 mM PIPES, 10 mM MgCl2, pH 7.0.  
2.2.5. Size exclusion chromatography 
CaFADS is purified as a mixture that contains monomeric protein and small 
proportions of other oligomeric species [85]. These different species were separated 
through size exclusion chromatography, using the SuperdexTM 200 10/300 GL column, 
previously calibrated with the Gel Filtration Calibration Kit LMW (both from GE 
Healthcare). The mobile phase was 20 mM PIPES, 10 mM MgCl2, pH 7.0. The pure 
monomeric CaFADS was preserved at -20 ºC (Fig. 2.1). 
 
Figure 2.1. Elution profile for the separation by size exclusion chromatography of the 
different oligomeric (1) and monomeric (2) species from a pure sample of CaFADS. The 
peak showing an elution volume of 8 ml corresponds to denatured protein. The mobile phase 
was 20 mM PIPES, 10 mM MgCl2, pH 7.0. 
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3. Production of Δ (1-182) CaFADS 
E. coli cells overexpressing Δ(1-182) CaFADS were produced as indicated in 2.1. 
3.1. Purification of Δ(1-182) CaFADS 
The RFK module of CaFADS was purified following a modification of the protocol 
described for the full-length protein (section 2.2) [84]. 
After preparation of the crude extract through sonication, a fractionation with 20 % 
ammonium sulphate (10.6 g per 100 ml of crude extract) was performed. The 
supernatant was loaded onto a Phenyl-Sepharose column previously equilibrated with 
50 mM Tris/HCl pH 8.0 20 % ammonium sulphate, which allowed eliminating the 
flavin bound to the protein as well as other protein impurities. The purest fractions, 
which presented impurities of higher molecular weight, were concentrated in saccharose 
for 16 hours and then loaded in the SuperdexTM 200 10/300 GL column (GE 
Healthcare). This column has been previously equilibrated with 50 mM Tris/HCl pH 
8.0, 150 mM NaCl. The purity of the different fractions was determined by 14 % SDS-
PAGE. Fractions containing the pure RFK module were dialyzed against 20 mM PIPES 
pH 7.0, and quantified using the theoretical extinction molar coefficient in water at 279 
nm (14.44 mM-1 cm-1). The pure protein was preserved at -20 ºC.  
4. Production of SpnFADS 
4.1. Cloning and over-expression of SpnFADS 
The DNA sequence encoding SpnFADS (accession number ADM84672, 
SPAP_1083), containing the NdeI and XhoI restriction sites and codon optimized for its 
expression in E. coli, was synthetically produced by Gen-Script. This DNA sequence 
was cloned into a modified pET-15b vector (Novagen) that contains an N-terminal His6-
Tag sequence followed upstream by a site for a PreScission Protease (GE Healthcare). 
The final construct was sequenced by Sistemas Genómicos (www.sistemasgenomicos. 
com). The BL21 Star TM (DE3) E. coli strain (Invitrogen) was transformed with the 
construct following the protocol described in 1.2. The transformed cells were grown at 
37 ºC in 2xTY medium (1.6 % tryptone, 1% yeast extract and 0.5 % NaCl), containing 
ampicillin 100 g/ml (which was the selection antibiotic in this case) until reaching an 
O.D600 ~0.6. Then the expression of the protein was induced through addition of 1 mM 
IPTG at 18 ºC during 20 hours. After that, cells were harvested by centrifugation at 4 
ºC.  
María Sebastián Valverde 
 76 
4.2. Purification of SpnFADS 
4.2.1. Preparation of the crude extract 
E. coli cells containing overexpressed SpnFADS were resuspended in 2 ml of lysis 
buffer (20 mM sodium phosphate pH 7.4, 10 mM imidazole, 1mg/ml lysozyme, 0.1 
mg/ml DNAse and 0.2 mM protease inhibitor) per gram of cells. After 30 min 
incubation, cells were broken by ultrasonic treatment at 4ºC in a sonicator DRH UP200 
DR Hielsher, using 10 cycles of 30 s with 30 s rests between them. The cellular pellet 
was discarded by 4 rounds of 20 min centrifugations at 4 ºC and 19000 x g.  
4.2.2. His-trap affinity chromatography 
The supernatant, which contains the soluble protein, was loaded onto a His-Trap 
affinity column (HisTrap HP, GE Healthcare), previously equilibrated with 20 mM 
sodium phosphate pH 7.4, 10 mM imidazole and 0.5 M NaCl. The column was washed 
with the same buffer and the flow-through discarded. Then the protein was eluted 
through linear 10500 mM imidazole gradient in the same buffer. Absorbance at 280 
nm was registered while 3 ml fractions were collected. Fractions corresponding with 
peaks containing protein were analyzed through 17 % SDS-PAGE and those containing 
the purest SpnFADS were selected. Buffer was exchange to 25 mM Tris/HCl, pH 7.4, 
0.15 M NaCl, using a HiPrep Desalting Column (GE Healthcare).  
4.2.3. Cleavage of the His-Tag and His-trap/GS-trap chromatography 
The protein was quantified using the Bradford assay [158] and the His6-Tag was 
removed by 48 hours incubation at 4ºC with the PreScission protease (GE Healthcare). 
2 mg of protease per 10 mg of protein were added. To eliminate both the remained His6-
Tagged SpnFADS and the protease, which is fused with GST to facilitate its 
elimination, the solution was loaded onto the HisTrap HP and GST Trap (GE 
Healthcare) columns connected as shown in Fig. 2.2.  
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Figure 2.2. Disposition of the GST Trap and the HisTrap columns along purification of 
SpnFADS.  
5. Biophysical characterization of proteins 
5.1. Spectroscopic characterization 
5.1.1. Absorption spectroscopy in the UV-visible 
Absorption spectra in the UV-visible region were routinely recorded for all the 
proteins to check their integrity and to calculate their concentrations. The spectra were 
registered between 250 and 700 nm at 25 ºC in 20 mM PIPES pH 7.0 using a Cary 100 
spectrophotometer (Agilent Technologies). Quartz cuvettes with a 10 mm light path 
were used, being the scan velocity 200 nm.min-1.  
Proteins were quantified according to the Beer-Lambert equation: 
𝐴𝑏𝑠 = 𝜀. 𝑐. 𝑙  Eqn. 2.1. 
Where Abs is the registered absorbance at a given wavelength, ε the molar extinction 
coefficient at that particular wavelength and l the light path of the cell. The extinction 
molar coefficients, at 278 nm, were 27.8 mM-1.cm-1 for the WT CaFADS and all its 
variants, with the only exceptions of Δ (1-182) CaFADS and F206W variant whose 
theoretical coefficients were 14.44 and 33.9 mM-1.cm-1, respectively. The theoretical 
extinction molar coefficient for SpnFADS was 28.8 mM-1.cm-1. 
5.1.2. Circular dichroism   
Circular dichroism (CD) spectra for the WT CaFADS and all its variants, as well as 
for SpnFADS, were recorded to check their correct folding. The far UV region of the 
spectrum provides information about the secondary structure of the proteins, while the 
near UV region depends on the aromatic residues and their environment [159-161]. 
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Therefore this last spectral region procures information about the tertiary structure of 
the proteins [162].  
CD spectra were recorded at 25 ºC in a spectropolarimeter Chirascan (Applied 
Photosystem Ltd.). The CD spectra in the far UV region were registered between 190 
and 260 nm using a 0.1 cm light path quartz cuvette. The protein concentration was ~5 
μM and the buffer 5 mM PIPES, pH 7.0, 10 mM MgCl2. Low buffer concentration was 
used since organic buffers absorbs in this spectral region, saturating the detector at high 
concentrations. Near UV-CD spectra were obtained also at 25 ºC between 260 and 600 
nm. In this case a 0.4 cm light path quartz cuvette was used, being 20 μM the protein 
concentration and the buffer 20 mM PIPES, pH 7.0 10 mM MgCl2. The resolution was 
5 nm, both for near and far UV-CD spectra. The number of measurements per point was 
10 s in the case of the far UV region and 16 s for the near UV. CD spectra were 
corrected resting the signal corresponding to the buffer. The CD-signal was expressed 





Where θ is the signal (mdeg), c is the protein concentration, l the light path of the 
cuvette and N the number of residues of the protein.  
5.1.3. Analysis of the formation of flavin-FADS complexes through difference 
spectroscopy 
Difference spectroscopy allows observing changes in the absorption spectra of some 
ligands when they are interacting with proteins [163]. When the ligands are flavins, 
these variations are consequence of perturbations in the dielectric environment of the 
isoalloxazine ring, produced by residues of the protein close to it. Comparing the 
spectra obtained for the variants with those registered for the WT, differences in the 
way in which flavin and CaFADSs interact can be detected [164].  
Difference spectra for the flavin-CaFADS complexes were obtained, both in the 
presence and in the absence of ADP. The spectra were recorded at 25ºC in a double 
beam spectrophotometer Cary 100 (Agilent Technologies), using two cuvettes of 1 cm 
light path. In a typical experiment the sample cuvette contains 600 l of ~5 
CaFADS while the reference one contains the same volume of buffer. Sequential 
additions of the same volume of ~20  flavin were performed over both cells, until 
saturation of the protein was reached. For the experiments performed in the presence of 
ADP, it was added to 450 at both the reference and sample cuvettes. All the 
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experiments were carried out in 20 mM PIPES, pH 7.0, 10 mM MgCl2. After each 
addition and previously to recording the spectra, all the samples were incubated at 25ºC 
for 3 min. 
5.2. Analysis of the formation of quaternary organizations 
As indicated in section 2.2.5, CaFADS stabilizes oligomeric assemblies [85, 100]. 
To determine the role that the mutated residues play in the stabilization of such 
structures, size exclusion chromatographic assays were performed, as well as native 
electrophoresis and atomic force microscopy (AFM) experiments. The influence of the 
different substrates and products in the formation of the oligomeric assemblies was also 
analyzed through these methods.  
The same techniques were also used to elucidate whether SpnFADS forms 
macromolecular assemblies.  
5.2.1. Native electrophoresis 
Different fractions of WT CaFADS and of its variants were analyzed at 4 ºC by 
native electrophoresis using 10 % polyacrylamide gels without SDS (N-PAGE). Gels 
were pre-run for one hour to eliminate remainders of acrylamide. 20 μl of each sample 
(containing loading buffer (SB) without SDS) were loaded into the gel. A potential 
difference of 90 mV was applied until the disappearance of the coomasie front. Protein 
spots were visualized with coomasie stain. Since in native electrophoresis the mobility 
of the proteins depends on their weight and also on their charge, results only procure 
qualitative information about the presence of oligomeric states, and its molecular 
weights cannot be estimated (Fig. 2.3). 
 
Figure 2.3. 10 % native gel (N-PAGE) showing: (A) Mixture fraction containing monomeric 
and oligomeric CaFADS, (B) Oligomeric CaFADS and (C) monomeric CaFADS.  
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5.2.2. Size exclusion chromatography 
To separate and analyze the different oligomeric assemblies, 500 l of ~100 
CaFADS samples were loaded onto a SuperdexTM 200 10/300 GL column (GE 
Healthcare), previously equilibrated with 20 mM PIPES, pH 7.0, and calibrated with the 
Gel Filtration Calibration Kit LMW (GE Healthcare). The column was connected to an 
Akta Prime FPLC System (GE Healthcare). The obtained chromatograms were fit to a 
set of Gaussian functions (Origin 8.0, OriginLab) (Fig. 2.4) to determine the number of 
components, their estimated masses and relative areas. Taking into account the 
difficulty derived from the different hydrodynamic radius of the different protein 
organizations (monomer, dimer, trimer, tetramer, hexamer; different volumes and 
shapes) [165] for unequivocally correlating them with the elution volumes, averaged 
values have been taken for peaks mainly considered as monomeric or quaternary 
assemblies. 
 
Figure 2.4. Example of fitting analysis to Gaussian functions of the gel filtration 
chromatograms, obtained for the CaFADS variant E301K, after incubating the samples at the 
indicated conditions. The chromatograms are shown in black lines and the different 
populations assigned by the Gaussian analysis in colored lines. The legend shows the 
calculated molecular weight for the maxima peak of each population. Chromatograms 
obtained at 4ºC, in 20 mM PIPES, pH 7.0.  
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5.2.3. Evaluation of the effect of substrates and products on the monomer-
oligomer equilibrium  
The purpose of this study was to determine the effect that the flavin (RF and FMN) 
and the adenine nucleotide (ADP and ATP) ligands have in the monomer-oligomer 
equilibrium of CaFADS.  
Monomeric and oligomeric CaFADS samples, obtained through exclusion molecular 
chromatography (see section 2.2.5), were incubated at 25ºC for 30 min with different 
combinations of ligands. Reaction mixtures contained 25 μM CaFADS (monomeric or 
oligomeric fraction), and the ligand (or combination of ligands) that was being studied, 
at a final concentration of 500 μM for ADP and ATP or of 100 μM for RF and FMN. 
The final reaction volume was 20-25 μl for the analysis by electrophoresis and 500 μl 
for the size exclusion chromatography.  
For the experiments performed in the presence of a cross-linker, the samples were 
prepared in 50 mM Tris/HCl, pH 8.0, 10 mM MgCl2. 2 mM 
bis(sulfosuccinimidyl)suberate (BS3) was added to the samples after its incubation with 
the ligand, and the resulting mixture was incubated for 30 min at room temperature. The 
Cross-linking reaction was stopped through addition of the quenching buffer (500 mM 
Tris/HCl pH 8.0) at a final concentration of 50 mM. Once again samples were incubated 
for 15 min.  
The amount of monomer and oligomer in the samples was analyzed through different 
techniques according to the protocol used for its preparation.  
 The samples produced in the absence of the cross-linker were analyzed by N-
PAGE as we have indicated in section 5.2.1. 
 The samples which were exposed to the cross-linker were examined by 10% SDS-
PAGE. Denaturant electrophoresis was used since the cross-linker avoids 
breaking of non-covalent interactions that stabilize oligomeric structures. These 
interactions do not remain under denaturant conditions in the absence of the cross-
linker. Loading buffer was added to the samples, which were boiled for 5 min 
before loaded onto the gel. 20 μl of each sample (containing loading buffer with 
the SDS denaturing agent), were loaded into the gel. A potential difference of 90 
mV was applied until the disappearance of the coomasie front. Protein spots were 
visualized with coomasie stain. To estimate the weight of the different proteins, a 
molecular weight patron was included in one of the lanes. 
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 Both types of samples were finally analyzed through molecular exclusion 
chromatography as described in 5.2.2. In addition this technique allows estimating 
the molecular weight of each species.  
5.3. Steady-state kinetic analysis of the RFK and the FMNAT activities  
5.3.1. Qualitative study of the RFK, the FMNAT and the FADpp activities through 
Thin Layer Chromatography 
The RFK, the FMNAT and the FADpp activities of CaFADS and SpnFADS were 
qualitatively assayed by separation of the flavins produced during these reactions 
through Thin Layer Chromatography (TLC) [166, 167].  
200 μl of reaction mixtures containing 50 μM RF or FMN, 250 μM ATP, 0.8 or 10 
mM MgCl2 (for the RFK or FMNAT reactions respectively), 1 μM CaFADS or 
SpnFADS in 20 mM PIPES pH 7.0, were incubated at 25 ºC for 30 min. The reactions 
were stopped by boiling the samples for 5 min. To determine the effect that a reducing 
environment has in the RFK and FMNAT activities of SpnFADS, these reactions were 
also performed at different concentrations of sodium dithionite (0-16 mM). 
Separation of flavins within the supernatant reaction mixtures was carried out 
through TLC in 200 x 200 x 0.25 mm glass sheets coated with SIL G-25 silica gel 
(Macherey- Nagel). Dipole-dipole interactions, between the adsorbent and the molecule 
that is being analyzed, are the predominant ones in separations by silica gel. Under 
these conditions the flavins elution order is RF-FMN-FAD (Fig. 2.5), since more polar 
molecules interact in a stronger way with the polar Si-O bonds of the silica gel, and 
show smaller retardation factors (Rf) than the less polar components [167]. 
150 μl of the reaction mixtures were loaded on a sheet previously activated at 110 ºC 
for 1 hour. A patron sample (a RF-FMN-FAD mixture) was included. Samples were 
applied at a distance of 2 cm from the border of the sheet, and separated enough to 
avoid their mixing. The application of the samples was performed in several times, 
loading 20 μl each time and drying between applications. A mixture of butanol:acetic 
acid:H2O in proportion 12:3:5 was used as eluent. The chromatographic separation was 
executed during ~ 7 hours, in a tray hermetically closed that has been previously 
saturated with the eluent vapor. Flavin spots were visualized under UV light using a 
transiluminator.  
FAD shows two different bands that correspond with its two molecular 
conformations (one open and the other one closed). One of these bands presents a very 
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small Rf value, while the displacement of the other is slightly higher than that of the 
FMN.  
 
Figure 2.5. TLC separation of the flavins of the patron sample containing 50 μM RF, FMN 
and FAD, using as eluent a 12:3:5 mixture of butanol:acetic-acid:H2O. 
5.3.2. Quantitative analysis of the CaFADS riboflavin kinase (RFK) activity and 
determination of kinetic parameters through High Performance Liquid 
Chromatography (HPLC) 
 
Figure 2.6. RF transformation into FMN catalyzed by the RFK activity of CaFADS.  
Chromatographic conditions for separation of flavins 
The CaFADS RFK activity (Fig. 2.6) was quantitatively analyzed by separating the 
flavins produced during this reaction through High Performance Liquid 
Chromatography (HPLC) [168]. For that purpose, an Alliance HPLC (Waters) system 
equipped with a 2707 Autosampler injector (Waters) and with a 2475 Multi-
Wavelength fluorescence detector (Waters) was used. The chromatographic conditions 
for the flavin separation are displayed in Table 2.1. 
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Table 2.1. Chromatographic conditions for flavin separation from reactions mixtures 
through HPLC.  
Stationary Phase HSS T3 (4.6x150mm, 3.5 µm, Waters)a 
Mobile Phase 
5mM ammonium acetate, 40% methanol 
 pH 6.0 
Method Isocratic 
Flux 1ml/min 
Detection System Fluorescence, λex=470 nm; λem=530 nm (gaining10) 
aTo prolong its lifespan, the column is preceded by a pre-column of the same material (4.6 x 20mm, 
3.5 μm, Waters). 
Under these conditions, flavin chromatograms were solved in 7 min, being the 
retention times 2.3, 3.5 and 5.5 for FAD, FMN and RF, respectively (Fig. 2.7). 
 
Figure 2.7. Retention times for the different flavins under the conditions specified in Table 
2.1. 
Flavins were quantified using calibration lines that relate the area of each peak with 
the corresponding flavin concentration (Fig. 2.8).   
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Figure. 2.8. Calibration lines for FMN and FAD quantification under the conditions 
specified in Table 2.1.  
Experimental procedure and analysis of the results 
The steady-state RFK activity of CaFADS was analyzed by quantifying the amount 
of RF transformed during this reaction. Since there is no way to avoid the second 
reaction of the enzyme, the transformed RF was calculated as the addition of the FMN 
plus the FAD present at the end of the reaction.  
For that purpose, sets of reaction mixtures containing 0.5-30 μM RF, 10-400 μM 
ATP in 20 mM PIPES, pH 7.0 and 0.8 mM MgCl2 were prepared in a final volume of 
500 μl. The reactions were performed in the presence of 0.8 mM Mg2+, because at this 
concentration the CaFADS shows the maximum value for its RFK activity, while its 
FMNAT one is minimized [94]. The samples were pre-incubated at 25 ºC and then the 
RFK reaction was initiated through addition of ~ 50 nM CaFADS (final concentration). 
The samples were incubated for 1 min and then, the reaction was stopped by boiling the 
samples for 5 min. The denatured protein was eliminated through centrifugation.  
To separate the different flavins present in the mixture, aliquots of 20 μl of each 
reaction sample were loaded into the HSST3 column (Table 2.1). The FMN and FAD 
concentrations were calculated using their corresponding calibration lines (Fig 2.8), 
obtained in the same chromatographic conditions (Table 2.1).  
To determine kinetic parameters, measurements were carried out varying the 
concentration of one of the substrates, while keeping constant and at saturating 
concentration the second one. The reaction set performed at fixed concentration of RF 
was interpreted using the Michaelis-Menten model (Fig. 2.9A) [169]. For these 
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measurements, ~ 5-7 μM RF was used (concentration for which the enzyme shows the 
80% of its maximal apparent activity). The reactions containing saturating ATP and 
variable RF concentrations did not show this hyperbolic behavior, but they presented a 
profile characteristic of inhibition by substrate (Fig 2.9B). Therefore, the experimental 
data were fit to a model that describes the substrate inhibition effect produced in 
enzymes with bi-substrate kinetics (Fig 2.9B) [170].  
 
Figure 2.9. Kinetic profiles dependences for the RFK activity of CaFADS (A) as a function 
of ATP at saturating concentration of RF (Michaelis-like kinetic) and (B) as a function of RF 
at saturating concentration of ATP (profile characteristic of enzymes showing inhibition by 
substrate). Measurements performed at 25 ºC, 20 mM PIPES, pH 7.0, 0.8 mM MgCl2.  
Mathematical analysis of the results 
Kinetic parameters for the reactions that show a Michaelis-like saturation profile 
(Fig. 2.9A), were obtained by fitting the velocities, obtained as a function of the 




  Eqn. 2.3. 
Where v0 is the initial velocity for each reaction sample, Vmax is the maximum rate 
achieved by the system, Km is the concentration of substrate for which the reaction rate 
is half of the Vmax, and [S] the substrate concentration. 
When inhibition by the RF substrate was detected (Fig. 2.9B), the kinetic parameters 
for the RFK reaction were obtained fitting the initial rates to the general equation for 
















 Eqn. 2.4. 
Where Ki
RF is the inhibition constant for the RF substrate. Vmax and Km are apparent 
values, since due to the inhibitory effect of the RF, it is not possible to work at 
saturating concentration of this substrate.  
The turnover number, or kcat, (maximum number of substrate molecules transformed 




  Eqn. 2.5. 
The kcat/Km relation provides information about the catalytic efficiency of the enzyme. 
5.3.3. Fluorometric characterization of the FMN adenylyl-transferase activity 
(FMNAT) of CaFADSs 
 
Figure 2.10. FMN transformation into FAD catalyzed by the FMNAT activity of CaFADS. 
As indicated in section 2.4.2, FMN and FAD are fluorescent molecules with different 
quantum yields. Consequently the transformation of the first one into the second can be 
followed in a continuous assay, by measuring the decrease of the flavin fluorescence 
[155].  
Experimental procedure 
Two sets of reactions were prepared, keeping constant and saturating the 
concentration of ATP while varying the concentration of FMN and vice versa. 
Reactions performed at ATP saturating concentration contained 0.5-30 µM FMN, while 
the ATP concentration was 10-350 µM for those experiments carried out at saturating 
FMN. All the experiments were carried out at 25 ºC in 20 mM PIPES, pH 7.0, 10 mM 
MgCl2, with a final volume of 1 ml. The reaction was initiated through addition of ~100 
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nM CaFADS. The fluorescence was registered during 30 s using a Varian Cary Eclipse 
Fluorescence spectrophotometer (Agilent Technologies) (Fig 2.11). The excitation and 
emission wavelengths were 420 and 530 nm, respectively.  
 
Figure 2.11. Evolution of the flavin fluorescence upon FMN transformation into FAD by 
CaFADS. Kinetic trace (black) recorded at 25ºC, in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2. 
The fitting of the initial lineal stretch to a line is shown in red, the slopes of the fitted lines 
will be used to calculate initial velocities at the different concentrations of each substrate. 
To determine the initial velocity (v0) for each reaction sample, calibration lines (Fig. 
2.12) for FMN and FAD were separately obtained under the experimental conditions 
indicated above. Fluorescence constants were calculated from the slope of the 
calibration lines, being the constant for FMN (KFMN) ~10 times higher than the one for 
FAD (KFAD).  
 
Figure 2.12. Calibration lines for FMN (maroon) and FAD (blue), which relate the 
fluorescence intensity to the flavin concentration. Data obtained at 25ºC, 20 mM, pH 7.0, 10 
mM MgCl2. 
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Mathematical analysis of the results 
The rate of FAD formation, or initial velocity (v0), for each reaction sample was 
determined from the fluorescence decrease during the measurement time as ΔF/Δt using 




 Eqn. 2.6. 
Where KFMN and KFAD are the slopes obtained from their corresponding calibration lines 
(Fig. 2.12).  
The v0 values obtained for the FMNAT reaction of CaFADS, both at saturating ATP 
and FMN concentrations, showed a Michaelis-Menten kinetic profile (Fig. 2.9) [169]. 
Therefore, the kinetic parameters for this activity were calculated by fitting of the 
experimental data to Eqn. 2.3.  
5.3.4. Analysis of the RFK and FMNAT activities of SpnFADS through HPLC 
Both the RFK and the FMNAT activities of SpnFADS were quantitatively assayed 
through HPLC, using the experimental procedure and chromatographic conditions 
specified in section 5.3.2.  
The RFK reaction was measured at 25 ºC in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2. 
The reaction samples were prepared using the protocol and substrates concentrations 
described in section 5.3.2, and the data processed as indicated in that same section. 
Initial velocities (v0) showed a Michaelis-Menten saturation profile both at ATP and RF 
saturating concentrations (Fig. 2.9A, Eqn. 2.3) [169].  
The results of the TLC experiment described in section 5.3.1 revealed that the 
FMNAT reaction of SpnFADS only takes places under strong reducing conditions. This 
fact prevents determining this reaction by the continuous fluorimetric assay used for the 
FMNAT activity of CaFADS, since reduced flavins have not fluorescent properties 
[55]. Therefore, kinetic parameters for this activity were obtained in 20 mM PIPES, pH 
7.0, 10 mM MgCl2, by quantifying the products of the reaction through HPLC 
(chromatographic conditions indicated in 5.3.2), using a modification of the protocol 
described above, consisting on all samples being prepared in the presence of 3 mM 
sodium dithionite. The FMN and ATP concentrations were that detailed in 5.3.3 for 
CaFADS. Vmax and Km were obtained by fitting the v0 values to the Michaelis-Menten 
model (Fig. 2.9A, Eqn. 2.3) [169].  
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5.3.5. Analysis of the FMNAT activity of SpnFADS using photorreduced FMN 
The FMNAT activity of SpnFADS only takes place under strong reducing 
conditions. To elucidate whether reduced flavins are needed for the FMNAT activity, or 
the protein requires the reducing environment, the reaction was measured using reduced 
FMN and oxidized protein. Reaction mixtures containing 500 μM ATP, 15 μM FMN, 2 
μM 5-deazaRF (5-dRF) and 0.8 mM Mg2+, in a final volume of 1 ml were deoxygenated 
during 1 h through Argon bubbling in the dark (to avoid FMN degradation). Once 
oxygen was displaced from the samples, previously deoxygenated SpnFADS was added 
at a final concentration of 100 nM. Then samples were illuminated during 15 s to photo-
reduce FMN (the triplet state of light excites 5-dR that quickly evolves to a radical state, 
which returns to the fundamental state by ceding an electron to FMN) [171]. After 3 
min of additional incubation the system was open to the air. Samples were boiled for 5 
min to precipitate the protein and then centrifuged. Flavins presented in the supernatant 
were identified using the Alliance HPLC system (as indicated in 5.3.2). 
5.4 Kinetic study of the inhibition of the RFK activity of CaFADS and SpnFADS 
by the products of the reaction 
The RFK activity of CaFADS shows an inhibition pattern when the RF concentration 
increases. To identify whether products of the reaction might also contribute to the 
inhibition and to elucidate their mechanisms of action, a kinetic inhibition study was 
carried out [172-174].  
The inhibitory effect of the products of the RFK activity was evaluated using 
reaction mixtures containing 0-20 μM FMN, 1-30 μM RF, and 350 μM ATP when 
analyzing the FMN effect, or 0-400 μM ADP, 10-350 μM ATP, and 5 μM RF when 
examining the inhibition by ADP. Reactions were initiated through addition of the 
enzyme at a final concentration of ~ 40 nM, followed by 1 min incubation and finally, 
reactions were stopped by bowling the samples at 100ºC for 5 min. The precipitated 
protein was eliminated through centrifugation. The flavin composition of the 
supernatant was analyzed using the Alliance HPLC system, following the protocol 
described in 5.3.2, and the data were analyzed as described in that section. All the 
experiments were performed by triplicate.  
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Figure 2.13. Characteristic plots for the common inhibition types. Left, plots of 1/v against 
inhibitor concentration (Dixon plots) and right, s/v against inhibitor concentration for all the 
types of inhibition. In every case the intersection point between lines provides an estimation 
of Ki and Ki’ [172].  
The inhibition mechanisms performed by FMN and ADP, were identified by 
evaluating the effect of both products in the Km and kcat values, obtained by the 
independent fitting of data sets to the Michaelis-Menten model. Additionally, Dixon 
plots and Cornish-Bowden representations were used to reveal the type of inhibition 
(Fig. 2.13) [172]. Finally, the different data sets were globally fit using the Lineweaver-
Burk equations for competitive, uncompetitive and mixed inhibitors (Eqns. 2.7, 2.8 and 
2.9), respectively [173]. 
 














































 Eqn. 2.9. 
Where v0 is the determined observed rate constant at each experimental condition, [e] is 
the enzyme concentration in the assay, [S] is the concentration of the inhibitory 
substrate, and Ki
P is the corresponding product inhibition constant [175]. Estimated 
errors in kcat, Km, Ki and Ki values are, in general, within ±15 % of its value, but when 




5.5. Pre-steady state kinetics: Stopped-flow spectrophotometry 
Kinetic measurements using stopped-flow spectrophotometry allow to visualize fast 
individual processes taking place in the course of a reaction and to determine their 
velocities [176-178]. Some of these processes can be ligand binding or dissociation, 
conformational changes or the reaction itself.  
5.5.1. Basis of the technique  
Stopped-flow is a fast mixing technique that allows studying very fast reactions 
(occurring in milliseconds to seconds). The stopped-flow equipment (Fig. 2.14) has two 
identical reaction syringes (A and B) that contain the reactants, and their pistons are 
connected to a valve moved by compressed air. The exit of both syringes (after passing 
by another valve each) are joined and arrive to a mixing chamber. The exit of the 
chamber is connected to another syringe, which is the stop syringe. The process starts 
through fast emptying of the stop syringe when compressed air pushes its piston (1), 
and continues with the subsequent impulse of the pistons (2) that makes both syringes 
liberating the same volume. Then, solutions contained in the reaction syringes are 
mixed at the measuring chamber the exit, where the reaction takes place. Using an 
appropriate detector, such as fluorescence, absorbance or circular dichroism, the kinetic 
of the reaction can be determined in the measuring chamber. The main difference 
between conventional techniques for measuring reaction kinetics and stooped-flow is 
the death time. Stopped-flow allows determining processes occurring within 
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milliseconds to seconds, making possible to get kinetic parameters in the pre-steady 
state.  
 
Figure 2.14. Diagram of the stopped-flow equipment, showing its different components. 
Syringes A and B contain the reactants that are going to be mixed in the mixing and 
mearuring chamber. 1 and 2 denote for the stop and drive pistons, indicating the order in 
which they are activated. The arrows indicate the direction of the flow. In our case the light 
source and the detector are perpendicularly placed, since the measured magnitude is 
fluorescence.  
5.5.2. Determination of observed rate constants (kobs) for different processes 
involving flavins and FADS 
Stopped-flow measurements were performed to identify the different steps that take 
place during a single cycle of the enzymes and to get apparent kinetic constants for each 
of these processes. It is necessary to clarify that the registered magnitude is the 
fluorescence of flavin, therefore only the processes affecting the environment of the 
isoalloxazine ring [51], and consequently the flavin fluorescence, might be observed.  
Stopped-flow measurements were performed on an Applied Photophysics SX17.MV 
spectrophotometer linked to an Acorn computer using the Xscan software from Applied 
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Photophysics. The fluorescence of the flavins was measured in a continuous assay being 
the excitation wavelength 445 nm while the emission was recovered using a 530 nm 
filter. The selected voltage was 350 V and 800 points were taken in every measurement. 
Measures were carried out at 25ºC in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0. Either 
SpnFADS, or the CaFADS RFK module (0.2 μM) were mixed with reaction samples 
varying the concentration of FLV (herein for either RF or FMN) −0.05-5 μM− both in 
the absence of adenine nucleotides and in the presence of saturating concentration of 
ANP (herein for either ATP or ADP ligands). Control experiments were also recorded 
in the same buffer but in the absence of MgCl2. All the concentrations indicated are the 
final ones in the reaction cell. Every kinetic trace was recorded until getting at least 
three reproducible traces.  
5.5.3. Analysis of the data 
Kinetic traces related to changes in fluorescence were fit to exponential processes 
(Eqn. 2.10), where each exponential term describes at least a different process. When a 
particular process is not finished in the measure time frame a linear term can be added 
to the equation to account for it (Eqn. 2.11).  
 
𝑦 = ∑ 𝐴𝑖𝑒
−𝑘𝑜𝑏𝑠,𝑖·𝑡 Eqn. 2.10. 
𝑦 = ∑ 𝐴𝑖𝑒
−𝑘𝑜𝑏𝑠,𝑖·𝑡 + 𝑏𝑡  Eqn. 2.11. 
Where Ai and kobsi are the amplitude and the observed rate constant, respectively, for 
each of the processes that contribute to the overall fluorescence change and b is the 
slope of an unfinished process during the measure time.  
When kobs values showed a linear dependence with the flavin concentration they 
were fit to an one step model (Eqn. 2.12), which describes the association-dissociation 
equilibrium of enzyme-flavin complexes.  
𝑘𝑜𝑏𝑠 = 𝑘𝑜𝑛[𝑓𝑙𝑎𝑣𝑖𝑛] + 𝑘𝑜𝑓𝑓   Eqn. 2.12. 
Where kon and koff are the kinetic constants for the complex formation and dissociation 
respectively.  
Due to the well-known deterioration that flavins undergo when exposed to light, we 
also evaluated the flavin photobleaching decay produced under our stopped-flow 
experimental conditions. Due to this effect, the RF and FMN fluorescence linearly 
decays along the time. The slopes for these kinetic traces show an inverse linear 
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dependence with flavin concentrations, with slopes corresponding to rates of 4.6·10-3± 
1.8·10-4 min-1 and 4.1·10-3± 1.8·10-4 min-1 for RF and FMN, respectively (Fig. 2.15). 
 
Figure 2.15. Slopes for linear fluorescence decays on the flavin concentration for samples 
containing RF (black), FMN (red). Data obtained in 20 mM PIPES pH 7.0, 10 mM MgCl2. 
5.6. Determination of thermodynamic parameters for ligand binding to FADS 
through Isothermal Titration Calorimetry (ITC) 
5.6.1. Basis of the technique  
Isothermal Titration Calorimetry (ITC) is an analytical technique that allows 
determining thermodynamic parameters for the interaction between two molecules 
[179-181]. Since binding processes usually involve liberation or absorption of heat, the 
nature of the interaction can be characterized through the quantification of the 
interchanged heat. ITC experiments are carried out in a calorimeter at constant pressure 
and temperature, and allow directly calculating the binding enthalpy (ΔH), the 
equilibrium association constant (Ka) and the stoichiometry for the binding (N) [179, 
182]. 
An isothermal titration calorimeter is composed of two identical cells (sample and 
reference cells) surrounded by an adiabatic jacket (Fig. 2.16). Thermocouple circuits 
detect differences of temperature between the reference cell, which is filled with water, 
and the sample cell, which contains the molecule to be titrated. Prior to addition of the 
titrating ligand, a constant power is applied to the reference cell. This produces a 
feedback circuit that activates a heater located on the sample cell. During the 
experiment, perfectly known aliquots of the titrating ligand are added to the sample cell 
that contains the other ligand, producing heat to be either taken up or released. The 
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measured magnitude is the time-dependent input of power required to maintain both 
cells at the same temperature.  
5.6.2. Titration of FADS with a single ligand 
Experimental procedure 
ITC measurements were performed using a high precision Auto-ITC200 MicroCal 
calorimeter (Malvern) thermostated at 25 ºC (or at 20 ºC for SpnFADS titrations). The 
reference cell contained distilled water while the sample cell contained 207 μl of a ~25 
μM protein solution. The concentration of the titrating ligand in the syringe was 10-15 
times higher, that is ~250 μM in the case of flavins or 300 μM in the case of ADP and 
ATP. Due to the low solubility of RF, a saturated solution of this ligand, ~200 μM, was 
used. Both the ligand and the protein were dissolved in the same buffer, 20 mM PIPES 
pH 7.0 and variable concentrations of MgCl2; 0, 0.8 or 10 mM depending on the 
experiment. This buffer was selected because of its low ionization enthalpy, which 
prevents any buffer influence on the observed binding enthalpy caused by 
de/protonation events. Up to 19 injections of 2 μl were added to the calorimetric sample 
cell and mixed using a stirring speed of 1000 r.p.m.  
To elucidate whether SpnFADS is able to bind reduced flavins, ITC experiments 
were performed in the presence of a reducing agent. Since the Auto-ITC200 MicroCal 
calorimeter has some parts that could be damaged in the presence of such agents, these 
titrations were performed using a high precision VP-ITC system (MicroCal LLC). The 
experimental sets were similar to those described above. Thus, 25 μM SpnFADS were 
titrated at 20 ºC with FMN ~200 μM or FAD ~300 μM. Both the protein and the ligands 
were dissolved in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2, 4 mM sodium dithionite, 10 
mM glucose, 0.5 U/ml glucose oxidase, and degassed. Each titration was initiated by a 4 
μl injection followed by 25–28 stepwise injections of 10 μl. Glucose and glucose 
oxidase were added to avoid the oxidation of sodium dithionite by molecular oxygen, 
which would liberate unspecific oxidation heat, masking the one corresponding to the 
flavin:protein interaction.  
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Figure 2.16. Diagram of a typical ITC experiment. The sample cell contains the protein 
while the reference one contains buffer or water. The measured magnitude is the power 
applied to maintain both cells at the same temperature. Addition of the titrating ligand to the 
sample cell produces liberation or absorption of heat, depending on if the reaction is 
exothermic or endothermic. The interchanged heat is proportional to the increment of the 
ligand fraction bound to the protein. The great signal observed during the first additions is 
due to the majority of the ligand being bound to the protein. During the following additions 
the protein is saturated and the signal decrease because less heat is interchanged [179].  
Analysis of thermograms 
The heat evolved after each ligand injection was obtained from the integral of the 
calorimetric signal (μcal·s-1 vs time). The heat derived from the binding process was 
calculated as the difference between the binding heat and the corresponding dilution 
heat. This last was estimated as a constant heat throughout the experiment and included 
as an adjustable parameter in the analysis. Finally, the kcal.mol-1 values for each 
injection were represented versus the molar fraction of ligand as [ligand]/[FADS]. The 
resulting data were fit to a different mathematical model, depending on the number of 
binding sites, Eqn. 2.13 and Eqn. 2.14 for a single binding site and for two binding sites, 
respectively. 
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The differential heat associated to each injection (i) results from the difference 
between the total heat accumulated after the injection i, and that corresponding to the 
injection i-1.  
𝑞𝑖 = 𝑄𝑖 − 𝑄𝑖−1 (1 −
𝑣
𝑉0
) = 𝑉 [[𝑀𝐿]𝑖 − [𝑀𝐿]𝑖−1 (1 −
𝑣
𝑉0
)] ∆𝐻  Eqn. 2.13 




= 𝑉 [[[𝑀𝐿]𝑖 − [𝑀𝐿]𝑖−1 (1 −
𝑣
𝑉0





The dilution factor is considered through the (1-v/V0) term. The thermodynamic 
parameters Ka, ΔH and N, in the case of Eqn. 2.13 and Ka1, Ka2, ΔH1, ΔH2, N1 y N2, for 
Eqn. 2.14 were obtained through non-lineal regression of the experimental data to the 
corresponding equations, implemented in Origin 7.0. Estimated errors were in general 
~0.3 kcal/mol for ΔH and ± 10% for Ka.  
Calculation of thermodynamic parameters from ITC experiments  
The association constant (Ka), the enthalpy change (ΔH), and the stoichiometry of the 
binding (N) were obtained as just described. The dissociation constant (Kd), the free 
energy change (ΔG), and the entropy change (ΔS) were obtained from the previous ones 
using basic thermodynamic relationships (Eqns. 2.15, 2.16 and 2.17). 
∆𝐺 = −𝑅𝑇𝑙𝑛𝐾𝑎  Eqn. 2.15 




  Eqn. 2.17 
Where Ka is the association constant obtained from the fitting, ΔG, ΔH and ΔS are the 
free energy, the enthalpy and the entropy contributions to the binding , respectively and 
R is the universal gas constant (1.987·10-3 kcal/mol K).  
Usually when N~2 there was not enough information in the titrations for using a 
model with two different binding sites and averaged binding parameters are given. 
Normally, the estimated errors were ~ 15 % in Kd and ± 0.3 kcal/mol in ΔG, ΔH and –
TΔS.  
5.6.3. Titration of pre-formed binary FADS:ligand complexes 
Titrations with FLV ligands of mixtures containing the enzyme prebound to ANP 
ligands were also carried out, as well as titrations with ANP of mixtures of the enzyme 
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prebound to FLV ligands. The methodology and the data treatment were the same as the 
ones described above.  
Determination of cooperativity constants between flavin and adenine 
nucleotide ligands 
Some bi-substrate proteins show cooperativity effects between their ligands [183]. 
Cooperative ligands change the affinity of the protein for the other ligand. For instance, 
considering a system where a protein has two ligands, A and B. A and B are cooperative 
ligands if the binding of A alters the affinity of the protein for B, and vice versa. 
Cooperativity effects can be positive, if the binding of A increases the protein affinity 
for B (and vice versa) [184], or negative, if the affinity for the second ligand decreases 
[185, 186]. Cooperation effects can be related to conformational changes, induced by 
binding of one of the ligands that somehow favors or hinders the binding of the other 
one [184].  
To determine the cooperation coefficients (α) between the ANP ligands and the FLV 
ones, sets of six experiments were carried out. Solutions of the ANP ligands were used 
to titrate mixtures, located in the calorimetric cell, containing the RFK module at six 
different FLV concentrations (0-180 μM). These experiments allowed to determine the 
apparent association constants for the ANP ligand, 𝐾𝑎
𝑎𝑝𝑝,𝐴𝑁𝑃
, at each concentration of 
the FLV one.  
Mathematical processing of the data 
Values were fit to the equation describing the dependency of 𝐾𝑎
𝑎𝑝𝑝,𝐴𝑁𝑃
 as a function 
of the FLV concentration and α (cooperativity constant for the heterotropic interaction 







  Eqn. 2.18 
Being 𝐾𝑎
𝑎𝑝𝑝,𝐴𝑁𝑃
 the association constant for the ANP ligand at each [FLV], 𝐾𝑎
𝐹𝐿𝑉  the 
association constant for the FLV one, and [FLV] the concentration of flavin in the 
calorimetric cell. 
Additionally, particular titrations performed at saturating FLV concentration (150 
µM) were fit to a homemade model that considers the influence of the FLV ligand on 
the protein affinity for the ANP one [187], yielding similar α values.  
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Experiments were performed in duplicate or triplicate. The errors considered in 
the measured parameters (±15% in Kd and Ka values, ±0.3 kcal mol
-1 in ΔG, ΔH and 
TΔS and ±20% in ) were taken to be larger than the standard deviation between 
replicates and the numerical error after fitting analysis.  
6. Discovery of antibacterial drugs 
As mentioned previously, the CaFADS shows sequence and structural homology 
with other prokaryotic FADSs. Therefore, CaFADS can be a good target (section 1.3, 
Introduction) model in the development of new antibacterial drugs against pathogenic 
microorganisms [89]. Particularly, due to the homology of CaFADS with the MtFADS 
(showing 45% homology), the first protein seems to be an optimal model for the second 
one [89].  
6.1. Activity-based high-throughput screening for CaFADS 
HTS is a drug discovery process that has become very popular in the last decades, 
since it allows the assaying of a large number of potential biological modulators against 
a chosen target. This methodology automates the screening process and it is useful to 
discover ligands for enzymes, receptors or other pharmacological targets [188, 189]. 
Different properties can be exploded to perform a HTS. For instance ligand binding to 
the target can be detected through variations on its Tm using thermal upshift assays 
[190, 191], or we can identify compounds that inhibit the activity of the target through 
an activity-based HTS [192, 193]. Additionally, this process also allows directly 
assaying the effect of the compounds in cells [194].  
 To find CaFADS inhibitors, we performed the HTS of the Prestwick Chemical 
Libary® that contains 1040 compounds. These compounds have been approved by the 
Food and Drug Administration (FDA) and by the European Medicines Agency (EMA), 
and they have been selected for their known bioavailability and safety in humans. The 
screening was activity based, what means that we directly determine how the 
compounds affected any of the activities of the protein or both of them. In this assay, 
the measured magnitude was the flavin fluorescence. As indicated in section 5.3.3, 
FMN transformation into FAD involves a linear decrease of the fluorescence along the 
time. Therefore, when the RFK or the FMNAT activities are inhibited, less FAD is 
produced and consequently the fluorescence decrease (registered in a specific time 
interval) is less pronounced.  
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Measurements were carried out using a multimode microplate reader, SynwergyTM 
HT Biotek, with BRAND plates- pure GradeTM (96-well plates). To optimize the 
conditions of the assay, a previous study was performed using constant concentrations 
of RF, ATP and CaFADS (~5 µM, ~50 µM and ~ 0.4 µM respectively), and variable 
concentrations of MgCl2 (0.2-10 mM) and DMSO (0%-12.5% v/v). Additionally, 
different instrumental sensitivities were tried to select the one that produces the highest 
signal but without saturating it. Optimum conditions were 2.5% DMSO, 10 mM MgCl2 
and sensitivity 70.  
Experiments were executed in 96-well plates. Reaction mixtures contained 5 µM RF, 
0.4 µM CaFADS, 10 mM MgCl2, in PIPES 20 mM, pH 7.0, and the corresponding 
compound of the chemical library (dissolved in DMSO) at a concentration of 250 µM. 
Reactions were initiated through addition of 50 µM ATP, being the final volume 100 µl. 
Controls, which contained the reaction mixture but not any compound, were added both 
to the first and last rows. Flavin fluorescence in each well was registered at 25 ºC, every 
50 s during 15 min. Excitation and emission wavelengths were 440 and 530 nm, 
respectively.  
The slope of the resulting line, recoded between 0 and 6 min, was calculated for 
every compound and also for the controls, as the fluorescence increase per time unit 
(ΔF/Δt). Those compounds that decreased the reaction rate bellow the average reaction 
rate of the controls minus the standard deviation (Eqn. 2.19), were preselected as 






− 𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙𝑠 Eqn. 2.19 
 
6.1.2. Identification of the activity inhibited by each of the primary HTS hits 
As previously indicated in section 3.5 (Introduction), the HTS hits that showed 
lowest rates for the FMNAT activity, affecting to a lesser degree the RFK one, are the 
preferable ones to continue the study.  
Since the only detectable fluorescence change is that produce during the FMNAT 
activity, the primary HTS hits might inhibit the RFK activity, the FMNAT one, both of 
them, or be a false positives also known as pan assay interference compounds (PAINS), 
which tend to nonspecifically react with numerous targets. Therefore, to determine 
which of the CaFADS activities was inhibited, both reactions were assayed through 
HPLC in the presence of the HTS hits. The experimental procedure is similar to that 
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described in section 5.3.2, but in this case, reaction mixtures contained 50 µM ATP, 5 
µM RF, 0.4 µM CaFADS in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2 and 250 µM of 
each HTS hit (when assaying the RFK activity), or 50 µM ATP, 5 µM FMN, 0.4 µM 
CaFADS in 20 mM PIPES, pH 7.0, 10 mM MgCl2 and 250 µM of each HTS hit (when 
assaying the FMNAT one). Those HTS hits that decreased the FMNAT activity by 
more than 5 %, without significantly affecting the RFK one (remaining reaction rate 
higher than 75%) were selected as FMNAT hits to continue the study.  
Similarly, the HTS hits were also assayed against SpnFADS, following a 
modification of the procedure described above, consisting on when measuring the 
FMNAT activity 3 mM sodium dithionite was added to the reaction media.  
Data were processed as indicated in section 5.3.2. 
6.1.3. Determination of the potency of FMNAT hits 
The half maximal inhibitory concentration (IC50) of a compound reflects the 
concentration at which an enzyme shows the half of its maximal activity. The lower the 
IC50 is, the more potent the compound is as inhibitor.  
Once we have selected the FMNAT hits, this activity was assayed at different 
concentrations of the compound (0-100 µM). Experiments were performed as specified 
in section 5.3.2. Positive controls (without any compound) were included in every 
reaction set. To avoid differences in the percentage of DMSO among samples, DMSO 
was added to the samples so that: 
𝑉𝐷𝑀𝑆𝑂 +  𝑉ℎ𝑖𝑡 = 12.5 𝜇𝑙  Eqn. 2.20 
where VDMSO and Vhit are the volumes of DMSO and the assayed compound, 
respectively. 12.5 µl corresponds to the 2.5 % of the final reaction volume, which was 
500 µl.  
Experiments were performed in triplicate, and data were processed as indicated in 
section 5.3.2. The FMNAT hits that presented lowest residual activity and IC50 were 
selected to be furthermore characterized.  
6.1.4. Determination of the inhibition mechanism of selected in the FMNAT 
activity 
Experimental procedure 
To identify the inhibition mechanism performed by selected FMNAT hits (C24, C27 
and C31), this reaction was evaluated in the following conditions. Reaction mixtures 
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containing 0-100 µM of each compound, 1-20 µM FMN and 400 µM ATP were used 
when analyzing the inhibitory effect of the compound regarding the FMN substrate, 
while 5-400 µM ATP, 15 µM FMN, when analyzing the effect of the inhibitor regarding 
the ATP substrate. All the experiments were carried out in 20 mM PIPES, 10 mM 
MgCl2, pH 7.0, being the final reaction volume 500 µl. The reactions were initiated by 
addition of the enzyme at a final concentration of ~40 nM, followed by 1 min 
incubation. Finally, reactions were stopped by bowling the samples at 100ºC for 5 min, 
and the precipitated protein was eliminated through centrifugation. The flavin 
composition of the supernatant was analyzed using the Alliance HPLC system, as we 
described in 5.3.2. All the experiments were performed in triplicate. 
Analysis of the data 
The inhibition mechanisms of the selected compounds were identified by evaluating 
their effect in the Km and kcat values obtained as indicated in section 5.3.2. Additionally, 
the different data sets were fit to Lineweaver-Burk equations for competitive, 


















 Eqn. 2.21 
6.1.5 Thermodynamic characterization of binding of the selected FMNAT hits to 
CaFADS through ITC 
Beside the affinity that a compound has for its target, ITC experiments also provide 
additional valuable information such as the enthalpic and entropic contributions to the 
binding free energy. Depending on the thermodynamic term (that is ΔH or ΔS) that 
dominates the interaction between a ligand and a protein, we can distinguish between 
“enthalpic” or “entropic ligands” [195, 196]. The binding of the first type of ligands is 
favored by the formation of a great number of electrostatic interactions, such as H-
bonds or Van der Waals forces. On the other hand, the binding of “entropic ligands” is 
directed by entropic contributions, being the hydrophobic effect an important 
determinant for these interactions. This information is essential to determine the 
suitability of potential bioactive compound, and also for its future improvement through 
rational design.  
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ITC experiments were performed to characterize the affinity of the protein for the 
selected compounds, as also the thermodynamic parameters that drive the interaction. 
The experimental procedure and the data processing were those indicated in section 
5.5.2. In these experiments, ~400 µM of each compound were used to titrate ~25 µM 
CaFADS. However, when saturation of the protein was not reached, higher 
concentrations of compounds were employed,  
6.1.6. In-vivo determination of the antibacterial effect of the hits 
To determine the effect that the hits have in the cellular growth, the HTS hits were 
tested in C. ammoniagenes cells. The assay was based on the redox reactions that take 
place in living cells. Resazurin, which is blue in its oxidized form, but when it is 
reduced inside metabolically active cells change into pink, was used as indicator. 
Therefore, the color change produced in the course of the experiment, is a measurement 
of the cellular viability [197, 198]. 
Experiments were carried out in 96-well plates, BRAND plates®-pure Grade TM. 
100 µl of the corresponding culture media were added to each well. Within a column, 4 
different concentrations of each HTS hit (75-600 µM) were prepared through serial 
dilutions. The first column of each plate was the positive control, and no compound was 
added to it. The last columns of each plate contained the negative controls, and were 
included to detect contaminations by other microorganisms. These last wells neither 
contained cells nor any compound. All the wells, except those of the last column, were 
inoculated with 100 µl of culture, which contained the cells at a concentration of 106 
CFU/ml. Cells were incubated at 30ºC for 24 hours. After that, 20 µl of 0.01% (0.1 
mg/ml) resazurin solution, were added to each well, and cultures were incubated 24 
hours more.  
Positive and negative controls were checked to verify that cells have grown in 
positive controls (pink), and that they have not grown in the negative ones (blue). When 
the compound had inhibited the cellular growth in a well, the resazurin did not change 
from blue to pink.  
Similarly, the HTS hits were also assayed against M. tuberculosis and S. 
pneumoiniae cells. In these experiments the cell concentration of the inoculum was 
5·105 CFU/ml and plates were incubated for 10 hours (S. pneumoniae), and 6 days (M. 
tuberculosis), before the addition of the resazurin.  
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7. Statistical analysis of the data 
Along this thesis, results are expressed as the mean ± the standard deviation (SD) or 
as the mean ± the standard error (SE) of the regression. When it was convenient, one-
way analysis of variance (ANOVA) was performed to determine statistical significance. 
Statistical analyses were carried out using the GraphPad Software (GraphPad Prism 7), 
and the Turkey test with a 95% confidence interval.  
8. AFM measurements 
All the AFM experiments included in this thesis were performed by the group of the 
Dr. Anabel Lostao, in the Laboratorio de Microscopias Avanzadas at the Instituto de 
Nanociencia de Aragón de la Universidad de Zaragoza.  
9. Crystallographic structures 
The crystallographic structures displayed in the results chapters of this thesis were 
obtained by Dr. Beatriz Herguedas and/or Dr. Marta Martinez. 
10. Culture of pathogenic microorganisms 
Pathogenic bacterial strains were grown in the following culture media: 
-S. pneumoniae: brain-heart infusion medium (BHI) supplemented with 4 % bovine 
serum albumin (BSA), (Gibco). 
-M. tuberculosis: Middlebrook 7H9 culture medium (Difco) supplemented with 10% 
ADC (0.2% dextrose, 0.5% V fraction BSA and 0.000·% bovine catalase) (BD Difco) 
and with 0.5% glycerol (Scharlau). 
In-vivo assays using S. pneumoniae and M. tuberculosis were carried out by Ernesto 
Anoz-Carbonel in the Centro de Investigación Biomédica de Aragón and with the 
collaboration of Dr. Jose Antonio Ainsa. 
11. Software  
The analysis of the most of the data, and the production of the charts were made 
using the programs Origin 7.0 and Origin 8.0 (OriginLab). Structures were produced 
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As previously indicated, the crystal structure of CaFADS showed a quaternary 
organization composed of a hexameric structure formed by a dimer of trimers (Figs. 
1.21 and 1.22), which was stabilized by H-bonds, salt-bridges, and hydrophobic 
contacts [85]. The head-tail disposition of the monomers within each trimer approaches 
the RFK and FMNAT catalytic sites of neighboring protomers, placing them at a 
distance and orientation compatible with channeling of FMN between modules during 
FAD biosynthesis [85]. The physiological relevance of this quaternary organization was 
further supported by its observation at single molecule level, by the identification of 
oligomeric species in C. ammoniagenes cells as well as by the fact that binding of some 
substrates induces the interconversion between the monomer and the dimer of trimers 
[100]. Several structural elements contribute to stabilize each trimer within the 
hexamer; loop L4n in the FMNAT-module together with loops L1c and L6c, and helix 
α1c in the RFK-module conform the interface between two protomers and help to build 
the RFK- and FMNAT- active sites (Fig. 3.1). Especially relevant is the salt-bridge 
formed between R66 (situated at L4n) and the catalytic base of the RFK activity, E268, 
conserved in FADS and RFK families [88]. Mutations at E268 affect the binding 
parameters and the catalytic efficiency at the FMNAT active site of CaFADS, 
supporting the relevance of this interaction [88]. 
Here, we evaluate the roles of R66 in both the RFK and FMNAT activities, as well 
as in the stabilization of the quaternary organization. For this purpose, we produced and 
characterized two CaFADS variants at R66 that prevent formation of the salt-bridge: 
one completely eliminating the side-chain, R66A variant, and other replacing its 
positive charge by a negative one, R66E variant. Even though the complexity of the 
system, which includes two catalytic processes and an oligomerization equilibrium 
occurring within the same time scale, characterization of such variants indicates that in 
CaFADS R66 contributes to sustain the RFK activity, to maintain the geometry of the 
FMNAT and RFK active sites and to stabilize the dimer of trimers. 
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Figure 3.1. Cartoon detail of the head-tail disposition between the RFK-module and the 
FMNAT-module of contiguous protomers within the CaFADS trimer (PDB code: 2X0K). 
Positions of the products of the reaction, FMN and ADP:Mg2+, at the RFK-module were 
predicted based on the structure of the complex for human RFK (PDB code: 1P4M), and that 
of the FMN substrate at the FMNAT-module was modeled as previously described [85]. The 
interactions established by the R66 side-chain with the RFK-module are shown in black 
dashes, while those predicted with the modeled FMN are shown in red dashes. The RFK-
module and the FMNAT-module are colored in orange and green respectively. L4n is 
highlighted in yellow. R66 and E268 side-chains are shown in sticks and CPK colored. 
Modeled FMN and ADP molecules are CPK colored sticks with carbons in grey. Mg2+ is 
shown as a green sphere. 
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1. Expression, purification and distribution profile of quaternary 
organizations for R66 CaFADS variants 
The expression level for the variants was similar to that of WT CaFADS. R66A and 
R66E CaFADSs show three bands when analyzed by N-PAGE, similarly to the WT 
[100], but differences in the relative intensities of bands for the higher molecular weight 
species suggested changes in their relative distribution (Fig. 3.2). To analyze the 
oligomeric state of the different variants we used gel filtration chromatography. WT 
CaFADS showed several populations (Fig. 3.3A), with the main contribution 
corresponding to the monomer and the other peaks assigned to the dimer, trimer, and 
hexamer and higher aggregates (Fig. 3.4), as previously described [100]. When 
similarly analyzed, the R66E and, particularly, R66A CaFADS showed a considerable 
increase in the amount of oligomeric species, as well as a displacement of the 
monomeric peak to smaller elution volumes (Fig. 3.3A). Therefore, mutations at R66 
modulate the trend of the protein to organize its quaternary structure.   
 
Figure 3.2. Species detected by N-PAGE after the purification of WT (lane 1), R66E (lane 
2) and R66A (lane 3) CaFADS. 
To further study this modulation, the isolated samples corresponding to either 
monomeric or oligomeric species were loaded again into the gel filtration column (Fig. 
3.3). In the absence of ligands, the monomer peak (Fig. 3.3A, peak 2) remained mainly 
monomeric for all variants (Fig. 3.3B). On the other hand, we had previously shown 
that WT CaFADS stabilizes quaternary organizations in the presence of the products of 
the RFK reaction, FMN and ADP [100]. When both R66 variants were analyzed in 
similar conditions, the amount of oligomeric species decreased, particularly for the R66 
variant (Fig. 3.3C). In addition the gel filtration profile of the oligomeric peaks (Fig. 
3.3A, peak 1) in the presence of the products of the RFK activity (FMN and ADP) did 
not show the typical profile observed in the WT CaFADS protein (Fig. 3.3D). 
Therefore, all the filtration data indicate that the point mutation at R66 modify the 
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equilibrium between monomeric and oligomeric species in the presence of the products 
of the RFK reaction. 
 
Figure 3.3. The quaternary organization of WT, R66A and R66E CaFADSs. Elution profiles 
obtained after passing through a SuperdexTM 200 10/300 GL column in 20 mM PIPES, pH 
7.0: (A) the just purified samples, (B) the monomeric fraction (peak 2) after incubation with 
0.8 mM MgCl2, (C) the monomeric fraction (peak 2) after incubation with 25 µM FMN and 
200 µM ADP and (D) the oligomeric fraction (peak 1) after incubation with 25 µM FMN 
and 200 µM ADP. The corresponding profiles for WT, R66A and R66E are shown as black, 
blue and red lines, respectively. The insets show the percentage of monomeric (red, peak 2) 
and oligomeric (blue, peak 1) fractions obtained from the chromatograms. 
To quantify the effects of these mutations on the oligomeric state and on the 
conformation of CaFADS oligomers, we used AFM (Fig. 3.5E). This single molecule 
technique had been successfully used before not only to analyze the oligomeric state of 
the WT protein, but also to determine the topology of the oligomers and the effects on 
those of different ligand combinations [100]. Whereas the WT enzyme was mainly 
visualized as a homogeneous distribution of monomers in the absence of ligands [100] 
R66A and R66E CaFADS immobilized samples showed a mixture of species where 
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monomers accounted for the 34 and 44% of the total molecules, respectively (Table 3.1, 
Fig. 3.5, panel 1). The remaining species –with similar ratio in both variants- 
correspond to dimers (~40%) (Fig. 3.5, panel 1), tetramers (~15%) (Fig. 3.5, panel 2) 
and amorphous hexamers (~4%) (Table 3.1, Fig. 3.5 panels 3-4). Upon addition of the 
products of the RFK activity, FMN and ADP, the WT enzyme stabilized more than 70% 
of the molecules as a homogeneous compact dimer of trimers [100] However, similar 
treatment of the R66E and R66A variants did not promote this quaternary organization: 
for R66E the ligands induce formation of dimers and amorphous hexamers and for the 
R66A stabilization of tetramers and amorphous hexamers (Table 3.1, Fig. 3.5). It is also 
remarkable that while the WT dimers adopt mainly a head-tail disposition [100], the 
dimers of variants, whose modules are less distinguishable than in the WT molecule, 
usually do not show such disposition. Altogether, these data indicate that the mutations 
introduced at R66 have a negative impact on the establishment of the functional dimer 
of trimers in CaFADS, as well as on the formation of the monomer:trimer:hexamer 
equilibrium upon ligand binding. 
 
Figure 3.4. Fitting analysis to a set of Gaussian functions of the chromatograms obtained for 
R66E CaFADS, right after its purification (A) and after incubation of the obtained 
oligomeric peak (peak 1) with FMN and ADP:Mg2+ (B). The chromatograms obtained in 
each elution are indicated in black lines and the different populations assigned by the 
Gaussian analysis are indicated in colored lines. The calculated molecular weight for the 
peak maxima of every population is shown. 
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Figure 3.5. AFM topography images of R66A samples upon incubation with 
ADP:FMN:Mg2+. Samples of 0.5 µM proteins were diluted in 20 mM PIPES, pH 6.0, and 2 
mM DTT. ADP, FMN and MgCl2 were added at 250 µM, 50 µM and 0.8 mM, respectively. 
Panels show the different representative features found at the images identified with the 
accurate profile functions of the WSxM software as monomers (above) and dimers (1), 
tetramers (2), and incomplete or amorphous (3) and not compact hexamers (4). The 
associates found in the R66E samples were very similar (not shown). The oligomers are 
shown in a proportional scale in the X-Y plane while the corresponding Z-scales appear in 
colors. All measurements were performed in 20 mM PIPES, 2 mM DTT and pH 6.0. 
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Table 3.1. Relative association ratios estimated for purified monomeric WT, R66E and 
R66A CaFADSs at different conditions in AFM samples. Protein samples of 0.5 µM were 
diluted in 20 mM PIPES, pH 6.0, 2 mM DTT. ADP, FMN and MgCl2 were added at 250 
µM, 50 µM and 0.8 mM, respectively. Features correspond to image units, while molecules 
refer to the amount of individual protein monomers in the corresponding image units. Error 
associated to percentage determination was ±5-10%. 
Association state (%) 
CaFADS 
variant 





WT − Features 97 3 − − − 




Features 30 28 2 − 40 
  Molecules 9 17 2 − 72 
R66A − Features 56 34 8 2 0 




Features 56 27 14 3 0 
  Molecules 31 30 29 10 0 
R66E − Features 65 30 4 1 0 




Features 54 39 5 2 0 
  Molecules 33 48 13 6 0 
 
2. Spectral properties of the R66 CaFADS variants 
Far-UV CD spectra of the CaFADS variants were similar to those of the WT protein, 
indicating that the mutation had no impact on the secondary structure of the enzyme 
(Fig. 3.6A). Near-UV CD showed spectra with similar shape to that of the WT protein 
(a broad negative 260-300 nm band with minima at 284 and 291 nm) [84], but 
alterations in the overall and relative intensity of the minima suggest local changes in 
the environment of some of the aromatic side-chains contributing to the signal, 
putatively tryptophans (Fig. 3.6B). 
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Figure 3.6. Circular dichroism spectra (molar ellipticity by residue) of (A) 5 µM CaFADS 
in 5 mM PIPES, 10 mM MgCl2, pH 7.0 in the far-UV (cuvette path length, 0.1 cm) and (B) 
20 µM CaFADS in 20 mM PIPES, 10 mM MgCl2, pH 7.0 in the near-UV (cuvette path 
length, 0.4 cm). Spectra were recorded at 25 °C. The corresponding spectra for WT, R66A 
and R66E are shown as black, blue and red lines, respectively. 
Titration of R66A and R66E CaFADSs with RF, FMN and FAD produced visible 
difference spectra (Fig. 3.7, left panels), indicating that both variants bind the 
isoalloxazine ring of these flavins in at least one of the two flavin binding sites reported 
for the WT enzyme [84, 88]. The magnitude of the difference spectra suffered a 
significant increase when saturating FMN concentrations were added to the already 
preformed R66A and R66E CaFADS:ADP complexes (Fig. 3.7, right panels). In a 
previous study of the WT protein we saw this increase was related to the formation of a 
binding site for FMN at the RFK-module in the presence of the adenine nucleotide [88, 
90]. Moreover, in the case of the mutants the magnitude of the difference spectra also 
increased noticeably upon titration of the preformed CaFADS:ADP complex with RF 
and FAD (Fig. 3.7B and 3.7F), indicating that in the mutants the presence of ADP 
favors RF and FAD binding. 
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Figure 3.7. Visible difference spectra obtained upon titration of WT (black), R66A (blue) 
and R66E (red) CaFADSs (panels on left column) and their preformed CaFADS:ADP 
complexes (panels on right column) with saturating concentrations of (A and B) RF, (C and 
D) FMN and (E and F) FAD. Spectra were recorded in 20 mM PIPES, 10 mM MgCl2, pH 
7.0 at 25 ºC. 
3. Effects of the mutations in the catalytic activities of CaFADS 
To determine whether the mutations at R66 of CaFADS were able to prevent its 
catalytic activities, we analyzed the products of the two reactions using TLC. These 
assays confirmed that both CaFADS mutants retain the ability to catalyze the RFK and 
FMNAT reactions.  
Further on, we determined the kinetic parameters for the RFK and FMNAT 
activities. First we studied the RFK activity by quantifying the amount of RF 
transformed at 25 ºC by the amount of FMN plus FAD present in the reaction mixture 
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after 1 min of reaction (Table 3.2). For WT CaFADS the steady-state parameters were 
similar to those previously reported at 37 ºC [88, 90]. Variants at R66 exhibited strong 
RF dependent inhibition profiles at saturating ATP concentration, as also reported for 
the WT, which prevented determination of the kinetic parameters in the case of R66A 
CaFADS. Kinetic analyses indicate noticeable decreases in appkcat
RF for both variants as 
well as in appKm
RF for R66E (Table 3.2). The similar decrease in both parameters for 
R66E CaFADS produces minor changes in the catalytic efficiency for the 
transformation of RF. On the contrary, catalytic efficiency significantly decreases for 
the transformation of ATP when RF is kept constant, particularly for R66A CaFADS. 
This behavior is mainly a consequence of the decrease in the appkcat value (6.5- and 15-
fold reduction for R66E and R66A, respectively). Therefore, R66, situated at the 
FMNAT-module of CaFADS, considerably contributes to modulate the activity taking 
place at the RFK-module. 
Table 3.2. Steady-state kinetic parameters for the RFK (RF  FMN (+ FAD)) and the 
FMNAT activities (FMN  FAD) of the CaFADS variants. Parameters obtained at 25 ºC in 
20 mM PIPES, pH 7.0, and 0.8 mM and 10 mM MgCl2, respectively, for the RFK and 

















WT 408.1 11.7 4.85 34.9 155.5 28.2 5.5 
R66A >30c ndc <<0.5c ndc 10.9 87.0 0.13 
R66E 42.1 0.89 8.2 47.3 23.8 21.5 1.1 













WT 5.5 10.1 22.4 0.54 0.25 
R66A 8.5 0.69 15.8 12.3 0.54 
R66E 4.5 0.38 31.1 11.8 0.14 
a Determined at saturating ATP concentrations. Strong inhibition by RF substrate prevents the determination of real 
parameters and these correspond to apparent ones; appkcat and appKm. Estimated errors in appkcat and appKm can increase 
up to ±35% due to the larger Ki values.  
b Parameters estimated using a RF concentration exhibiting 80% maximal before inhibition is detected.  
c Although the variant is active, the strong inhibition caused by RF prevents mathematical determination of the 
kinetic parameters, and only minimal and maximal values for appkcat and Ki can be provided.  
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Similarly, the effects of the R66 mutations on the CaFADS FMNAT kinetic 
parameters were determined by following the transformation of FMN into FAD at 25 
ºC. The FMNAT activity of WT CaFADS in 10 mM MgCl2 followed a Michaelis-
Menten model with kcat, Km
FMN and Km
ATP of 5.5 min-1, 10.1 μM and 22.4 μM, 
respectively (Table 3.2), indicating a slightly slower reaction at 25 ºC than the 
previously reported at 37 ºC [88, 90]. Mutations at R66 hardly produce effects on the 
kcat for this activity (Table 3.2), slightly modulate Km
ATP (within a 1.5-fold factor) and 
considerably decrease Km
FMN (14- and 25-fold reduction for R66A and R66E, 
respectively). This makes the R66A and R66E CaFADS variants more efficient than the 
WT in transforming FMN. These observations indicate that R66 modulates the 
catalytically competent binding of FMN during the FMNAT activity. 
4. Interaction parameters for CaFADS with flavins and ATP 
In order to deep into the effect produced by the mutations on ligand binding, we used 
ITC in 10 mM MgCl2 to determine the thermodynamic parameters for the formation of 
the complexes of R66A and R66E CaFADS with flavins. Thermograms revealed the 
ability of RF, FMN and FAD to bind to the enzyme, but relatively low occupancy was 
observed for all the flavins (Fig. 3.8). The unusual low flavin occupancy could not be 
related to contaminations or defective folding, but rather to the establishment of non-
productive quaternary organizations decreasing the accessibility of flavins to their 
binding sites. Even though several observations clearly indicate two different RF 
binding sites; i) RF stoichiometry for R66A CaFADS resulted twice as large as that of 
FMN and FAD and ii) in R66E CaFADS thermodynamic parameters were determined 
for two independent sites (Tables 3.3 and 3.5). The affinity for RF increased in R66E 
CaFADS relative to the WT (Table 3.5), while its affinity for FMN and FAD decreased 
(Kd
FMN and Kd
FAD increased up to 11-fold and 40-fold, respectively (Fig. 3.8A and 3.8B, 
Table 3.5). R66A CaFADS showed a similar behavior but milder effects. Changes in 
affinity for flavins resulted in general as a consequence of mutations having a slight 
negative impact on the enthalpic favorable contribution, while the entropic contribution 
became less unfavorable or even favorable for RF (Fig. 3.9A, 3.9B and 3.9C, Table 
3.3). Taking into consideration the previous studies confirming that under the employed 
experimental conditions FMN and FAD preferentially bind to the FMNAT-module [84, 
88, 90], our data indicate that mutations at R66 modify the organization of the flavin 
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substrates at the FMNAT-module of CaFADS. Similarly, data for RF also suggest 
changes in the RF binding architecture at the RFK-module. 
R66A and R66E CaFADS mutants showed two ATP binding sites in the presence of 
Mg2+ and a single ATP binding site in its absence (Fig. 3.8C), as reported for the WT 
protein [84, 88, 90]. Regarding ATP affinity, the mutations produced more relevant 
changes in the absence of the metal (Kd,av
ATP:Mg2+ 1.3-fold higher and 2-fold lower, and 
Kd,av
ATP 3-fold and 10-fold higher for R66A and R66E, respectively) (Table 3.5), 
indicating changes in the ATP binding conformation at the FMNAT-module. Although 
these patterns indicated that ATP binding is enthalpically driven with an opposing 
entropic contribution, the magnitude of both contributions to the binding was in general 
smaller than in the WT (Fig. 3.9D, Table 3.3). These results indicate that R66 
contributes to the ATP binding at both the FMNAT-module and the RFK-module. 
In WT CaFADS the adenine nucleotide promotes stabilization of FMN at the RFK-
module and increases its affinity at the FMNAT-module [84]. Therefore, we also 
investigated the interaction of FMN and RF to the preformed R66A and R66E 
CaFADS:ADP complexes (Fig. 3.8D). Under these conditions mutations neither 
prevented RF nor FMN binding at any of the two identified sites and occupancy for 
each site was close to the maximum (Table 3.5). Moreover, they had a slight positive 
impact on RF affinity, at least in one of the binding sites, and a slight negative impact 
on FMN affinity. Thermodynamic profiles for binding of RF and FMN to the 
CaFADS:ADP pre-formed complex for both mutants were similar to those for the WT 
protein: binding generally driven by favorable enthalpic contributions with small 
favorable entropic contributions at both sites (Fig. 3.9E, Table 3.4). This is in contrast 
with contributions driving the interaction of FMNA at the FMNAT-module in the 
absence of the adenine nucleotide (compare Fig. 3.9B with Fig. 3.9E, and Table 3.3 
with Table 3.4) [84, 88]. Regarding RF, it is worth to notice that the mutations 
modulated the enthalpic and entropic contributions to the binding at one of the sites. 
Altogether, these profiles confirm that, in general, mutations modulate favorable 
interactions at the FMNAT site and induce favorable interactions at the RFK-module, 
with replacement of R66 by Glu also having a negative impact on the entropic 
contribution to the binding.  
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Table 3.3. Thermodynamic parameters for the interaction of WT, R66A and R66E CaFADSs with flavins and ATP as determined by ITC. Data 
obtained at 25 ºC in 20 mM PIPES, pH 7.0, and, unless otherwise stated, 10 mM MgCl2. Errors in ΔG, ΔH and –TΔS were ±0.3 kcal/mol, taken in 
general larger than the standard deviation between replicates and the numerical error after fitting analysis. 






















WTa -6.3b -7.5b 1.2b  -7.0 -35 28  -8.4 -26 18  
R66A -5.9b -4.1b -1.9b  -5.7 -24 18  -7.8 -25.0 17.2  
R66E 
Site 1 -7.6 





 -5.5 -21 15 
 
-6.2 -27.6 21.4  
 














WTa  -6.2 -30 23  -7.0 -32.3 25.3 
R66A  -6.0 -31.8 25.8  -6.6 -16.8 10.1 
R66E  -6.6 -8.3 1.7  -6.0 -15.5 9.5 
a Data from[88, 90]. 
b Data correspond to an average of two independent binding sites. 
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Table 3.4. Thermodynamic parameters for the interaction of RF and FMN with the preformed CaFADS:ADP complexes. Data obtained at 25 ºC in 
20 mM PIPES, pH 7.0, and 10 mM MgCl2. Errors in ΔG, ΔH and –TΔS were ±0.3 kcal/mol, taken in general larger than the standard deviation 
between replicates and the numerical error after fitting analysis. 
 FADS:ADP:RF  FADS:ADP:FMN  





























WT -8.3b -4.9b -3.5b      -10.0a -4.1a -6.0a  -8.2a -4.5a -3.8a  
R66A -10.4 -9.6 -0.8  -8.8 -5.5 -3.3  -8.6 -3.4 -5.2  -7.8 -5.6 -2.2  
R66E -10.2 -11.4 1.2  -8.8 -6 -2.8  -8.2 -2.2 -6.0  -7.8 -7.1 -0.6  
a Data from[88, 90]. b Data correspond to an average of two independent binding sites. 
Table 3.5. Parameters for the interaction of WT and mutated CaFADS forms with RF, FMN, FAD and ATP, and for RF and FMN interaction with 
the preformed CaFADS:ADP complexes, determined by ITC. The stoichiometry for the interaction is shown in brackets. Data obtained at 25 ºC in 
20 mM PIPES, pH 7.0, and unless otherwise stated, 10 mM MgCl2. Estimated errors in Kd are ±15% 
Kd (μM) 
 FADS:RF  FADS:FMN FADS:FAD  FADS:ATP  FADS:ADP:RF  FADS:ADP:FMN 
        MgCl2 Without MgCl2  Site 1 Site 2  Site 1 Site 2 
WT 24.1 (2)a,b  7.8 (1)a 0.74 (1)a  30.2 (2)a,b 3.9 (1)a  0.79 (2)b   0.04 0.90 
R66A 45.6 (<2)b  66.2 (<1) 1.9 (<1)  40.0 (2)b 13 (1)  0.03 0.35  0.49 1.80 
R66E Site 1 5.0 (<1) Site 2 22 (<1) 89.0 (<1) 30.2 (<1)  14.7 (2)b 38 (1)  0.03 0.36  0.94 2.07 
a Data from[88, 90]. b Data correspond to an average Kd (Kd,av) of two independent binding sites 





Figure 3.8. Calorimetric titrations of CaFADS with (A) FMN, (B) FAD and (C) ATP, and 
of the preformed CaFADS:ADP complex with (D) FMN. The upper panels show the 
thermograms for R66E and WT CaFADS (inset) interaction and lower panels show the 
corresponding binding isotherms with integrated heats for R66E (●) and WT (○) CaFADSs. 
Experiments were carried out at 25ºC in 20 mM PIPES, 10 mM MgCl2, pH 7.0. 




Figure 3.9. Thermodynamic dissection of the interaction of R66A and R66E CaFADS with 
(A) RF, (B) FMN, (C) FAD and (D) ATP, as well as of the preformed R66A and R66E 
CaFADS:ADP complexes with (E) FMN. All measurements were carried out in 20 mM 
PIPES, 10 mM MgCl2, pH 7.0. The binding Gibbs energy (ΔG), enthalpy (ΔH), and entropy 
(-TΔS) are represented in dark blue, green and red, respectively. In (E) the energetic profiles 
for both independently detected binding sites are displayed separately. 
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5. Crystal structure of the CaFADS variants 
 
Figure 3.10. Structural effects induced by R66 replacement in the interactions stabilizing the 
CaFADS trimer interface. Head-tail disposition between the RFK-module (orange) and the 
FMNAT-module (dark green) of two contiguous protomers in the WT CaFADS trimer (PDB 
code 2x0k), with the superposition of the respective RFK- and FMNAT-modules of R66A 
(in magenta and lemon green, respectively, PDB code 4uze) and R66E CaFADS (in pale 
pink and yellow, respectively, PDB code 4uzf). (A) Key interactions established by position 
66 at the interaction surface between the RFK-module and the FMNAT-module of 
contiguous protomers are shown in black for WT, magenta for R66A and green for R66E 
CaFADS. (B) Model showing the expected position of the FMN, product of the RFK 
reaction, at the RFK-module (based on PDB code: 1P4M) and the detail of the K296-E66 
(green) and R66-FMN (black) interactions present in R66E and WT CaFADSs, respectively. 
Key residues are shown in sticks and CPK colored. Modeled FMN in the RFK-module is 
colored in CPK sticks with carbons in gray. 
The overall structures of R66A and R66E CaFADSs (PDB codes 4uze and 4uzf 
respectively) hardly differ from that of the WT (A chains shows r.m.s.d values of 0.121 
and 0.151 Å, for 288 and 293 C  atoms, respectively) [85, 86]. Model for R66A 
CaFADS showed all residues, i.e. 1-338, whereas in model for R66E residues 258-263 
in chain A and 260-262 in chain B were not refined due to the lack of local electron 
density. The PISA server predicted for both variants a stable hexameric assembly in 
solution with similar stability parameters to the WT, but the R66E CaFADS trimeric 
assembly (A3 or B3) was not predicted as stable in solution (Table 3.5). The variants 
show slight differences when looking at the interface between the RFK- and the 
FMNAT-modules of neighboring protomers within each trimer (Fig. 3.10A). The 
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shorter and non-charged A66 side-chain in the R66A variant cannot interact with E268 
of the neighboring protomer. In the R66E variant the OE1 atom of E66 establishes a 
salt-bridge with K296 on loop L6c of the FMNAT-module of the neighbor protomer, 
neutralizing the introduced negatively charge and taking it far from the expected 
binding sites for the ATP phosphates and the ribityl chain of RF during RFK catalysis 
(Fig. 3.10B). In both variants the R65 side-chain and the regions where conformational 
changes are predicted during catalysis at the RFK-module (loop L4c-FlapII (residues 
258-263) and, to a lesser extent, loop L1c-FlapI (193-208)) show higher B factors than 
in the WT [85]. Finally, changes in the orientation of T165 and, particularly, of D298 
are observed regarding their conformations in the WT structure. 
Table 3.6. Predicted stability parameters for quaternary organizations inferred from the 
PISA server. 
 Specie Hexamer (A3B3) Trimer B3 (A3) Dimer (AB) 
Surface area 
sq.·Å 
WT 82800 45020 (44480) 31390 
R66A 81760 44570 (43760) 30730 
R66E 82140 44920 (44160)a 30820 
Buried area 
sq.·Å 
WT 19770 6550 (6520) 2800 
R66A 18680 5770 (6350) 2750 
R66E 19050 593º (6170)a 2910 
ΔGint b 
kcal/mol 
WT -189.0 -73.0 (-72.0) -52.7 
R66A -201.4 -78.4 (-78.3) -52.8 
R66E -188.2 -72.3 (-70.1)a -50.2 
ΔGdiss c 
kcal/mol 
WT 22.5 3.1 (2.7)  12.4 
R66A 20.8 4.4 (0.1) 9.8 
R66E 19.0 -0.2 (1.2)a 12.4 
a These structures might not be stable in solutions. 
b Indicates the solvation free energy gain upon formation of the assembly. The value is calculated as difference in 
total solvation energies of isolated and assembled structures. This value does not include the effect of satisfied H-
bonds and salt bridges across the assembly's interfaces. 
c Indicates the free energy of assembly dissociation. The free energy of dissociation corresponds to the free energy 
difference between dissociated and associated states. Positive values of ΔGdiss indicate that an external driving force 
should be applied in order to dissociate the assembly, therefore assemblies with ΔGdiss>0 are thermodynamically 
stable. 
6. Discussion  
Specific self-association of enzymes is very common in living organisms. Oligomers 
provide structure and stability, regulate activity by modulating conformation and 
accessibility of binding sites, facilitate concentration and channeling of molecules, 
III. Quaternary organization in a bifunctional FADS: role of an Arg on the RFK activity 
 127 
generate links between different cellular components, transmit signals or regulate 
ligands homeostasis. In many oligomers the active sites are formed at the subunit 
interface, while in others, conformational changes are propagated from the interface to 
catalytic sites [200-202]. Active site residues are usually conserved among species since 
they are constrained by the specific chemical functionality to catalyze the reaction, but 
residues that make up the subunit interface evolve as rapidly as the overall protein 
sequence. Quaternary organizations have been related to the function in several 
members of the nucleotidyltransferase superfamily [203-206]. Stabilization of 
quaternary organizations in the prokaryotic FADS family has already been shown for 
CaFADS [85, 100] but characterization of other family members is reduced to the 
structures for the FADSs from Thermotoga maritima (TmFADS, PDB 1MRZ) and 
Streptococcus pneumoniae (SpnFADS, PDB 3OP1) [74]. Moreover, recent data from 
our laboratory indicate that this later enzyme might stabilize dimers (unpublished 
results). The main structural difference between CaFADS and SpnFADS is an insertion 
of 12 residues in the L3c (L232-V246, RFK-module) only present in sequences of the 
Corynebacterium and Mycobacterium genus (Fig. 1.29). This loop reinforces the 
interface between trimers in the formation of the dimer of trimers and might be an 
enabling determinant contributing to mediate interactions between protomers [207]. The 
second most important difference is the conformation of loop L4n at the FMNAT 
module (L63-T73). This loop contains R66 and situates at the interface between trimers 
in the dimer of trimers (Fig. 3.1). In TmFADS the corresponding loop and the preceding 
α2n helix are displaced towards the α6n helix (Fig. 3.11A), while in SpnFADS part of 
the loop folds into a short α helix (Fig. 3.11B). Non conserved motifs are present in 
sequences of loop L4n itself and all type of residues are at the equivalent position of 
R66 in CaFADS. However, the loop usually contains at least two prolines and a group 
of polar residues with lack of a motif in distribution (Fig. 3.11) [76]. Both facts suggest 
that L4n might be involved in highly flexible interactions with other protein regions. 
Even though mutations at R66 in CaFADS do not prevent the formation of oligomeric 
species, experimental data and theoretical evaluation of structures revealed a negative 
impact on the stabilization of putatively functional quaternary organizations, trimers 
and hexamers, as well as on their regulation by ligand binding (Figs. 3.2, 3.3 and 3.5, 
Tables 3.1 and 3.3). Surface and charge complementarities within this organization 
result considerably decrease in the mutants regarding the WT enzyme (Table 3.6 and 
Fig. 3.12), which might favor other types of quaternary arrangements. These 
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observations indicate that R66 is involved in the establishment and stability of the 
compact dimer of trimers of CaFADS, but is far from being a single determinant of the 
enzyme quaternary organization. 
Noticeably, kinetic parameters for R66A and R66E CaFADS mutants point to a 
relevant role for this arginine in modulating the enzyme RFK catalytic efficiency; R66 
particularly contributes to maintaining a high turnover and to moderate the large 
inhibitory effect produced by the RF substrate (Table 3.2). Changes in the affinity of 
ligands and in the magnitude of the enthalpic and entropic contributions for their 
binding to the mutants, showed that R66 contributes to place: i) flavins at the FMNAT-
module, ii) ATP at the FMNAT-module of one protomer and iii) ATP at the RFK-
module of the neighboring protomer within the trimer (Fig. 3.8 and 3.9, Tables 3.5 and 
3.3). Both replacements prevent direct interaction of position 66 with the E268 catalytic 
base of the neighboring protomer within each trimer (Fig. 3.10A), as well as the 
expected interaction with the ribityl chain of RF during its phosphorylation in this 
second protomer (Fig. 3.10B) [85, 88]. Thus, lack of a side-chain in A66 position of the 
R66A variant prevents any contribution of this position to ligand binding at the RFK 
module, while the E66 side-chain in the R66E variant is located far from the catalytic 
site (Fig. 3.10B). Therefore, R66 plays a key role in modulating the orientation of the 
E268 catalytic base and of the reacting atoms during the RFK activity, as previously 
hypothesized [85]. Nevertheless, the role of R66 in the chemistry of the RFK activity of 
CaFADS might hardly extrapolate to other members of the prokaryotic FADS family, 
since this position is not conserved between species [76]. This might be in agreement 
with other members of the family stabilizing organizations different from the trimer, 
where a different relative orientation between protomers would be expected and a 
residue different from that at position 66 in CaFADS might be involved in bridging the 
catalytic base. To test this hypothesis we should wait to the characterization of other 
enzymes of the family. 
Changes in the efficiency of the FMNAT activity for FMN upon replacing R66 seem 
to be a consequence of a different interaction mode for substrates/products relative to 
the WT enzyme (Tables 3.2, 3.5 and 3.3, Fig. 3.9), indicating that R66 plays a role in 
their accommodation for the production of the catalytic competent complex. However 
R66 and the loop L4n are relatively far from the FMNAT active site, and exposed either 
to the solvent in the monomer or to the neighboring protomer within the trimer. 
Therefore, a priori they are not expected to participate in the conformation of the flavin 
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binding site at the FMNAT module, unless conformational changes in loop L4n are 
produced (as observed in TmFADS and SpnFADS, (Fig. 3.11A and 3.11B). Structures 
for R66A and R66E variants do not reveal important conformational changes in loop 
L4n that might occlude/expose the ligand binding site (Fig. 3.11C), but the mutations 
alter the electrostatic potential surface at one of the sites of the binding cavity (Fig. 
3.12A). This observation might explain on one hand the very low occupancy for 
binding of flavins to the free mutants and on the other the full occupancy of flavins 
when binding to preformed CaFADS:ADP complex and of ATP:Mg2+ when binding to 
the free enzyme These facts suggest that: i) binding of AT(D)P:Mg2+ to the variants 
might overcome the negative effect introduced by the mutations in the CaFADS ability 
to bind flavins at the FMNAT site, and ii) the integrity of the adenine nucleotide 
binding sites at the RFK- and FMNAT-modules is maintained. 
 
 
Figure 3.11. Comparison of the conformation of the residues forming the loop L4n in 
CaFADS (protein in green, L4n in yellow) with those found in the structures of (A) 
TmFADS (PDB 1MRZ, pink) and (B) SpnFADS (PDB 3OP1, wheat). Equivalent residues to 
R66 are highlighted. (C) Detail of the conformation of side-chain at position 66 regarding 
modeled ligands at the FMNAT-module of one CaFADS protomer. WT, R66A and R66E 
CaFADS are colored in dark green, lemon green and yellow, respectively. Modeled FMN 
and AMP ligands are in CPK sticks. 
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Figure 3.12. Effects on the electrostatic potential surface of CaFADS upon replacement of 
R66. (A) Electrostatic potential surface of one protomer in the surroundings of the FMNAT 
catalytic site of WT, R66A and R66E CaFADSs. Modeled FMN and AMP ligands are in 
CPK sticks. (B) Electrostatic potential surface at the interface between the FMNAT-module 
and the RFK-module of neighboring protomers within the trimer. The first panel shows 
protomer A1 in electrostatic potential surface, while the RFK-module of protomer A2 is 
shown for the three variants in cartoons with residue at position 66 in sticks. Rest of panels 
show the RFK-module of protomer A2 as electrostatic potential surface for each variant. 
Both catalytic and ligand binding behaviors of these variants indicate that the 
mutation of R66 situated at the FMNAT-module of CaFADS affects the activity 
catalyzed by the RFK-module. These observations can be explained considering the 
quaternary of the enzyme into the dimer of trimers, particularly in each trimer. A 
negative effect on the binding properties of flavins at the FMNAT-module of CaFADS 
was already described when mutations at E268 also disrupted the R66-E268 salt-bridge 
[88]. The magnitudes of the enthalpic and entropic contributions to FMN, FAD and 
ATP binding in WT CaFADS indicate that these ligands induce a large number of 
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interactions as well as the displacement of numerous well-ordered water molecules on 
the protein surface upon binding (Table 3.3). Considering that FMN:ADP:Mg2+ and 
ATP:Mg2+ have been reported as inducing the formation of the dimer of trimers [100], 
the large values of the enthalpic and entropic contributions observed for ligand binding 
may reflect the overall coupled process; ligand binding and assembly of the dimer of 
trimers. Moreover, changes in conformation of the quaternary organizations in the 
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Many biological processes take place through the formation of protein oligomers or 
multiprotein assemblies as a response to conformational changes, being that an 
extended mechanism for protein activity modulation [208-210]. Protein-protein 
association or dissociation processes can be regulated by the binding of partner proteins, 
metal cofactors or small allosteric effectors, as well as by conformational modifications 
coupled to geometry changes after a catalytic event [211]. Regarding the protein of our 
study, the CaFADS, the formation of such species might regulate cellular processes, 
such as flavin delivery to apo-flavoproteins or those dependent on flavin homeostasis 
[212, 213]. The assembly takes place through self-association and self-dissociation 
processes as response to conformational changes induced by the substrates of the two 
enzymatic activities: FMN-adenylyltransferase (FMNAT) and particularly riboflavin 
kinase (RFK) [100]. Thus, as previously shown, the head-tail disposition of the 
monomers within each trimer of the CaFADS dimer-of-trimers approaches the RFK and 
the FMNAT catalytic sites of neighboring protomers (Fig. 4.1A), placing them at 
adequate distance and orientation for FMN channeling between modules during FAD 
biosynthesis [85]. 
Different structural elements have been proposed to stabilize such quaternary 
organization through H-bonds, electrostatic and hydrophobic interactions. Some of 
these elements are: loop L3c located in the FK domain and composed by residues 231-
246, loop L4n at the FMNAT module and loops L1c-FlapI and L6c (both in the RFK 
module) that together with the helix α1c of the same domain, conform the interface 
between two protomers of the trimer and contribute to the building of the active sites 
(Fig. 4.1A) [85]. In addition, L1c-FlapI, L6c and α1c, together with loop L4c-FlapII, 
conform the closed conformation of the RFK flavin-binding site. This conformation is 
reached after substrate/product binding triggering dramatic conformational changes 
(Fig. 4.1B) [99].  
In the present chapter, we analyze at the molecular level the structural determinants 
that stabilize the trimer interfaces by evaluating the effect produced through the 
mutation of residues at L1c-FlapI (K202, E203, and F206), L6c (D298), and α1c (V300, 
E301 and L304) of CaFADS, which contribute to the trimer stabilization through 
electrostatic and hydrophobic interactions (Fig. 4.1A) [85]. As we have just indicated, 
these secondary structural elements also contribute to build the active sites for FMN and 
FAD synthesis of two contiguous protomers (Fig. 41A) [85] and are involved in 
important conformational changes contributing to flavin binding at the RFK module 
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(Fig. 4.1B) [99]. Therefore, the introduced mutations are expected to somehow alter the 
formation of the oligomeric structures or the catalytic activities of the enzyme. 
 
Figure 4.1. Structure of CaFADS. (A) Cartoon representation of the CaFADS monomer 
(PDB code: 2x0k) and of the dimer of trimers model predicted by the PISA server (one of 
the trimers is represented as a surface). The RFK-module and the FMNAT-module are 
colored in green and pink, respectively. The right panel shows a detail of the head-to-tail 
disposition between the RFK and FMNAT modules of neighboring protomers, within each 
one of the trimers. Residues involved in the stabilization of the trimer are shown as sticks 
and the ones mutated in the present work are labelled. H-bonds and salt-bridges established 
by these residues are indicated with dotted lines. Predicted positions for flavin and adenine 
nucleotide ligands are shown as sticks with carbons in yellow and gray, respectively. (B) 
Cross-eye stereo view of the superposition of the RFK modules of CaFADS (PDB code: 
2x0k; green) and the ternary complex CaFADS RFK:FMN:ADP:Mg2+ (PDB code: 5a89; 
blue). Relevant residues are shown in sticks. FMN, ADP (in sticks CPK colored with C in 
yellow) and Mg2+ (blue sphere) are from the ternary complex structure. Backbones of the 
PTAN motifs (207-210 residues) of CaFADS and the ternary complex are highlighted in 
orange and red, respectively. 
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1. Spectral properties of CaFADS variants 
The expression levels of all variants are similar to that of WT CaFADS (10-17 mg 
per g cells). Most mutants primarily purified as monomers, with a small population of 
oligomeric species (Fig. 4.2), similar to WT CaFADS [87, 100]. Far-ultraviolet (UV) 
circular dichroism (CD) spectra were similar to those of the WT [84] indicating minor 
impact of the mutations on the enzyme’s secondary structure (Figs. 4.3A and 4.3B). 
However, some mutations considerably decreased the intensity of the near-UV CD 
signal (Figs. 4.3C and 4.3D), suggesting local changes in the region contributing to the 
signal.  
 
Figure 4.2. Relative area of the monomeric and oligomeric species detected after passing the 
just purified variants of CaFADS at ~20 µM through a SuperdexTM 200 10/300 GL column 
in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0. The one-way ANOVA test (n=3, confidence 
interval 95%) did not show statistically significant differences regarding the WT. 
Visible difference spectra monitored during titration with flavins indicated that all 
the CaFADS variants interact with RF, FMN and FAD (Fig. 4.4). Noticeably, while 
mutations at charged residues increase the magnitude of the difference spectra in 
comparison to the WT enzyme, the opposite effect was observed for mutations at 
hydrophobic residues. The most significant changes of peak shapes in the spectra were 
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observed when titrating with FAD and FMN, particularly for the F206W, D298E and 
E301K variants (Figs. 4.4C and 4.4F), suggesting different environments of the 
isoalloxazine ring in the flavin binding site at the FMNAT-module. The increase in the 
magnitude of the difference spectra upon titration of the preformed WT 
CaFADS:ADP:Mg2+ complex with FMN (~8-times higher than in the absence of ADP) 
is related to the formation of the FMN binding site at the RFK module [84, 87, 88]. 
Noticeably, this effect was smaller for most of our variants and undetectable for E301K 
(Figs. 4.4G and 4.4H). Calorimetric results (discussed below) indicate that, as reported 
for the WT, all variants maintain two binding sites for FMN in the presence of ADP. 
Difference spectra suggest that the mutations alter the closed conformation of the flavin 
isoalloxazine binding site at the RFK module, as described for WT [99].  
 
Figure 4.3. Circular dichroism spectra (molar ellipticity per residue) (A and B) in the far-
UV region and (C and D) in the near-UV region for the different CaFADS variants. Spectra 
were recorded in 20 mM PIPES, 10 mM MgCl2, pH 7.0 at 25 °C. 
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Figure 4.4. Visible difference spectra obtained upon titration the different CaFADS variants 
with saturating concentrations of (A and B) RF, (C and D) FAD, (E and F) FMN and (G and 
H) FMN in presence of ADP:Mg2+. Spectra were recorded in 20 mM PIPES, pH 7.0 at 25 
°C. 
 
María Sebastián Valverde 
 140 
2. Size distribution of CaFADS variants 
Previous studies showed that monomeric WT CaFADS, incubated with the products 
of the RFK activity (FMN and ADP in the presence of Mg2+), stabilizes a transient 
dimer of trimers, which mostly dissociates into the monomer form upon the ligands’ 
removal by gel filtration chromatography [87, 100]. This is due to the protomers of 
CaFADS rapidly assembling in response to ligand binding, and disassembling when 
ligands are eliminated. However, a small fraction of oligomers always remain after gel 
filtration, which probably reflects the presence of poorly fit assemblies with a large 
kinetic barrier to dissociation. This might be a consequence of the thermodynamic 
complexity of the system (see text below and corresponding Figs. 4.2 and 4.5), forming 
other assemblies than the transient dimer of trimers [87, 100]. In practice, these 
observations allow the evaluation of whether the introduced mutations modulate 
assembly and disassembly profiles of WT CaFADS [100]. Taking advantage of this, we 
next studied whether the mutations influence the CaFADS monomer-oligomer 
interconversion associated to the binding and dissociation of ligands. We used freshly 
purified fractions containing either monomeric or oligomeric (which included all 
oligomeric fractions isolated by gel filtration of freshly purified variants) species and 
independently incubated them with the products of RFK activity. Monomeric and 
oligomeric species in the absence of ligands were similarly treated but used as controls. 
Gel filtration chromatography was then used to remove ligand and separate monomers 
and oligomers and quantify their relative percentages (Figs. 4.5 and 4.6). For all 
variants, in the absence of ligands, samples that began as freshly prepared monomers 
eluted again mostly as monomers (peak labelled 2 in Figs. 4.5A, 4.6A and 4.6B). 
Variants, when prepared as monomers that had been incubated with the products of the 
RFK activity, were also isolated mainly as monomers after gel filtration (Figs. 4.5B, 
4.6C and 4.6D), as has been reported for WT CaFADS. The only exception was E301K 
CaFADS, which recovered less than 20% of the monomer.  
When oligomeric fractions (the peak labelled 1 in the chromatograms) were similarly 
treated in the absence of ligands, the monomer/oligomer ratio was 0.8 for WT, with no 
statistically relevant differences for most of the variants (Figs. 4.5E, 4.5F and 4.6C). 
This agrees with the large amount of oligomeric assemblies that remain, which, as 
mentioned above, possess a large kinetic barrier to disassembly [87, 100]. 
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Figure 4.5. Gel filtration elution profiles of purified monomeric and oligomeric fractions of 
the different CaFADS variants under different conditions. (A and B) The peak 
corresponding to the monomeric form. (C and D) The band corresponding to the oligomeric 
forms. (E and F) The peak corresponding to the monomeric form incubated with 25 μM 
FMN and 200 μM ADP. (G and H) The band corresponding to the oligomeric forms 
incubated with 25 μM FMN and 200 μM ADP. Panels on the right show the corresponding 
percentages of monomer (peak 2) in orange bars and the bulk of oligomeric species (peak 1) 
in violet obtained from each chromatogram, with * indicating values showing statistically 
significant differences to the WT ones as determined by the one-way ANOVA test (P < 
0.002; n=3, confidence interval 95%). All samples contained 15-20 µM of protein, 20 mM 
PIPES, 0.8 mM MgCl2, pH 7.0, and where incubated 10 min at room temperature before 
passing through a Superdex™ 200 10/300 GL column in the same buffer. 
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Figure 4.6. Gel filtration elution profiles of monomeric and oligomeric samples of WT 
(black line), F206A (orange line) and E301K (green line) CaFADSs after incubation under 
different conditions. (A) The peak corresponding to the monomeric form, which was used as 
a control. (B) The peak corresponding to the monomeric form, after incubation with 25 μM 
FMN and 200 μM ADP. (C) The band corresponding to the oligomeric forms, which was 
also used as a control. (D) The band corresponding to the oligomeric forms, after incubation 
with 25 μM FMN and 200 μM ADP. The insets show the percentage of monomer 
(represented by the peak labelled peak 2) and the bulk of oligomeric species (labelled as 
peak 1) obtained from the chromatograms, with * indicating values that show statistically 
significant differences from the WT, as determined by the one-way ANOVA test (P < 0.002; 
n=3, confidence interval 95%). All samples contained 15-20 µM of protein, 20 mM PIPES, 
0.8 mM MgCl2, pH 7.0, and were incubated 10 min at room temperature before passing 
through a Superdex™ 200 10/300 GL column in the same buffer.  
Nevertheless, this ratio significantly increased for the F206W, V300K and L304 
variants, indicating the greater conversion of such assemblies into monomers (panel to 
the right of Figs. 4.5E and 4.5F). Finally, when the original oligomeric fractions were 
treated with FMN and ADP, most of the variants exhibit monomer/oligomer ratios 
similar to the corresponding control. However, no traces of monomer were detected for 
the F206A variant (Fig. 4.6D), indicating that this mutation prevents recovery of misfit 
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assemblies by ligand binding and dissociation. In contrast, the V300K and L304K 
mutations clearly promote the recovery of the monomeric form (Figs. 4.5E and 4.5F). 
Altogether, these data indicate that point mutations introduced at F206 in L1c-FlapI and 
V300, E301 and L304 in α1c modulate the reestablishment of monomeric forms as well 
as the type of assemblies that are produced. 
3. Effects of the mutations in the catalytic activities of CaFADS 
variants 
Qualitative analysis of RFK and FMNAT reactions by thin layer chromatography 
(TLC) indicates that all the variants retained both catalytic activities (not shown).  
The RFK activity was quantitatively analyzed by monitoring the conversion of RF 
into FMN and FAD (because there is no way to fully avoid FMNAT activity) (Table 
4.1). At saturating ATP concentrations, all the variants exhibit the WT-like RF-
inhibition kinetic profile (not shown). The calculated inhibition constants suggest that 
only mutation L304A slightly reduces the RF inhibitory effect (see Ki in Table 4.1). 
while the effect is large enough for F206W, D298E, V300A and E301K variants to 
prevent determination of accurate kinetic parameters. All mutants except V300K and 
L304K reduce both kcat (1.5-8 times lower than CaFADS WT) and Km
RF values (up to 4-
fold lower), maintaining the catalytic efficiency of RF transformation within a factor of 
three from that of WT CaFADS (Table 4.1). When determining the RFK activity as a 
function of ATP concentration, (experiments performed at RF concentrations producing 
80% of the maximal measured activity), most of the variants show a significant appkcat 
decrease (Table 4.1), except for F206A, F206K, V300K, L304A and L304K. Under 
such conditions, the introduced mutations significantly increased Km
ATP in the cases of 
non-conservative mutations at F206 and E203A, and slightly decreased its value for 
V300K, L304A and L304K (4-7 times less). When RF is kept constant, most of the 
variants reduce the catalytic efficiency for ATP and only V300K and variants with 
mutations at L304 show higher efficiency, because of a stronger apparent affinity for 
ATP (Table 4.1). These observations indicate that although the mutated residues are not 
critical to maintain the RFK activity, they are in some way implicated in the adequate 
allocation of substrates during catalysis.  
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Table 4.1. Steady-state kinetic parameters for the RFK activity (RF + ATP  FMN + ADP) 
of the different CaFADS variants (n=3; means ±SE). Data obtained at 25 °C in 20 mM 
PIPES pH 7.0, 0.8 mM MgCl2. 
 
kcat a, b 
(min-1) 
KmRF a, b  
(µM) 
Ki a, b 
(µM) 





KmATP c  
(µM) 
kcat / KmATP c 
(min-1 µM-1) 
WT 408 ±230 11.7 ±3.0 4.9 ±3.9 34.9 ±21.6  155 ±5 28.2 ±3.9 5.5 ±0.8 
K202A 63.8 ±11.7 0.8 ±0.4 e 19.4 ±8.5 9.9 ±5.3  34.5 ±1.0 e 52.7 ±5.3 0.66 ±0.07 
E203A 128 ±67 3.7 ±1.3 3.5 ±3.2 34.6 ±21.8  50.1 ±2.8 e 89.2 ±13.9 e 0.56 ±0.09 
F206A 189 ±70 3.2 ±1.9 9.5 ±5.0 59.7 ±41.8  139 ±12 121 ±29 e 1.14 ±0.3 
F206K 176 ±25 4.0 ±1.2 29.0 ±8.3 44.4 ±14.7  150 ±8 140 ±24 e 1.07 ±0.2 
F206W >50 d n.d. d n.d. d n.d. d  70.2 ±6.0 e 24.7 ±11.1 2.84 ±1.3 
D298A 78.4 ±18.9 0.7 ±0.4 e 8.7 ±3.9 9.1 ±5.6  32.2 ±0.8 e 26.6 ±2.8 1.2 ±0.13 
D298E >20 d n.d. d n.d. d n.d. d  20.9±0.8 e 64.9±6.9 0.32 ±0.03 
V300A >50 d n.d. d n.d. d n.d. d  69.7 ±1.4 e 37.5 ±2.5 1.86 ±0.13 
V300K 359 ±145 9.7 ±6.4 31.8 ±24.1 36.8 ±28.5  187 ±10 e 7.25 ±2.9 25.8 ±10.4 
E301A 53.0 ±15.9 0.1 ±0.3 e 18.0 ±11.9 10.2 ±30.7  36.7 ±1.1 e 30.9 ±4.1 1.2 ±0.2 
E301K >30 d n.d.d n.d.d n.d.d  59.9 ±2.0 e 59.3 ±6.4 1.0 ±0.1 
L304A 260 ±63 3.3 ±1.9 58.4 ±40.7f 78.8 ±49.2  177 ±10 4.0 ±3.0 44.3 ±33.3f 
L304K 540 ±201 14.9 ±5.7 5.0 ±2.8 36.4 ±19.4  131 ±6 4.8 ±2.8 27.4 ±16 
a Determined at saturating ATP concentrations. 
b Inhibition by substrate prevented the determination of true parameters and these correspond to apparent constants; 
appkcat and appKm. Estimated errors in appkcat and appKm values can increase up to ±35% for the larger Ki values. 
c Parameters estimated using an RF concentration at which 80% of maximal activity is exhibited. 
d Despite these variants being active, the high degree of inhibition prevented mathematical determination of their 
kinetic parameters. 
e Values showing statistically significant differences, P < 0.002, from the WT, as determined by the one-way 
ANOVA test (n=3, confidence interval 95%). 
f Values showing statistically significant differences, P <0.02, from the WT, as determined by the one-way ANOVA 
test (n=3, confidence interval 95%). 
The effects of the mutations on FMNAT activity were similarly evaluated (Table 
4.2). The mutations produced minor effects on the kcat and Km
ATP values (generally 
within a factor of two of those of the WT), but decreases in the Km
FMN were, in general, 
more significant (up to 25-fold in the case of E301A). Thus, these variants were more 
efficient than WT in transforming FMN. These data suggest that mutated residues at the 
RFK module of CaFADS modulate the catalytically competent binding of FMN during 
the FMNAT activity of the enzyme.  
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Table 4.2. Steady-state kinetic parameters for the FMNAT activity (FMN  FAD) of the 
different CaFADS variants (n=3; means ±SE). Data obtained at 25 °C in 20 mM PIPES pH 
















WT 5.5 ±0.5 10.1 ±1.0 22.4 ±2.0 0.54 ±0.07 0.25 ±0.03 
K202A 2.3 ±0.2 a 2.9 ±0.5 a 12.1 ±2.9 0.80 ±0.10 0.19 ±0.05 
E203A 3.2 ±0.2 a 0.70 ±0.10 a 10.8 ±2.6 4.5 ±0.7 a 0.30 ±0.07 
F206A 4.2 ±0.2 a 2.9 ±0.7 a 38.0 ±7.2 1.45 ±0.4 0.11 ±0.02 
F206K 6.2 ±0.3 5.4 ±0.6 a 38.8 ±3.3 1.15 ±0.1 0.16 ±0.02 
F206W 4.6 ±0.2 1.7 ±0.5 a 25.2 ±6.1 3.3 ±1 0.22 ±0.05 
D298A 6.1 ±0.4 a 1.2 ±0.2 a 20.7 ±6.4 5.1 ±0.9 a 0.30 ±0.09 
D298E 3.3 ±0.3 0.95 ±0.30 a 10.4 ±3.3 3.47 ±1.1 0.31 ±0.10 
V300A 4.9 ±0.2 1.4 ±0.2 a 46.2 ±7.6 a 3.5 ±0.5 0.11 ±0.02 
V300K 4.6 ±0.3 8.3 ±1.7 9.5 ±1.4 0.55 ±0.10 0.48 ±0.08 
E301A 6.9 ±0.2 0.42 ±0.02 a 19.7 ±3.6 16.4 ±0.9 a 0.35 ±0.06 
E301K 6.3 ±0.5 0.85 ±0.20 a 15.3 ±3.6 7.4 ±1.8 a 0.41 ±0.10 
L304A 2.5 ±0.2 a 2.8 ±0.3 a 34.7 ±9.4 0.91 ±0.10 0.07 ±0.02 
L304K 5.2 ±0.5 15.2 ±3.1 a 11.5 ±1.8 0.34 ±0.08 0.45 ±0.08 
a Values showing statistically significant differences from the WT, as determined by the one-way ANOVA test (P < 
0.002; n=3, confidence interval 95%). 
4. CaFADS variants interacting with flavins and ATP 
Isothermal titration calorimetry (ITC) was used to determine the binding parameters 
that describe the formation of CaFADS:flavin complexes (Table 4.3, Fig. 4.7). Upon 
titration with RF, a single binding site was detected for K202A, E203A, F206W, 
V300A and L304A CaFADSs. Thermograms for F206A and V300K variants reveal that 
their interaction with RF, although observed in difference spectra (Fig. 4.4), is weak or 
occurs with a very low enthalpy change. The remaining variants exhibit the same 
binding stoichiometry as the native protein (two RF sites) but with altered affinities. 
F206K and D298A CaFADSs present slightly higher affinity for RF (Kd values only 2- 
and 4.5-fold lower than WT, respectively), while replacement of E301 by Lys decreases 
the affinity (Fig. 4.7A, Table 4.3).  
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Figure 4.7. Calorimetric titrations of CaFADS with: (A) RF, (B) FMN, (C) FAD and (D) 
ATP. Upper panels show thermograms for E301K and WT (inset) and lower panels show the 
corresponding binding isotherms with normalized integrated heats for E301K (●) and WT 
(○). Experiments carried out in 20 mM PIPES, 10 mM MgCl2, pH 7.0, at 25 °C. 
When studying the interaction of these variants with FAD and FMN, several 
demonstrate low occupancy for either one or both of these flavins (Table 4.3), 
suggesting non-productive assemblies that block flavin access to their binding sites 
[87]. Differences in FMN affinity were observed, with relatively weaker interactions for 
D298 and L304 variants, and a very low enthalpy change for V300K. Most of the 
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introduced mutations reduced FAD affinity, particularly E203A, L304A and L304K (Kd 
increases up to 80-fold relative to WT). In general, these differences in binding 
affinities reveal that the mutations modulate the interactions of flavins with their 
binding cavity in the FMNAT module.  
When analyzing the interaction of the CaFADS variants with ATP, in the presence of 
10 mM MgCl2, a single binding site was observed for K202A and L304A, while the rest 
of the variants retained the two independent ATP binding sites of WT CaFADS [84, 
90]. Mutations only produced minor effects in the average ATP affinity, with changes 
introduced at charged residues causing slight decreases and changes at some 
hydrophobic residues causing slight increases (Table 4.3). Thus, these mutated residues 
barely modulate ATP binding at either or both of the FMNAT or RFK modules. 
We have also investigated the interaction of FMN with the preformed 
CaFADS:ADP:Mg2+ complex. None of the mutations prevents the FMN binding to the 
two independent binding sites reported for WT [84]. In general, the mutations appear to 
disturb the FMN interaction at the high-affinity binding site, presumably the site in the 
FMNAT-module, demonstrating significantly higher Kd values for F206A, D298A, 
D298E and L304K (Table 4.3). Only the E203A, F206A, D298A and E301K mutations 
significantly decrease the affinity of the second FMN-binding site, putatively in the 
RFK module (Kd 10-15-fold higher) (Fig. 4.8, Table 4.3). These results suggest that 
E203, F206, D298, E301 and L304 modulate the interaction of the FMN substrate at 
both the RFK and FMNAT binding sites. 
The large values of the enthalpic and entropic contributions reported for FMN, FAD 
and ATP binding to WT CaFADS have been related to the formation of a large number 
of interactions, as well as the displacement of numerous well-ordered water molecules 
on the protein surface, as a consequence of both ligand binding and the assembly of the 
dimer of trimers [87]. The corresponding values for the mutants in this work are 
presented in Figures 4.9 and 4.10 and Tables 4.4 and 4.5. In short, these data indicate 
that these mutations noticeably modulate enthalpic and entropic contributions to ligand 
binding, with the mutations inducing, in general, the loss of favorable interactions at the 
FMNAT binding site and the formation of favorable interactions in the RFK module. 
These data further support the presence of differences between the conformations of the 
assemblies in these variants. 
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Figure 4.8. Calorimetric titration of the preformed CaFADS:ADP:Mg2+ complex with FMN. 
The upper panel shows thermograms for the D298A and WT (inset) titrations and the lower 
panel displays the corresponding binding isotherms with normalized integrated heats for 
D298A (●) and WT (○). Experiments carried out in 20 mM PIPES, 10 mM MgCl2, pH 7.0, 
at 25 °C. 
IV. The trimer interface in the quaternary structure of the bifunctional CaFADS 
 149 
Table 4.3. Interaction parameters for the interaction of WT and mutated CaFADSs with RF, FMN, FAD and ATP, as determined by ITC (n=3; means 
±SD). The stoichiometry for the interaction is shown in brackets. For those showing a stoichiometry of N=2, data correspond to an average Kd (Kd,av) of 
two independent binding sites. Data obtained at 25 °C in 20 mM PIPES pH 7.0, 10 mM MgCl2.  
 Kd (µM) 
 FADS:RF FADS:FMN FADS:FAD FADS:ATP FADS:ADP:FMN 
    10 mM MgCl2 FMNAT site RFK site 
WT a 24.1 (2) ±3.6 7.8 (1) ±0.9 0.74 (1) ±0.10 30.2 (2) ±4.5 0.04 ±5 10-3 0.90 ±0.10 
K202A 31.4 (1) ±4.7 12.2 (<<1) ±1.0 6.4 (<<1) ±1.0 64.5 (1) ±16.9 0.01 ±1.5 10-3 1.4 ±0.3 
E203A 10.3 (1) ±2.3 7.2 (1) ±1.6 61.8 (1) ±15.2 c 43.4 (2) ±9.3 0.94 ±0.20 9.12 ±1.4 c 
F206A n.d. b 6.8 (1) ±3.8 1.9 (<<1) ±0.1 15.3 (2) ±2.4 1.2 ±0.7 c 9.71 ±2.7 c 
F206K 7.6 (2) ±2.5 3.1 (<<1) ±0.5 11.5 (1) ±1.7 29.1 (2) ±8.0 0.10 ±0.03 0.39 ±0.06 
F206W 10.3 (1) ±4.0 3.6 (<<1) ±1.1 0.68 (<<1) ±0.30 26.5 (2) ±11.0 0.05 ±0.01 0.85 ±0.30 
D298A 5.3 (2) ±1.1 18.8 (1) ±2.9 c 3.0 (<<1) ±0.3 32.9 (2) ±2.7 1.2 ±0.2 c 12.09 ±2.1 c 
D298E 17.9 (2) ±8.5 19.1 (1) ±1.8 c 3.7 (<<1) ±0.2 46.2 (2) ±14.5 1.4 ±0.3 c 3.4 ±0.6 
V300A 22.6 (<<1) ±1.7 2.5 (<<1) ±0.5 2.2 (<<1) ±1.0 31.6 (2) ±9.1 0.10 ±0.005 3.1 ±0.5 
V300K n.d. b n.d. b 4.0 (1) ±0.5 15.3 (2) ±2.4 0.22 ±0.03 2.2 ±0.4 
E301A 58.0 (2) ±8.4 5.9 (1) ±0.7 2.4 (1) ±0.9 60.7 (2) ±9.5 0.35 ±0.07 4.7 ±0.6 
E301K 142 (2) ±42c 13.6 (1) ±1.2 2.9 (1) ±0.4 60.2 (2) ±10.1 0.19 ±0.04 13.2 ±1.9 c 
L304A 1.2 (1) ±0.4 18.3 (1) ±0.8 c 28.2 (1) ±3.3 c 17.6 (1) ±1.0 0.51 ±0.20 1.1 ±0.3 
L304K 40.6 (2) ±7.7 37.1 (1) ±3.0 c 26.2 (1) ±1.0 c 39.6 (2) ±2.5 1.7 ±0.1 c 2.2 ±0.5 
a Data from [88, 90]. b Despite these variants exhibiting different spectra upon mixing with the ligand, no heat exchange was detected in the corresponding ITC titration, indicating a very low 
binding enthalpy. c Values showing statistically significant differences from the WT, as determined by the one-way ANOVA test (P < 0.002; n=3, confidence interval 95%).  
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Table 4.4. Thermodynamic parameters for the interaction of WT and mutant CaFADSs with flavins and ATP determined by ITC. Data obtained at 25 °C 
in 20 mM PIPES, 10 mM MgCl2, pH 7.0. ΔG, ΔH and –TΔS in kcal/mol. Standard errors in ΔG, ΔH and –TΔS where ±0.3 kcal/mol, taken in general 
larger than the standard deviation between replicates (n=3) and the numerical error after fitting analysis. 





























WT -6.3 -7.5 1.2  -7.0 -35 28  -8.4 -26 18  -6.2 -30 23 
K202A -6.1 -4.2 -1.9  -6.7 -21.5 15  -7.1 -31 24  -5.7 -56 50 
E203A -6.8 -1.6 -5.2  -7.0 -13 6.2  -5.7 -41 35  -5.9 -24 18 
F206A n.d.a n.d.a n.d.a  -7.1 -6.7 -0.4  -7.8 -29 21  -6.6 -17 10.9 
F206K -7.0 -0.5 -6.5  -7.5 -12.5 5.0  -6.7 -17 10  -6.2 -24 17.4 
F206W -6.8 -9.9 3.1  -7.4 -19 11  -8.4 -18 9.1  -6.2 -23 17 
D298A -7.2 -1.5 -5.7  -6.4 -23 16  -7.5 -40 32  -6.1 -27 21 
D298E -6.5 -4.3 -2.2  -6.4 -23 16  -7.4 -56 48  -5.9 -38 32 
V300A -6.3 -11.2 4.9  -7.6 -10 2.8  -7.7 -13 5.7  -6.1 -30 24 
V300K n.d.a n.d.a n.d.a  n.d.a n.d.a n.d.a  -7.4 -5.9 -1.5  -6.6 -4.8 -1.8 
E301A -5.8 -13 6.7  -7.1 -13 6.1  -7.7 -13 5.8  -5.7 -39 33 
E301K -5.2 -59 54  -6.6 -22 15  -7.5 -24 16  -5.7 -48 42 
L304A -8.1 -5.9 -2.2  -6.5 -7.8 1.3  -6.2 -21 15  -6.3 -26 20 
L304K -6.0 -32.1 26.1  -6.0 -8.2 2.1  -6.3 -17 11  -6.0 -12 6.0 
a No heat effects were detected in these ITC titrations. 
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Table 4.5. Thermodynamic parameters for the interaction of FMN with the preformed WT 
and mutant CaFADS:ADP complexes determined by ITC. Data obtained at 25 °C in 20 mM 
PIPES, 10 mM MgCl2, pH 7.0. ΔG, ΔH and –TΔS in kcal/mol Standard errors in ΔG, ΔH 
and –TΔS where ±0.3 kcal/mol, taken in general larger than the standard deviation between 
replicates (n=3) and the numerical error after fitting analysis. 
 FADS:ADP:FMN 















WT -10 -4.1 -6.0  -8.2 -4.5 -3.8 
K202A -11 -3.3 -7.7  -7.8 -3.7 -4.3 
E203A -8.2 -1.4 -6.9  -6.9 -2.3 -4.5 
F206A -8.1 -6.3 -1.8  -6.8 -8.0 1.1 
F206K -8.7 -1.7 -7.1  -9.6 -2.3 -7.3 
F206W -9.9 -3.2 -6.7  -8.3 -1.6 -6.7 
D298A -8.1 -3.9 -4.2  -6.7 -8.9 2.2 
D298E -8.0 -1.7 -6.3  -7.5 -3.1 -4.3 
V300A -9.5 -15 5.6  -7.5 -15 7.9 
V300K -9.1 -5.5 -3.6  -7.7 -6.6 -1.1 
E301A -8.8 -3.0 -5.8  -7.3 -4.6 -2.7 
E301K -9.2 -2.7 -6.5  -6.7 -3.2 3.5 
L304A -8.6 -4.3 -4.3  -8.1 -4.9 -3.2 
L304K -7.9 -2.3 -5.6  -7.7 -6.3 -1.4 
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Figure 4.9. Thermodynamic dissection of the interaction of the different CaFADS variants 
with (A) RF, (B) FMN, (C) FAD and (D) ATP in 20 mM PIPES, 10 mM MgCl2, pH 7.0, at 
25 °C. The binding Gibbs energy (ΔG), enthalpy (ΔH), and entropy (-TΔS) contributions to 
the binding are represented in blue, green and red bars, respectively. 
These data show that the enthalpic contribution turns into more favorable and the 
entropic contribution into more unfavorable for variants at E301, particularly E301K, 
and for L304K when are compared with the WT (Fig. 4.9A, Table 4.4). For the rest of 
the variants RF binding is driven by the enthalpic contribution (more favorable than for 
WT CaFADS) and by a favorable entropic contribution. FMN and FAD binding to WT 
CaFADS is driven by a large enthalpic change with a big entropic cost (Fig. 4.9 panels 
B and C, Table 4.4). All the mutations made the enthalpic contribution for the 
CaFADS:FMN interaction considerably less favorable, while the entropic contribution 
was less unfavorable (even favorable for F206A) (Fig. 4.9B, Table 4.5). Larger 
differences in both magnitudes were observed for the FAD interaction regarding WT; 
more favorable enthalpic and less favorable entropic binding contributions for E203A, 
D298A and D298E, less favorable enthalpic and less unfavorable entropic contributions 
for F206K, F206W, V300A and E301A, and a favorable entropic contribution for 
V300K (Fig. 4.9C, Table 4.4), resulting in an obvious example of enthalpy-entropy 
compensation. Regarding ATP binding two patterns for thermodynamic parameters 
were observed regarding the WT. F206, V300 and L304 variants showed less favorable 
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enthalpic and less unfavorable entropic contributions, while for the rest the magnitude 
of these parameters slightly increased (particularly for K202 and E301) (Fig. 4.9D, 
Table 4.4). 
 
Figure 4.10. Thermodynamic dissection of the interaction of the mutated CaFADS:ADP 
preformed complex with FMN. Profiles at the two FMN binding sites are displayed 
separately. The binding Gibbs energy (ΔG), enthalpy (ΔH), and entropy (-TΔS) contributions 
to the binding are represented in blue, green and red, respectively. Experiments carried out in 
20 mM PIPES, 10 mM MgCl2, pH 7.0, at 25 °C. 
As reported for the WT [84, 88] these data show that FMN binding to the preformed 
CaFADS:ADP:Mg2+ complex is driven, in general, by favorable enthalpic and entropic 
contributions at both sites (Table 4.5). This fact contrasts with the thermodynamic 
contributions driving FMN binding at the FMNAT module in the absence of ADP 
(compare Fig. 4.9B with Fig. 4.10 and Table 4.4 with Table 4.5). Changes in the 
magnitude of enthalpic and entropic contributions to the binding regarding the WT were 
particularly observed for V300A, for which the enthalpic contribution becomes more 
favorable and the entropic one becomes unfavorable at both sites (Table 4.5). A similar 
change in the entropic contribution was observed for mutations F206A, D298A and 
E301K when analyzing FMN binding at the RFK module (Table 4.5). 
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7. Crystal Structure of the CaFADS variants 
The overall structures of F206W, D298E and E301A CaFADSs (5fnz, 5fo0 and 
5fo1, respectively) are quite similar to that of the WT (A chains r.m.s.d. values 0.149, 
0.152 and 0.251 Å, superimposing 274, 309 and 317 atoms, respectively). They all have 
two chains in the asymmetric unit and the relative positioning between the two modules 
of each protomer is identical to that of WT [85, 86]. All mutants contain residues 1 
through 338, corresponding to the whole sequence, although in some high-mobility 
regions the lack of electron density prevents determining of the structural location of 
some residues. Thus, in the F206W structure, residues 200-204 in chain A and 201-202 
in chain B from L1c, as well as residues 259-263 (in chain A) and 261-264 (in chain B) 
from L4c-FlapII, are not observed. The D298E structure lacks density for residues 259, 
260, 261 and 262. The E301A structure shows all residues in chain A but lacks 260, 261 
and 262 in chain B. All mutant structures contain, in addition, one sulfate ion and one 
pyrophosphate molecule, as ligands in each chain. The PISA server [214] predicts a 
stable dimer of trimers assembly in solution for the three variants, with similar stability 
as the WT; in contrast, prediction of a single stable trimeric assembly is uncertain 
(Table 4.6). Low beta factors at residues forming the interface between modules of a 
single protomer do not predict hinge movements in any of the variants, similarly to that 
reported for the WT enzyme [85]. 
For the F206W variant, the side chain of the introduced tryptophan was refined in 
slightly different conformations for each of the two molecules of the asymmetric unit. 
Both differ from those of F206 in the WT structure and in the substrate-bound complex 
(Figs. 4.11A, 4.11B and 4.11C). Moreover, residues 197-199 on L1c-FlapI of F206W 
CaFADS were displaced relative to those of the WT (Figs. 4.11A and 4.11C), 
contributing to the opening of the cavity where ADP binds in the RFK module (Fig. 
4.11B). Noticeably, these residues immediately precede the region that stabilizes a 310 
-helix (199-204) in the ternary complex structure of the CaFADS RFK module that 
contains the reaction products, FMN:ADP:Mg2+ (Fig. 4.11B). The PISA server predicts 
a dimer of trimers for the F206W structure, in which the orientations of F62 and W206 
side chains from the two neighboring protomers differ from the WT, and the distance 
between the aromatic rings increases by 1.34 Å (Fig. 4.11D).  
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a These structures may or may not be stable in solution 
b Indicates the solvation free energy gain upon formation of the assembly, in kcal/mol. The value is calculated as 
difference in total solvation energies of isolated and assembled structures. This value does not include the effect of 
satisfied hydrogen bonds and salt bridges across the assembly interfaces. 
c Indicates the free energy of assembly dissociation, in kcal/mol. The free energy of dissociation corresponds to the 
free energy difference between dissociated and associated states. Positive values of ΔGdiss indicate that an external 
driving force should be applied in order to dissociate the assembly, therefore assemblies with ΔGdiss>0 are 
thermodynamically stable. 
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Figure 4.11. Structural analysis of CaFADS variants. Detail of the RFK module around the 
F206 position in (A) WT CaFADS (PDB code: 2x0k) (green), (B) the WT CaFADS ternary 
complex with the reaction products (PDB code: 5a89) (blue) and (C) superposition of the 
two chains of the asymmetric unit (A light gray and B dark gray) in F206W CaFADS with 
the two different conformations adopted by W206 (PDB code: 5fnz). Relevant residues are 
represented in sticks and CPK colored, and residues 197, 198 and 199 of L1c-FlapI are 
highlighted in pink, green and red, respectively. FMN and ADP ligands of the ternary 
complex are depicted as narrow sticks with orange carbons and the Mg2+ ion is shown as a 
green sphere. (D) Superposition of predicted macromolecular head-to-tail interfaces at the 
RFK and FMNAT modules of contiguous protomers within each trimer in WT CaFADS 
(modules in green and pink, respectively) and in F206W CaFADS (modules in gray and 
yellow, respectively). Residues 62 and 206 are shown in colored sticks. An arrow indicates 
the change in side chain conformations at position 206 in the mutant. (E) Detail of the 
predicted trimer head-to-tail interface region around position 301 in WT (left panel, RFK 
module in green and FMNAT module in pink) and E301A (right panel, RFK module in gray 
and FMNAT module yellow, respectively) CaFADS variants. In (D) and (E) FMN and AMP 
ligands in the FMNAT module have been modelled as previously described and are shown in 
sticks colored with carbons in orange [85]. 
IV. The trimer interface in the quaternary structure of the bifunctional CaFADS 
 157 
No differences were observed in the D298E CaFADS structure relative to that of 
WT. Replacement of D298 with Glu allows carboxylic oxygen atoms to maintain their 
bond with T165 of the neighboring protomer in the trimer (Fig. 4.12). Finally, no 
conformational changes were observed in L6c or in the α1c helix, which contains the 
E301A mutation, when comparing this mutant’s structure to that of the WT. However, 
the H-bond between E301 of one protomer and T127 on loop L8n of the neighboring 
protomer, which is predicted for the WT dimer of trimers, is not expected in this case 
(Fig. 4.11E). 
 
Figure 4.12. Detail at the macromolecular interfaces predicted by PDBePISA among the 
RFK- and FMNAT-modules of contiguous protomers within the trimers for (A) WT 
(modules in green and pink, respectively) and D298E (in grey and yellow, respectively) 
CaFADSs. Modules are represented as surfaces with cartoon representation of secondary 
structure elements implicated in the interaction of the side-chain at position 298 with T165 
(shown as colored sticks). Theoretical position for FMN and AMP ligands in the FMNAT 
module is shown in yellow and grey CPK sticks, respectively, accordingly to the model 
previously proposed for the interaction to WT CaFADS [85]. 
6. Discussion 
All studied variants with mutations in L1c-FlapI, L6c and helix α1c are active, as 
well as able to bind ligands and to stabilize transient quaternary assemblies. The lack of 
drastic changes prevents us from making conclusions regarding channeling between 
modules of different protomers, a question previously raised for the CaFADS dimer of 
trimers [85]. Despite the fact that the effects are not drastic, point mutations, 
particularly in L1c-FlapI and helix α1c, affect the equilibria between CaFADS 
monomeric/oligomeric assemblies, as well as kinetic and ligand binding parameters. All 
mutants also maintain the WT inhibition profile induced by an excess of the RF 
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substrate. This is a critical aspect of the regulation of the RFK activity in CaFADS, to 
which product inhibition might also contribute [88, 90]. Work is underway to 
understand the different levels of inhibition occurring in this enzyme. Nevertheless, 
those studies are beyond the scope of the present work (although they will be addressed 
in the next chapter) since the variants presented here do not demonstrate statistically 
significant differences in Ki
RF relative to the WT (Table 4.1). Therefore, in this work, 
we emphasize interpreting the effects of mutations on the kinetic and binding 
parameters in view of the available structural information 
 Mutations in L1c-FlapI (K202, E203 and F206) modulated the kinetic 
parameters for the RFK activity of CaFADS, as well as ligand binding parameters in the 
C-terminal module (Tables 4.1, 4.3 and 4.4). Therefore, although the relevant residues 
are not directly involved in catalysis, they somehow contribute to achieving the 
appropriate RFK catalytic geometry. This relationship is consistent with the recently 
reported structure for the CaFADS RFK:FMN:ADP:Mg2+ ternary complex (Fig. 4.1B) 
[99]. Complex formation induces conformational changes in L1c-FlapI, β2c and the 
207-PTAN-210 motifs, which displace Cs of K202 and E203 by 8.1 and 7.2 Å, 
respectively. Concomitantly, the F206 side chain (highly conserved in FADS [76]) 
moves more than 7 Å to stack against M307 of helix 1c and the isoalloxazine ring of 
the flavin ligand [85, 99] (Fig. 4.1B). In these variants, Km
FMN for the FMNAT activity, 
as well as thermodynamic parameters for ligand binding at the FMNAT module (Tables 
4.2, 4.3 and 4.4), reveal the importance of L1c-FlapI residues in FMN and FAD binding 
in the N-terminal module. Moreover, the low fraction of protein that is capable of FAD 
and FMN binding that some of these variants exhibit is consistent with the coexistence 
of competent conformations in equilibrium with non-competent assembles that hinder 
flavin binding (Table 4.3) [87]. Furthermore, the strong effect of the E203A and F206A 
mutations on FMN binding at the FMNAT site in the CaFADS:ADP:Mg2+ preformed 
complex (Tables 4.3 and 4.5) align with the observation that their monomer/oligomer 
ratios after purification differ from that of the WT (Fig. 4.2A). In the WT CaFADS 
dimer of trimers, K202 and E203 stabilize salt-bridges with E130 and N131 from loop 
L8n of the neighboring protomer within the trimer, while F206 interacts with F62 of 
helix α2n (Fig. 4.1A) [85]. The mutation of K202 and E203 to Ala would prevent 
formation of the salt-bridges, while substitution of F206 by Ala or Lys will abrogate its 
hydrophobic interaction with F62. With the elimination of such interactions, the shape 
of the isoalloxazine hydrophobic cavity in the FMNAT site should change, as found 
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when evaluate this cavity in the dimer of trimers assembly for the F206W variant (Fig. 
4.11D). This conservative substitution apparently reduces the amount of oligomeric 
assemblies able to bind FMN and FAD at the FMNAT site, relative to the WT, an effect 
that is clearly overcome in the ternary complex (Table 4.3). Altogether, these data 
indicate that L1c-FlapI and, particularly, F206, contribute to modulating the 
conformations and the catalytic properties of quaternary assemblies of CaFADS, 
although the individual residues studied here are neither critical for catalysis nor key 
determinants in assembling the protein structure. 
Mutations in L6c (D298) and the contiguous N-terminal helix α1c (V300, E301 and 
L304) considerably modulate kcat and Km
RF for the RFK activity as well as Km
FMN for 
the FMNAT activity (Tables 4.1 and 4.2). In general, the mutations decreased the 
affinity for FAD and FMN, and V300A and D298 variants also show low flavin 
occupancy (Table 4.3). These results, together with the observed changes in the 
thermodynamic parameters (Figs. 4.9 and 4.10, Tables 4.4 and 4.5), indicate that these 
residues contribute to the binding of flavins in the FMNAT module as well as to the 
stabilization of quaternary assemblies. These mutations also affect the flavin binding in 
the RFK module, as seen in the decrease of the FMN affinities of their 
CaFADS:ADP:Mg2+ complexes (Table 4.3). These effects (Tables 4.1 and 4.3) are 
consistent with recent studies that show that ligand binding and catalysis at the RFK site 
triggers dramatic conformational changes in L1c-Flap1, L4c-FlapII, L6c and helix α1c 
(Fig. 4.1B) [99].  
Residues here mutated do not directly interact with the flavin substrate, but L6c and 
helix α1c regions are part of the hydrophobic core that closes the re-face of the 
isoalloxazine ring (Fig. 4.11B). In addition, L6c and the N-terminal end of helix α1c 
also contribute to closing the FMNAT flavin-binding site of the neighboring protomer 
within the CaFADS trimer (Figs. 4.1A and 4.11E). In particular, D298 establishes H-
bonds with T165 at α1n of the adjacent protomer [85], a residue reported as critical for 
substrate binding and FMN adenylylation (Fig. 4.12) [90]. D298 replacement by Ala 
would prevent this interaction, but in the D298E mutant, the introduced Glu can still 
retain it (Fig. 4.12). However, the presence of more than one orientation of carboxylic 
oxygens suggests that alterations to the FMNAT ligand-binding cavity within the dimer 
of trimers (Fig. 4.12) is a factor that determines the low flavin occupancy in the 
FMNAT sites of these variants (Table 4.3). 
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Among the residues mutated in helix α1c, only V300 is predicted to directly interact 
with the FMN isoalloxazine ring (1.38 Ǻ) in the FMNAT module of the adjacent 
protomer [85] (Fig. 4.1A and 4.11E). Substitution of V300 by Ala or Lys will affect the 
hydrophobic interactions, which can explain the changes observed in FMN and FAD 
binding parameters (Tables 4.3 and 4.4). E301 and L304 are predicted to interact with 
T127 and A132, respectively, of L8n of the neighboring protomer FMNAT site (Figs. 
4.1A, 4.11E) [85]. The lack of interactions between the side chain of residue 301 and 
T127 in the E301A mutant and the substitution of L304 by Ala would both affect the 
van der Waals contacts with L8n in the dimer of trimers, producing local effects at this 
loop that helps close the FMNAT substrate binding site. These mutations can also alter 
the positive end of the helix α1c dipole, which contributes to the stability of substrate 
phosphate groups and is located near the FMNAT substrate binding site (Fig. 4.11E) 
[85]. Since ligand binding and catalysis in the RFK module also trigger the 
conformational change of L6c and the bending of the helix α1c [99], it is very likely 
that interplay between RFK and FMNAT modules of protomers, within the trimer, will 
differ when introducing mutations at L6c and α1c (Figs. 4.2 and 4.5). However, we 
cannot further speculate until structures containing the FMNAT module in complex 
with ligands become available. All these structural considerations also explain the 
changes in kinetic and binding parameters of the FMNAT module for the CaFADS 
mutants (Tables 4.1, 4.2 and 4.3), which suggest a different conformation for flavin 
binding, especially, for FMN (Table 4.4 and Fig.4.5).  
Altogether, our data indicate that the secondary structural elements of the CaFADS 
RFK module investigated herein tune protomer-protomer contacts within the trimer. 
This confirms the interplay between protein-protein assembly and catalysis, with a 
possible role of macromolecular interfaces contributing to flavin homeostasis [100]. In 
this direction, recent studies on the human FMNAT, FADS2, have proven direct 
delivery of the flavin cofactor to the recipient apoflavoprotein through heterologous 
protein-protein interactions [156]. If this mechanism also occurs in CaFADS, we might 
envisage the possibility of macromolecular assemblies as part of a cell strategy to 
control the delivery of FMN and FAD to apoflavoproteins. However, the study of such 
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Despite the fact that all the bacterial FADSs share function and structure, some 
functional differences have been found among them. For instance CaFADS does not 
required reducing environment for its FMNAT activity while other FADS from 
pathogenic bacteria such as S. pneumoniae or L. monocytogenes require the presence of 
a reducing agent [79]. Another important difference is that the RFK activity of CaFADS 
shows inhibition when RF concentration increases [88], while other members of the 
family do not show this behavior. These differences suggest dissimilar regulatory 
mechanisms that, as a last resort, might be related with the pathogenic/non pathogenic 
character of the microorganism. In the present study we focus on this second regulatory 
topic, and specifically we work with the isolated RFK domain of CaFADS or Δ(1-
182)CaFADS. This isolated module has shown to be fully active and to show the same 
behavior that the complete enzyme [99]. Therefore, and due to the intrinsically 
difficulties inherent to some of the techniques here used, the isolated C-terminus 
domain seems to be perfect for the characterization of the regulation of the CaFADS 
RFK activity. In addition available crystal structures of the RFK domain free and in 
complex with some of its products (which reveal necessary conformational changes 
during the catalytic cycle) let us to connect our results with the 3D structures [99]. 
In this chapter we present a complete study of the inhibition of the CaFADS RFK 
domain both from the kinetic and the thermodynamic points of view, identifying the 
inhibitors of the enzyme and its course of action. Regarding to the kinetic approach, 
stopped flow spectrophotometry provides a deep sight of how the substrates and the 
products bind the enzyme before the equilibrium is reached and also of the 
conformational changes during the catalytic cycle, while kinetic measurements in the 
steady state yield the type of inhibition suffered by the enzyme and the inhibition 
constants. From the thermodynamic point of view, isothermal titration calorimetry 
experiments allow tracing the complex network of interactions between the enzyme and 
its ligands, identifying the most favorable pathways and the effect that one specific 
substrate or product has over the others. 
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1. The RFK activity shows inhibition by the RF substrate as well as by 
the products of the reaction.  
The independently expressed RFK module of CaFADS retains the ability to 
catalyze the phosphorylation of RF, and conserves the structural determinants 
responsible for the strong inhibition by its RF substrate (bold lines in Figs. 5.1A and 
5.2A) [99]. Fitting of the observed steady-state rates either to the Michaelis-Menten 
equation (Eqn. 2.3) (Fig. 5.1A, bold line), or to the equation describing a dead-end 
inhibition by substrate excess (Eqn. 2.4) (Fig. 5.2A, bold line), allowed determining the 




kcat values of 60.3±11.5 µM, 10.4±1.6 µM, 1.9±0.2 µM and up to 440 min
-1, 
respectively (Table 5.1). 
 
Figure 5.1. Inhibitory effects produced by the ATP substrate and the ADP product in the 
steady-state RFK activity of the RFK module of CaFADS. (A) Michaelis-Menten plots as a 
function of the ATP substrate at different concentrations of the ADP product and the 
corresponding (B) Dixon plot with the representation of the slopes vs. 1/[ATP] in the inset, 
(C) Cornish-Bowden plot and (D) Lineweaver-Burk representation with global fit to the 
equation for competitive inhibition. Reaction rates were obtained in 20 mM PIPES, 0.8 mM 
MgCl2, pH 7.0, at 25°C, with 5 μM RF (concentration for which the enzyme shows the 80% 
of its maximal apparent activity at saturating ATP), varying the concentration of the ATP 
substrate (10-350 μM) and the ADP product (0-400 μM).  
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Figure 5.2. Inhibitory effects produced by the RF substrate and the FMN product in the 
steady-state RFK activity of the RFK module of CaFADS. (A) Michaelis-Menten plots as a 
function of the RF substrate at different concentrations of the FMN product (high 
fluorescence yields in mixtures simultaneously containing RF and FMN prevented accurate 
determination of data over 7 µM RF) and the corresponding (B) Dixon plot, (C) Cornish-
Bowden plot and (D) Lineweaver-Burk representation with global fit to the equation for 
uncompetitive inhibition. Reaction rates were obtained in 20 mM PIPES, 0.8 mM MgCl2, pH 
7.0, at 25°C and saturating ATP (350 μM ATP), varying the concentration of the RF 
substrate (0-30 μM ) and the FMN product (0-7 μM).  
To evaluate whether any of the products of the RFK reaction also produce 
inhibition, we analyze the evolution of steady-state rates at increasing concentrations of 
either ADP or FMN (Figs. 5.1 and 5.2). The fitting of the rates, obtained as a function 
of the ATP concentration while varying ADP concentration, to the Michaelis-Menten 
model, shows that while 𝐾𝑚
𝐴𝑇𝑃 values increase with ADP concentration, kcat ones remain 
constant (Fig. 5.1A, Table 5.1). Dixon and Cornish-Bowden plots for these data were 
then used to identify the type of inhibition produced by ADP. 
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Table 5.1. Steady-state kinetic parameters describing the RFK activity of the RFK module 
and the inhibition by its different substrates and products. Data obtained at 25 °C in 20 mM 
PIPES, 0.8 mM MgCl2, pH 7.0. Inhibition by the RF substrate prevented the determination 
of true parameters and data presented correspond to apparent constants.  


















0 162±8 60.3±11.5 0 443±47 10.4±1.6 1.9±0.2 
 




















20 162±13 114±20 1 278±39 5.0±1.1  
50 138±8 137±18 2 266±53 7.7±1.4  
90 170±8 257±23 3 139±28 3.6±0.9  
170 168±66 697±276 5 116±39 5.5±2.1  
 


















17.0±3.3 133±32 40.3±11.9 1.4±0.2 318±33 6.9±0.4  
a Parameters estimated using a RF concentration exhibiting 80% maximal activity before the maximum 
experimentally detected as a function of RF concentration and saturating ATP.  
b Determined at saturating ATP concentrations. 
 These data indicate that the RFK activity of CaFADS is inhibited by the RF 
substrate, as well as by both products of the reaction, with ADP acting as a competitive 
inhibitor and FMN as an uncompetitive one.  
The Dixon plot shows lines intersecting at negative values of the x-axis, while in the 
Cornish-Bowden representation lines are parallels (Figs. 5.1B and 5.1C). These plots 
reveal that the ADP product acts a competitive inhibitor. Representation of the slopes in 
the Dixon plot vs 1/[ATP] confirms a pure competitive inhibition (Fig. 5.1B, inset). 
Global fit of the data in the Lineweaver-Burk representation to the equation describing 
competitive inhibition (Eqn. 2.7), yields values of kcat, 𝐾𝑚
𝐴𝑇𝑃   and 𝐾𝑖
𝐴𝐷𝑃 of 133±32 min-1, 
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40.3±21.9 μM and 17.0±6.4 μM, respectively (Fig. 5.1A and 5.1D, Table 5.1). In this 
case, the high affinity for the ADP product inhibitor considerably increases the 
estimated error for 𝐾𝑚
𝐴𝑇𝑃. The fits to the Michaelis-Menten equation of the observed 
rates vs RF, in experiments carried out at saturating ATP and increasing FMN, show 
that kcat values decrease, while 𝐾𝑚
𝑅𝐹  ones do not significantly change (Table 5.1, Fig. 
5.2A). This indicates that the FMN product also behaves as inhibitor of the RFK 
activity. In this case, the Dixon plot displays parallel lines (Fig. 5.2B), while lines 
intersect at negative values of the x-axis in the Cornish-Bowden graphic (Figs. 5.2B and 
5.2C). These plots are typical of uncompetitive inhibitors. Global fit of the Lineweaver-
Burk plots to the uncompetitive inhibition equation (Eqn. 2.8) yields 318±40 min-1 for 
kcat, 6.9±0.4 μM for 𝐾𝑚
𝑅𝐹  and 1.4±0.2 μM for 𝐾𝑖
𝐹𝑀𝑁 (Fig. 5.2D, Table 5.1).  
2. Changes in flavin fluorescence upon binding allow studying the 
association and dissociation kinetics of flavinic ligands to the RFK 
module.  
We used stopped-flow spectrophotometry to kinetically differentiate some of the 
steps implicated in the RFK reaction under pre-steady-state situations. These processes 
can be identified by changes in the fluorescence of the flavin isoalloxazine ring, 
property highly dependent on its environment [51]. Since RF and FMN share the same 
fluorescence spectra and yields [55], direct transformation of the first one into the 
second is not expected to be observed by this method. However, we should be able to 
detect processes inducing changes in the electronic environment of the flavin 
isoalloxazine; including flavin binding, flavin dissociation or even any conformational 
change around the isoalloxazine ring taking place along catalysis. When we mix FLV 
ligands with the protein in the stopped-flow equipment and follow flavin fluorescence 
evolution, we only detect slow linear fluorescence decays, whose slopes linearly 
decrease with the FLV concentration, and are consistent with the photobleaching range 
(rates of 4.5·10-3 ±1.2·10-4 min-1 for RF and 4.1·10-3±2.4·10-4 min-1 for FMN) (see 
methods and Fig. 5.3). These results reveal that the RFK module is not able to directly 
bind the FLV ligand, and/or to internalize its isoalloxazine ring into the active site in a 
competent enclosed conformation. 




Figure 5.3. (A) Kinetic traces for the evolution of the RF fluorescence (1 μM) in the 
stopped-flow equipment follow zero order decays both in the absence (black line) and 
presence (red line) of the RFK module (0.2 μM). (B) Slopes of linear fluorescence decays on 
the flavin concentration for samples containing RF (black), FMN (blue), as well as RF (red) 
and FMN (green) in the presence of the RFK module. All show linear dependences on flavin 
concentrations with similar negative slopes. They, therefore, indicate that increasing flavin 
concentrations protect from photobleaching during measurements. Experiments were 
performed in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0 at 25ºC.  
Kinetic traces were then recorded when the RFK module was mixed with different 
combinations of flavin and adenine nucleotide ligands. These traces show kinetic 
processes taking place in time frames considerably lower than those related to flavin 
photobleaching. The number of processes detected depends on the ligands present in the 
mixture (Fig. 5.4A-D). All the analyzed mixtures show a fluorescence decay in the 5 s 
time frame that fits to a single exponential process, allowing to determine the 
corresponding kobs1 values (Fig. 5.4A-D, see a highlighted example for FMN in Fig. 
5.4B). This feature is not observed when flavins are independently mixed with either 
ANP ligands in absence of the RFK module (not shown), or with the RFK module in 
the absence of ANP ligands (Fig. 5.3A). Therefore, this process can be identified as the 
ANP ligand promoting changes in the polar environment of the flavin isoalloxazine 
ring, and must be related to flavin binding and/or to its internalization within the protein 
matrix. kobs1 values follow, in general, a linear dependency on FLV concentration (Fig. 
5.4E). The fit of kobs1 values to Eqn. 2.11, yields the flavin association rates, kon, as the 
slope, and the corresponding dissociation rate, koff, as the independent term. These 
values are reported in Table 5.2, and show how at saturating concentrations of the ADP 
product, the RF binding is two times faster than the FMN binding. On the contrary, the 
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binding of the substrates of the RFK reaction, RF and ATP, is the slowest process. 
Thus, apparently, the products of the reaction bind the RFK module faster than the 
substrates and, as consequence, substrate binding appears slightly weaker (Table 5.2). 
Noticeably, kobs1 values for non-productive mixtures containing the FMN product and 
the ATP substrate are considerably slower than the rest and show a biphasic dependence 
on the FMN concentration that prevents the determination of kon and koff (Fig. 5.4D). 
This indicates that excess of FMN in the presence of ATP, hinders its own binding 
and/or a conformational change in the flavin environment.  
Table 5.2. Pre-steady-state kinetic parameters for the binding and dissociation of flavins to 
the RFK module in the presence of adenine nucleotides. Experiments were carried out in 20 











FMN-ADP 63.6 ± 2.1 96.9 ± 5.5 1.52 ± 0.10 -7.9 ± 0.5 
RF-ADP 127 ± 3.4 109 ± 8 0.86 ± 0.08 -8.2 ± 0.1 
RF-ATP 27.0 ± 0.9 97.6 ± 2.6 3.62 ± 0.15 -7.4 ± 0.3 
FMN-ATP NA NA NA  
 
After the initial decay, here related to flavin recognition in the presence of the 
ANP, experiments performed with ADP only show slow decays consistent with flavin 
photobleaching, which are therefore not assumed as part of the reaction. However, 
experiments carried out with mixtures of FLV and ATP show an exponential increase in 
fluorescence, characterized by kobs2, (Fig. 5.4A, 5.4C and 5.4D) before the 
photobleaching decay starts. These observations suggest that after the initial interaction 
of ligands with the protein, a subsequent ATP-dependent conformational rearrange is 
produced in the flavin environment. Such rearrange brings back the isoalloxazine ring 
to the external media. Interestingly, both the amplitude and kobs2 values increase with 
flavin concentrations below 0.25-0.5 µM, but considerably decrease at higher flavin 
concentrations (Fig. 5.4C and 5.5). This biphasic profile agrees with excess of FLV 
ligands inhibiting the catalytic process (Fig. 5.2A). These data indicate that this second 
process is related to the release of the isoalloxazine ring to the solvent, which, according 
to the kobs2 values, appears the limiting step in the catalytic reaction. 
 




Figure 5.4. Pre-steady-state kinetic analysis of the binding of the flavins to the RFK module 
of CaFADS. (A) Kinetic traces for the evolution of the flavin fluorescence upon mixing the 
RFK module (0.2 μM) with RF (1 μM) at saturating ATP (250 μM) and ADP (250 μM), as 
well as of FMN (1 μM) at saturating ATP (250 μM) and ADP (250 μM). (B) Evolution of 
kinetic traces on the FMN concentration for its interaction with the RFK module in the 
presence of 250 μM ADP. Traces are fit to a mono-exponential decay with steady-state. 
Residuals are shown at the bottom for fitting of 1 μM FMN data. (C) Dissection of the 
exponential processes for kinetic traces observed upon mixing the RFK module (0.2 μM) at 
saturating ATP (250 μM) with FMN (1 μM). The panel shows the fit to a two exponential 
process with its fitting residual at the bottom. (D) Traces obtained when mixing the RFK 
module (0.2 μM) at saturating ATP (250 μM) different with RF concentrations. (E) 
Evolution of kobs1 on the flavin concentration for the mixing of the RFK module with 
RF+ADP (), FMN+ADP (), RF+ATP (RFK reaction, ) and (C) FMN+ATP (). For 
those data showing linear dependences slopes are related with the kon for the binding and the 
independent term with the koff. All the experiments were carried out in the stopped-flow 
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Figure 5.5. Evolution of kobs2 values on the FMN concentration for reaction mixtures of the 
RFK module with FMN+ATP (red) and with RF+ATP (black) follow a biphasic behavior 
with maximum 0.5 µM FMN and 0.25 µM RF. All the experiments were carried out in the 
stopped-flow equipment at 25ºC in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0 with 0.2 µM of 
the RFK module.   
Altogether, and despite differences in experimental settings, these data show that the 
fast kinetic rates, kobs1 and kobs2, for processes compatible with RFK catalysis 
(containing RF, ATP, and Mg2+) are in the kcat range (Figs. 5.4D-5.4E, Table 5.1). This 
indicates that the here depicted pre-steady-state kinetics are relevant for catalysis, being 
the final recovering of solvent accessibility of the flavin the limiting step of the 
reaction. 
3. The thermodynamic diagram for the RFK-ligand interactions 
We performed ITC experiments to verify that the observed pre-steady-state kinetic 
processes were significant to reach the thermodynamic equilibrium. Titrations with the 
different ligands (substrates and products) of either the isolated RFK module, or of its 
mixtures with either FLV or ANP ligands, provide values of the thermodynamic 
parameters (free Gibbs energy (ΔG), enthalpy (ΔH) and entropy (–TΔS), as well as the 
corresponding Kd) for each binary and ternary interaction. The corresponding numeric 
data are summarized in Table 5.3, while thermodynamic dissections and some examples 
of the titrations are displayed in Figs. 5.6 and 5.7. Titrations were performed in 0.8 mM 
MgCl2 (conditions showing the highest efficiency for the RFK activity [82]) (Fig. 5.6A 
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and upper panel Table 5.3), as well as in the absence of MgCl2 to avoid catalysis when 
both substrates, RF and ATP, are present (the catalytic reaction heat would mask the 
binding enthalpy) (Fig. 5.6B and lower panel in Table 5.3).  
 
 
Figure 5.6. Thermodynamic dissection of the interaction of different ligands with either the 
free RFK module, or with the preformed mixtures of the RFK module with the different 
ligands (RFK:X). Parameters obtained (A) in the presence of 0.8 mM MgCl2 and (B) in the 
absence of MgCl2. Experiments were carried out in 20 mM PIPES, pH 7.0, at 25 °C. The 
binding Gibbs energy (ΔG), enthalpy (ΔH), and entropy (-TΔS) contributions to the binding 
are represented in blue, green and red bars, respectively. 
 
Figure 5.7. Calorimetric titrations with ATP of mixtures that contain different ratios of the 
RFK module and the RF ligand. Experiments were performed at (A) 7.5, (B) 15, and (C) 180 
μM of RF with 25 μM RFK module in 20 mM PIPES, pH 7.0 at 25 ºC. Data were fit to a 
home-derived model for a single binding site. Within each panel, upper charts show 
thermograms for the different interactions and the lower panels the corresponding binding 
isotherms with integrated heats. 
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Thermograms for the titration of the RFK module with the individual ligands 
indicate that: i) FMN does not interact or interact with undetectable H; ii) RF, ATP 
and ADP bind with appreciable enthalpic changes; iii) the presence of the Mg2+ cation 
modulates binding parameters (Table 5.3). When mixtures containing the RFK module 
and ANP (ATP or ADP) are titrated with FLV (RF or FMN), or viceversa, Mg2+ favors 
formation of ternary complexes, which are more stable than in the absence of the cation, 
as the more negative free binding energies show. This positive effect of the cation on 
the enzyme affinity for ligands in ternary complexes is, in general, consequence of the 
less unfavorable entropic contribution to the binding (Table 5.3, Fig. 5.6). Therefore, 
Mg2+ contributes to the overall conformation of the system in binary and particularly, 
ternary, interactions. 
Fig. 5.8 summarizes the free energy values (G) determined for all possible 
combinations of the RFK module, in binary and ternary complexes with different 
ligands, as well as the relative fraction of protein prone to interact, both in the presence 
(Fig. 5.8A) and in the absence of the divalent cation (Fig. 5.8B). All paths shown in the 
network compete with the one leading to the catalytically competent complex by 
decreasing the amount of the RFK module available to bind the substrates of the 
reaction, RF and ATP:Mg2+. As shown in the figure, paths with and without Mg2+, 
considerably differ both in the complex stability and in its production probability. 
Several remarkable facts need to be highlighted. We have no data for the reactive path 
containing RF and ATP:Mg2+ (the heat exchanged in the chemical reaction masks the 
binding one). We can include the path leading to a “pseudo reactive”-ternary complex 
in the absence of the cation, produced by titration of the RFK module:RF binary 
complex with ATP (shown in maroon in Fig. 4B), but in the absence of Mg2+ RF does 
not bind to the binary RFK module:ATP preformed complex. These data suggest that in 
the absence of the cation, the ATP substrate induces enzyme conformations that are not 
able to bind the RF substrate. All ternary interactions, as well as the single RF binding 
to the module, appear more favorable in the presence of Mg2+, furthermore the cation 
also increases the protein fraction in the competent conformation to bind the ligands (as 
indicated by the thicker lines in Fig. 5.8A). Paths leading to transformation of binary 
complexes into ternary ones, despite not being competent for catalysis, are in general 
thermodynamically more favorable (as the more negative ΔG values show) than the 
“pseudo reactive” one. It is also noticeable that, despite direct binding of FMN to the 
RFK module is not detected by ITC (neither by stopped-flow), free energies for ANP 
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binding to the RFK module are considerably more favorable when FMN is in the 
mixture. These data indicate that FMN might act as a slow binding ligand [215] in its 
interaction with the RFK module in the absence of ANP, and also suggest a cooperative 
binding of both ligands.  
 
 
Figure 5.8. Free Gibbs energy flow in the interaction between the RFK module and its 
ligands. Diagrams resume the thermodynamic flow representing the interaction of the RFK 
module and the different combinations of its ligands as obtained through ITC at 25°C (A) in 
20 mM PIPES, 0.8 mM MgCl2, pH 7.0 and (B) in 20 mM PIPES, pH 7.0. The RFK module 
is represented as maroon spheres, RF and FMN as yellow and orange hexagons respectively 
and ATP and ADP as blue and green triangles respectively. Numbers indicate the ΔG value 
for each particular titration. The thickness of the arrows is proportional to the fraction of 
protein that is able to bind the ligand in each case and the length of the lines to the ΔG value 
associated to each process. Dash lines indicate processes not observed directly by ITC but 
whose values are indirectly estimated once known the cooperativity coefficients. Red lines 
indicate the path leading to the simultaneous binding of both substrates of the RFK activity 
in the absence of the cation.  
María Sebastián Valverde 
 174 
Table 5.3. Thermodynamic interaction parameters for the combination of the RFK module 
with different ligands as obtained through ITC. Column named initial mixture indicates the 
starting composition of the calorimetric cell. Titrations were carried out at 25ºC in 20 mM 
PIPES, 0.8 mM MgCl2, pH 7.0 (upper table) and in 20 mM PIPES, pH 7.0 (lower table).  
0.8 mM MgCl2 
initial mixture ligand Kd (μM) ΔG (kcal/mol) ΔH (kcal/mol) -T Δ (kcal/mol) 
RFK ATP 28.7 -6.1 -5.6 -0.6 
RFK ADP 22.1 -6.4 -9.8 3.5 
RFK RF 15.2 -6.6 -10.6 4.1 
RFK FMN n.d.a n.d.a n.d.a n.d.a 
RFK:RF ADP 1.0 -8.2 -13.4 5.2 
RFK:RF ATP n.m.b n.m.b n.m.b n.m.b 
RFK:FMN ADP 0.6 -8.5 -10.3 1.8 
RFK:FMN ATP 0.04 -10.1 -19.5 9.3 
RFK:ATP FMN 6.6 -7.1 -6.9 -0.2 
RFK:ATP RF n.m.b n.m.b n.m.b n.m.b 
RFK:ADP FMN 0.8 -8.4 -6.4 -1.9 
RFK:ADP RF 2.3 -7.6 -19.2 11.5 
0.0 mM MgCl2 
Initial mixture ligand Kd (μM) ΔG (kcal/mol) ΔH (kcal/mol) -T ΔS (kcal/mol) 
RFK ATP 16.3 -6.5 -5.5 -1.0 
RFK ADP 51.4 -5.8 -6.4 0.6 
RFK RF 19.5 -6.9 -5.9 -0.9 
RFK FMN n.d.a n.d.a n.d.a n.d.a 
RFK:RF ADP 17.1 -6.5 -31.8 25.4 
RFK:RF ATP 50.4 -5.9 -72.5 66.6 
RFK:FMN ADP 14.8 -6.6 -15.9 9.3 
RFK:FMN ATP 0.5 -8.6 -17.9 9.3 
RFK:ATP FMN 23.9 -6.3 -21.7 15.4 
RFK:ATP RF n.d.a n.d.a n.d.a n.d.a 
RFK:ADP FMN 6.4 -7.1 -17.7 10.6 
RFK:ADP RF 14.5 -6.6 -74.3 67.7 
a n.d. Not detected. Not heat of interaction was detected for this titration. b n.m. Not measured. This combination of 
ligands in the presence of Mg2+ leads to the catalytic reaction, preventing determination of binding heats. 
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4. Adenine and flavin nucleotide ligands cooperate in their binding to 
the RFK module 
To prove the cooperativity between ligands, we performed sets of ITC experiments 
in which samples of RFK module containing different FLV ligands proportions were 
titrated with ANP ligands (Fig. 5.7). These experiments allowed determining the 
apparent cooperativity constants for the ANP binding in the presence of the FLV ligand, 
𝐾𝑎
𝑎𝑝𝑝,𝐴𝑁𝑃
. Plots of 𝐾𝑎
𝑎𝑝𝑝,𝐴𝑁𝑃
 vs FLV concentrations show different behaviors depending 
on the flavin-adenine nucleotide combination (Fig. 5.9A). FMN exhibits positive 
cooperativity with both ADP and ATP, as RF does with ADP. Although concentrations 
of the RF substrate up to 30 μM increase protein affinity for ATP (maximum 
cooperativity at ≈7.5 μM), higher RF concentrations hinder ATP binding (Fig. 5.9). 
This suggests that an excess of RF might block its binding. 
 
Figure 5.9. Cooperativity between the flavin and adenine nucleotide ligands to their binding 
to the RFK module. (A) Dependence of apparent ANP association constants, Ka
app,ANP, on the 
concentration of the flavinic ligand for the titration with ATP of mixtures of the RFK 
module with different amounts of RF (), as well as for the titration with ADP of mixtures 
of the RFK module with different amounts of FMN (). (B) Evolution of the Ka
app,ATP/Ka
ATP 
ratio as a function of the RF concentrations. All experiments were performed in 20 mM 
PIPES, pH 7.0 at 25 °C. Lines are included only as eye guides of the data evolution.  
We performed additional ANP titrations at saturating FLV; namely 150 μM for 
RF or FMN, as well as at 7.5 μM RF for the ATP titration. The binding isotherms can 
be fit to a model that considers the reciprocal effect between the FLV and ANP ligands 
[187]. In this way, cooperativity coefficients (α), the fraction of protein sample able to 
bind the titrating ligand (N) and the enthalpy change associated to each process (h), 
can be determined. Data are summarized in Table 5.4. The presence of the cation 
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dramatically increases the binding cooperativity between flavin and adenine nucleotides 
(compare upper and lower parts of Table 5.4). It is also remarkable that α values are 
larger than one, which indicates positive cooperativity, with the only exception of the 
combination of the RF and ATP substrates at high RF concentrations that showed 
negative cooperativity (α<1). Therefore, although low concentrations of the RF 
substrate favor binding of the ATP substrate, an excess of RF has a negative impact in 
ATP binding (Figs. 5.7 and 5.9B, Table 5.4). The products of the reaction (FMN and 
ADP) always favor binding of the rest of substrates and products (Fig. 5.9A, Table 5.4). 
Moreover, the presence of either Mg2+ or ATP considerably enhances cooperativity, 
being particularly large the cooperativity for the FMN-ATP:Mg2+ combination (Table 
5.4). This later observation probably relates to the fact that in the absence of ATP, FMN 
seems to act as a slow binding ligand, which makes its binding to the RFK module not 
detectable by fast kinetics or ITC methods. Once α values are known, the experimental 
𝐾𝑎
𝑎𝑝𝑝,𝐴𝑁𝑃
 can be also used to predict the association constant for FMN binding, 𝐾𝑎
𝐹𝑀𝑁, 
to the free RFK module, as well as the corresponding G values presented in Fig. 5.8 
(gray dotted lines), by using Eqn. 2.17.  
Table 5.4. Cooperativity coefficients (α) for the binding of the different combinations of 
FLV and ANP ligands to the RFK module. Experiments were carried out at 25°C in PIPES 
20 mM, 0.8 mM MgCl2, pH 7.0, as well as in the same buffer without MgCl2. α represents 
the cooperativity coefficient between each pair of ligands, N the fraction of total protein able 
to bind the titrating ligand and h the enthalpy change associated to each process. Errors 
were taken in general larger than the standard deviation between replicates and the numerical 
error after fitting analysis. 
 ligands α N Δh (kcal/mol) 
0.8 mM MgCl2 
FMN-ADP 56.0±4.5 0.6±0.01 -8.1±1.9 
FMN-ATP 917±70 0.2±0.01 -22.1±0.1 
RF-ADP 24.0±2.5 0.3±0.01 -7.1±0.3 
0 mM MgCl2 
FMN-ADP 3.8±0.2 0.2±0.01 -9.7±0.8 
FMN-ATP 15.7±0.6 0.02±0.003 -30.0±0.8 
RF-ADP 3.3±0.1 0.2±0.02 -20.3±0.8 
RF-ATPa 19.2±5.7 0.5±0.06 -8.1±1.1 
RF-ATPb 0.8±0.1 0.8±0.07 -15.0±4.1 
a Data from the titration at the maximum of cooperativity, 7.5 μM RF. b Data from the titration at 100 μM RF. 




The collective binding of adenine and flavin nucleotides induces important 
conformational changes in the CaFADS RFK module 
Analysis of our steady-state, pre-steady-state and binding data in the context of the 
available structures for the RFK module, free and in the FMN:ADP:Mg2+ non-
productive ternary complex (Fig. 5.10) [85, 99], allows inferring new insights about the 
binding and dissociation of substrates and products in the course of the enzyme catalytic 
cycle. Although changes in the RF fluorescence are not detected upon its fast mixing 
with the RFK module, ITC experiments reveal that RF is able to interact with the RFK 
module with moderate affinity (Table 5.3). Such way of RF binding is consistent with 
the wide-open cavity that the free RFK module shows at the ribityl and isoalloxazine 
binding sites (Fig. 5.10, panel B1). Thus, RF can be somehow recognized by the RFK 
module, but its isoalloxazine is not enclosed within the protein. On the contrary, in the 
free protein crystal structure several loops and side-chains block the adenine nucleotide 
binding site, including the pocket for the phosphate groups [85, 99], (Fig. 5.10, panels 
B1 and C1). ATP (as well as ADP) reduces the access of the RF isoalloxazine to the 
solvent (Fig. 5.4, Table 5.3), suggesting its competent binding. This agrees with the 
formation of a ternary complex as the one in the RFK module:FMN:ADP:Mg2+ crystal 
structure (Fig. 5.10) [99]. Comparison of these two structures shows significant 
rearrangements. They include displacements of loops L3c, L5c and L1c-FlapI to allow 
the binding of the adenine nucleotide, as well as a noticeable change in the 
conformation of loop L4c-FlapII that encloses the isoalloxazine ring inside the protein 
(Fig. 5.10). The large unfavorable entropic and favorable enthalpic contributions for 
ATP binding to the RFK module:RF mixture, as well as for RF binding to the RFK 
module:ADP mixture (Table 5.3 and Fig. 5.6), further support such rearrangements 
occurring upon concerted ligand binding. Therefore, it appears that large 
conformational changes take place in the transformation of binary interactions into 
ternary complexes [99]. 
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Figure 5.10. Structure of the RFK module of CaFADS. Crystallographic structures for the 
RFK module when free (blue, PDB 2x0k) and in the ternary complex with the FMN and 
ADP:Mg2+ products (orange, PDB 5a89). (A) Superposition of the both structures. (B) Detail 
of the flavin nucleotide binding cavity. B1 shows the open conformation of the cavity in the 
free enzyme, where the phosphate of FMN and the Mg2+ cation will find their binding site 
blocked by residues of L1c. B2 shows the enclosed of the flavin ring by L4c in the ternary 
complex. (C) Detail of the adenine nucleotide binding cavity. C1 shows the closed 
conformation of the ANP binding site in the free enzyme, where the phosphates of ANP and 
the Mg2+ cation will find their binding site blocked by residues of L1c. C2 shows the open 
conformation of this cavity with bound ADP:Mg2+ in the ternary complex. In all panels the 
ligands correspond to those in the 5a89 structure. ADP and FMN ligands are shown in sticks 
and CPK colored with carbons in yellow and purple respectively, and the Mg2+ cation is 
shown as a green sphere. 
Mg2+and concerted fit of substrates to achieve the catalytically competent complex  
Fast kinetic methods allowed to determining a dissociation constant in the low 
micromolar range for the productive RFK module:RF:ATP:Mg2+ ternary interaction 
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(Table 5.2). Such interaction, which is not thermodynamically detected in the absence 
of the cation, suggests that previous ATP:Mg2+ binding is required for the competent 
RF binding to the RFK module (Fig. 5.10). Three observations support this mechanism; 
i) the cation-mediated conformational changes which enclosures the flavin ring and fits 
the ribityl end in a competent geometry for its phosphorylation [99] ii) the previously 
reported molecular dynamics simulations, which show how phosphates Mg2+-bridged to 
the active site promote the adenine binding site opening [99] and iii) the fact that RF is 
not able to interact with the preformed RFK module:ATP complex in the absence of the 
cation, but it is transformed into FMN when we mixed it with the RFK 
module:ATP:Mg2+ mixture. Collectively, these results indicate that a concerted binding 
of ATP:Mg2 and RF is necessary to achieve the substrates induced fit in the catalytic 
competent conformation. 
The RFK activity is highly regulated by inhibition of substrates and products 
The substrates of the RFK reaction showed positive cooperativity at low RF 
concentration, while higher RF concentrations hinder ATP binding (Fig. 5.9 and Table 
5.4). This fact points to the formation of non-productive RFK module:RF interactions as 
the main cause for the RF substrate inhibition (Figs. 5.2A and 5.10) [95]. Fast kinetic 
data indicate that the opening of the flavin binding cavity to release the flavin products 
is the process prevented (Figs. 5.4 and 5.5), whereas cooperative binding data (Table 
5.4) point to an increase in the protein occupation by ligands as the RF concentration 
increases. Such observations are consistent with excess of RF inducing binding modes 
that prevent conformational reorganizations which are required for products release to 
initiate a new catalytic cycle. 
The FMN and ADP products, accumulating as the RFK reaction proceeds, also 
inhibit the RFK reaction through different mechanisms (Fig. 5.11). FMN is not able to 
bind fast enough to the free RFK module, but it behaves as an uncompetitive inhibitor 
that binds to the ATP-enzyme preformed complex and forms a highly stable dead-end 
complex (Table 5.1 and Table 5.3 and Figs. 5.6 and 5.8). Apparently, the phosphate 
group at the ribityl end in the FMN product might prevent the placement and enclosure 
of this cofactor (Fig. 5.10). When combining FMN and ATP with the RFK module, fast 
kinetic binding rates show a biphasic profile on the flavin concentration. The faster rates 
are produced in the lower range concentrations, but rates rapidly decrease with FMN 
concentration (Fig. 5.4E). The combination of these ligands also produces a huge 
cooperativity (Table 5.4) and very stable non-productive ternary complex (dead-end 
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complex), while FMN binding to the preformed enzyme:ATP binary complex is 
considerably less stable (Fig. 5.8). Considering that FMN and ATP are the substrates of 
the reaction catalyzed by the CaFADS FMNAT module, it is likely that under situations 
which require FAD synthesis, the dead-end ternary complexes might facilitate 
channeling of FMN and ATP to the FMNAT module. This must be considered within 
the framework of the RFK-to-FMNAT modules head-to-tail disposition between 
protomers within trimers, in the dimer-of-trimers reported for the complete enzyme 
[85]. On its side, ADP acts as competitive inhibitor, competing with ATP for the same 
binding site (Fig. 5.11). The higher Km/Ki ratio for FMN relative to ADP, ≈ 5 and ≈ 2.4 
respectively, points to the flavinic product as a more potent inhibitor. This fact, together 
with the negative cooperativity between RF and ATP at high RF concentrations (Table 
5.4), can explain why inhibition of the CaFADS RFK activity by ADP has not been 
detected before. 
Our data suggest that FMN and ADP are able to inhibit the RFK reaction through the 
formation of different non-productive ternary complexes (Fig. 5.8). The kinetic rising of 
flavin fluorescence, observed in samples containing ATP (not observed for ADP) after 
ternary complex formation (Fig. 5.4), suggests dissimilar organizations of complexes 
with the ANP substrate and product. This is also supported by differences in their 
thermodynamic binding parameters (Table 5.3 and Fig. 5.8). Noticeably, the binding of 
substrates is slower than the formation of all the non-productive adenine-flavin 
nucleotide combinations (Fig. 5.4E, Table 5.2), as well as less thermodynamically 
favorable. Therefore, all combinations of ternary complexes might compete with the 
catalytic one as the reaction progresses on, being the ternary non-productive interactions 
containing the ADP:Mg2+ product particularly populated (thicker lines in Fig. 5.8A) 
(Fig. 5.11). This contributes to reduce the number of enzyme molecules available to 
initiate a new catalytic RFK cycle. Moreover, the higher the concentration of one of the 
ligands in ternary non-productive complexes is, the stronger the second ligand binds 
(Fig. 5.9, Table 5.4). Thus, binding of substrates of the RFK reaction is less favorable 
when products accumulate. 




Figure 5.11. Cleland representation of the kinetic mechanism for the transformation of RF 
into FMN by the RFK module of CaFADS. The different inhibition processes identified are 
summarized. 
FMN synthesis is a key process that requires tight regulation  
Our data indicate that FMN production by CaFADS is highly regulated by substrates 
and products inhibition of its RFK activity, to avoid overproduction of flavin even 
though the RF substrate might reach high concentration in the media. Moreover, they 
show that the ADP and the ATP nucleotides bind similarly to the RFK module, while 
the binding pockets for RF and FMN are dissimilar. In addition, we must keep in mind 
that the FMNAT activity, at the N-terminus module, of the CaFADS does not show any 
type of regulation by substrates or products inhibition [90]. Considering that selective 
inhibition of key enzymes is a common tool to regulate metabolic pathways [216-219], 
inhibition of the RFK activity by its substrates and products appears a useful tool to 
regulate the availability of both FMN and FAD in C. ammoniagenes. Most bacteria are 
able to synthesize their own RF [61, 220], as well as to assimilate it from the 
extracellular media [58, 60, 220, 221]. Therefore, mechanisms avoiding FMN and FAD 
overproduction when profusion of RF is produced must be relevant to maintain the 
cellular flavin homeostasis. Although characterization of additional family members is 
required to evaluate the generality of this mechanism, the few FADSs already 
characterized suggest strategies different from RFK inhibition to regulate FADS 
activity. Such differences among family members might provide with a framework to 
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  Chapter VI 
 The FAD synthetase from the human pathogen 
Streptococcus pneumoniae: a bifunctional enzyme 
exhibiting activity-dependent redox requirements 
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Up to now, only three crystallographic structures of bifunctional FADSs are 
available, those of Thermotoga maritima (TmFADS, PDB 1MRZ [74, 75]) 
Corynebacterium ammoniagenes (CaFADS PDB 2X0K [76]), and of the human 
pathogen Streptococcus pneumoniae (SpnFADS, PDB 3OP1). Except for the exhaustive 
biochemical and biophysical characterization of CaFADS [84, 88, 90] the rest of family 
members have been poorly studied [79, 222, 223]. As indicated in Chapter I, section 
3.3, SpnFADS shows the typical sequence and structural features of prokaryotic 
bifunctional FADSs, and therefore, it is likely to perform the RFK, FMNAT and 
FADpp activities as other bifunctional FADSs. SpnFADS structurally differs from the 
corresponding mammalian enzymes, and consequently, it can be exploded as a 
therapeutic target. Taking this into consideration, and also the fact that S. pneumoniae is 
the causative agent of invasive bacterial pneumoniae disease in children, in the elderly 
and in immunodepressed patients, SpnFADS appears as a protein worthy to be studied.  
In this chapter we present a first biophysical characterization of SpnFADS, 
addressing the study of its both RFK and FMNAT activities, its oligomerization 
tendency as well as the thermodynamic of the interaction with its substrates.   
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1. SpnFADS is purified free of flavin ligands 
Typically, the yield after purification was 3.5 mg of SpnFADS per liter of E.coli 
culture. Enriched SpnFADS fractions did not absorb notoriously at 450 nm along 
purification, and the final absorption spectrum of purified SpnFADS exhibits a single 
peak at 279 nm. Thus, in contrast to CaFADSs [76] SpnFADS does not co-purify with 
FAD, suggesting a much lower affinity for the oxidized flavinic substrates/products. 
Far-UV CD spectrum of SpnFADS exhibits a negative band at 208 nm typical of 
secondary α-helix structure and a slightly less intense negative band around 222 nm 
(Fig. 6.1A). Analysis of the far-UV CD spectrum using the method of Raussens [224] 
predicted 28.3, 19.9, 12.5 and 34.5 % of content in α helix, ß strand, turn and random, 
respectively, in agreement with its 3D-structure containing 29% α helix and 28% β 
strand (Fig. 6.2B). Near-UV CD spectrum of SpnFADS shows a broad 265-290 nm 
negative band with minima at 280.5 and 287 nm related with the protein tertiary 
structure organization (Fig. 6.1B). Altogether these data indicate that the purified 
protein is correctly folded. 
 
Figure 6.1. Spectroscopic properties of SpnFADS. (A) Far-UV circular dichroism spectrum 
of SpnFADS (5 µM). (B) Near-UV circular dichroism spectrum of SpnFADS (20 µM). 
Spectroscopic measurements were performed in 25 mM Tris/HCl, pH 7.5 at 20 ºC.  
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Figure 6.2. Structural properties of SpnFADS. (A) Structural alignment of SpnFADS (PDB 
3op1) and CaFADS (PDB 2x0k) according to the SSM server (http://www.ebi.ac.uk/msd-
srv/ssm/). Identical residues are shown in dark blue and conservative ones in light blue. 
Consensus motives are highlighted with boxes. SpnFADS contains the 30-HKGH-33, 126-
GFD-128 and 161-KISSTRIR-168 consensus motifs in the N-terminal module contributing 
to ATP stabilization for FMN adenylylation, as well as in FAD stabilization for the FADpp 
activity. The enzyme also conserves the 206-PTAN-209 motif and E254 at the RFK module 
to set up the catalytic site to transform RF into FMN. (SpnFADS numbering, highly 
conserved residues along family are shown in bold). (B) Three dimensional structures of 
SpnFADS (N- and C-terminal modules colored in green and yellow, respectively) and 
CaFADS (orange and brown, respectively). On the right it is shown the superposition of both 
structures showing an r.m.s.d. of 1.63 Å for 247 Cα atoms (structural alignment by PyMol). 
(C) Topology of the N-terminal FMNAT module (green) and the C-terminal RFK module 
(orange) of SpnFADS. α helices are shown as solid dark rectangles and β strands as light 
arrows. Numbers indicates residue positions. 
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2. SpnFADS catalyzes the RFK, FMNAT and FADpp activities.  
A qualitative assay was initially performed to evaluate whether SpnFADS was able 
to catalyze the RFK, FMNAT and FADpp activities by resolving the flavin reaction 
products by TLC. As shown in Figure 6.3A, SpnFADS catalyzes the conversion of RF 
into FMN, both in the absence and in the presence of a reducing agent. However, 
reducing conditions (2.5 mM of sodium dithionite) are required for the transformation 
of FMN into FAD (Fig. 6.3A) and vice versa (Fig. 6.3B).  
3. The reduced state of flavins is critical for the FMNAT activity 
but not for the RFK one. 
Prior to determining the kinetic parameters for the RFK activity of SpnFADS, we 
evaluated the influence of the reducing environment (sodium dithionite) as well as of 
Mg2+ on this reaction. Under saturating concentrations of substrates (RF and ATP) rates 
for RF transformation were independent on the reducing agent concentration in the 
media (Fig. 6.4A), indicating that the SpnFADS RFK activity does not depend on its 
redox environment. On the contrary, Mg2+ enhances the RFK activity, being the rate of 
the process practically constant at cation concentrations over 0.4 mM (Fig. 6.4B). Thus, 
herein a concentration of 0.8 mM MgCl2 was used. Steady-state rates for the RFK 
activity showed saturation profiles for both of the substrates (Fig. 6.3C), contrary to 
CaFADS that has strong inhibition by excess of RF [88, 90]. Thus, profiles for the RFK 
activity of SpnFADS were fit to the Michaelis-Menten model, allowing determination 
of kcat, Km
RF and Km
ATP values of 18.7 min-1, 0.9 µM and 54.0 µM, respectively. These 
values were only slightly influenced by the presence of the reducing agent (Table 6.1, 
Fig. 6.3C). Similarly, we also evaluated the effect of Mg2+ concentration and of 
reducing conditions on the FMNAT activity of SpnFADS before determining it. This 
activity was measured following the transformation of FMN into FAD. The presence of 
sodium dithionite was a requirement for the transformation of FMN into FAD (Fig. 
6.4A), being the rate of the process constant over 2 mM sodium dithionite. On the 
contrary, the FMNAT activity was very poor in the presence of milder reducing agents 
as DTT (not shown), suggesting that strong reducing conditions are required to achieve 
catalysis. Maximal activity was observed in the range of 0.8-1.2 mM of the divalent 
cation (Fig. 6.4B), being the observed rates in its absence up to 5-fold lower. Thus, 0.8 
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mM MgCl2 and 3 mM sodium dithionite were selected to further characterize the 
FMNAT kinetic parameters of SpnFADS. 
 
Figure 6.3. The RFK, FMNAT and FADpp activities of SpnFADS. (A) Thin layer 
chromatography of the products of the RFK and FMNAT activities. Reaction mixtures 
contained 500 nM SpnFADS, 50 μM RF, 0.2 mM ATP, and several concentrations of 
sodium dithionite. First lane to the left corresponds to a standard solution containing RF, 
FMN and FAD at 50 μM each. (B) Thin layer chromatography of the products of FADpp 
activity. Reaction mixtures contained 500 nM SpnFADS, 50 μM FAD, 0.2 mM PPi, and 
several concentrations of sodium dithionite. First lane corresponds to the standard solutions 
and second line to a free FAD sample with 10 mM MgCl2. (C) Rates for RFK activity as a 
function of the RF concentration at saturating ATP (412 μM) without (●) and with 2.6 mM 
(■) sodium dithionite. (D) Rates for the FMNAT activity as a function of the FMN 
concentration at saturating ATP (252 μM) and 3 mM sodium dithionite. Unless otherwise 
stated all measurements were carried out at 25 ºC in 20 mM PIPES, pH 7.0, with 0.8 mM 
MgCl2.  
Observed rates exhibited Michaelis-Menten saturation profiles (Fig. 6.3D) with kcat, 
Km
FMN and Km
ATP values of 34.9 min-1, 9.8 µM and 31.6 µM, respectively (Table 6.1). 
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The need of reducing conditions for the FMNAT activity suggests that either the 
isoalloxazine ring of FMN needs to be reduced for the reaction to occur, or the reaction 
depends on a conformational change of the flavin binding site of the FMNAT module of 
SpnFADS induced by the redox environment. To clarify this matter an additional 
experiment was performed. The FMNAT activity of SpnFADS was measured under 
anaerobic conditions, but in the absence of dithionite, using as substrate the photo-
reduced FMN. The HPLC analysis of the reaction products revealed that SpnFADS is 
able to transform FMN into FAD in the samples containing photo-reduced FMN in 
contrast with the negative controls where FMN is oxidized. Therefore, we demonstrate 
that FMN needs to be in its reduced form to get adenylylated by SpnFADS.  
 
Figure 6.4. Rates of the RFK (■) and FMNAT (●) activities of SpnFADS as a function of 
(A) sodium dithionite and (B) MgCl2 concentrations. Reaction mixtures contained ATP 
(240 μM), RF (6 μM) and SpnFADS (25 μM) for the RFK activity; ATP (~250 μM), FMN 
(20 μM) and SpnFADS (25 μM) for the FMNAT activity. In all assays MgCl2 was used at 
0.8 mM when varying sodium dithionite, while sodium dithionite was used at 3 mM when 
varying MgCl2. 
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Table 6.1. Steady-state kinetic parameters for the RFK and FMNAT activities of SpnFADS. Parameters obtained at 25 ºC in 20 mM PIPES, pH 7.0, 0.8 
mM MgCl2 and, when indicated 3 mM sodium dithionite as reductant. Estimated errors in kcat and Km are within ±10%. 





























CaFADSa,b - < 302 < 13 23.2 68 13.7 4.9 
LmFADSIc + 0.40 6.9 0.057    
HsRFKe + 0.50 36 0.014    
BsFADSf + 0.70 55 0.013    
SdFADSf + 0.30 40 0.007    
EcFADSg + 0.39 2 0.20    
 










kcat / KmATP 
(min-1 µM-1) 
SpnFADS + 34.9 9.8  3.6 23.2e 31.6 0.7 
CaFADSa - 17.0 1.2  14.3 17.0 35.7 0.5 
LmFADSIe + 4.39 29.2  0.15    
LmFADSIIe + 0.51 12.9  0.04    
EcFADSg + 0.06  4  0.015    
a Data from [88]. Data were obtained at 25 ºC in 20 mM PIPES, pH 7.0 and 0.8 mM and 10 mM MgCl2, respectively, for the RFK and FMNAT activities.  
b Inhibition by substrate prevented the determination of true parameters and these correspond to apparent constants, kcat,app, Km,appRF, Km,appATP, kcat,app/Km,appRF and kcat,app/Km,appATP. 
c Data from [79]. Data obtained in 50 mM potassium phosphate, pH 7.5. 
d kcat measured at 27.7 µM of FMN.   
e Data from [225]. Data obtained in 50 mM potassium phosphate, pH 7.5. 
f Data from [222]. Data obtained in 100 mM potassium phosphate, pH 7.5. 
g Data from [226]. Data obtained in 50 mM potassium phosphate, pH 7. 
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4. SpnFADS does not bind oxidized flavins by itself 
ITC thermograms for the titration of SpnFADS with oxidized RF, FMN or FAD, 
either in presence or absence of Mg2+, indicated that under the assayed aerobic 
conditions none of these flavins binds to the protein with detectable enthalpic 
contribution (Fig. 6.5). Therefore, we also titrated SpnFADS with FMN and FAD in a 
flavin reducing buffer and in the presence of 0.8 mM Mg2+. As shown in Fig. 6.6A, 
under such conditions binding of the reduced forms of FMN and FAD to the enzyme 
was detected. Both reduced cofactors bind to a single SpnFADS binding site (Fig. 6.6A 
and Table 6.2). Kd
FMN is in the low micromolar range, and binding of reduced FAD is 
15-fold weaker. Enthalpic contributions to the binding are very similar for both flavins, 
but the entropic contributions favor FMN binding (Fig. 6.6C). Therefore, these results 
indicate that the FMNAT/FADpp sites of SpnFADS only bind the reduced states of 
FMN or FAD.  
 
Figure 6.5. Representative calorimetric titrations of the interactions between SpnFADS with 
flavin cofactors: RF, FMN and FAD. The upper panels show the thermograms for the 
interactions and the lower panels show the corresponding binding isotherms with integrated 
heats. Experiments were carried out in 20 mM PIPES, pH 7.0 in 10 mM MgCl2 at 20 °C and 
indicated flavins were not binding under these conditions. 
Thermograms for the titration of SpnFADS with ATP indicated a single binding 
site for this nucleotide (presumably at the FMNAT site as in CaFADS), both in the 
absence and presence of 0.8 mM of Mg2+ (Fig. 6.6A and Table 6.2), although binding 
affinities and interaction parameters differ between these two conditions. Thus, ATP 
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and ATP:Mg2+ allocate differently into the protein binding site, suggesting that the ion 
contributes to the nucleotide-protein-bound conformation. Titrations at higher Mg2+ 
concentrations showed two independent ATP binding sites, putatively related with each 
catalytic site, with similar affinities between them, and also similar to that of the site 
found at lower Mg2+ concentrations. However, enthalpic and entropic contributions to 
the ATP binding result highly influenced by Mg2+; in its absence, and at low 
concentrations, the nucleotide binding is enthalpically driven with an opposing entropic 
contribution, while at high cation concentrations relatively mild entropic and enthalpic 
contributions favor the binding (Fig. 6.6B). Thermodynamic parameters for the 
SpnFADS titration with ADP also differ depending on Mg2+ concentration. In the 
absence of the cation, a single high affinity binding site is observed, being the binding 
driven by a favorable enthalpic contribution. At 10 mM of Mg2+, a second binding site 
appears with lower affinity for the nucleotide, being the averaged Kd (Kd,av) at least 7-
times higher. ADP binding in the presence of 10 mM Mg2+ is also enthalpically driven, 
but in this case the enthalpic contribution is much higher, being the entropic term 
mightily unfavorable. Thus high Mg2+ concentrations induce the generation of a second 
binding site for the adenine nucleotide ligands, both ATP and ADP, and influence the 
way the ligands allocate into the active site, as also supported by the different 
thermodynamic contributions to free energy of the binding.  
Thermograms for the titration of mixtures containing SpnFADS plus ADP with 
oxidized RF or FMN showed that the presence of the adenine nucleotide promotes 
binding of both of these flavins (Fig. 6.6 and Table 6.2). Under these conditions RF in 
presence of 10 mM MgCl2, apparently binds at two independent binding sites with 
moderate affinity, Kd,av 51.3 µM, being the averaged binding enthalpically driven and 
the entropic contribution highly unfavorable. However, in the absence of Mg2+ only one 
binding site with strong affinity is detected. By contrast FMN binds at a single site with 
stronger affinity than those found for RF, being the binding driven by the enthalpic 
contribution and the binding parameters just modulated by the presence of Mg2+. 
Finally, binding of FAD to SpnFADS in the presence of PPi could not be detected by 
enthalpic change, similarly to that occurred when titrating the PPi-free enzyme with 
FAD.  
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Figure 6.6. (A) Calorimetric titrations of SpnFADS with reduced FMN and FAD, performed 
at 20 °C in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2, 4 mM sodium dithionite, 10 mM glucose, 
0.5 U/ml glucose oxidase (degassed). (B) Calorimetric titrations of SpnFADS with ATP and 
of the preformed SpnFADS:ADP complex with RF or FMN, at 20 °C in 20 mM PIPES, pH 
7.0, and at the indicated concentrations of MgCl2. In all titration figures upper panels show 
the thermograms for the interactions and the lower panels show the corresponding binding 
isotherms with integrated normalized heats. (C) Thermodynamic dissections of the 
interaction of SpnFADS with ATP, as well as of the preformed SpnFADS:ADP complex 
with RF and FMN. The binding Gibbs energy (ΔG), enthalpy (ΔH), and entropy (-TΔS) are 
represented in dark grey, light grey and white bars, respectively. MgCl2 concentrations in 
mM used in each experiment are indicated by numbers.  
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Table 6.2. Thermodynamic parameters for the interaction of SpnFADS with the substrates 
and products of its activities obtained by ITC. Data obtained at 20 ºC in 20 mM PIPES, pH 7.0. 















0 1.7 -7.9 -19.1 11.2 1 
0.8 9.4 -6.9 -27.8 23.0 1 
10 9.2 a -6.9 a -3.0 a -3.9 a 2 
ADP 
0 4.1 -7.3 -12.9 5.5 1 




n.d. n.d. n.d. n.d. n.d. 
10 
FMNb 0.8 0.8 -8.3 -5.8 -2.5 1 




0 0.3 -9.0 -17.2 8.2 1 
10 51.3 a -5.9 a -51.6 a 45.7 a 2 
FMN 
0 1.5 -7.9 -12.8 4.9 <1 
10 5.9 -7.1 -28.6 21.5 <1 
SpnFADS:
PPi 
FAD 0 n.d. n.d. n.d. n.d. n.d. 
a Data corresponding to average values of two similar and independent binding sites (Kd,av, Gav, Hav, -TSav). 
b Measurements performed in the presence of 4 mM sodium dithionite, 10 mM glucose and 0.5 U/ml glucose oxidase. 
n.d. No enthalpic change was detected along the titration. 
5. SpnFADS exists mainly as a monomer but other oligomeric 
states are populated during catalysis 
SpnFADS eluted in a main peak with a small shoulder in the gel filtration column 
used as a last step in its purification. The presence of the shoulder might be indicative of 
freshly purified SpnFADS stabilizing quaternary assemblies, as described for CaFADS 
[84]. To check for such possibility we passed through the gel filtration column a freshly 
purified SpnFADS fraction considered as monomeric. This protein eluted as a main 
broad peak at ~14.5 mL (96% of the protein) but also produced a shoulder at ~13 mL 
(Fig. 6.7). The peak at ~14.5 mL deconvolutes in three populations with apparent MWs 
of 61.2, 63.7 and 70 kDa. These values are slightly higher than the theoretic one for the 
monomer (34.8 kDa), but the elongated structure of SpnFADS and the different 
conformations expected for its external loops suggests that they might be assigned to 
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either different conformers of monomers or dimers. In contrast, the apparent MW of the 
shoulder is 127.4 kDa, suggesting this small fraction is populated by high MW 
oligomers. These pure preparations of SpnFADS also migrated in two bands on native 
gel electrophoresis, although the one putatively assigned to the monomer was the most 
populated (Fig. 6.7B).  
SDS-PAGE resolved the protein in a single band corresponding to the monomer 
MW, but pre-incubation of the protein with the BS3 crosslinker stabilized an additional 
band with an apparent MW of 78.6 kDa that can be assigned to a dimer (Fig. 6.7C). 
Altogether these data suggest that purified SpnFADS can be found in a monomer-dimer 
equilibrium that is mainly shifted towards the monomeric form, with traces of higher 
MW assemblies. 
 
Figure 6.7. Hydrodynamic properties of SpnFADS. (A) Gel-filtration chromatogram of pure 
SpnFADS (20 µM) using a precalibrated SuperdexTM 200 10/300 GL column (GE 
Healthcare) equilibrated with 50 mM Tris/HCl, pH 8.0, 150 mM NaCl, and calibrated with 
the Gel Filtration Calibration Kit LMW (GE Healthcare). The inset shows the percentage of 
the fractions obtained from the chromatogram. (B) 12% Native PAGE of pure SpnFADS and 
(C) 15% SDS-PAGE of SpnFADS without crosslinker and after incubation with the BS3 
crosslinker.  
We used AFM to shed light on the SpnFADS assembly in solution, as well as on the 
possible effect of ligands in the monomer-oligomer equilibrium (Fig. 6.8A-F). AFM 
topography images of free SpnFADS indicate a compact monomer (height ~7 ± 1 nm) 
(Fig. 6.8A). Incubation of the enzyme with different combinations of substrates and/or 
its reaction products produced some dimers and trimers, while ADP also promoted the 
formation of tetramers (Fig. 6.8 and Table 6.3). Two types of images were found for 
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dimers. In one of them the two protomers dispose parallel in the same plane with the 
tallest module of one interacting protomer with the smallest of the other, leaving the rest 
of these molecules free of contact (Fig. 6.8B). In the other dimer, the most frequent, 
both protomers are on the same plane establishing different angles and slightly 
overlapping one module of the first onto one of the modules of the other (Fig. 6.8C). 
Both dimers appear as intermediate steps in the formation of the two trimeric species 
visualized in the images (Figs. 6.8D and 6.8E), which situate an additional monomer 
over one of the monomers of the dimeric structures. Considering the disposition 
adopted by the three molecules present in the asymmetric unit of the SpnFADS crystal 
(Fig. 6.8G), where each protomer is situated in a different plane, the trimers in solution 
differ from such crystallographic association. Finally, tetramers form two layers of two 
overlapped monomers (Fig. 6.8F). Incubation of SpnFADS with ATP and FMN, ADP 
and FMN, or FAD and PPi, produced the higher ratios of trimeric species, ~41 %, while 
the RFK activity reactants, ATP and RF, generated 30 % of dimeric molecules and only 
16 % of trimers. ATP by itself produced 37 % of trimers, meanwhile ADP makes 20 % 
of trimers and 47 % of tetramers (Table 6.3). Incubation with the reactants of the 
FMNAT and FADpp activities resembles the same oligomeric yields. Since neither 
oxidized FMN nor FAD are able to bind to SpnFADS in the absence of adenine 
nucleotides, these data suggest that binding of adenine nucleotides (ATP and ADP) 
promotes the observed quaternary assemblies.  
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Figure 6.8. Image analysis of SpnFADS assemblies. Topography AFM images of a scanned 
area of 167 x 167 nm and Z-height profiles associated to the lines on the features of 
SpnFADS samples. (A) Monomer. (B) Dimer on the same plane. (C) Dimer with an 
overlapping on a monomer on the other. (D) Trimer from (B) showing an overlapped dimer 
interacting with a monomer. (E) Trimer from (C) showing overlapping of the dimer on a 
monomer. The different sizes of the original scanned images slightly change the roughness 
of the surface and the lateral resolution. This affects the size of the features in X-Y but not 
the Z-height measured in the profiles. (F) Tetramer. (G) Blender simulation of different 
assemblies according to the presence or absence of ligands and assembly of the three 
SpnFADS molecules in the crystal asymmetric unit (PDB 3op1). 
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Table 6.3. Percentages of SpnFADS assemblies imaged by AFM. Samples of 0.5 μM 
SpnFADS were analyzed in 20 mM PIPES, pH 6.0, 2 mM DTT and 0.8 mM MgCl2 at room 
temperature. When indicated, ADP, ATP or PPi were added at 250 M, while oxidized FAD, 
FMN and RF were used at 50 μM. Features correspond to image units, while molecules refer 
to the amount of individual protein monomers in the corresponding image units. Error 
associated to percentage determination was ± 10 %. 











Features 97 3 ---- ---- 
Molecules 94 6 ---- ---- 
ADP 
Features 60 7 13 20 
Molecules 31 7 20 47 
ATP 
Features 70 12 18 ---- 
Molecules 47 16 37 ---- 
ATP, RF 
Features 73 20 7 ---- 
Molecules 54 30 16 ---- 
ATP, FMN 
Features 73 7 20 ---- 
Molecules 50 9 41 ---- 
ADP, FMN 
Features 63 15 22 ---- 
Molecules 40 19 41 ---- 
FAD, PPi 
Features 73 7 20 ---- 
Molecules 50 9 41 ---- 
 
6. Discussion  
Sequence alignments, structural comparisons [76, 85, 99] and ligand binding models 
(Fig. 6.2A and Fig. 6.9A) suggested that SpnFADS contains all the features of 
prokaryotic FADSs that contribute to substrates stabilization and catalysis. Accordingly, 
we show here that the enzyme catalyzes the RFK, FMNAT and FADpp activities, but 
we also highlight different requirements for catalysis and binding of ligands relative to 
other family members. Interestingly while transformation of RF into FMN by SpnFADS 
occurs similarly under both aerobic and reducing conditions, the FMNAT and FADpp 
activities require reduced flavins (Fig. 6.3). Reducing conditions hardly influence any of 
the CaFADS activities [88, 90] (Table 6.1), but some bifunctional FADSs as well as the 
monofunctional HsRFK are more active in the presence of high concentrations of 
reducing agents [79, 222, 225, 226]. Moreover, studies of enriched samples of the 
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FADS from Bacillus subtilis (BsFADS) early suggested specificity for reduced flavins 
in all its activities [223].  
Despite the differences in the redox requirements for the RFK and FMNAT activities 
between SpnFADS and CaFADS, both enzymes showed the highest efficiency for the 
synthesis of FMN and FAD compared to the other family enzymes reported up to now 
(Table 6.1) [79, 88, 90, 225] with the lack of inhibition by the RF substrate for the RFK 
activity in SpnFADS (Fig. 6.3C) as a notable difference between these two enzymes. 
Our ITC data indicate that SpnFADS does not bind any of its oxidized flavinic 
substrates when adenine nucleotides are not present (Fig. 6.5), contrary to CaFADS [88, 
90]. Reducing conditions are not a requirement for the binding of adenine nucleotides 
(ATP and ADP) (Fig. 6.6), and the presence of the adenine nucleotide also induces 
binding of oxidized RF or FMN. Nevertheless, ternary interactions in SpnFADS are 
slightly weaker than in CaFADS [84]. Moreover, in the presence of the adenine 
nucleotide, oxidized FMN only binds at one site, which according to the enzyme 
capability to transform oxidized RF into FMN must be the RFK site (Table 6.2). The 
fact that oxidized RF does not bind to free SpnFADS, the lack of inhibition by RF, and 
the enzyme being catalytically efficient at low RF concentrations, suggest a dissimilar 
RFK mechanism between this enzyme and CaFADS [81]. Furthermore, the enzymatic 
and ligand binding characterizations of SpnFADS altogether confirm that competent 
flavin binding for catalysis at the FMNAT site requires the flavin ring in its reduced 
state. In addition, SpnFADS needs higher concentrations of substrates than CaFADS to 
achieve maximal efficiency. 
The need for reduced flavinic substrates in BsFADS was interpreted as the 
geometry of the active site only allowing the incorporation of isoalloxazine rings in the 
reduced bended conformations, contrary to the highly stable planar organization 
adopted by their oxidized states [39, 223, 227]. Despite the high conservation grade in 
overall folding (Fig. 6.2B) and key active sites residues, CaFADS and SpnFADS are 
dissimilar in some regions involved in ligand binding (Figs. 6.9B and 6.2C). In the 
FMNAT module of SpnFADS helixes α310n and α5n break loops L4n and L6n, 
respectively. These regions form the external part of the cavity where substrates for the 
FMNAT and FADpp activities bind. The sites for the ribityl and isoalloxazine moieties 
are formed in both enzymes by hydrophobic and aromatic side-chains (Fig. 6.10A), 
whose differential spatial position might determine cavity volumes and, therefore, 
modes for flavin binding. The cavity appears slightly broader and deeper in SpnFADS 
María Sebastián Valverde 
 202 
than in CaFADS, although in SpnFADS the isoalloxazine binding site surface is 
rougher and shows a more negative surface electrostatic potential (Fig. 6.10B). The side 
chains of two Met residues, M54 and M118, form also part of the flavin ring cavity in 
SpnFADS, with M54 particularly prone to contact with the inner isoalloxazine ring (Fig. 
6.10C). These Met residues are not conserved in most family members, which have 
instead hydrophobic residues [76]. Moreover, M54 forms part of a conserved sequence 
motif that is included only in few members such as BsFADS. 
 
 
Figure 6.9. The structure of SpnFADS. (A) Model (based on PDB 3op1) for the interaction 
of SpnFADS with its ligands. The FMNAT module is shown in green and the RFK in 
yellow. Flavin and adenine nucleotide ligands are in CPK colored sticks with carbons in 
white. Mg2+ ions are shown as grey balls. Modelling performed using PyMol. (B) 
Superposition of the structures of SpnFADS (green, PDB 3op1) and CaFADS (orange, PDB 
2x0k). Dissimilar regions are highlighted in blue and pink, respectively, including the 
numbers of implicated residues in SpnFADS.  
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Figure 6.10. Comparative analysis of the SpnFADS and CaFADS active sites in the 
FMNAT module. (A) Site for ligands binding in SpnFADS (green) and CaFADS (orange). 
Hydrophobic and aromatic side chains are shown in sticks. (B) Surface electrostatic potential 
for the isoalloxazine binding cavity in SpnFADS (left panel) and CaFADS (right panel). 
Arrows point to differences in sign of surface electrostatic potential at the SpnFADS and 
CaFADS isoalloxazine sites. (C) Relative disposition of M54 and M118 regarding the 
isoalloxazine moiety of the flavin substrate. In all panels, FMN and AMP have been 
modelled on the crystals structures of SpnFADS (PDB 3op1) and CaFADS (PDB 2x0k) and 
represented in CPK sticks with carbons in grey [85]. 
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Figure 6.11. Comparative analysis of the RFK sites of SpnFADS, CaFADS and the 
CaFADS:FMN:ADP-Mg2+ ternary complex. (A) Cartoon representation of the RFK domains 
of SpnFADS (green, PDB 3op1), CaFADS (orange, PDB 2x0k) and ternary complex of the 
RFK module of CaFADS (blue, PDB 5a8a). L1c-FlapI is highlighted in red, pink and 
yellow, respectively. Residues of the PTAN motif are in CPK sticks. The FMN and ADP 
ligands bound to the CaFADS RFK module are in white CPK and Mg2+ is included as a 
green sphere. (B) Detail of the PTAN motif in SpnFADS and superposition of the PTAN 
motives of the three structures. (C) Superposition of the RFK domain of SpnFADS (green) 
and CaFADS (orange). The salt bridge between D214 at L2c and R190 at β1c of SpnFADS 
is in black dashes. Equivalent residues in CaFADS, D215 and T190, are drawn in sticks. 
Loops L3c are colored in blue (SpnFADS) and pink (CaFADS).  
Structural differences are also observed when comparing the SpnFADS RFK 
module with the structures available for the CaFADS RFK module free and in complex 
with ligands (Figs. 6.9 and 6.11) [99] : i) D214 at loop L2c of SpnFADS salt bridges 
R190 at β1c; ii) loop L3c is 12 residues shorter; iii) the C-terminal is considerably 
shorter; and iv) an extra α helix, α1c, breaks loop L1c-Flap I. In addition, conformations 
of the conserved PTAN motif and of L1c-FlapI in free SpnFADS resemble those 
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elements in the CaFADS:FMN:ADP-Mg2+ complex. Such organization leaves the 
adenine nucleotide binding site open and the PTAN motif ready to stabilize the ligand 
(Fig. 6.11), contrary to free CaFADS [99]. Thus, the weaker affinity of SpnFADS for 
the RFK activity products might be related with the lack of large conformational 
changes at the active site for substrates association and products dissociation during 
catalysis. These traits surely also contribute to the lack of inhibition by the RF substrate 
in SpnFADS.  
Table 6.4. List of probable quaternary structures in solution for SpnFADS and CaFADs as 
predicted by the PISA server 
 
Finally, substrates and products of SpnFADS induce formation of dimers, 
tetramers and particularly trimers with head-to-tail contacts between the RFK module 
and the FMNAT module of different protomers (Table 6.3, Fig. 6.8). None of these 
organizations resembles the dimer-of-trimers reported for CaFADS and in general the 
SpnFADS monomer appears to be majority [100]. The PDBePISA server predicts 
dimeric assemblies with head-to-tail fits (Table 6.4, Fig. 6.12), but it does not predict 
any higher oligomer as stable in solution. Differences in oligomerization profiles might 
relate with differences in protein oligomerization regions. In fact, a long L3c, only 
expected for Corynebacterium and Mycobacterium species, is predicted as a 
determinant to stabilize the dimer of trimers [100]. The shorter loop in SpnFADS agrees 
with this hypothesis, being less prone to oligomerization and establishing different 
contacts among protomers, which might also contribute to the dissimilar binding, 
kinetic and inhibition properties among species. The dimer-of-trimers in CaFADS 
envisaged a controlled interplay between the regions involved in the formation of the 












   
CC´ yes 24440 7030 -82.0 9.2 
AB yes 28530 5090 -33.2 2.9 





   
A3B3  yes  82800 19770 -189.0 22.5 
B3  yes  45020 6550 -73.0 3.1 
A3  yes  44480 6520 -72.0 2.7 
AB  yes  31390 2800 -52.7 12.4 
María Sebastián Valverde 
 206 
RFK and/or FMNAT catalytic sites of different protomers as well as in flavin delivery 
to client apoflavoproteins [87, 156]. However, such mechanism might not be required 
for SpnFADS, since in this enzyme the main regulation mechanism for the FAD 
synthesis seems to be the reducing environment.  
 
 
Figure 6.12. (A) Oligomeric organizations predicted by the PDBePISA server based on the 
structure of SpnFADS (PDB 3op1). The asymmetric unit contains three chains, A, B, and C, 
coloured in yellow, blue and red, respectively. Besides, the three predicted as possible stable 
dimers in solution. Chains A´ (pink) and C´ (green) belong to other asymmetry unit. (B) 
Oligomeric assembly predicted for CaFADS as a dimer-of-trimers (hexamer, A3B3). The left 
panels show the protomers of the trimer at front coloured in orange, green and yellow and 
the others at the back in grey. The right panels show the location of the two chains of 
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The FADS from the human pathogen S. pneumoniae shows the consensus sequences 
assigned to the RFK, FMNAT and FADpp activities (Fig 1.11). Comparison of 
SpnFADS with CaFADS reveals that the overall structures of both proteins are quite 
similar despite the fact that they only show 25% of sequence identity. Nevertheless, the 
previous study exposed in chapter 6, revealed important behavioral differences between 
both proteins. Among the dissimilarities, two stand out: Firstly, SpnFADS requires 
reduced FMN for its FMNAT reaction, while CaFADS does not show such 
requirement. Secondly, contrary to CaFADS, the RFK activity of SpnFADS does not 
show inhibition by excess of the RF substrate. Due to the potentiality of bifunctional 
FADSs as exploitable drug targets, the differences among them are worthy of study to 
take advantage of them when designing species-specific drugs. 
The first issue was addressed in the previous chapter, while in the present one we 
tackle the apparent lack of inhibition of the RFK activity of SpnFADS. For that purpose, 
we performed a complete kinetic and thermodynamic characterization of the RFK 
catalytic cycle of the enzyme, similar to that displayed in chapter 5 for the RFK module 
of CaFADS. Comparison of the results obtained for both enzymes might reveal key 
aspects of their RFK activity. 
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1. The RFK activity of SpnFADS is inhibited by the products of 
the reaction 
 
Figure 7.1. Inhibitory effects produced by the FMN and ADP products of the SpnFADS 
RFK reaction. (A) Michaelis-Menten plots as a function of ATP obtained at different 
concentrations of the ADP product. (B) Lineaweaver-Burk representation at different ADP 
concentrations with global fit to the equation for mixed inhibition. (C) Michaelis-Menten 
plots as a function of RF obtained at different concentrations of the FMN product. (D) 
Lineaweaver-Burk representation at different FMN concentrations with global fit to the 
equation for mixed inhibition. All the experiments were performed at 25ºC in 20mM PIPES, 
pH7.0, 0.8 mM MgCl2. Reaction rates represented in (A) and (B) were obtained at 10 μM RF 
and variable concentrations of the ATP substrate (25-450 μM) and of the ADP product (25-
500 μM). Reaction rates displayed in (C) and (D) were obtained at 350 μM ATP and variable 
concentrations of the RF substrate (1-15 μM) and of the FMN product (1-14 μM). 
Experiments were carried out in triplicate.  
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Table 7.1. Steady-state kinetic parameters obtained for the SpnFADS RFK activity in 
presence and absence of the products of the reaction. Data obtained at 25 °C in 20 mM 
PIPES, 0.8 mM MgCl2, pH 7.0.  















0 53±3 62±12 0 42±1 1.0±0.1 















25 51±12 71±8 1 31±1*** 2.3±0.3 ** 
50 52±2 107±10 3 18±1*** 2.3±0.5 ** 
200 41±2*** 125±18** 5 21±1*** 2.9±0.6 ** 
400 38±2*** 105±14 ** 7 N.A. N.A. 
500 36±3*** 136±30 ** 9 N.A. N.A. 
Data showing statistical significance differences when compared with the activity of SpnFADS in the absence of the 
products of the reaction (***, p<0.0001; **, 0.0021>p>0.0001. 
N.A. Not applicable. The complete inhibition of the enzyme prevented the determination of any kinetic parameter. 























130.7±16.4 844±97 55±2 75±7 1.3±0.4 7.1±1 39±3 1.2±0.3 
 
The RFK reaction of SpnFADS follows a bisubstrate Michaelis-Menten kinetics, 
with Km
ATP, Km
RF and kcat values of 62± 13 μM, 1.0± 0.1 μM and 50± 3 min
-1 , 
respectively (Fig. 7.1, Table 7.1). To evaluate if the products of the RFK reaction (ADP 
and FMN) inhibit this activity, we also studied the evolution of the steady-state rates at 
increasing concentrations of ADP and FMN (Figs. 7.1A and 7.1C). Michaelis-Menten 
plots obtained as a function of the ATP substrate at increasing concentrations of the 
ADP product revealed that both kcat and Km
ATP were altered. kcat decreased while Km
ATP 
increased with the ADP concentration (Fig. 7.1A, Table 7.1). Similar results were 
observed for plots obtained as a function of the RF substrate when increasing the FMN 
product concentration. This behavior (both kcat and Km are modified) is typical of mixed 
and uncompetitive inhibitors. We used then Lineweaver-Burk representations to 
discerning between these two mechanisms of inhibition. Lines intersected at negative 
VII. The RFK catalytic cycle of SpnFADS 
 213 
values of the x-axis and positive ones of the y-axis for both reaction products, indicating 
that both ADP and FMN are mixed inhibitors of the RFK activity. Thus, FMN and ADP 
can bind to the free enzyme as well as to a SpnFADS:ATP or SpnFADS:RF complex, 
respectively. However, affinities for the free protein and for the complex differ (Table 
7.1). Global fitting of the double inverses plots (Figs. 7.1B and 7.1C) to the model 
describing mixed inhibition (Eqn. 2.21), yielded the inhibition constants for ADP and 
FMN, being Ki
ADP and K´i
ADP 131± 16 μM and 844± 97 μM, respectively; and Ki
FMN and 
K´i
FMN 1.3± 0.4 μM and 7.1± 1.3 μM, respectively. These data indicate that FMN is a 
stronger inhibitor than ADP, and that both inhibitors bind preferentially to the free 
enzyme. 
2. Fast kinetics in the pre-steady state RFK reaction of SpnFADS 
We used stopped-flow spectrophotometry to kinetically identify the different 
processes that might take place during the RFK reaction of SpnFADS. As in chapter 5, 
the magnitude change we follow is the fluorescence of the oxidized FLV ligands [51]. 
Two aspects must be considered at this point. Since RF and FMN show the same 
fluorescence spectra and yields [55], we do not expect to observe the transformation of 
the first into the second one. Thus, we will follow changes affecting the isoalloxazine 
ring environment (such as its binding or dissociation to the protein or conformational 
changes in its surroundings). The second relates to the FMNAT module of SpnFADS 
that only binds and transforms flavins in their reduced state, as indicated in chapter 6. 
Taking advantage of this, working under oxygen atmosphere will allow us to 
independently study flavin binding processes to the RFK module of the protein. When 
we mixed SpnFADS with FLV ligands, we only distinguished very slow linear 
fluorescence decays, whose slopes linearly decreased with the FLV concentration. The 
rates for these decays were within the photobleanching range (4.5·10-3 ± 1.2 ·10-4 min-1 
and 4.1·10-3 ± 2.4 ·10-4 min-1 for RF and FMN, respectively) (Fig. 5.3B). As discussed 
elsewhere, these data indicate that SpnFADS, and particularly its RFK module, is 
neither able to bind oxidized FLV ligands, nor to internalize their isoalloxazine rings 
(Chapter 5, section 2).  
We next mixed SpnFADS simultaneously with ANP and FLV ligands, observing 
fluorescence changes that were considerably faster and more intense that those related 
to photobleaching. The number of processes identified in these kinetic traces depends 
on the nature of the ANP ligand in the mixture (Fig. 7.2A). All mixtures show a 
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fluorescence decay within the 5 s after mixing (Fig. 7.2A-D), but mixtures containing 
ATP also show a subsequent rising of the flavin fluorescence up to the initial values. In 
a previous study with the RFK module of the CaFADS enzyme, we suggested that the 
initial fluorescence decay was related to flavin binding and internalization within the 
protein previously bound to the ANP ligand (Chapter 5, section 2). Noticeably, it is 
apparent that under the assayed conditions the amplitude of the fluorescence kinetic 
decay is considerably larger when mixing SpnFADS with the substrates of the RFK 
reaction, RF and ATP, than with any other FLV-ANP combination (Fig. 7.2A). These 
data indicate a greater fraction of protein prone to bind the RF and ATP substrates. The 
fitting of the fluorescent decay traces to a single exponential equation (Eqn. 2.9) yields 
kobs1 values (Fig. 7.3A) that, in general, follow a linear dependence on the FLV 
concentration for mixtures containing RF-ATP or FMN-ADP. However, when mixing 
SpnFADS with RF-ADP kobs1 values exhibit an upward curvature, indicating that as the 
RF concentration increases the SpnFADS:ADP binary complex internalizes it faster. As 
a consequence, at low RF concentrations its binding to SpnFADS is faster when induced 
by the ATP substrate than by the ADP product, while as RF concentration increases this 
behavior is inverted. The fitting of the kobs1 values to Eqn 2.11 allows calculating the 
corresponding flavin association rate constants, kon, and the dissociation rate constants, 
koff, whose values are summarized in Table 7.2 together with the kinetic dissociation 
constants derived from them. The binding of the RFK substrates, RF and ATP, is in 
general the faster process, and only at high RF concentrations RF and ADP binding is 
slightly faster. This observed effect of RF concentration on its internalization rate in the 
presence of ADP, might be due to the two different paths that lead to the formation of 
the non-productive SpnFADS:RF:ADP ternary complex (Fig. 7.4B). Thus, no matter 
which ligand binds the protein firstly, the binding of the second one induces the 
conformational change that encloses the RF within the active site. As our inhibitory 
study in the steady state revealed, ADP act as a mixed inhibitor, being able to bind both 
the free protein and the preformed SpnFADS:RF binary complex (being these processes 
characterized by the inhibition constants Ki
ADP and K´i
ADP, respectively). Since K´i
ADP> 
Ki
ADP, at low RF concentrations ADP might bind the protein first and then RF would do 
it. Higher RF concentrations increase the amount of the SpnFADS:RF binary complex, 
and under these conditions, ADP might be in fact the second ligand binding the protein. 
The two different slopes observed when plotting kobs1 on RF concentration might be 
related with variations in the RF internalization rates, which depend on the order in 
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which the ligands get bound. Thus, RF binding to SpnFADS:ADP (and its 
internalization), which predominates at low concentrations of this flavin (kon1  102 ± 6 
min-1) , is slower than ADP binding to SpnFADS:RF (k´on1  297 ± 9), which is favored 
at high RF concentrations. In contrast, the FMN binding to SpnFADS in the presence of 
ATP is a very slow process. Considering also the small amplitude of the fluorescence 
change in this process, this combination of ligands is the least favored (from the kinetic 
point of view) for flavin enclosure within the RFK module of SpnFADS.  
Table 7.2. Pre-steady-state kinetic parameters for the binding and dissociation of flavins to 
SpnFADS in the presence of the adenine nucleotides. Experiments were carried out in 20 











FMN-ATP a a   
RF-ADP 102 ± 6 b 84 ± 11 b 0.83 ± 0.12 -8.3 ± 1.4 
RF-ATP 128 ± 14 73 ± 16 0.57 ± 0.14 -8.5 ± 2.0 
FMN-ADP 85 ± 7 65 ± 20 0.80 ± 0.24 -8.3 ± 2.5 
a The kobs1 values close to 0 prevented the determination of kon and koff values. 
b Values obtained when [RF]≤ 3 μM. When [RF] ≥ 3 μM, kon  297 ± 9, koff could not been determined.  
Kinetic traces obtained when mixing SpnFADS with FLV-ATP mixtures show a 
subsequent exponential rising of fluorescence (Fig. 7.2A green and black lines, 7.2C 
and 2D). This process has been previously related with an “ATP-induced” 
conformational change in the isoalloxazine environment that increases its solvent 
accessibility (Chapter 5, section 2). The fitting of the kinetic traces to an exponential 
equation provides with kobs2 values (Fig. 7.3B) that show a linear dependency on RF 
concentration. On the contrary, kobs2 values for processes with FMN and ATP are 
considerably slower and even exhibit a biphasic behavior on FMN concentration. This 
indicates that the conformational rearrangement is considerably faster when the RF 
substrate is the flavin initially bound to the active site (Fig. 7.3B). Comparison of kobs1 
and kobs2 values indicates that the binding and internalization of the reaction substrates is 
at least 4 times faster than the subsequent conformational change that might lead to 
flavin release. 
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Figure 7.2. Pre-steady state stopped-flow kinetics for the binding of flavins to SpnFADS in 
the presence of adenine nucleotides. (A) Kinetic traces for the flavin fluorescence evolution 
upon mixing the protein (0.2 μM) with RF (1 μM) at saturating ATP (250 μM) or ADP (250 
μM), as well as with FMN (1 μM) at saturating ATP (250 μM) and ADP (250 μM). (B) 
Evolution of kinetic traces for FMN fluorescence when SpnFADS is mixed in the presence 
of 250 μM ADP with increasing FMN concentrations. Traces are fit to a mono-exponential 
decay with steady-state. Residual is shown at the bottom for fitting of the 2 μM FMN trace. 
(C) Dissection of the exponential processes for kinetic traces observed upon mixing the 
SpnFADS (0.2 μM) at saturating ATP (250 μM) with RF (1 μM). The panel shows the fit to 
a two exponential process. Fitting residual is shown at the bottom. (D) Evolution of kinetic 
traces when mixing SpnFADS (0.2 μM) at saturating ATP (250 μM) with increasing RF 
concentrations. All the experiments were carried out in the stopped-flow equipment at 25°C 
in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0. All concentrations indicated are final ones in the 
mixing cell. 
Finally, since kon and koff values obtained for processes involving RF and ATP, are in 
the range of the kcat for the RF phosphorylation (50 min
-1), both of the observed 
processes are relevant for catalysis. 
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Figure 7.3. Dependence of the pre-steady-state observed rates on the flavin ligand 
concentration. (A) Evolution of kobs1 for the mixing of SpnFADS with RF-ATP (black), RF-
ADP (red), FMN-ADP (blue) and FMN-ATP (green). For those data showing linear 
dependences slopes are related with the kon for the binding and the independent term with the 
koff. (B) Evolution of kobs2 values on the flavin concentration for mixtures of SpnFADS with 
(A) RF+ATP (black) and with (B) FMN+ATP (green). kobs2 exhibits a linear dependence on 
the RF concentration, while in the case of FMN shows a biphasic behavior with a maximum 
at 0.25 μM. Experimental conditions as in Fig. 7.1. 
3. Thermodynamics of the interactions of SpnFADS with its 
ligands 
Then we performed ITC experiments to determine whether the processes identified 
in our pre-steady state kinetic study were relevant to reach the thermodynamic 
equilibrium. We titrated with the substrates and the products of the RFK reaction, both 
free SpnFADS and its binary mixtures with either ANP or FLV ligands. These 
experiments provided us with the dissociation constant (Kd), the protein fraction 
available to bind the ligand (N), as well as with Gibbs free energy (ΔG), enthalpy (ΔH) 
and entropy (-T ΔS), for each interaction (Table 7.3, Figs. 7.4 and 7.5). The titrations 
were performed both in the presence of 0.8 mM MgCl2, Mg
2+ concentration at which 
the RFK activity of SpnFADS shows its maximum activity (Fig. 6.4), and in the 
absence of the divalent cation, to avoid catalysis in those titrations that involve both 
reaction substrates (the reaction heat would mask the binding enthalpy). Fig. 7.4 
illustrates all the possible interactions pathways of SpnFADS with substrates and 
products of the RFK reaction, as well as the protein fraction prone to interact with a 
specific ligand (N) as the thickness of the arrows.  
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Figure 7.4. Free Gibbs energy diagrams for the interaction of SpnFADS with its ligands. 
Diagrams resuming the thermodynamic flow representing the interaction of the RFK module 
and the different combinations of its ligands as obtained by ITC at 20 ºC in (A) in 20 mM 
PIPES, pH 7.0 and (B) in 20 mM PIPES, 0.8 mM MgCl2, pH 7.0. SpnFADS is shown as 
violet spheres, RF and FMN as yellow and orange hexagons respectively and ATP and ADP 
as blue and green triangles respectively. Numbers indicate the ΔG value in Kcal/mol for each 
titration. Thickness of the arrows is proportional to the fraction of protein able to bind the 
ligand in each case, and the length of the lines is related to the ΔG value associated to each 
process. Dashed lines indicate processes not observed directly by ITC but whose values are 
indirectly estimated once known the cooperativity coefficients. Orange lines indicate the 
paths leading to the simultaneous binding of both substrates of the RFK activity in the 
absence of Mg2+. NM accounts for processes where the heat exchanged in the catalytic 
reaction masks the interaction heat. 
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Table 7.3. Thermodynamic interaction parameters for the combination of SpnFADS with 
different ligands as obtained through ITC. Column named initial mixture indicates the 
starting composition of the calorimetric cell. Titrations were carried out at 20ºC in 20 mM 
PIPES, pH 7.0 (upper table) and in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2 (lower table). 
Errors in ΔG, ΔH and –TΔS were estimated in ± 0.3 kcal/mol, taken in general larger than 
the standard deviation between three replicates and the numerical error after fitting analysis. 
0.0 mM MgCl2 









SpnFADS ATP 1.7  -7.9 -19.1 11.2 
SpnFADS ADP 4.1 -7.3 -12.9 5.5 
SpnFADS RF n.d.a n.d.a n.d.a n.d.a 
SpnFADS FMN n.d.a n.d.a n.d.a n.d.a 
SpnFADS:RF ADP 4.6 -7.3 -4.8 -2.5 
SpnFADS:RF           ATP 
(1) 0.32 -8.9 -17.6 8.8 
(2) 2.0 -7.8 -9.3 1.5 
SpnFADS:FMN ADP 27.7 -6.2 -25.6 19.4 
SpnFADS:FMN ATP 1.2 -8.1 -15.6 7.5 
SpnFADS:ATP FMN n.d.a n.d.a n.d.a n.d.a 
SpnFADS:ATP RF 2.5 -7.6 -1.9 -5.7 
SpnFADS:ADP FMN 7.9 -7.0 -21.9 14.9 
SpnFADS:ADP RF 0.3 -9.0 -17.2 8.2 
0.8 mM MgCl2 









SpnFADS ATP 8.1 -6.9 -11.8 4.9 
SpnFADS ADP 14.2 -6.6 -7.0 0.4 
SpnFADS RF n.d.a n.d.a n.d.a n.d.a 
SpnFADS FMN n.d.a n.d.a n.d.a n.d.a 
SpnFADS:RF ATP b n.m. n.m.   
SpnFADS:RF ADP 1.7 -7.9 -17.1 9.2 
SpnFADS:FMN ADP 0.24 -9.0 -7.8 -1.2 
SpnFADS:FMN ATP 0.23 -9.1 -17.1 8.1 
SpnFADS:ATP FMN 1.6 -7.9 -6.0 -1.9 
SpnFADS:ATP RF b n.m. n.m.   
SpnFADS:ADP FMN 2.3 -7.7 -8.1 0.4 
SpnFADS:ADP RF 1.6 -7.9 -6.9 -1.0 
a n.d. Not detected. Not heat of interaction was detected for this titration. b n.m. Not measured. This combination of 
ligands in the presence of Mg2+ leads to the catalytic reaction, preventing determination of binding heats 
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Figure 7.5. Thermodynamic dissection of the interaction of different ligands with either free 
SpnFADS, or with preformed mixtures of the protein with different ligands (indicated as 
FADS:X). Measurements were performed in 20 mM PIPES, pH 7.0 (A and B) and in 20 mM 
PIPES, 0.8 mM MgCl2, pH 7.0 (C and D). The binding Gibbs energy (ΔG), enthalpy (ΔH), 
and entropy (-TΔS) contributions to the binding are represented in blue, green and red bars, 
respectively. 
Several aspects are highlighted when evaluating these results. First, paths in the 
presence and in the absence of MgCl2 considerably differ. The divalent cation alters 
both the stability of the complexes and the protein fraction binding a specific ligand. 
Mg2+ makes highly more favorable the formation of all ternary complexes but the 
SpnFADS:RF:ADP one, and considerably destabilizes SpnFADS:ANP binary 
complexes. Stabilization of ternary complexes by Mg2+ is mainly a consequence of the 
less unfavorable, or even favorable, entropic contributions to the binding (Fig. 7.5, 
Table 7.3). The cation also increases the amount of protein prone to interact and, 
consequently, the probability of a particular path to occur. All these data suggest 
different conformations in binary and ternary complexes with and without MgCl2. As 
shown in chapter 6, binding of FLV ligands to the free protein is not directly observed 
either with or without Mg2+. Nevertheless, the presence of the FLV ligands considerably 
modifies the affinity of the protein for the ANP ligands when Mg2+ is in the reaction 
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medium, and only slightly alters it in the absence of the cation (compare in Fig. 7.4B, 
the ΔG values for the titration of the free protein with ANP ligands with those for 
SpnFADS:FLV complexes). In that way, ΔG values for FLV binding to SpnFADS can 
be indirectly estimated [183, 187]. These results suggest that FLV ligands bind the 
protein either without an appreciable enthalpy change or too slowly (and in that case 
flavins act as slow binding ligands) to detect their binding within the experimental time 
[215]. 
4. FLV and ANP ligands show cooperative effects in their 
binding to SpnFADS 
The presence of FLV ligands modifies the binding of ANP ones to SpnFADS, and 
vice versa (compare titrations with a particular ligand, of the free protein and of binary 
complexes, Fig. 7.4 and Table 7.3). Two facts are especially remarkable regarding these 
observations; ANP ligands facilitate the FLV binding to SpnFADS (no FLV binding is 
detected in the absence of ANP), and RF induces ATP binding to a second site (upper 
part of Table 7.3). To further analyze these cooperative effects, we fit the thermograms 
for titrations of SpnFADS:FLV mixtures with ANP to a home-derived model (Fig 7.6) 
[187], that considers the reciprocal effect between ANP and FLV ligands. This allows 
us to calculate cooperativity coefficients (α), the protein fraction able to bind the 
titrating ligand (N), and the enthalpy change associated to each process (Δh) (Table 
7.4). This model also allows inferring association constants for the FLV binding to 
SpnFADS (Ka
FMN and Ka
RF), and subsequently the ΔG values for the formation of the 
SpnFADS:FLV binary complexes that could not be directly determined (dashed lines in 
Fig. 7.4).  
As α values show (Table 7.4), cooperativity between ligands highly depends on the 
presence of Mg2+. In its absence, the affinity of SpnFADS for the ANP ligands is, in 
general, only slightly affected by the RF or FMN presence. In this way, FMN barely 
favors ATP binding to the enzyme, as the α value hardly higher than 1 indicates (upper 
part of Table 7.4). In addition, both FLV ligands only slightly hinder ADP binding (α < 
1), having FMN a more negative impact. This agrees with ANP nucleotides binding 
preferably to the FMNAT active site in the absence of the cation (as discussed in 
Chapter 6, section 4).  
Special attention requires the cooperative binding of the substrates of the reaction. 
RF induces the formation of a second binding site for ATP, even in the absence of 
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MgCl2, but it does not alter the ATP binding to the site existing in the absence of the 
flavin (compare in Table 7.3 the titrations with ATP in the presence and in the absence 
of RF). 
 
Figure 7.6. Calorimetric titrations with ADP of free SpnFADS, and of binary SpnFADS-
FLV mixtures. (A, D) Titrations of the free protein with ADP. (B, E) titrations of SpnFADS-
RF mixtures with ADP, (C, F) titrations of SpnFADS-FMN mixtures with ADP. 
Experiments were performed at 20ºC, in 20 mM PIPES, pH 7.0, without Mg2+ (A, B and C), 
and in the presence of 0.8 mM MgCl2 (D, E and F). The concentration of SpnFADS was 25 
μM in all the experiments, being the ADP concentration 300 μM (A, B and C) or 250 μM 
(D, E and F). In titrations of the preformed mixtures of SpnFADS with flavin ligands, these 
were included at saturating concentrations (200 μM RF or 250 μM FMN) with the protein in 
the sample cell. Data were fit to a home-derived model for a single binding site. Within each 
panel, upper charts show thermograms for the different interactions and the lower panels the 
corresponding binding isotherms with integrated heats.  
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Table 7.4. Cooperativity coefficients (α) for the binding of the different combinations of 
FLV and ANP ligands to SpnFADS. Experiments were carried out at 20°C in 20 mM PIPES, 
0.8 mM MgCl2, pH 7.0, or in 20 mM PIPES, pH 7.0. α is the cooperativity coefficient 
between each pair of ligands, n the fraction of total protein able to bind the titrating ligand 
and h the enthalpy change associated to each process. Errors were taken in general larger 
than the standard deviation between replicates and the numerical error after fitting analysis. 
 
 
Ligands α n 
Δh 
(kcal/mol) 
0 mM MgCl2 
FMN-ADP 0.35 ± 0.06 0.40 ± 0.03 -58 ± 3 
FMN-ATP 1.3 ± 0.2 1.1 ± 0.1 -0.2 ± 0.05 
RF-ADP 0.7 ± 0.1 0.9 ± 0.1 2.1 ± 0.1 
RF-ATPa    
0.8 mM MgCl2 
FMN-ADP 24 ± 4 0.70 ± 0.01 -3.9 ± 0.4 
FMN-ATP 34 ± 4 1.0 ± 0.1 -2.4 ± 0.2 
RF-ADP 5.2 ± 0.8 0.40 ± 0.01 -15 ± 1 
a Not aplicable 
5. Discussion 
Regardless of overall structural similarities between SpnFADS and CaFADS, they 
differ in the conformation of structural elements located at the RFK module, such as the 
PTAN motif and the loops L2c, L3c and L4c (Fig. 7.7), and in the lack of RF substrate 
inhibition at the RFK activity of SpnFADS. Moreover, contrary to CaFADS, SpnFADS 
requires reduced flavins for their binding and transformation in its FMNAT site. Taking 
advantage of this last observation, we are here able to characterize the mechanism of the 
RFK activity in SpnFADS, by kinetically and thermodynamically analyzing the binding 
of its ligands (substrates and products), as well as their potential as modulators of the 
activity. In addition, similar data available for the RFK module of CaFADS are used to 
explain different behaviors along the RFK activity of these two bacterial FADSs. 
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Figure 7.7. Structural alignment of the C-terminal modules of CaFADS (PDB 2x0k) and 
SpnFADS (PDB 3op1). (A) Superposition of the overall structures of the RFK modules of 
SpnFADS (blue) and CaFADS (orange). (B) Zoom into the PTAN consensus motif residues 
and the E255 putative catalytic base of SpnFADS (shown in CPK code, with carbons in light 
blue), corresponding residues in CaFADS are also shown (CPK code, with carbons in red). 
(C) Comparison of the conformation of the PTAN motif in SpnFADS (CPK code, with 
carbons in light blue) and in the Δ(1-182)CaFADS:FMN:ADP-Mg2+ ternary complex (PDB 
entry 5a89, CPK code, with carbons in red).  
Mg2+ plays a key role in the binding of adenine and flavin nucleotides to SpnFADS  
Our ITC thermodynamic parameters reveal that Mg2+ is key in the formation of 
SpnFADS:ANP:FLV ternary complexes (Figs. 7.4 and 7.6, Table 3). The cation 
increases the protein fraction prone to interact with a determined ligand, and favors the 
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formation of ternary complexes from the binary ones (compare Fig. 7.4A and 7.4B). 
This last point is related to the cooperativity enhancement between ANP and FLV 
ligands in the presence MgCl2 (compare α values on upper and lower Table 7.4). Figure 
7.8 shows the products of the RFK activity modeled [99] on RFK active site of 
SpnFADS. Contrary to that reported for CaFADS, allocation of these ligands does not 
require major reorganizations in the free RFK active site (Fig. 7.8). Interestingly, our 
data show that Mg2+ has a negative impact in the stabilization of the binary complexes 
of the protein with ANP ligands, and especially with ATP (Fig. 7.4, Table 7.3). This 
fact appears a priory counterproductive for catalysis. However, it might have the 
opposite effect when considering the formation of the catalytically competent 
SpnFADS:RF:ATP-Mg2+ ternary complex. In this way, destabilization of the 
SpnFADS:ATP-Mg2+ complex increases the Gibbs free energy difference between the 
binary and the ternary complexes, making thermodynamically more favorable the 
formation of the last one.  
 
Figure 7.8. Detail of a structural model for the PTAN motif of SpnFADS in complex with 
FMN and ADP. The substrates of the RFK reaction are allocated as in the crystal structure of 
the Δ(1-182)CaFADS:FMN:ADP-Mg2+ ternary complex. The residues are highlighted in 
sticks and colored in CPK code, with the carbons in light blue. FMN and ADP ligands are 
shown in lines colored in CPK code, with the carbons in purple and green, respectively. The 
Mg2+ cation is shown as a green sphere. 
Considering now the Mg2+ effect on binding of FLV ligands to the free SpnFADS, 
the following conclusion can be extracted. Although we are not able to directly observe 
it, neither by stooped-flow nor by ITC, both RF and FMN are able to someway bind to 
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SpnFADS in the presence of the cation. This fact is evident through comparison of the 
ΔG values obtained when titrating with ANP ligands the free protein, and the binary 
SpnFADS-FLV mixtures. The large differences in ΔG (from -1.3 to -2.4 kcal/mol) can 
only be due to a cooperative effect of the FLV ligand previously interacting with the 
protein, specifically with the RFK module. These titrations also allow us to indirectly 
calculate, in addition to ΔG values (Fig. 7.4B), the ΔH for RF and FMN binding (-5.7 
and -3.5 kcal/mol, respectively). This stabilizing effect of MgCl2 was also reported for 
the ternary complexes of the CaFADS RFK module with its flavin and adenine 
nucleotide ligands (Chapter 5). 
 
The RFK catalytic cycle of SpnFADS  
Taken together our kinetic and thermodynamic data allow shedding light on some 
aspects of the RFK catalytic cycle of SpnFADS, identifying similarities with the 
CaFADS corresponding cycle, and highlighting differences. Stopped-flow experiments 
reveal that the presence of ANP is a requirement for FLV ligands binding and/or 
internalization (no FLV binding is observed in the absence of ANP). Thus, the initial 
abrupt decrease in fluorescence, observed upon mixing FADS with mixtures of ANP 
and FLV ligands is related to this process. In CaFADS this fluorescence decrease was 
identified as the flavin internalization produced by the conformational change of L4c 
subsequent to the binding of FMN and ADP (Chapter 5). In the case of SpnFADS, we 
can reach the same conclusion. Nonetheless, the relative rate at which the different 
ANP-FLV mixtures bind the FADSs differs between both proteins. Binding of 
substrates of the RFK reaction (ATP:RF) is the fastest process for SpnFADS, but the 
slowest one for CaFADS (Table 7.2). This fact, together with the high difference in the 
values of Ki
ADP for both proteins (approximately 10 times higher for CaFADS), and in 
the Ki
 FMN/Km
RF ratio (1 and 0.2, for SpnFADS and CaFADS, respectively) might 
explain the larger inhibition by the products of the reaction observed for CaFADS than 
for SpnFADS. Another important difference between both proteins appears when 
comparing kobs2 values (Figs. 7.3 and 5.5), which have been identified as an ATP-
induced conformational change in both FADSs. During the RFK reaction of CaFADS 
such conformational change results inhibited by increasing RF concentrations, while 
such inhibition is not detected for SpnFADS. That might be a determinant factor in the 
inhibition by the RF substrate that CaFADS shows, and SpnFADS does not.  
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Considering all these data, we can conclude that although the steps occurring during 
the RFK reaction of CaFADS and SpnFADS are the same, their rates differ. The final 
consequence of these differential behaviors is inhibition by products being less relevant 
at the kinetic level (both by RF and by the products of the reaction) in SpnFADS.  
 
Differences in the inhibition of the SpnFADS and CaFADS RFK activities can be 
thermodynamically explained 
The thermodynamic data of the interaction of both proteins with all the substrates 
and the products of the RFK reaction also expose important differences. Similar ΔG 
diagrams can be established upon titration of the proteins with the substrates and the 
products of the reaction (Figs. 7.4 and 5.8), but important differences can be detected. 
The first noteworthy fact is that in Fig 7.4 two different paths lead to the 
“pseudoreactive” SpnFADS:RF:ATP ternary complex, while in CaFADS this complex 
only can be reached through a single path. Apparently, RF cannot bind to the preformed 
CaFADS:ATP complex, but it is able to bind to SpnFADS:ATP. This suggests that 
during the RFK catalytic cycles of both enzymes, the substrates get bound in different 
order. As described in chapter 5, the CaFADS:RF:ATP catalytically competent complex 
is achieved through the concerted fit of the substrates, while SpnFADS seems to follow 
a random sequential binding of its substrates. Structurally, this important difference 
might be related to the simpler conformational changes postulated for SpnFADS to 
reach the ternary competent complex. Thus, Fig 7.7 shows the relative position of the 
PTAN motif in SpnFADS and CaFADS (Fig. 7.7B), and in SpnFADS and 
CaFADS:FMN:ADP (Fig. 7.7C). Remarkably, the position of this motif in SpnFADS 
resembles that of the CaFADS ternary complex with the products of the RFK reaction. 
So, the conformational change of the PTAN motif, which is crucial for the RFK cycle 
of CaFADS, is not necessary for SpnFADS, and this might allow some flexibility in the 
allocation order of the substrates in the active site of the latter enzyme. 
Another important difference is the absence of specially stable SpnFADS:FLV:ANP 
complexes. CaFADS establishes a highly stable ternary complex with FMN and ATP 
(Fig. 5.8), whose kinetic relevance was also discussed in chapter 5. Additionally to this 
complex, all the non-productive CaFADS:FLV:ANP ternary complexes are more 
favored than the only CaFADS:RF:ATP competent one. This situation is completely 
distinct in SpnFADS (Fig. 7.4), where the ternary complexes with RF and ATP are, 
together with SpnFADS:RF:ADP, the most stable ones. These dissimilar diagrams 
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involve important differences in the tendency of both enzymes to bind substrates or 
products, when the reaction draws on and the products start to accumulate. In that way, 
although FMN and ADP accumulate in the reaction media, SpnFADS would preferably 
bind the substrates of the reaction, and no inhibition would be detected, at least until 
reaching a high products/substrates ratio. CaFADS shows the opposite behavior, and 
inhibition by products is quickly detected as soon as products accumulate.  
Finally, SpnFADS and CaFADS also exhibit dissimilarities in the cooperative 
binding of the substrates of the RFK reaction. Thus, as explained in chapter 5, RF and 
ATP show positive cooperativity during their binding to CaFADS at low concentration 
of the flavin ligand, while high RF concentrations hinder ATP binding. This effect is 
not observed for SpnFADS, where RF and ATP have positive cooperativity at high RF 
concentration. This differential fact might explain the inhibition by the RF substrate that 
CaFADS shows but not SpnFADS. Structurally, this effect might be also related with 
the conformation of the PTAN motif in both enzymes. In CaFADS the occupation of 
the ANP binding site by a RF molecule might somehow prevent the ANP-Mg2+-induced 
conformational change of the PTAN motif, and consequently the ATP binding. 
Nevertheless, the huge conformational change of the PTAN motif does not appear 
necessary for the ATP binding to SpnFADS, and therefore it might not be hindered by 
the RF excess.  
 
Different organisms use distinct strategies to regulate flavin synthesis 
FMN and FAD are involved in a huge amount of essential metabolic processes, 
acting as cofactors of flavoproteins and flavoenzymes [32, 33, 152]. Most bacteria are 
able to synthesize RF [220, 228], as well as to assimilate it from the extracellular media 
[58, 60, 220, 221]. Therefore, regulatory mechanisms to control RF transformation into 
FMN and FAD, when profusion of RF is produced, are required to maintain the flavin 
homeostasis. Having into account the data available for CaFADS and SpnFADS, 
apparently different organisms use assorted strategies to regulate their FADSs. As 
discussed in the previous chapter, the FMNAT activity of SpnFADS only takes place 
with reduced FMN, which might constitute a regulatory point of the FAD synthesis in S. 
pneumoniae. This regulatory point is not observed in CaFADS, whose FMNAT activity 
does not show any type of inhibition [90]. Consequently, and in agreement with our 
data, the RFK activity of CaFADS might require a more carefully regulation by excess 
of substrates and products than the RFK activity of SpnFADS.  
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Such differences among members of the FADSs family might provide with a 
framework to design selective compounds targeting these enzymes for the treatment of 
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The emergence during the last decades of bacterial strains resistant antibiotics 
reveals the need to find new effective antibacterial targets, as well as compounds able to 
inhibit them. We propose prokaryotic bifunctional FADSs as exploitable drug targets. 
These proteins appear as a good option for several facts; i) the inhibition of FADSs 
avoids FMN and FAD synthesis, which prevent from the very beginning all the 
pathways that implicate flavoproteins and flavoenzymes [153, 154], ii) prokaryotic 
FADSs differ structurally and biochemically from the mammalian proteins that 
transform FMN into FAD [81, 88, 155, 229], so drugs that target these proteins are 
likely to be selective for bacteria [89], and iii) the availability of crystallographic 
structures of several bacterial FADSs facilitates the design of inhibitory drugs and 
activity assays [74, 75, 86].  
In this chapter we present the results obtained for the activity-based HTS performed 
using the CaFADS, as well as the subsequent characterization of the selected hits, their 
specificity, and their effect on the cellular growth of different bacterial strains.  
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1. Identification of Potential Inhibitors of the CaFADS activities 
through HTS 
Among the 1240 compounds of the chemical library, 140 (13.5 %) produced CaFADS 
activity levels lower than the mean of the positive controls minus twice its standard deviation, 
and 37 (3.6 %) reduced the positive controls average rate for FAD formation in a factor 
higher than 0.5 (Fig. 8.1B). Those 37 compounds were selected as the primary HTS hits.  
 
Figure 8.1. Activity-based high-throughput screening for the discovery of HTS hits inhibiting the 
RFK and/or the FMNAT activities of CaFADS. (A) Example of the flavin fluorescence evolution 
over time for three of the identified hits (black) and for the controls of the assay (orange). Reaction 
mixtures were incubated at 25 °C and contained 5 µM RF, 50 µM ATP, 0.4 µM CaFADS, 10 mM 
MgCl2, in PIPES 20 mM, pH 7.0, 2.5 % DMSO, and when indicated (black symbols and lines) the 
corresponding compound of the library at 250 µM. (B) Initial velocities, determined as 
Δfluorescence/s, for the reactions in each of the wells of the HTS plates. Data from wells 
containing compounds of the chemical library are shown in black and those for controls in the 
absence of chemical library compounds are in orange. The solid line represents the average 
velocity obtained for the positive controls of the reaction and the dotted lines this average velocity 
minus and plus the standard deviation. The letters and numbers indicate the position of the well in 
the plate (row and a column respectively) for each specific selected measurement.  
2. Effect of the HTS hits on RFK and FMNAT activities of CaFADS 
As indicated before, the FMNAT module of CaFADS shares neither sequence nor 
structural homology with the corresponding mammal protein, while the RFK module belongs 
to the eukaryotic RFKs family. Therefore, we decided to continue the study with those HTS 
hits that inhibit the CaFADS FMNAT activity, since they are more likely to be specific for 
the bacterial proteins. With this aim, we assayed the effect of the HTS hits both on the 
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CaFADS RFK and FMNAT activities. Figure 8.2 and Table 8.1 summarize the results. 
Comparison of Fig. 8.2A and 8.2B shows that, in general and under the assayed conditions, 
HTS hits produced a stronger deleterious effect on the FMNAT activity (all decrease the 
activity of the controls in more than 50%) than on the RFK one. We choose to continue the 
study the HTS hits that decreased the FMNAT activity below 5 % of that of the controls, but 
maintained over 75% the RFK activity (Fig. 8.2, Table 8.1). Thus, among the 37 HTS hits, 9 
compounds (C2, C11, C15, C17, C19, C24, C27, C31 and C43) were selected as FMNAT hits 
(Fig. 8.3).  
 Figure 8.2. Effect of the HTS hits on the RFK and FMNAT activities of CaFADS. Residual (A) RFK 
activity and (B) FMNAT activity when assayed in the presence of 250 μM of the 37 HTS hits. In panel 
A, data below the dashed line show statistical significant inhibition (p<0.002, 67% remaining activity) 
for samples containing compounds regarding the control CaFADS RFK activity. In panel B, all hits 
produce statistical significant inhibition (p<0.0001, dashed line) when compared with the CaFADS 
FMNAT activity of controls in their absence. Solid lines indicate 75% and 5% of the control RFK and 
FMNAT activities, respectively. Those HTS hits displaying <5% of the control FMNAT activity and 
>75% of the control RFK one were selected to continue the study. Experiments were carried out in 20 
mM PIPES, pH 7.0, 2.5 % DMSO at 25 ºC, with 7.5 μM RF, 350 μM ATP, 0.8 mM MgCl2 (for the 
RFK activity) or 15 μM FMN, 350 μM ATP, 10 mM MgCl2 (for the FMNAT activity) (n=3; mean ± 
SD).  
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Table 8.1. RFK and FMN residual activities of CaFADS in the presence of HTS hits. Values 
measured at 25 ºC, in 20 mM PIPES, pH 7.0, 2.5 % DMSO, and 0.8 or 10 mM MgCl2 when 
assaying the RFK or the FMNAT activities, respectively. The final concentration of each HTS 
compound was 250 μM and saturating concentrations of all the substrates were used. The 
compounds highlighted in black, which completely inhibited the FMNAT activity with minor 
effects on the RFK one, were selected as FMNAT hits to continue the study.  
  % residual RFK activity 
 



























C2, C11, C15, C17, C19, 
C24, C27, C31, C43 
5-50 C35 C38 
C22, 
C32 
C1, C3, C4, C5, C6, C7, 
C8, C10, C12, C13, C16, C18 
C25, C28, C39, C40, C44, 
C46 
≥50 -- -- -- -- 
 
Table 8.2. Effect on the FMNAT activity of CaFADS of the FMNAT hits. All the experiments 
were carried out at 25 ºC, in 20 mM PIPES, pH 7.0, 10 mM MgCl2 at saturating concentrations of 
FMN and ATP. All samples contained 2.5% DMSO (n=3, mean ± SD).  
FMNAT hit Residual activitya (%) IC50b (μM) 
C2 41.1 ± 5.2 8.9 ± 1.0 
C11 34.6 ± 4.9  9.0 ± 1.3  
C15 45.3 ± 4.2 40.7 ± 3.9 
C17 33.5 ± 10.1  12.8 ± 3.4 
C19 43.3 ± 3.9 20.8 ± 2.6 
C24 3.6 ± 0.2 0.4 ± 0.1 
C27 6.9 ±0.8 0.5 ± 0.1 
C31 24.5 ± 1.9 6.6 ± 0.6 
C43c 20.3 ± 5.2 1.0 ± 0.5 
a Remaining activity in the presence of 50 μM of each compound. All data show statistical significance differences when 
compared with activity in the absence of compound (***, p<0.0001). 
b Compounds assayed in the 0-100 μM concentration range. 
c This compound shows very low water solubility, so it was discarded to continue the study even though its good properties. 
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To rate the power of these 9 FMNAT hits as inhibitors of the CaFADS FMNAT 
activity, their IC50 values and the remaining activity at 50 μM of each compound, were 
determined (Fig. 8.4, Table 8.2). The 9 compounds yielded IC50 values in the micromolar 
range, reducing by over the half the activity of the controls. Considering both their IC50 value 
and residual activity, the more potent inhibitors were C24 (Chicago sky blue, IC50 = 0.4 ± 0.1 
μM), C27 (Gossypol IC50 = 0.5 ± 0.1 μM) and C31 (Flunixin meglumine IC50 =6.6 ± 0.6 μM), 
the three of them producing residual activities below 25% of the controls ones. Compound 
C43 (oxaprozine) also showed high inhibitory potency, but due to its low solubility in the 
working buffer, it was discarded and only the effect of the three previous inhibitors was 
further characterized.  
 
Figure 8.3. Chemical structures of compounds selected as FMNAT hits for CaFADS. 
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Figure 8.4. Dose-response curves for the FMNAT activity of CaFADS in the presence of 
representative hits. IC50 values derived from these representations are included in Table 8.2. 
Experiments were performed at 25 ºC in 20 mM PIPES, pH 7.0, 10 mM MgCl2, 2.5 % DMSO, 
with 15 μM FMN and 350 μM ATP (n=3, mean ± SD).  
3. The Inhibition Mechanisms of C24, C27 and C31 
To determine the inhibition mechanism of C24, C27 and C31, we measured the CaFADS 
FMNAT activity in the presence of increasing concentrations of each of them, at i) saturating 
ATP concentration and a range of RF concentrations, and at ii) saturating RF concentration 
and increasing concentrations of ATP. Fitting of the experimental data to the Michaelis 
Menten equation (Figs. 8.5, 8.6, and 8.7, Table 8.3) allowed identifying the inhibitory 
mechanism of each hit. Additionally, through global fitting of Lineawever-Burk plots to a 
model that describes the corresponding inhibition mechanism, we obtained the inhibition 
constant/s (Ki or, Ki and Ki’) for each compound (Table 8.4). 
C24 inhibits CaFADS in a non-competitive manner regarding the FMN (ATP 
saturating). Non-competitive inhibitors do not compete with the substrate of the reaction, 
since they bind to the enzyme at a position different from the substrate binding site. 
Therefore, kcat decreases while Km keeps constant because the inhibitor does not affect the 
affinity of the enzyme for the substrate (Fig. 8.5A and Table 8.3). Lineawever-Burk plots 
intercept on the negative part of the x-axis, which is also characteristic for non-competitive 
inhibitors, providing a Ki of 0.07 ± 0.01 μM (Table 8.4). On the other hand, regarding the 
ATP substrate (FMN saturating), C24 behaves as an uncompetitive inhibitor, which does not 
bind to the free enzyme but to a preformed enzyme-substrate complex resulting in a non-
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catalytically competent complex. Through the law of mass action, this complex reduces the 
amount of free enzyme available to perform the reaction; therefore, both kcat and Km values are 
affected, and Lineawever-Burk plots run in parallel (Figs. 8.5C, 8.5D and Table 8.3). In this 
case, the Ki value for C24 was 0.08 ± 0.03 μM (Table 8.4).  
 
Figure 8.5. Hit C24 as inhibitor of the FMNAT activity of CaFADS. Michaelis-Menten plots at 
different concentrations of C24 under obtained at saturation (A) of ATP and (B) of FMN. 
Lineaweaver-Burk representations with global fit to the equation for (C) non-competitive inhibition 
at saturating ATP and (D) for competitive inhibition at saturating FMN. Reaction rates were 
obtained in 20 mM PIPES, pH 7.0, 10 mM MgCl2, 2.5 % DMSO, at 25 ºC, with 15 μM FMN and 
10-450 μM ATP (FMN saturating) or with 350 μM ATP and 0.5-20 μM FMN (ATP saturating) 
(n=3, mean ± SD). 
C27 also behaves as a non-competitive inhibitor regarding the FMN substrate. kcat 
decreases and Km does not significantly change, while Lineawever-Burk plots intercept on the 
negative part of the x-axis (Figs. 8.6A, 8.6B and Table 8.3). Regarding the ATP, C27 behaves 
as a competitive inhibitor (Lineawever-Burk plots intercept on the y-axis) (Fig. 8.6D), 
competing with this substrate for the active site of the CaFADS FMNAT module. C27 
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reduces the affinity of the enzyme for ATP (Km increases) while kcat does not significantly 
change (Fig. 8.6C and Table 8.3). Ki values for C27, when acting as a FMN non-competitive 
and as an ATP competitive inhibitor, are 0.08 ± 0.01 μM and 0.06 ± 0.01 μM respectively 
(Table 8.4).  
 
Figure 8.6. Hit C27 as inhibitor of the FMNAT activity of CaFADS. Michaelis-Menten plots 
obtained at different concentrations of C27 under saturation (A) of ATP and (B) of FMN. 
Lineaweaver-Burk representations with global fit to the equation for (C) non-competitive inhibition 
at saturating ATP and (D) for competitive inhibition at saturating FMN. Reaction rates were 
obtained in 20 mM PIPES, pH 7.0, 10 mM MgCl2, at 25 ºC, with 15 μM FMN and 10-450 μM 
ATP (FMN saturating) or with 350 μM ATP and 0.5-20 μM FMN (ATP saturating). All the 
samples contained 2.5% DMSO (n=3, mean ± SD). 
C31 follows a similar inhibitory mechanism than C24 and C27 under ATP saturating 
conditions, being its Ki 0.09 ± 0.03 μM (Figs. 8.7A and 8.7B, Tables 8.3 and 8.4). 
Nevertheless, regarding the ATP substrate (FMN saturating), the inhibitory mechanism of 
C31 becomes more intricate. C31 acts as a mixed inhibitor. These inhibitors are able to bind 
both to the free enzyme and to an enzyme-substrate complex, reducing the kcat and increasing 
the Km (Fig. 8.7C and Table 8.3). Lineawever-Burk plots for mixed inhibition intercept at a 
negative value of the x-axis, but at the positive part of the y-axis and not on the x-axis (Fig. 
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8.7D). Although C31 is able to interact with CaFADS and with the complex CaFADS-ATP, it 
preferably binds to the free CaFADS as its lower Ki value 3.5 ± 1.0 μM shows, being its 
Ki’18.4 ± 4.0 μM (Table 8.4).  
 
Figure 8.7. Hit C31 as inhibitor of the FMNAT activity of CaFADS. Michaelis-Menten plots at 
different concentrations of C31 under saturation (A) of ATP and (B) of FMN. Lineaweaver-Burk 
representations with global fit to the equation (C) for non-competitive inhibition at saturating ATP, 
and (D) for competitive inhibition at saturating FMN. Reaction rates were obtained in 20 mM 
PIPES, pH 7.0, 10 mM MgCl2, 2.5% DMSO, at 25 ºC, with 15 μM FMN and 10-450 μM ATP 
(FMN saturating) or with 350 μM ATP and 0.5-20 μM FMN (ATP saturating) (n=3, mean ± SD).  
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Table 8.3. Apparent kinetic parameters for the FMNAT activity of CaFADS at different 
concentrations of the C24, C27 and C31 inhibitors. Data obtained at 25ºC in 20 mM PIPES, pH 
7.0, 10 mM MgCl2, 2.5% DMSO.  













0 34 ± 3.8  16.3 ± 3.2 0 22.4 ± 0.7 29.4 ± 4.9 
0.12 24.3 ± 4.1 a 14.0 ± 3.9 0.04 22.5 ± 4.8 11.5 ± 0.7 a 
0.2 9.8 ± 1.3 a 10.6 ± 2.4 0.12 7.2 ± 0.4 a 42.1 ± 3.9 a 
0.4 5.6 ± 0.6 a 4.3 ± 1.0 a 0.2 4.3 ± 0.4 a 35.8 ± 3.2 
0.6 5.7 ± 1.3 a 11.1 ± 3.9 0.4 1.8 ± 0.1 a 12.0 ± 3.6 a 
 













0 34 ± 3.8 a 16.3 ± 3.2 0 22.4 ± 0.7 29.4 ± 4.9  
0.05 21.6 ± 2.9 a  10.1 ± 2.9 0.1 22.8 ± 1.3 59.7 ± 5.7 a 
0.1 16.1 ± 1.7 a 7.7 ± 2.1 0.2 22.2 ± 1.4 48.2 ± 5.6 a 
0.2 15.1 ± 1.5 a 13.5 ± 2.6 0.4 18.1 ± 1.6 51.8 ± 5.5 a 
0.75 10.0 ± 0.8 a 12.8 ± 2.1 0.75 17.1 ± 3.3  51.5 ± 4.9 a 
1 6.5 ± 0.2 a 15.0 ± 2.0 1 12.5 ± 0.5 a 40.9 ± 5.7 
 













0 34 ± 3.8 16.3 ± 3.2 0 22.4 ± 0.7 29.4 ± 4.9 
1 24.6 ± 2.9 a 13.3 ± 3.1 4 19.7 ± 1.0 a 43.3 ± 7.9 
4 18.1 ± 1.4 a 6.8 ± 1.3 5 17.3 ± 1.1 a 47.5 ± 5.7 a 
5 6.4 ± 1.2 a 24.4 ± 7.0 7 16.9 ± 0.6 a 79.1 ± 8.7 a 
7 3.0 ± 0.4 a 13.3 ± 3.6 10 15.3 ± 1.3 a 103 ± 24 a 
10 3.0 ± 0.4 a 12.3 ± 3.6 12 13.8 ± 1.0 a 92.1 ± 14.9 a 
a Values showing statistically significant differences, p < 0.002, from the values in the absence of compounds, as determined 
by the one-way ANOVA test (n=3, confidence interval 95%). 
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Table 8.4. Kinetic parameters for the FMNAT activity of CaFADS in the presence of the best FMNAT hits. Kinetic rates obtained at 25 ºC in 20 mM 
PIPES, pH 7.0, 10 mM MgCl2, and in the presence of 2.5% DMSO. The kinetic parameters were calculated by globally fitting the experimental data to the 
corresponding Lineweawer-Burk inhibition model.  
























C24 75.5 ± 17.5 18.3 ± 4.0 0.07 ± 0.01 Non-competitive 13.4 ± 4.2 32.1 ± 9.8 0.08 ± 0.03 - Uncompetitive 
C27 87.1 ± 30.0 16.7 ± 6.2 0.08 ± 0.01 Non-competitive 21.8 ± 1.2 16.7 ± 6.2 0.06 ±0.01 - Competitive 
C31 29.8 ± 1.2  15.7 ± 5.2 0.09 ± 0.03 Non-competitive 21.0 ± 2.6 28.0 ± 9.0 3.5 ± 1.0 18.4 ± 4.0 Mixed 
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4. ITC constants for the CaFADS interaction with C24, C27 and 
C31 
The interaction of CaFADS with C24, C27 and C31 was characterized using 
ITC. All the three compounds were able to bind the enzyme at, at least, one binding site 
(Fig. 8.8A, Table 4). CaFADS presents a unique binding site of moderate affinity for 
C31 (N ≈ 1, Kd = 30.9 ± 2.8 μM), while shows two binding sites of high and equivalent 
affinity for C27 (N ≈ 2, Kd,av = 0.7 ± 0.07 μM), as well as favorable enthalpic and 
entropic contributions to the binding. Therefore, parameters displayed in Table 8.5 for 
C27 are average values for both binding sites. The binding sites for C27 and C31 are 
expected to be located at the FMNAT domain of the enzyme, since that is the inhibited 
activity. The interaction between C24 and the enzyme resulted more complicated. C24 
appears to bind to the protein at three sites, two of them equivalent and the third one 
independent from the other two. The two equivalents binding sites exhibit great affinity 
for C24 (Kd,av = 1.1 ± 0.1 μM) and they are expected to be located at the FMNAT 
module of CaFADS, while the third site is a low affinity binding site (Kd
a = 161 ± 20 
μM) and presumably it might be at the RFK domain, since C24 mildly inhibits this 
activity.  
Table 8.5. Thermodynamic parameters for the interaction of CaFADS with hits C24, C27 
and C31. ITC experiments were performed at 25 ºC, in PIPES 20 mM, pH 7.0, 10 mM 











Site 1 ≈ 2 1.1 ± 0.1a -8.1 ± 1.0a -4.2 ± 0.5a -3.9 ± 0.5a 
Site 2 ≈ 1 161 ± 20 -5.2 ± 0.7 18.4 ± 2.2 -23.6 ± 1.9 
C27 ≈ 2 0.7 ± 0.07a -8.4 ± 0.9a -3.1 ± 0.05a -5.3 ± 0.4a 
C31 ≈ 1 30.9 ± 2.8 -6.2 ± 0.6 -7.2 ± 0.4 1.1 ± 0.1 
a These parameters correspond to average values for the binding of two hit molecules.  
Regarding the enthalpic contributions to the binding free energy for the three 
different compounds; all of them (with the only exception of the low affinity binding 
site for C24, presumably at the RFK module) show favorable enthalpic contributions 
(Fig. 8.8B, Table 8.5). Negative binding enthalpies are related with a neat gain of 
hydrogen bonding and ion-pair interactions, which indicate a specific interaction 
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between the compound and the protein. Concerning the entropic contribution to the 
binding free energy (Fig. 8.8B, Table 8.5), it is small and favorable for C24 and C27, 
and slightly unfavorable for C31. Favorable entropic contributions, usually relate to a 
less important loss of freedom degrees by the ligand and the protein, or to a gaining of 
freedom degrees by the solvent, as a consequence of changes in the local structure of 
water surrounding both molecules [230]. 
 
Figure 8.8. Thermodynamic analysis of the binding of selected FMNAT hits to CaFADS. 
(A) Calorimetric titrations for the C24, C27 and C31 compounds. The upper panels show the 
thermograms for the interaction and the lower ones the corresponding binding isotherms 
with integrated heats. (B) Thermodynamic dissections of the interaction of CaFADS with 
each of the selected compounds. The binding Gibbs energy (ΔG), enthalpy (ΔH), and 
entropy (-TΔS) are represented in black, gray and white bars, respectively. Experiments were 
carried out at 25 ºC, in 20 mM PIPES, pH 7.0, 10 mM MgCl2 and 3% DMSO.  
VIII. Discovery of antibacterial compounds 
 247 
The predicted binding of C24 to the RFK module is driven by a hugely favorable 
entropic contribution that compensates the unfavorable binding enthalpy. That fact 
reveals that this C24 binding might not be specific, but takes places due to the 
hydrophobic nature and rigidity of this compound.  
5. Effect of the HTS hits on the RFK and FMNAT activities of 
SpnFADS 
Table 8.6. Effect of selected HTS hits on the RFK and FMNAT activities of SpnFADS. All 
the experiments were carried out at 25 ºC, in 20 mM PIPES pH 7.0, 10 mM MgCl2 at 
saturating concentrations of FMN and ATP and in the presence of 2.5% DMSO. (n=3, mean 
± SD).  
 RFK activity FMNAT activity 
HTS hit 








C1 100 ± 15 -- 0 ± 0 *** 69 ± 5  
C2  78 ± 10 >100 100 ± 12 -- 
C7 92 ± 10  >100 0 ± 0 *** 73 ± 7 
C9  0 ± 0 *** 6 ± 1 7 ± 1 *** 78 ± 6 
C10 100 ± 12  -- 0 ± 0 *** 68 ± 7 
C14 100 ± 10  -- 63 ± 7 *** >100 
C24 84 ± 9  >100 0 ± 0 *** 70 ± 6 
C25 81 ± 8  >100 0 ± 0 *** 70 ± 6 
C27 25 ± 4 *** 6 ± 1 0 ± 0 *** 51 ± 6 
C29 71± 8* >100 0 ± 0 *** 64 ± 5 
C33 26 ± 3 *** 33 ± 4 93 ± 11 >100 
C37 96 ± 10 >100 0 ± 0 *** 7 ± 1 
C38 40 ± 5 *** 88 ± 6 68 ± 7 ** >100 
C43 32 ± 3 *** 14 ± 2 100 ± 15 -- 
a Remaining activity in the presence of 100 μM of each compound. Data showing statistical significance differences 
when compared with activity in the absence of compound (***, p<0.0001; **, 0.0021>p>0.0001; *, 
0.033>p>0.0021). 
b Compounds assayed in the 0-100 μM concentration range. 
To determine whether our HTS hits were specific for CaFADS or might have effect 
on other similar bacterial FADS family members, we tested their effects on the RFK 
and FMNAT activities of the also bimodular and bifunctional SpnFADS. 16 out of 37 
HTS hits did not inhibit the activity of SpnFADS, but 11 of the 37 HTS hits inhibited 
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either the RFK or the FMNAT activities of SpnFADS (Table 8.6). However, most of 
them exhibited IC50 values in the high micromolar range (>65 μM). Only C37 for the 
FMNAT activity, and C9 and C27 for the RFK one showed IC50 values lower than 10 
μM. C37 and C9 inhibit completely the corresponding activity, but the residual activity 
for the RFK activity with C27 was too high to be considered as a good inhibitor. 
6. Effect of selected HTS hits on different bacterial cells 
Table 8.7. Minimal Inhibitory Concentration (MIC) of selected HTS hits against different 
microorganisms. FMNAT hits are shown in italics. Compounds were assayed in the 0.125-








C1 >64 >64 >64 
C2  >64  >64   >64   
C9  2 16 1-2 
C11 >64 >64 >64 
C14 0.25 8 2 
C15 32 >64 64 
C17 8 >64 >64 
C24 16-32 16-32 >64 
C27 64 >64 >64 
C29 0.125 16-32 1 
C31 32-64 >64 >64 
C32 8 >64 64 
C33 0.125 2-4 0.5 
C35 16-32 >64 64 
C37 >64 >64 >64 
C38 32 >64 16-32 
C47 2-4 8 4 
 
To determine the effect of our HTS hits on the growth of different bacteria, we 
determined their minimal inhibitory concentration (MIC) (Table 8.7). With that aim, 
bacterial cells of C. ammoniagenes, M. tuberculosis and S. pneumoniae were growth in 
the presence of increasing concentrations of the selected HTS hits. Among the 37 HTS 
hits, only 11 and 5 inhibited, respectively, the growth of C. ammoniagenes and M. 
tuberculosis. From them, only C9, C14, C29, C33, and C47 showed MIC values for C. 
ammoniagenes lower than 2 µM, while C17, C24, C32, and C35 show values between 2 
and 16 μM. (Table 8.7). Interestingly, those compounds that present better properties 
against the CaFADS FMNAT activity (C24, C27 and C31) have poor growth inhibitory 
effect on whole bacterial cells (C24 and C27 have MIC ≈ 32 and 64 µM, respectively, 
whereas the MIC of C31 was >64 µM). However, it is worth to notice the effect as 
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growth inhibitors of compounds C9, C14, C29, C33 and C47, which show in common 
their ability to inhibit considerably both CaFADS enzymatic activities (Table 8.1, Fig. 
8.8). Regarding M. tuberculosis growth, C9, C8, C24 and C29 produced mild effects on 
cell growth, but only C14 and C33 showed MIC values below 8 µM. Table 8.7 also 
summarizes the effect of some selected compounds on S. pneumoniae, indicating that 
C9, C14, C29 and C33 inhibit moderately their growth. 
 
Figure 8.8. Venn diagrams for the effects of the HTS hits on C. ammoniagenes and S. 
pneumoniae. (A) Effect of the HTS hits on the RFK and FMNAT activities of CaFADS as 
well as on the growth of C. ammoniagenes cells. (B) Effect of the HTS hits on the RFK and 
FMNAT activities of SpnFADS and on the S. pneumoniae cellular growth. The HTS hits 
including within each circle inhibit (with statistical significance) the specified activity or the 
cell growth. The hits highlighted in bold in (A) (those that completely inhibited the FMNAT 
activity without affecting the RFK one), were selected to continue the study. Hits rounded, 
both in (A) and (B), were also able to inhibit the proliferation of M. tuberculosis.  
7. Discussion 
Validation of the HTS protocol 
Here we have designed and optimized an enzymatic activity-based HTS protocol 
to discover specific inhibitors for CaFADS. In this protocol, the direct evaluation of the 
FMNAT enzymatic activity allows maximizing the specificity [194]. Our HTS protocol 
is simple, effective and consumes scant protein quantity, 1.5 ng/compound, against the 
~5 μg/compound required for some differential scanning fluorescence-based HTSs 
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[190]. Our protocol directly monitors the activity of the enzyme that we want to inhibit 
(Fig. 8.1A), therefore, the number of false positives and PAINS is minimized. In 
addition, since chemicals in the library are approved drugs, their toxicity in mammalian 
cells will be limited. The 37 HTS hits obtained in this way (3.6% of the chemical 
library) were further assayed against the RFK and FMNAT activities of CaFADS. Nine 
of the HTS hits (when assayed at 250 μM) almost completely inhibited the FMNAT 
activity without practically affecting the RFK one (Table 8.1). Since the FMNAT 
activity of the enzyme appeared as a more useful target, due to its difference in active 
site geometry regarding eukaryotic enzymes, these FMNAT hits were selected to 
continue the study. 
Inhibitors targeting the FMNAT activity of CaFADS.   
 We choose the three FMNAT hits showing the lowest IC50 and residual activity 
(C24, C27 and C31, 8% of the HTS hits) (Table 8.2) to further determine their binding 
affinities to the enzyme and inhibition mechanisms. The first one was Chicago Sky Blue 
(CSB), here C24. It is an allosteric inhibitor of the Macrophage Inhibitor Factor, and 
shows promising in vivo-effects for the treatment of spinal cord injury [231]. 
Additionally, CSB appears to act an anticancer drug through the specific inhibition of 
Rad 51, as well as a potential resource for the Alzheimer disease treatment by inhibiting 
the binding of β-amyloid to the prion protein [232, 233]. Furthermore, the inhibition of 
vesicular glutamate transporters by CSB seems to attenuate expressions of behavioral 
sensitization [234]. In our study, CSB is the most potent inhibitor of the CaFADS 
FMNAT activity as shown by its lowest values of residual activity and IC50 (Table 8.2), 
targeting both the free enzyme and an ATP-protein complex (Table 8.4, Fig. 8.5). CSB 
binds to both modules of the enzyme, being its binding to the FMNAT one highly 
favorable and enthalpically driven (Table 8.5, Fig. 8.8). This fact is positive for an 
inhibitor, since high binding enthalpy denotes lots of specific interactions, H-bounding 
and/or Van der Waals interactions, formed upon binding [195]. 
 Gossypol, here C27, was used some years ago in China as a masculine 
contraceptive [235], although its side effects stopped its pharmacological use. More 
recently, gossypol has demonstrated anticancer effects through the inhibition of 
antiapoptotic proteins that belong to the Bcl-2 family and of molecules implicated in 
tumor progression [236, 237]. Additionally, gossypol inhibits the HIV-1 replication in 
vitro [238]. Gossypol is a potent inhibitor of the CaFADS FMNAT activity that shows 
low IC50 and residual activity values (Table 8.2), while it does not affect the RFK one 
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(Table 8.1, Fig. 8.2). This compound competes with ATP for its binding at the FMNAT 
site of the protein (Table 8.4, Fig. 8.6). The lower Kd value for gossypol when compared 
with that of FMN [84], makes the inhibitor a preferred ligand for CaFADS.  
C31, or flunixin meglumine (flunixin is the bioactive part and meglumine the 
excipient), is a non-steroidal anti-inflammatory drug, analgesic and antipyretic 
extensively used in horses, pigs and cattle [239-241]. This fact guarantees that flunixin 
can be used securely in mammals. In this study, flunixin arises as a mixed inhibitor of 
the CaFADS FMNAT activity. Although flunixin is the less potent inhibitor of the three 
here characterized (Table 8.2, Fig. 8.4), its great binding thermodynamic properties, 
together with its bio-security in mammals, reveal its potentiality as a drug.  
Antimicrobial activity of the FMNAT hits 
S. pneumoniae is the causative agent of more than 25 % of all cases of community-
acquired pneumonia [112], causing more deaths than any other vaccine-preventable 
bacterial disease. On the other hand, M. tuberculosis causes tuberculosis, one of the 
most common causes of death from infectious disease (World Health Organization, 
2015). S. pneumoniae FADS (SpnFADS) shows only 29% sequence identity with 
CaFADS, but it owns the consensus sequences of prokaryotic FADSs and both proteins 
show very similar structures (Fig 8.9). The M. tuberculosis FADS (MtFADS) sequence 
shows 45% identity with CaFADS and 59% of conservative substitutions [76]. Since so 
far attempts to produce stable purified MtFADS have failed, CaFADS is considered a 
good model for the formers, as well as for other proteins of these two genera [242]. 
Thus, we tested the inhibitory activity of the best FMNAT hits on the growth of C. 
ammoniagenes, S. pneumoniae and M. tuberculosis cultures. CSB shows moderate 
effects on C. ammoniagenes and M. tuberculosis growth (Table 8.7, Fig. 8.8), although 
it does not inhibit at all the pneumococci growth. A priori, gossypol and flunixin do not 
inhibit the growth of C. ammoniagenes, S. pneumoniae and M. tuberculosis cells. This 
might be due to their inability to enter in the bacterial cell, or because efflux pumps 
eject them once in the bacterial cytoplasm. However, derivatization of these compounds 
in second generation hits, the utilization of vehiculization systems to move drugs across 
the membrane, or the use of efflux pumps inhibitors might be tools to favor their 
bactericide effects [243-245]. Among the other FMNAT hits not further characterized, 
only C15, C17 and C31 show mild inhibitory activity on the growth of C. 
ammoniagenes, not having any effect on S. pneumoniae and M. tuberculosis cultures 
(Fig 8.8). 
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Figure 8.9. Sequence and structure similarity within selected members of the bacterial 
bifunctional FADS family. (A) Sequence alignment of CaFADS (Q59263), SpnFADS 
(A0A0H2UPY5) and MtFADS (NP_217302.1) obtained using the CLUSTAL W algorithm 
(http://www.ebi.ac.uk/clustalw/) with default parameters. The consensus sequence is 
indicated. Equivalent residues at each position are shown in the same color. (B) 
Crystallographic structures of CaFADS (PDB 2x0k), with the FMNAT and RFK modules 
shown in blue and light blue respectively, and of SpnFADS (PDB 3op1), with the FMNAT 
and RFK modules shown in pink and light pink respectively, and structural alignment, 
showing an r.m.s.d. of 1.63 Å for 247 Cα atoms. Structural alignment and figures produced 
with PyMol [246]. The reaction catalyzed by each module is shown next to the 
corresponding module structure.  
Selectivity of the HTS hits 
The specificity of the HTS hits for CaFADS was also tested by determining their 
effects on the SpnFADS RFK and FMNAT activities. Thus, regarding the three 
FMNAT hits: CSB has a poor inhibitory effect on SpnFADS (Table 8.6), which might 
be of interest for a selective inhibitor; gossypol inhibits both CaFADS and SpnFADS 
activities (Tables 8.6 and 8.7), appearing as a broad inhibitor of FADS; and flunixin has 
no effect on SpnFADS (Table 8.6), indicating the specificity of this compound for 
CaFADS. Furthermore, only 30% of the HTS hits have inhibitory effects on SpnFADS, 
despite conservation of sequential and structural motives among both proteins (Fig. 
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8.9), In addition, high values for residual activities and IC50 reveal that they are worse 
inhibitors for SpnFADS than for CaFADS (Table 8.6).  
Among the HTS hits C9, C27, C37 and C43 appear as interesting inhibitors of 
SpnFADS (Table 8.6). Curiously, C27 and C43, which did not reduce the CaFADS 
RFK activity (Table 8.1), have an important effect on the SpnFADS one. C9, 
thonzonium bromide, inhibits both SpnFADS activities (Table 8.6). This compound is a 
monocationic detergent that has been commonly used in cortisporin-TC ear drops to 
help penetration of active ingredients through cellular debris. Additionally, thonzonium 
bromide has appeared as an inhibitor of the vacuolar ATPase, showing cytotoxic effects 
at concentrations higher than 10 μM [247], and a inhibitor of the RANK-L induced 
osteoclast formation [248]. C37, fluvastatin sodium salt, inhibited both CaFADS 
activities, but only affects the FMNAT one in SpnFADS. Fluvastatin inhibits the HMG-
CoA reductase being used to treat hypercholesterolemia [249]. Fluvastatin seems to 
have positive effects in myocardial fibrosis by favoring ACE2 expression, and also 
appears to inhibit modestly the replication of hepatitis C virus [250, 251]. Oxaprozine, 
here C43, is used as analgesic (inhibits anandamide hydrolase in neurons) and an anti-
inflammatory drug [252, 253] and acts as a nonselective cyclooxigenase inhibitor. 
Additionally, it inhibits NF-κβ in activated monocytes, being a promising drug for the 
treatment of rheumatoid arthritis [254].   
Recent studies [79, 99, 100, 222], as well as the presented in the chapters 6 and 
7, have revealed important differences in the catalytic cycle of bifunctional FADS, 
which might be related to dissimilarities in the conformation of the active sites during 
catalysis. That fact is consistent with the differential inhibitory activity of the HTS hits 
against CaFADS and SpnFADS, as we have observed in the present work. Such 
mechanistic variations appear to determine the capability of hits to bind and/or to 
produce inhibition. These observations highlight the potentiality of our method to find 
selective drugs targeting a specific protein of a particular microorganism, without 
affecting homologous proteins in other microorganisms. The development of such 
species-selective drugs is of great importance in the treatment of infections, in order to 
avoid undesired side-effects on the normal microbioma of the host [255], and to 
minimize the selection of resistant bacterial strains.  
Besides FMNAT hits whose inhibitory activity on CaFADS only had mild or no 
effects on bacterial cells, 5 HTS hits (C9, C14, C29, C33 and C47) appear as strongly 
inhibitors of the C. ammoniagenes growth (Table 8.6, Fig. 8.8). These 5 HTS hits also 
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inhibit the growth of S. pneumoniae (Table 8.7, Fig. 8.8), while only the first four 
mildly affect M. tuberculosis. Noticeably, these 5 HTS hits are good inhibitors of both 
CaFADS activities (Table 8.1, Fig. 8.8). C9 and C29 also appear as potent inhibitors of 
the SpnFADS RFK and/or FMNAT activities respectively. The effect of the others as 
SpnFADS inhibitors is milder, suggesting that in these cases mechanisms that do not 
involve FADS prevent cell proliferation. Considering our results collectively, the 
development of drugs targeting both activities of bifunctional FADSs appears as a 
strategy to consider in the discovery of new antibacterial drugs. In this context, the non-
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1. Quaternary organizations of bifunctional prokaryotic FAD 
synthetases  
The crystal structure of CaFADS suggested the formation of a transient oligomeric 
assembly that consists on a dimer of trimers [85, 100]. Such quaternary organization 
might approach the RFK and FMNAT active sites of neighboring protomers, facilitating 
the channeling of the FMN produced in the RFK module of a protomer to the FMNAT 
site of the contiguous one, for its transformation into FAD [85]. Besides the dimer of 
trimers, other oligomeric assemblies of lower molecular weights (dimers, trimers and 
tetramers) have been observed both in vitro and in vivo assays [100]. Additionally, it 
has been proven that the presence of different substrates and products of the RFK and 
FMNAT reactions promotes the transformation of some oligomers into others [100]. All 
these data suggested that the dimer of trimers might play an active role in the catalytic 
cycle of the CaFADS, as well as in the regulation of FMN and FAD synthesis.  
Structural analysis of the CaFADS dimer of trimers suggested that loop L3c (only 
present in FADS from Corynebacterium and Mycobacterium genera) might be key for 
the stabilization of that structure [85]. Additionally, loops L4n, L1c-FlapI and L6c 
together with helix α1c form the interface between two protomers within each trimer, 
contributing to the structure of the active sites [85]. With the purpose to clarify the 
relevance of such elements of secondary structure in the stabilization of the quaternary 
assembly, we produced point mutations at L4n (R66, which forms a salt bridge with the 
E268 that is the catalytic base of the RFK activity), L1c-FlapI (K202, E203 and F206), 
L6c (D298), and α1c (V300, E301 and L304).  
Among the mutated residues, R66 was the only one located at the N-terminus 
module (specifically at the loop L4n) [85]. Mutants of this residue (R66A and R66E) 
showed altered RFK and FMNAT activities, as well as modified affinities for the 
ligands, both at the RFK and FMNAT binding sites. Even though the substitution of 
R66 did not prevent the stabilization of oligomeric assemblies, surface and charge 
complementarities within these organizations decreased regarding the WT. Considering 
that within a monomer, R66 at the FMNAT module is far enough from the RFK active 
site to affect the activity and ligands binding to this second site, the effects observed 
upon mutation of R66 only can be explained in the context of the dimer of trimers. 
Thus, all these data revealed that the salt bridge between R66 of a monomer and E268 
of the neighboring protomer contributes to the stabilization of the trimer within the 
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dimer of trimers, validating the hypothesis of the formation of quaternary organizations. 
Nevertheless, this salt bridge is not the main determinant in the stabilization of such 
structure, where other secondary structure elements, such as loop L3c, might have a 
more relevant role.  
Mutations in L1c-FlapI (K202, E203 and F206) altered the kinetic parameters for the 
CaFADS RFK activity, as well as ligand binding parameters in the C-terminal module, 
revealing the implication of these residues in the achievement of the appropriate RFK 
catalytic geometry. F206 interacts with F62 of helix α2n, while K202 and E203 
establish salt bridges with E103 and N131, respectively, from loop L8n of the N-
terminus module of the neighboring protomer. Substitutions of these residues would 
prevent such interactions, and consequently the shape of the flavins cavity in the 
FMNAT module would change, explaining the decreased fraction of protein able to 
bind FMN and FADS at this module.  
Mutations in L6c (D298) and in the helix α1c (V300, E301 and L304) highly 
modulated kinetic parameters for both RFK and FMNAT activities, reducing as well the 
affinity for FMN and FAD. That fact revealed the implication of these residues inflavins 
binding to the FMNAT module and in the stabilization of quaternary organizations. 
Thus, L6c and the N-terminal end of helix α1c contribute to close the FMNAT flavin 
binding site of the neighboring protomer within the trimer. Mutation of D298 might 
prevent its H-bound with T165 that is critical for flavin binding and the FMN 
adenylylation, which would explain the obtained results. Similarly, substitutions of 
E301 and L304 might hinder its interaction with T127 and A132, respectively, affecting 
van der Waals contacts between α1c and L8n, within the timer. These facts would 
explain the altered parameters for flavin binding that the mutants show. V300 is 
expected to directly interact with the isoalloxazine ring in the FMNAT module of the 
adjacent protomer, therefore the altered binding constants that the variants of this 
residue showed were the expected ones. Finally, the mutations also modified flavin 
binding at the RFK module, consistently with the conformational changes in L1c-FlapI, 
L4c-FlapII, L6c and helix α1c induced by substrates binding.  
All these data revealed that despite none of the mutated residues is by itself 
determinant for the stabilization of quaternary assemblies, neither for the RFK or 
FMNAT activities of CaFADS, they modulate the oligomerization equilibrium, altering 
as well the RFK and FMNAT activities and the thermodynamic parameters for ligands 
binding, specially to the FMNAT module. Therefore, among the secondary structure 
IX. General discussion 
 259 
elements proposed as key in the formation of the dimer of trimers, the loop L3c acquires 
special relevance. This hypothesis is supported by the fact that the dimer of trimers is 
neither predicted, nor experimentally observed for SpnFADS. During The RFK and 
FMNAT catalytic cycles, and despite the fact that the monomer was the most populated 
state, SpnFADS appeared to stabilize dimers, tetramers and specially trimers. 
Nevertheless, none of these structures resembles the dimer of trimers observed for 
CaFADS. Having into account that SpnFADS presents a loop L3c that is 12 residues 
shorter than CaFADS, the results obtained for SpnFADS reinforce the supposition of 
the key role of L3c in the stabilization of the dimer of trimers.   
2. Catalytic cycles of CaFADS and SpnFADS 
CaFADS and SpnFADS only share 25% of sequence identity, although both proteins 
present the consensus sequences related to the RFK and FMNAT activities [76]. 
Despite the low sequence homology, both FADSs display great similarity in their 
overall structures. Regarding their catalytic cycle, CaFADS and SpnFADS are able to 
transform RF into FMN, and FMN into FAD but the RFK and FMNAT activities of 
these enzymes show important differences. Thus, the RFK activity of SpnFADS is not 
inhibited at high concentrations of the RF substrate (as that of CaFADS is), and their 
FMNAT activity only takes place under strong reducing conditions. 
During the FMNAT catalytic cycle of SpnFADS, and contrary to that observed for 
CaFADS, FMN only is transformed into FAD when it is in the reduced form. The 
reduced isoalloxazine ring seems to be an absolute requirement for flavins binding to 
the FMNAT module of the enzyme, and for its subsequent transformation. This could 
be due to the FMNAT active site of SpnFADS only allows the incorporation of the 
isoalloxazine ring in their reduced bended conformation. Such difference might be a 
consequence of important changes in regions involved in ligands binding, for instance 
in loops L4n and L6n, which form the external part where substrates and products of the 
FMNAT activity bind. Additionally, the flavin cavity at the FMNAT module of 
SpnFADS is slightly broader and deeper than that of CaFADS, which might influence 
the way in which flavins bind to this cavity.  
The RFK catalytic cycle of CaFADS and SpnFADS also presents important 
differences, being the most obvious one the lack of inhibition by excess of the RF 
substrate that SpnFADS shows. Thus, the CaFADS RFK activity is noticeably inhibited 
at RF concentrations higher than 5 μM. A more detailed study revealed that besides 
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the RF inhibition, the products of the reaction (FMN and ADP) also affected the RFK 
activity of CaFADS. ADP acts as a competitive inhibitor, while FMN performs a 
uncompetitive inhibition mechanism, yielding a CaFADS:ATP:FMN dead-end 
complex. Nevertheless, inhibition constants for RF and FMN are considerably lower 
than that for ADP, which makes both flavins more potent inhibitors than ADP and also 
explains the fact that inhibition by ADP stayed unnoticed up today. A similar analysis 
of the RFK activity of SpnFADS revealed that, although the RF substrate does not 
produce any inhibitory effect, the FMN and ADP products do. The inhibitory 
mechanism carry out by these products differs from those observed for CaFADS, and in 
this case both FMN and ADP are uncompetitive inhibitors, being FMN more potent as 
inhibitor than ADP. Nevertheless, the Ki
FMN/ Km
RF ratio is approximately 5 times higher 
for SpnFADS than for CaFADS, which explains the apparent lack of inhibition of the 
SpnFADS RFK activity.  
Rapid mixing stopped flow experiments allowed inferring some evidences of the 
RFK catalytic cycle for both enzymes. Both proteins are not able to either bind or 
internalize FLV ligands in the absence of ANP ligands, but ATP and ADP promote 
flavins binding and/or its internalization through a conformational change in loop L4c 
that closes the flavin binding cavity [99]. Nonetheless, the rates at which the ANP-FLV 
mixtures bind the FADSs differ between these proteins, being the ATP-RF substrate 
binding the fastest and the slowest process for SpnFADS and CaFADS, respectively. As 
a consequence of that, as the RFK reaction draws on and the products start to 
accumulate, they would bind the CaFADS preferably, producing kinetic inhibition. In 
the case of SpnFADS, although products accumulate the ATP-RF binding would be the 
most favored process. When mixing ATP-RF with FADSs, an ATP-induced 
conformational change is observed for both proteins (characterized by kobs2), although 
the behavior of kobs2 on RF concentration differs. Thus, during the CaFADS RFK 
reaction, increasing RF concentration inhibits such conformational change, while this 
inhibition is not observed for SpnFADS. These differences might be explained 
considering the conformational rearrangement of the PTAN motif required to reach the 
catalytically competent conformation by CaFADS but not by SpnFADS. Hence, we can 
conclude that although the steps occurring during the RFK reactions of CaFADS and 
SpnFADS are similar, their rates differ being the final consequence the lesser kinetic 
inhibition level that SpnFADS shows.  
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Regarding the thermodynamic data of the interactions of both proteins with all the 
substrates and products of the RFK reaction, some aspects need to be pointed. 
SpnFADS can reach the “pseudoreactive” ternary complex with RF and ATP through 
two paths, while just one path leads to the CaFADS:RF:ATP ternary complex. The 
interaction diagram also suggest that the substrates bind the protein in different order, 
since RF cannot bind to the preformed CaFADS:ATP binary complex. Thus, CaFADS 
seems to reach the catalytically competent complex through the concerted fit of the 
substrates, while SpnFADS apparently follows a random sequential binding of its 
substrates. Another important difference is the relative stability of the FADS:ANP:FLV 
ternary complexes. CaFADS establishes a highly stable ternary complex with FMN and 
ATP, and also all the CaFADS:ANP:FLV ternary complexes are more favored than 
CaFADS:ATP:RF. For its part, the SpnFADS:RF:ATP together with the 
SpnFADS:RF:ADP are the most stable complexes. All these observations explain from 
the thermodynamic point of view, the more potent inhibition profiles observed for 
CaFADS. Additionally, for CaFADS the substrates of the RFK reaction present 
different cooperation tendency depending on the RF concentration. Thus, RF and ATP 
show high positive cooperation at low RF concentrations, while their cooperation is 
negative at high concentrations of this flavin. This fact, which is not observed for 
SpnFADS, might explain the inhibition by the RF substrates that CaFADS presents and 
SpnFADS does not.  
All these regulatory differences between both proteins might be due to dissimilar 
strategies to regulate FMN and FAD synthesis to keep the flavoproteome homeostasis. 
So, considering the huge amount of processes in which FMN and FAD are involved, 
acting as cofactors of flavoproteins, regulation of the synthesis of these flavins appears 
as a highly important process. Since the FMNAT activity of CaFADS does not appear 
to present any type of regulation, its RFK activity requires a more carefully control than 
SpnFADS, whose FMNAT activity needs strong reducing conditions.  
3. Discovery of antibacterial drugs targeting bifunctional FADSs  
The apparition during the last decades of resistant bacterial strains [11], together with 
the fact that effective antibiotics have not been developed since the 90s [256], reveal the 
need to explore new effective antibacterial targets, as well as drugs against them. 
Among the possible new targets, bifunctional FADSs appear as attractive candidates for 
different reasons. i) They are essential proteins and their inhibition prevent from the 
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beginning all the routes in which FMN and FAD are involved [153, 154]. ii) 
Bifunctional FADSs, and especially the FMNAT module, differ from the eukaryotic 
proteins that synthetize FMN and FAD [81, 90, 155, 229], thus, drugs targeting these 
proteins are more likely to not affect the human proteins. iii) There are available several 
crystallographic structures of FADSs, which facilitates the design of inhibitory assays 
and the improvement of the drugs [74, 75, 86]. Therefore, taking all these facts into 
consideration, we decide to explode the potentiality of FADSs as drug targets, searching 
inhibitors of such proteins using as model the member of the family best characterized, 
that is CaFADS [76, 84, 85, 87, 89, 95, 99]. 
Using an activity-based HTS against CaFADS, we identified 37 compounds with 
potential inhibitory effect on the RFK or FMNAT activities. Among these HTS hits, 9 
inhibited the FMNAT activity (FMNAT hits), having no effect on the RFK one. Since 
hits that only altered the FMNAT activity were more likely to not inhibit the 
corresponding human enzymes (the RFK module of bacterial FADSs and mammal 
RFKs highly differ) [74, 85, 155], we continue the study characterizing the three most 
potent hits among the 9 FMNAT ones. We determined the inhibition mechanism 
performed by each hit, as also the thermodynamic parameters that lead their interaction 
with CaFADS. Among these three compounds, namely Chicago Sky Blue, Gossypol 
and Flunixin meglumine, the last one appeared as a promising inhibitor. Despite 
Flunixin meglumine is the least potent inhibitor, it stands out as potential drug due to its 
great thermodynamic binding properties and the fact that its biosecurity in mammals has 
been proven before. 
The specificity of the HTS hits was tested on SpnFADS. In general the HTS hits are 
less potent inhibitors of the SpnFADS activities than of CaFADS, highlighting the 
ability of our method to find specie-specific inhibitors.  
When we checked the ability of the HTS hits to inhibit the growth of C. 
ammoniagenes, M. tuberculosis and S. pneumoniae cells, we found that just a few 
compounds have inhibitory effect at the cellular level. That might be due to their 
inability to enter in the bacterial cell, or because efflux pumps eject them once in the 
bacterial cytoplasm. However, derivatization of these compounds in second generation 
hits, the utilization of vehiculization systems to move drugs across the membrane, or the 
use of efflux pumps inhibitors might be tools to favor their bactericide effects [243-
245]. Noticeably, those hits that inhibited both the RFK and the FMNAT activities of 
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CaFADS and SpnFADS were the most effective inhibiting the bacterial growth, which 










1. The FADS from C. ammoniagenes 
 In CaFADS the residue R66, located at the FMNAT module of the protein, 
modulates the RFK activity of the C-terminal module.  
  R66 stabilizes the substrates of the RFK reaction, RF and ATP, during catalysis.  
 The salt bridge that R66 establishes with E268 of a contiguous protomer 
contributes to the stabilization of the trimer within the CaFADS dimer of trimers, 
reinforcing the theory of the formation of transient quaternary organizations during 
both RFK and FMNAT activities of the enzyme  
 The R66-E268 salt-bridge is not the only and main determinant in the stabilization 
of CaFADS quaternary organization. 
 R66 does not play any key role in the FMNAT activity, and only has a minor 
contribution to substrates/products location in this active site.  
 Residues K202, E203 and F206 in loop L1c-FlapI, D298 in L6c and V300, E301 
and L304 in helix α1c of the CaFADS RFK module are not unique determinants in 
the formation of quaternary assemblies, but modulate the oligomerization profiles. 
 K202, E203, F206, D298, V300, E301 and L304 modulate binding and kinetic 
parameters of the RFK and FMNAT activities.  
 The conformation of the secondary structural elements containing these residues is 
modulated by their nature. Therefore, the nature of these residues also modulates 
the packing architecture within the quaternary assemblies, as well as ligand binding 
and kinetic parameters.  
 The RFK activity of CaFADS, is inhibited by the RF substrate, as well as by both 
products (FMN and ADP) of the RFK reaction. ADP acts as a competitive 
inhibitor, being its inhibition constant 17.0 μM, while FMN is an uncompetitive 
inhibitor with an inhibition constant of 1.4 μM. Having into account that the Km 
values for the RF and ATP substrates are 10.4 and 60.3 μM, respectively, both 
products of the reaction are very potent inhibitors.  
 During the RFK catalytic cycle, the collective binding of adenine and flavin 
nucleotides induces important conformational changes in the RFK module.  
 The RFK catalytic cycle of CaFADS requires Mg2+ and the concerted fit of the 
substrates to achieve a catalytically competent geometry.  
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 All possible combinations of adenine and flavin nucleotides produce inhibition of 
the RFK activity. The binding of substrates of the RFK reaction is the slowest 
process, as well as the least favored one from a thermodynamic approach. Thus, All 
possible RFK:ANP:FLV ternary complexes compete kinetically and 
thermodynamically with the catalytically competent one (with RF and ATP).  
 The careful regulation of the RFK activity of CaFADS might have a relevant role at 
the physiological level for the production of flavins according to C. ammoniagenes 
cellular needs.  
2. The FADS from S. pneumoniae 
 SpnFADS is a prokaryotic bifunctional FADS that folds in two modules, the C-
terminal module has RFK activity, and the N-terminal one FMNAT and FADpp 
activities.  
 Both the RFK and FMNAT activities show Michaelis-like kinetic profiles. The kcat, 
Km
RF, and Km
ATP for the RFK activity are 18.7 min-1, 0.9 μM and 54.0 μM, 
respectively. For the FMNAT activity the kcat, Km
FMN, and Km
ATP are 34.9 min-1, 9.8 
μM and 31.6 μM, respectively. 
 SpnFADS shows three main behavioral differences regarding CaFADS: 
o The SpnFADS FMNAT module only binds and transforms flavins in their 
reduced state.  
o The SpnFADS RFK activity does not show inhibition by the RF substrate. 
o Only dimers and trimers are stabilized during catalysis. 
 The RFK activity of SpnFADS is inhibited by both products of the RFK reaction 
(FMN and ADP). FMN and ADP are mixed inhibitors, being Ki
FMN and K’i
FMN 1.3 
and 7.1 μM, respectively; and Ki
ADP and K’i
ADP 131 and 844 μM, respectively. Thus, 
the inhibition by ADP suffered by SpnFADS is weaker than that experimented by 
CaFADS.  
 During the SpnFADS RFK catalytic cycle, RF and ATP get allocated within the 
active site through a random sequential binding. 
 Although all the SpnFADS:ANP:FLV  complexes can be formed in complex 
mixtures of substrates and products of the RFK reaction, the binding of RF and 
ATP substrates is the fastest and thermodynamically the most favored process. That 




 Using reduced flavin as substrates, substrate inhibition, or the formation of 
oligomeric assemblies reflect different regulation mechanisms used by prokaryotic 
FADSs. 
 Dissimilar behaviors among prokaryotic FADS family members provide with a 
framework to design species-selective compounds targeting bacterial FADSs. 
3. Discovery of antibacterial compounds targeting prokaryotic 
FADS 
 We have optimized a HTS protocol that can be used for the discovery of new 
antibacterial drugs, targeting RFK and/or FMNAT activities of bifunctional 
prokaryotic FADSs. The method is quick, effective and requires a small quantity of 
protein, additionally minimizes the number of PAINS. 
 Among the 1240 compounds contained in the library, 37 inhibited CaFADS, and 
three were selected as good inhibitors of its FMNAT activity. 
 Two of the three selected compounds were not species-selective, since they also 
affected SpnFADS, but the third one, C31, was selective for CaFADS. Therefore, 
we can identify promising compounds at the non-selective or selective enzyme 
inhibitors level. 
 The three selected compounds do not produce observable antimicrobial effects, 
probably due to a poor uptake, efficient efflux, or a fast degradation by other 
bacterial enzymes. 
 The HTS hits with the best antimicrobial properties against the different bacteria 
analyzed were those that inhibited both the RFK and FMNAT activities.  









1. La FADS de C. ammoniagenes 
 El residuo R66, situado en el módulo N-terminal de CaFADS, tiene un papel 
fundamental en la modulación de la actividad RFK del módulo C-terminal. 
 Durante la catálisis, R66 estabiliza los substratos RF y ATP. 
 El puente salino formado entre R66 y E268 contribuye a la estabilización del 
trímero en el dímero de trímeros descrito para CaFADS, reforzando la teoría de la 
formación transitoria de estructuras cuaternarias durante las sus actividades RFK y 
FMNAT.  
 El puente salino entre R66 y E268 no es el determinante más relevante en la 
estabilización de los ensamblados cuaternarios de CaFADS. 
 El residuo R66 no juega ningún papel relevante en la actividad FMNAT y sólo 
contribuye ligeramente a la colocación de sustratos y productos en el sitio activo. 
 Aunque los residuos del módulo RFK de CaFADS K202, E203 y F206 del bucle 
L1c-FlapI, D298 en L6c y V300, E301 y L304 de la hélice α1c no determinan por 
sí solos la capacidad de la enzima para formar agregados cuaternarios, modulan los 
perfiles de oligomerización. 
 K202, E203, F206, D298, V300, E301 y L304 modulan los parámetros cinéticos y 
de unión de las actividades RFK y FMNAT de CaFADS. 
  La conformación de los elementos de estructura secundaria que contiene estos 
residuos depende de la naturaleza de sus cadenas laterales. Por tanto, su naturaleza 
determina la arquitectura de las estructuras cuaternarias, así como los parámetros 
cinéticos y de unión.  
 La actividad RFK de CaFADS resulta inhibida tanto por el substrato RF como por 
ambos productos de la reacción (FMN y ADP) . El ADP actúa como un inhibidor 
competitivo, siendo su constante de inhibición 17.0 μM. Por su parte, el FMN es un 
inhibidor acompetitivo, y con una constante de inhibición de 1.4 μM. Teniendo en 
cuenta que los valores de Km para RF y ATP son de 10.4 y 60.3 μM, 
respectivamente, los dos productos de la reacción son inhibidores muy potentes.  
 
 Durante el ciclo catalítico de la actividad RFK, la unión conjunta de nucleótidos de 
flavina y adenina induce importantes cambios conformacionales en este módulo. 
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 Para alcanzar una geometría catalíticamente competente durante el ciclo catalítico 
de la actividad RFK de CaFADS, es necesaria la intervención del cation Mg2+ y la 
unión concertada de los sustratos. 
 Todas las combinaciones posibles de nucleótidos de adenina y flavin producen la 
inhibición de la actividad RFK. La unión de los sustratos es el proceso más lento 
tanto desde el punto de vista cinético como desde el termodinámico. Por tanto, 
todos los complejos ternarios RFK:ANP:FLV compiten cinética y 
termodinámicamente con el catalíticamente competente (con RF y ATP) 
 La intrincada regulación de la actividad RFK de CaFADS podría tener un papel 
relevante para laproducción de flavinas de acuerdo a las necesidades celulares de C. 
ammoniagenes. 
2. La FADS de S. pneumoniae 
 SpnFADS es una enzima procariota bifuncional que se pliega en dos módulos: el C-
terminal cataliza la actividad RFK y el N-terminal  las actividades FMNAT y 
FADpp. 
 Tanto la actividad RFK como la actividad FMNAT de SpnFADS presentan perfiles 
cinéticos que siguen el modelo de Michaelis. Los valores de kcat, Km
RF, y Km
ATP son 
18.7 min-1, 0.9 μM y 54.0 μM, respectivamente, para la actividad RFK. Para la 
actividad FMNAT, los valores de kcat, Km
FMN, y Km
ATP son 34.9 min-1, 9.8 μM y 
31.6 μM, respectivamente.  
 SpnFADS presenta tres diferencias fundamentales respecto a CaFADS 
o El módulo FMNAT de SpnFADS únicamente une y transforma flavinas en su 
estado reducido. 
o La actividad RFK de SpnFADS no presenta inhibición por el sustrato RF. 
o SpnFADS sólo estabiliza dímeros durante ambos ciclos catalíticos. 
 La actividad RFK de SpnFADS es inhibida por ambos productos de la reacción 
(FMN y ADP). Ambos actúan como inhibidores mixtos, siendo los valores de 
Ki
FMN y K’i
FMN de 1.3 y 7.1 μM, respectivamente; y los de Ki
ADP y K’i
ADP 131 y 844 
μM, respectivamente. 
 Durante el ciclo catalítico de la actividad RFK de SpnFADS, RF y ATP ocupan el 
sitio activo de la enzima siguiendo un mecanismo secuencial aleatorio. 
 Aunque todos los posibles complejos SpnFADS:ANP:FLV pueden formarse en 
mezclas complejas de SpnFADS con los sustratos y los productos de la actividad 
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RFK, la unión de los productos, RF y ATP, es el proceso más rápido y 
termodinámicamente más favorable. Este hecho explica el menor nivel de 
regulación a través de la inhibición que presenta SpnFADS en comparación con 
CaFADS.  
 La necesidad de flavinas oxidadas o reducidas, la presencia o ausencia de 
inhibición por sustrato y las estabilización de diferentes especies oligoméricas 
durante las actividades RFK y FMNAT, ponen de manifiesto diferentes estrategias 
de regulación para la producción de los cofactores flavínicos utilizadas por distintas 
FADSs procariotas. 
 Los distintos comportamientos observados entre miembros de la familia de las 
FADSs bifuncionales proporcionan una herramienta útil para el desarrollo de 
nuevos compuestos antimicrobianos dirigidos contra estas dianas de forma que sean 
especie-selectivos.  
3. Desarrollo de nuevos compuestos antibacterianos 
 Se ha optimizado un protocolo de cribado de alto rendimiento (HTS) que puede ser 
utilizado para identificar fármacos utilizando como dianas las actividades RFK y/o 
FMNAT de FADSs bacterianas. El método es rápido, efectivo y consume muy poca 
cantidad de proteína. Además, minimiza el número de compuestos de interferencia 
(PAINS) detectado.  
 De entre los 1240 compuestos que componen la librería de compuestos ensayada, 
37 inhiben alguna de las actividades de CaFADS. De estos 37 compuestos, tres son 
buenos inhibidores selectivos de actividad FMNAT.  
 Dos de los tres compuestos seleccionados, dos no son selectivos de especie, dado 
que también inhiben SpnFADS. El tercero, C31, es selectivo para CaFADS. Por 
tanto nuestro método ha permitido identificar  prometedores inhibidores de la 
enzima que sean o bien selectivos o no selectivos.  
 Estos tres compuestos no presentan efectos antibacterianos, lo que puede deberse a 
una internalización deficiente, a que las bacterias expulsan el compuesto mediante 
bombas de eflujo, o a que los compuestos son degradados por la acción de otras 
enzimas bacterianas.  
 Los compuestos identificados en el cribado con mejores propiedades 
antibacterianas son aquellos que inhibenn tanto la actividad RFK como la FMNAT. 
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 Las FADSs bacterianas son prometedoras dianas terapéuticas para la identificación 
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α Cooperativity constant 
Ǻ Angstrom 
Abs Absorbance 
ADP Adenosine 5´-diphosphate 
AMP Adenosine 5’-monophosphate 
ANP Adenine nucleotide (denotes for either ADP or ATP) 
appkcat Apparent catalytic constant 
BCG Bacillus Calmette –Guérin 
BSA Bovine Serum Albumin 
BS3 bis(sulfosuccinimidyl)suberate 
CaFADS FAD synthetase from Corynebacterium ammoniagenes 
cal Calorie 
CD Circular Dichroism 
CPK Corey, Pauling, Koltun, colors code for atoms 
CSB Chicago Sky Blue 
CTP Cytosine 5’-triphosphate 
 Increment / deletion 
DEAE Diethylaminoethyl 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
O.D. Optical density 
DTT Dithiothreitol 
 Molar extinction coefficient  
EC Enzyme commission 
EDTA Ethylenediaminetetraacetic acid 
EMA European Medicines Agency 
Eox/sq Redox potential for the oxidized and the semiquinone species 
Eqn Equation 
Esq/hq Redox potential for the semiquinone and the reduced species 
et. al. Et alia (and collaborators) 
FAD Flavin adenine dinucleotide 
FADasa FAD hydrolase 
FADpp FAD pyrophosphorilase 
FADS FAD Synthetase 
FDA Food and Drug Administration 
FHy FMN hydrolase 
Fig Figure 
FLV Flavins (denotes for either RF or FMN) 
FMN Flavin mononucleotide / Riboflavin 5’-monophosphate 
FMNAT FMN adenylyltransferase 
FPLC Fast Protein Liquid Chromatography 
G Gibbs free energy  
GST Glutathione transferase 
GTP Guanosin 5’-triphosphate 
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H Enthalpy 
HPLC High Performance Liquid Chromatography 
HsRFK Riboflavin kinase from Homo sapiens 
HSS High Strength Silica 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
ITC Isothermal Titration Calorimetry 
Ka Association constant  
Ka 
app, ANP Apparent association constant for ANP ligands 
Kd Dissociation constant  
kDa kDalton 
Km Michaelis-Menten constant 
kcat Catalytic constant  
Ki Inhibition constant  
 Wavelength 
LB Lysogeny-Broth 
Lm1FADS Type I-FAD synthetase from Listeria monocytogenes 
Lm2FADS Type II-FAD synthetase from Listeria monocytogenes 
Mt Mycobacterium tuberculosis 
MtFADS FAD synthetase from Mycobacterium tuberculosis 
MRE Molar residue ellipticity 
MW Molecular weight 
N Stoichiometry for an interaction 
N-PAGE Native-Polyacrylamide gel electrophoresis 
O.N Over night 
PAIN Pan-assay Interference Compound 
PDB Protein Data Bank 
pH Potential of Hydrogen  
PIPES 1,4-Piperazine diethane sulfonic acid 
PMSF Phenylmethylsulfonyl Fluoride 
PPi Pyrophosphate 
RF Riboflavin 
RFK Riboflavin kinase 
r.m.s.d.  Root Mean Square Deviation 
r.p.m Revolutions per minute 
S Entropy 
SB Sample buffer 
SDS Sodium Dodecyl Sulphate 
SDS-PAGE Denaturing electrophoresis with SDS  
SpnFADS FAD Synthetase from Streptococcus pneumoniae 
SpRFK Riboflavin kinase from Schizosaccharomyces pombe 
TB Tuberculosis 
 Ellipticity  
[]mr Molar ellipticity per residue 
TLC Thin Layer Chromatography 
Tm Melting Temperature 




Vmax Maximum reaction velocity 
Abbreviations 
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WT Wild Type 
  
 
Name of the mutants: the mutants were named as R1nR2, where R1 is the residue of the 
WT protein, n is the position of the substituted residue in the protein sequence, and R2 is 
the residue that replace R1 in the mutant protein.  
